date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2017-12-18 13:01:32.100,679.85,686.8,677.0,685.25,2196746.0,"Orchid Pharma locked at 5% upper circuit as Aurobindo, Dr Reddy's in race to buy Co","According to the media report, Aurobindo Pharma and Dr Reddy's Laboratories are the frontrunners to buy out Orchid Pharma.",neutral,neutral,0.7942928587188317,neutral,-0.0363372093023255,neutral
2017-12-19 13:00:20.002,688.0,694.75,681.4,687.75,1712732.0,Orchid Pharma shares go up 5% on rumours about prospective buyers,"There were reports that Aurobindo Pharma and Dr Reddy's, are looking at buying the company, which is under Corporate Insolvency Resolution Process",positive,neutral,-0.0363372093023255,neutral,-0.5595930232558172,neutral
2017-12-19 18:01:51.970,688.0,694.75,681.4,687.75,1712732.0,"Market Now: Piramal Enterprises, Aurobindo Pharma hold Nifty Pharma index up","The Nifty Pharma index was trading 0.53 per cent up at 9,279 around 02:35 pm (IST).",neutral,positive,-0.0363372093023255,neutral,-0.5595930232558172,neutral
2017-12-27 13:02:04.666,698.65,700.9,680.55,684.0,2918884.0,"Buy Aurobindo Pharma, Voltas; JSPL may test Rs 240-250: Ashwani Gujral","Ashwani Gujral of ashwanigujral.com advises buying Aurobindo Pharma, Voltas and Sun Pharmaceutical Advanced Research Company.",neutral,neutral,-2.0969011665354578,negative,-0.3047895500725722,neutral
2017-12-27 18:00:56.679,698.65,700.9,680.55,684.0,2918884.0,Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection,"The approved ANDA is a bioequivalent and therapeutically equivalent to the reference listed drug product Arixtra Injection of Mylan Ireland, said Aurobindo Pharma.",neutral,positive,-2.0969011665354578,negative,-0.3047895500725722,neutral
2018-01-09 13:00:38.400,673.4,679.15,669.7,672.5,1010727.0,Aurobindo Pharma to diversify product portfolio to propel future growth,Aurobindo Pharma is strengthening its product pipeline and plans to have a diversified portfolio which will drive growth in the coming years,positive,positive,-0.1336501336501303,neutral,0.7313432835820861,neutral
2018-01-11 18:01:09.877,675.0,679.0,665.5,667.9,1480622.0,"Weak US sales, INR appreciation to drag earnings; Dr Reddy, Cadila top pick: Edelweiss","The USFDA granted 246 nods in Q3FY18, which is the highest-ever approvals in a single quarter. Cadila Healthcare received 23 and Aurobindo Pharma got 18 approvals.",positive,positive,-1.0518518518518551,negative,-1.2046389824167534,negative
2018-01-21 13:01:31.879,639.0,644.15,636.5,642.0,1231006.0,Pharma weekly wrap: Pharma stocks extend losses ahead of Q3 results,"Most stocks including Sun Pharma (-2.24 percent), Cipla (-1.79 percent), Aurobindo Pharma (-3.98 percent) and Cadila Healthcare (-2.1 percent) saw declines",negative,negative,0.4694835680751174,neutral,1.9106293379084456,positive
2018-02-07 13:00:17.827,615.75,620.0,600.0,601.55,4406249.0,"Aurobindo Pharma may post 18% growth in Q3 profit, US business seen up 12%",Europe and Rest of World sales are likely to grow 15-18 percent YoY while API business is likely to be flat.,positive,positive,-2.306130734876175,negative,-0.5329949238578642,neutral
2018-02-08 18:00:34.951,591.0,596.75,580.1,587.85,4993108.0,"Aurobindo Pharma Q3 profit up about 3%, misses estimates","Aurobindo Pharma , India’s third largest drugmaker, reports about 3% rise in profit at Rs595 crore ($92.6 million) in the third quarter ended 31 December",negative,positive,-0.5329949238578642,neutral,2.1715343826277405,positive
2018-02-09 13:00:18.051,591.0,596.75,580.1,587.85,4993108.0,Healthy outlook: Aurobindo Pharma posts Rs 5.95 billion net profit in Q3,"Aurobindo Pharma's reported profit after tax at Rs 5.95 billion for the December quarter (Q3), up a mere three per cent year-on-year, may have disappointed the street as the stock fell 2.4 per cent to Rs 602 on Thursday, but a look at the core",neutral,negative,-0.5329949238578642,neutral,2.1715343826277405,positive
2018-02-18 18:02:13.179,590.0,595.1,571.1,583.35,1717158.0,Aurobindo Pharma in poor health,Make use of declines to accumulate the stock while maintaining a stop-loss at ₹515,negative,neutral,-1.1271186440677927,negative,-1.7123287671232876,negative
2018-02-21 13:01:37.181,565.05,596.35,561.0,588.75,6740229.0,Aurobindo Pharma eyes European business of Apotex,"The deal may be valued at around $100 million and fits in with Aurobindos strategic road map of upping its presence in eastern Europe through bolt-on acquisitions, two sources told ET.",neutral,positive,4.194319086806486,positive,2.283531409168089,positive
2018-02-22 13:00:27.670,589.0,611.95,588.05,602.45,5795217.0,"Bajaj Finserv, Grasim and Titan to be part of Nifty 50 index from April 2","The three companies were being added as a substitute for Ambuja Cements, Aurobindo Pharma and Bosch; PNB has been excluded from the Nifty Mid-cap index",neutral,neutral,2.283531409168089,positive,2.0103007144043903,positive
2018-02-22 13:00:41.302,589.0,611.95,588.05,602.45,5795217.0,"Titan, Bajaj Finserv, Grasim up 1% on Nifty rejig","shares of Ambuja Cements, Aurobindo Pharma and Bosch slipped 1-2.5 percent as they were excluded from the Nifty 50 index.",positive,negative,2.283531409168089,positive,2.0103007144043903,positive
2018-05-09 23:00:36.990,602.0,612.45,588.05,595.15,1521423.0,Aurobindo Pharma LLC recalls over 1.5 million injections from US over 'lack of assurance of sterility',"According to a notification put up by the US Food and Drug Administration on its website, the recallshave beeninitiated by the firm under 'Class-II' classification.",negative,neutral,-1.1378737541528277,negative,2.256711409395981,positive
2018-05-11 13:00:46.603,596.0,616.5,584.8,609.45,2121708.0,Fosun Pharma Is Said to Vie for $2 Billion Novartis Portfolio,Indian drugmaker Aurobindo Pharma Ltd. has also been picked to make final offer.,neutral,positive,2.256711409395981,positive,1.4179104477611864,positive
2018-05-13 18:01:09.559,603.0,621.0,603.0,611.55,1478573.0,Aurobindo Pharma's arm recalls 2 antibiotic injections from US,"According to a letter issued to the USFDA, the recall of Ampicillin and Sulbactam has been initiated due to customer complaints of the presence of red particulate matter in the product.",neutral,negative,1.4179104477611864,positive,-1.0983606557377124,negative
2018-05-28 23:01:24.630,582.6,593.35,567.95,578.1,6489066.0,Aurobindo Pharma Q4 net profit falls marginally to Rs 528.8 crore,"Revenue from operations rose 11.2% to Rs 4,049.1 crore, compared to Rs 3,641.63 in the year ago period.",positive,positive,-0.772399588053553,neutral,-1.9965277777777777,negative
2018-05-29 13:00:24.213,576.0,583.0,562.0,564.5,3450543.0,Aurobindo Pharma tumbles 7% on muted Q4,"For 2017-18, the company posted a net profit of Rs 2,423.2 crore, up 5.3 per cent, from Rs 2,301.7 crore in 2016-17.",negative,positive,-1.9965277777777777,negative,-2.271526677231903,negative
2018-05-29 18:02:50.424,576.0,583.0,562.0,564.5,3450543.0,Aurobindo Pharma shares down 4.5% after Q4 results,"Aurobindo Pharma stock dropped 4.23%  to end at Rs579.50 on BSE. During the day, it tumbled 7.45% to Rs560. On NSE, shares of the company plunged 4.50% to close at Rs578",negative,negative,-1.9965277777777777,negative,-2.271526677231903,negative
2018-05-30 10:01:45.612,576.0,583.0,562.0,564.5,3450543.0,Strong growth outlook for Aurobindo Pharma after Q4 slip,"Large US portfolio, lower price erosion expected to drive earnings",neutral,positive,-1.9965277777777777,negative,-2.271526677231903,negative
2018-06-01 10:00:27.306,556.2,564.95,530.5,535.5,3282234.0,"Hold  Aurobindo Pharma, target Rs  650:   ICICI Direct",Hold  Aurobindo Pharma Ltd.  at a price target of Rs  650.0    .,neutral,positive,-3.721682847896448,negative,-0.501858736059488,neutral
2018-06-08 13:00:41.179,545.0,577.8,543.0,571.0,3970185.0,Aurobindo Pharma gets USFDA nod for heartburn drug,"Aurobindo Pharma has received final approval from the US health regulator to manufacture Omeprazole delayed-release tablets, used in the treatment of frequent heartburn. The approved product is a gene",neutral,positive,4.770642201834862,positive,0.2434782608695612,neutral
2018-06-12 13:02:00.940,595.55,606.5,582.6,584.55,3207550.0,Nifty Pharma index up for fifth straight day; Sun Pharma rises 14% on week,"Marksans Pharma, Alembic Pharma, Caplin Point Lab, Ajanta Pharma, Bliss GVS Pharma, Granules India, Aurobindo Pharma and Wockhardt were up in the range of 10% to 30% in past one week.",positive,positive,-1.8470321551507007,negative,5.533562822719445,positive
2018-06-18 10:00:33.818,614.0,618.55,603.2,613.9,2305186.0,Stock market prediction for June 18-22: Satish Gupta,"Lupin, Ajanta Pharma, Alembic Pharma, Glenmark Pharma, Aurobindo Pharma and Sun Pharmaceutical Industries will get astrological support, says Satish Gupta of astrostocktips.",neutral,positive,-0.0162866449511437,neutral,-0.629342051491626,neutral
2018-06-22 23:01:32.847,609.4,614.5,596.3,610.2,2533636.0,Aurobindo lines up over 30 products for US market,"Aurobindo Pharma Ltd has lined up around 30-40 products for launch in the US market in the present financial year and the next. Out of this pipeline, at least 10 products have already been approved, a",neutral,positive,0.1312766655727056,neutral,-0.6709212894779942,neutral
2018-06-26 13:00:15.105,611.9,619.5,601.1,613.95,3257283.0,Aurobindo Pharma rises 2% on USFDA nod,"EBITDA margin was below expectation, the brokerage said in its June 4 report.",positive,negative,0.3350220624285125,neutral,-2.249472145525422,negative
2018-07-02 13:02:17.342,604.0,629.75,602.0,628.75,4521073.0,Aurobindo Pharma gets approval to manufacture pain reliever Ibuprofen,"""The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Ibuprofen capsules OTC, 200 mg,"" Pharma said.",positive,positive,4.097682119205298,positive,-0.4769475357710651,neutral
2018-07-10 23:01:09.244,618.0,622.05,606.0,606.95,1286830.0,Aurobindo pharma likely to clinch Mallinckrodt deal for $800 mn this July,Street is cautious as Mallinckrodt biz is declining amid enhanced scrutiny on opioid drugs,positive,negative,-1.7880258899676302,negative,-0.9460892260011344,negative
2018-07-11 13:01:17.567,613.05,617.0,604.2,607.25,1377476.0,Aurobindo Pharma gets USFDA nod for Azithromycin tablets,Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture Azithromycin tablets. Azithromycin tablets are an AB-rated generic equivalent of Pfiz,neutral,positive,-0.9460892260011344,negative,-1.21430915654742,negative
2018-07-11 18:00:44.075,613.05,617.0,604.2,607.25,1377476.0,Aurobindo Pharma gets USFDA nod for infection treatment drug,"The approval has been granted in the strengths of 250 mg and 500 mg, and the product will be launched this month, Aurobindo Pharma said in a BSE filing.",neutral,positive,-0.9460892260011344,negative,-1.21430915654742,negative
2018-07-15 18:01:45.780,611.95,611.95,567.45,574.95,3412446.0,Hyderabad-based Aurobindo Pharma has inked a definitive agreement with Canadian pharmaceutical firm Apotex to take over its commercial operations in five European countries.,Hyderabad-based Aurobindo Pharma has inked a definitive agreement with Canadian pharmaceutical firm Apotex to take over its commercial operations in five European countries.,positive,positive,-6.046245608301332,negative,1.9230769230769231,positive
2018-07-16 13:00:56.703,572.0,586.05,565.6,583.0,1822212.0,Aurobindo Pharma drops 2.3%,"Shares of Aurobindo Pharma dropped as much as 2.26 per cent to Rs 589.30 on the BSE.After opening the session higher at Rs Rs 610 against the previous close of Rs 602.90, the stock touched intraday hi",neutral,negative,1.9230769230769231,positive,-1.6980971072617197,negative
2018-07-24 10:00:20.193,590.3,596.95,588.0,593.5,1121531.0,"Top trading ideas by Anand Rathi Research: Buy Sterlite, Aurobindo Pharma","Nifty outlook and Top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research.",neutral,neutral,0.5420972386921982,neutral,-2.0317725752508324,negative
2018-07-30 18:00:51.985,606.95,607.3,590.0,591.2,1426902.0,Aurobindo Pharma gets USFDA nod for anti-coagulant injection,Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Bivalirudin injection. The approved ANDA is a generic equivalent to the re,neutral,positive,-2.594941922728396,negative,1.0961214165261384,positive
2018-07-30 18:01:25.666,606.95,607.3,590.0,591.2,1426902.0,"Nod for Aurobindo Pharma to make, market Bivalirudin injection","Citing market reports, the release said the estimated market size of the Bivalirudin injection was USD 101 million for the year ending May 2018. 
",neutral,neutral,-2.594941922728396,negative,1.0961214165261384,positive
2018-08-02 18:00:27.522,616.0,626.0,616.0,624.0,1968069.0,Pharma shares in focus; Nifty Pharma index hits 6-month high,"Divi's Lab, Aurobindo Pharma, Lupin, Dr Reddy's Lab, Sun Pharma, Glenmark Pharma and Cipla from the Nifty pharma index were up in the range of 1% to 3% on the NSE.",neutral,positive,1.2987012987012987,positive,-0.3189792663476874,neutral
2018-08-08 23:00:20.253,613.0,614.5,592.8,600.0,3459436.0,"Jet Air, GTL, MRF, Sundaram Brake results","3M India, 63 Moons, Amrutanjan, Aurobindo Pharma, Bajaj Electricals, Bajaj Hindusthan, Bharat Forge, Coffee Day, Cummins India, Engineers India, GNFC, Godrej Agro, GTL, GTL Infra, Hindustan Copper, In",neutral,neutral,-2.1207177814029365,negative,1.2562396006655498,positive
2018-08-09 10:00:17.019,613.0,614.5,592.8,600.0,3459436.0,Aurobindo Pharma Q1 net profit seen at Rs 539.5 crore,"The analysts polled by Reuters see revenue rising 13 percent year-on-year to Rs 4,091.8 crore",neutral,positive,-2.1207177814029365,negative,1.2562396006655498,positive
2018-08-09 18:00:53.193,601.0,614.4,594.85,608.55,3239453.0,Q1 Results 2019: Aurobindo Pharma’s Profit Misses Estimates,"Aurobindo Pharma Ltd.’s profit in the quarter ended June missed analysts estimates. Net profit fell 12.1 percent from the year-ago period to Rs 456 crore, the drugmaker said in its exchange filing. That compares with Rs 533-crore consensus estimate by analysts tracked by Bloomberg.",neutral,negative,1.2562396006655498,positive,2.752902155887234,positive
2018-08-20 10:02:15.774,660.95,668.0,650.7,661.05,3197823.0,"HUL, Sun Pharma, Tech Mahindra, Bajaj Finance, United Spirits to get astrological support this week: Satish Gupta","Hindustan Unilever, Godrej Consumer, Marico and Colgate from the personal care space and Strides Shasun, Dr Lal PathLab, Aurobindo Pharma, Wockhardt and Sun Pharma from the pharma space will get astrological support, says Satish Gupta of astrostocktips.",neutral,neutral,0.0151297374990406,neutral,-0.0075187969924743,neutral
2018-08-27 13:00:52.801,688.8,691.9,679.2,684.6,2822238.0,Aurobindo Pharma drops plan to buy speciality generics biz of Mallinckrodt,Aurobindo was looking to acquire it for $800 million or so,neutral,neutral,-0.6097560975609657,neutral,1.023391812865497,positive
2018-09-06 10:00:13.876,699.0,764.4,698.0,761.5,16219245.0,Novartis sells parts of Sandoz US to Aurobindo Pharma for $900 million,Novartis has agreed to sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma for $900 million,neutral,neutral,8.94134477825465,positive,5.176933158584535,positive
2018-09-07 13:00:13.110,763.0,827.45,763.0,802.5,29679319.0,"Aurobindo Pharma, Glenmark Pharma hit 52-week highs","Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.",positive,positive,5.176933158584535,positive,-0.6845052893590542,neutral
2018-09-07 18:00:14.053,763.0,827.45,763.0,802.5,29679319.0,Deals Buzz: Ola founders get Temasek vote for secondary share purchase,"In other news, L&T Technology Services will buy Graphene Semiconductor Services for Rs 93 crore in an all cash deal, and Aurobindo Pharma has agreed to buy the dermatology business and three manufacturing units of Sandoz",neutral,neutral,5.176933158584535,positive,-0.6845052893590542,neutral
2018-09-09 18:00:55.152,803.5,816.8,782.35,798.0,10939903.0,Aurobindo Pharma,"Sweet deal for Aurobindo Pharma The stock of Aurobindo Pharma rose 12 per cent last week, reacting to news that the company has entered into an agreement with Sandoz Inc, US, to acquire its dermatolog",neutral,positive,-0.6845052893590542,neutral,-1.1867582760774515,negative
2018-09-11 13:01:12.829,792.0,794.0,766.25,772.75,6258454.0,"Actavis to Sandoz, Aurobindo Pharma is scaling up biz one acquisition at a time","Aurobindo’s past record of integrating and turning around acquired companies is what keeps investors excited about.
",neutral,positive,-2.430555555555556,negative,2.5310777905933617,positive
2018-09-14 13:00:22.337,780.3,810.0,778.7,800.05,7345246.0,"D-Street Buzz: Sugar stocks zoom after ethanol price hike led by Mawana Sugars, Aurobindo Pharma jumps 3%","Sugar stocks are buzzing led by Avadh Sugar, Uttam Sugar, Dalmia Bharat Sugar and Sakthi Sugars which zoomed up to 20 percent after government approved hiking the price of ethanol produced directly from sugarcane juice for blending in petrol by 25 percent.",positive,positive,2.5310777905933617,positive,-1.036204744069907,negative
2018-09-18 13:01:30.610,785.0,790.0,766.1,776.55,2621072.0,Aurobindo Pharma's HIV drug gets approval in South Africa,"Aurobindo Pharma Ltd has received approval from the South African Health Products Regulatory Authority (SAHPRA) for its Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (DLT) tablets. The ap",positive,positive,-1.076433121019114,negative,-1.797175866495507,negative
2018-09-18 18:02:07.671,785.0,790.0,766.1,776.55,2621072.0,Aurobindo Pharma gets nod from South African health authority for HIV drug,"The approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of millions of patients.",neutral,positive,-1.076433121019114,negative,-1.797175866495507,negative
2018-09-25 13:00:54.147,768.5,785.1,755.1,759.0,4944650.0,"D-Street Buzz: IT, pharma stocks up on weak rupee led by Aurobindo Pharma, HCL Tech; RIL gains","230 stocks have hit new 52-week low including names like Atul Auto, Bank of Baroda, BEML, Can Fin Homes, Castrol, Eicher Motors, Engineers India, Vodafone Idea, Jet Airways, JK Tyre, OBC and Reliance Infra among others",positive,negative,-1.236174365647365,negative,-2.775232360256569,negative
2018-10-10 10:00:50.064,772.0,785.0,761.25,781.0,3868423.0,"'BUY' or 'SELL' ideas from experts for Wednesday, 10 October 2018","Aurobindo Pharma is a 'Buy' call with a target price of Rs 800 and a stop loss of Rs 750.
",neutral,neutral,1.16580310880829,positive,-1.3853325454664769,negative
2018-10-11 18:00:48.706,755.0,764.65,732.0,735.1,3539702.0,"Aurobindo Pharma to produce, market oral syrup in US",Aurobindo Pharma Ltd Thursday said it would be making and marketing azithromycin oral suspension in the US market after getting final approval from the US Food and Drug Administration (USFDA). The ora,neutral,neutral,-2.6357615894039705,negative,2.5474254742547364,positive
2018-10-11 18:02:41.755,755.0,764.65,732.0,735.1,3539702.0,Aurobindo Pharma gets USFDA nod for infections treatment drug,Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin oral suspension,neutral,positive,-2.6357615894039705,negative,2.5474254742547364,positive
2018-10-12 10:01:51.656,755.0,764.65,732.0,735.1,3539702.0,USFDA nod for Aurobindo Pharma's anti-infection drug,"USFDA nod for Aurobindo Pharma's anti-infection drug Aurobindo Pharma will launch Azithromycin oral suspension, a generic version of Pfizer's Zithromax oral suspension, in the U.S. next month. The Hyd",neutral,positive,-2.6357615894039705,negative,2.5474254742547364,positive
2018-10-12 18:02:27.827,755.0,764.65,732.0,735.1,3539702.0,Aurobindo Pharma Q2 PAT may dip 23% YoY to Rs. 601.9 cr: ICICI Direct,"Net Sales are expected to increase by 4.6 percent Y-o-Y (up 9.1 percent Q-o-Q) to Rs. 4,638.9 crore, according to ICICI Direct.",neutral,positive,-2.6357615894039705,negative,2.5474254742547364,positive
2018-10-16 13:01:06.732,780.05,784.25,746.25,754.0,2246848.0,"Buy Aurobindo Pharma, says Ashish Chaturmohta",The stock can be bought at current levels and on dips to Rs 740 with a stop loss below Rs 720 and a target of Rs 850 levels.,neutral,neutral,-3.3395295173386264,negative,-1.34268139427212,negative
2018-10-17 18:02:03.655,780.05,784.25,746.25,754.0,2246848.0,Aurobindo Pharma Q2 PAT may dip 28.3% YoY to Rs. 560 cr: HDFC Securities,"Net Sales are expected to decrease by 3.9 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 4,260 crore, according to HDFC Securities.",neutral,negative,-3.3395295173386264,negative,-1.34268139427212,negative
2018-10-29 10:01:52.262,721.5,776.85,720.35,771.0,3123874.0,Future perfect: Bull-call spread on Aurobindo Pharma,"The stock of Aurobindo Pharma (&#8377;720.5) is ruling at a crucial level, and finds strong resistance at &#8377;773. A close above this resistance will trigger a fresh rally, taking the stock to a ne",neutral,positive,6.860706860706861,positive,0.1037411657913594,neutral
2018-11-04 23:00:39.523,777.9,785.9,770.8,783.0,1289002.0,Aurobindo recalls hypertension drug in US citing cancer risk,"US FDA  says Aurobindo Pharma has initiated recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension, from the US market due to the presence of an impurity, which is believed to cause cancer",neutral,negative,0.6556112610875463,neutral,0.2173357197647573,neutral
2018-11-12 10:02:08.395,819.0,822.2,790.5,798.0,2884430.0,Q2 preview: Muted US business growth likely to hit Aurobindo Pharma's performance,"Further, high R&D cost is likely to affect financials as well, one brokerage house wrote in its report.",negative,negative,-2.564102564102564,negative,-3.8461538461538463,negative
2018-11-12 23:01:53.822,806.0,815.0,759.3,775.0,6120562.0,Q2 results: Aurobindo Pharma profit falls nearly 22% to Rs611 crore,"Aurobindo Pharma’s net profit was Rs611 crore in the quarter ended 30 September, compared with Rs781 crore a year earlier",negative,positive,-3.8461538461538463,negative,0.2821236214414011,neutral
2018-11-13 10:02:03.293,806.0,815.0,759.3,775.0,6120562.0,"Aurobindo Pharma beats Q2 profit estimates, buys inhalation assets from Australian firm","The net profit was helped by depreciating rupee against dollar and euro in its key US and Europe markets, that constitute nearly three-fourths of sales.",positive,positive,-3.8461538461538463,negative,0.2821236214414011,neutral
2018-11-13 13:00:34.259,779.8,785.0,765.95,782.0,2107460.0,"Aurobindo to acquire under development product, related assets from Advent for $ 12.5 mn",Aurobindo Pharma said on Monday its arm Aurobindo Pharma USA Inc has signed a pact to acquire an under-development product and certain related assets from Australian Advent Pharmaceuticals Pty Ltd for,neutral,positive,0.2821236214414011,neutral,-0.3836317135549872,neutral
2018-11-13 18:00:45.564,779.8,785.0,765.95,782.0,2107460.0,Aurobindo Pharma inks pact to acquire Australian pharma firm's product,"Based out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.",positive,neutral,0.2821236214414011,neutral,-0.3836317135549872,neutral
2018-11-18 13:02:30.497,786.15,799.3,783.0,791.1,1647921.0,"Aurobindo Pharma to launch oncology, respiratory products in US by 2021",The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products.,neutral,neutral,0.6296508299942817,neutral,-1.580278128950695,negative
2018-11-27 10:00:52.806,798.5,807.75,778.2,784.2,2544218.0,"Improving margins, reducing debt key challenges for Aurobindo Pharma","While revenue growth is expected to be strong, improving margins and reducing debt could be challenging",negative,positive,-1.790857858484653,negative,0.3884113339700674,neutral
2018-12-05 18:00:25.297,795.0,795.0,750.0,750.3,5319452.0,Aurobindo named in a lawsuit for selling adulterated irbesartan products,"In October, Aurobindo Pharma announced a voluntary recall of 22 batches of irbesartan due to the detection of trace amounts of NDEA",neutral,negative,-5.622641509433968,negative,0.2857712500830699,neutral
2018-12-06 13:01:49.003,752.35,768.8,733.0,754.5,5698551.0,Aurobindo Pharma faces class action suit; shares slump 4%,"Shares of Aurobindo Pharma Ltd fell as much as 4 per cent to Rs 764.55, their lowest since November 13, as according to a media report, the company is facing a class action lawsuit in the US over carc",negative,negative,0.2857712500830699,neutral,-1.1348284247500795,negative
2018-12-11 23:02:05.219,735.95,747.85,729.05,740.85,2683372.0,Aurobindo Pharma arm enters pact to form JV in China with Luoxin,"""The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin,"" Aurobindo Pharma said.",positive,neutral,0.6658061009579423,neutral,-0.3195313540141096,neutral
2018-12-12 10:01:00.773,735.95,747.85,729.05,740.85,2683372.0,Aurobindo Pharma arm enters pact to form JV in China with Luoxin,"The JV will also undertake contract manufacturing for non-nebuliser inhaler products.

",positive,neutral,0.6658061009579423,neutral,-0.3195313540141096,neutral
2018-12-14 10:00:07.230,743.85,745.7,715.2,725.9,5543036.0,Plan to invest in pharma stocks? Remember minesweeper game,87 per cent of the analysts tracking Aurobindo Pharma have a buy recommendation.,neutral,positive,-2.4131209249176644,negative,0.6148648648648588,neutral
2018-12-21 18:00:35.331,726.0,732.5,714.15,718.2,2491914.0,Aurobindo Pharma to launch potassium chloride pills in US,"The tablet, a generic version of Upsher-Smith's Klor-Con extended release tablets, would be launched next month, said a press release here.",neutral,neutral,-1.07438016528925,negative,-0.7840144314160795,neutral
2018-12-24 13:01:06.445,720.65,738.65,712.55,715.0,3805586.0,Aurobindo Pharma gets USFDA nod for anaesthesia drug,"Quoting IQVIA data, Aurobindo Pharma said the approved product has an estimated market size of USD 11 million for the 12 months ending September 2018.",neutral,neutral,-0.7840144314160795,neutral,0.3980724910957341,neutral
2018-12-25 10:02:22.259,715.95,720.75,697.1,718.8,3095562.0,Aurobindo Pharma gets final approval from USFDA to market anaesthesia drug,The approved product is a generic equivalent of Organon's Norcuron Injection,positive,neutral,0.3980724910957341,neutral,-1.5421853388658335,negative
2019-01-01 13:00:04.057,729.0,732.4,719.0,722.1,1845646.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Cipla, Sun Pharma; Atul Auto gains 10%","Bharti Airtel, Bharat Wire Rope, Maruti Suzuki, Sangam India and Suyog Telematics are the most active shares on BSE.",positive,neutral,-0.9465020576131656,negative,-1.1373092926491049,negative
2019-01-01 18:01:52.347,729.0,732.4,719.0,722.1,1845646.0,Aurobindo Pharma USA recalls 80 lots of blood pressure drug from America,"To date, Aurobindo Pharma USA Inc has not received any reports of adverse events related to this recall, the release said.",neutral,neutral,-0.9465020576131656,negative,-1.1373092926491049,negative
2019-01-02 10:01:49.130,729.0,732.4,719.0,722.1,1845646.0,Aurobindo Pharma USA recalls 80 lots of blood pressure drug from US,"To date, Aurobindo Pharma USA Inc has not received any reports of adverse events related to this recall, the company said",neutral,neutral,-0.9465020576131656,negative,-1.1373092926491049,negative
2019-01-03 10:00:47.496,721.0,723.4,710.55,712.8,1355701.0,Aurobindo Pharma to recall 80 lots of blood pressure medicine Valsartan in US,"The impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets containing valsartan, the FDA said.",negative,neutral,-1.1373092926491049,negative,1.4705882352941175,positive
2019-01-08 13:02:53.377,749.0,759.0,742.4,756.85,2995597.0,Sun Pharma gain 2% as CLSA maintains buy; upgrades Aurobindo Pharma,CLSA like Torrent Pharma for its strong positioning in the chronic space in India.,positive,positive,1.048064085447266,positive,2.579365079365079,positive
2019-01-11 18:02:18.603,775.5,775.5,763.5,769.95,2470448.0,Aurobindo Pharma Q3 PAT seen up 13.8% YoY to Rs. 669.1 cr: ICICI Direct,"Net Sales are expected to increase by 15.8 percent Y-o-Y (up 5.7 percent Q-o-Q) to Rs. 5,022.3 crore, according to ICICI Direct.",positive,positive,-0.7156673114119865,neutral,0.2467692707318627,neutral
2019-01-17 23:00:36.170,780.1,781.0,763.0,775.55,2466991.0,Aurobindo’s US arm to buy 7 cancer drugs of Spectrum Pharma for $300 m,Aurobindo Pharma has entered into a definitive agreement to acquire a portfolio of seven branded oncology injectable products from the US-based Spectrum Pharmaceuticals Inc for $300 million.Acrotech,neutral,positive,-0.583258556595317,neutral,0.7009345794392494,neutral
2019-01-18 10:00:41.379,780.1,781.0,763.0,775.55,2466991.0,Aurobindo to buy 7 oncology injectables from Spectrum Pharma,"The deal between Aurobindo Pharma and Spectrum Pharma for seven oncology injectables involves an upfront payment of $160 million, plus up to $140 million on achieving sales-based and regulatory targets",positive,positive,-0.583258556595317,neutral,0.7009345794392494,neutral
2019-02-07 10:01:23.721,765.0,782.0,760.0,774.0,2022118.0,"Tata Motors, Suzlon, SAIL, P&G results today"," About 100 companies including Amtek Auto, Allsec Tech, Arvind, Aurobindo Pharma, Bajaj Electricals, Britannia, Balmer Lawrie, Cadila Healthcare, Elgi Rubber, Eros, Future Supply Chain, Gillette, Gras",neutral,neutral,1.1764705882352942,positive,-3.74730978604887,negative
2019-02-08 13:01:54.213,789.9,789.9,750.5,760.3,5239362.0,Aurobindo Pharma Q3 net up 20% at Rs 712 cr,"Aurobindo Pharma Ltd’s consolidated net profit increased 19.7 per cent to Rs 712 crore in the third quarter ended December 31, 2018, as against Rs 595 crore in the same period last year.The total reve",positive,positive,-3.74730978604887,negative,0.0850785340314106,neutral
2019-02-11 13:01:03.032,770.0,772.0,760.1,767.0,1281035.0,Aurobindo Pharma acquires Apotex’s operations in 5 European countries,Aurobindo Pharma on Monday said it has completed the EUR 74-million deal to acquire Apotex’s commercial operations and certain supporting infrastructure in five European countries.The company had inke,neutral,positive,-0.3896103896103896,neutral,-2.2418300653594745,negative
2019-02-21 10:00:44.417,723.0,732.9,720.2,730.95,1818113.0,"Top trading ideas by Prabhudas Lilladher: Buy Aurobindo Pharma, Infosys","Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.",neutral,neutral,1.0995850622406702,positive,-0.0341950485569689,neutral
2019-02-27 18:01:49.484,719.1,726.9,710.0,710.7,2827851.0,"Lacunae in Aurobindo Pharma's Medak facility in Andhra, says FDA report","Besides, the report said preparative apparel was not worn as necessary to protect drug products from contamination",neutral,negative,-1.1681268251981614,negative,1.048951048951049,positive
2019-02-28 10:00:18.381,719.1,726.9,710.0,710.7,2827851.0,"Wipro, Bharti Airtel and Aurobindo Pharma may hog the limelight today",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-1.1681268251981614,negative,1.048951048951049,positive
2019-03-05 10:01:33.891,729.0,740.75,720.0,734.4,2277063.0,"Stocks in the news: Adani Gas, RCom, GAIL, IDBI Bank, ONGC and Aurobindo Pharma","Manwhile, ICICI Bank said it will acquire 9.9% stake in non-banking finance company Kisan Finance ",neutral,neutral,0.7407407407407376,neutral,-1.720892713094912,negative
2019-03-12 13:00:18.453,776.0,782.9,755.1,766.1,2949437.0,Aurobindo Pharma jumps 5% on reports of USFDA clearing Unit-4 facility,Shares of Aurobindo Pharma opened at Rs 752.90 on BSE against its previous closing of Rs 748.80.,positive,positive,-1.2757731958762857,negative,1.544980443285531,positive
2019-03-13 10:01:23.499,776.0,782.9,755.1,766.1,2949437.0,Aurobindo Pharma Gets 11 Observations From U.S. FDA For Its Telangana Plant,"The regulator issued a Form 483 with 11 observations to the company’s Unit 16 in Telangana, which makes sterile drug products.",neutral,negative,-1.2757731958762857,negative,1.544980443285531,positive
2019-04-12 13:01:17.703,784.8,791.7,770.0,776.2,3481707.0,Aurobindo Pharma Q4 PAT seen up 18.2% YoY to Rs. 624.9 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 25.9 percent Y-o-Y (down 3 percent Q-o-Q) to Rs. 5,020.7 crore, according to Prabhudas Lilladher.",positive,positive,-1.0958205912334238,negative,0.0257069408740418,neutral
2019-04-17 18:02:06.163,785.0,794.0,779.0,789.15,1601167.0,Aurobindo Pharma Q4 PAT seen up 17.8% YoY to Rs. 641.6 cr: Kotak,"Net Sales are expected to increase by 26.5 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs. 5,121.6 crore, according to Kotak.",positive,positive,0.5286624203821627,neutral,-0.7388535031847077,neutral
2019-04-25 13:01:11.423,800.5,835.6,799.05,835.0,5509084.0,"D-St Buzz: Pharma stocks gain led by Aurobindo Pharma, RIL at record high; UltraTech spikes","The top Nifty gainers include UltraTech Cement which jumped 5 percent, followed by Grasim Industries, YES Bank, BPCL and UPL while Bharti Infratel, Vedanta, Infosys, ONGC and Tata Steel are the top losers.",positive,positive,4.309806371018113,positive,-1.7325392528424446,negative
2019-04-26 13:01:26.425,800.5,835.6,799.05,835.0,5509084.0,Aurobindo Pharma at over 4 month high; chart points to more upside,"Shares of Aurobindo Pharma Ltd has gained as much as 3.68 per cent to ₹ 824.8, highest since December 5, 2018The stock has broken above a resistance at ₹ 810.92, the 38.2 percent Fibonacci projection",positive,positive,4.309806371018113,positive,-1.7325392528424446,negative
2019-04-26 18:00:59.184,800.5,835.6,799.05,835.0,5509084.0,D-Street Buzz: Nifty Auto underperforms dragged by Tata Motors; Aurobindo Pharma at 4-month high,"The top Nifty gainers include Tata Steel, BPCL, Axis Bank, Cipla and GAIL India while Tata Motors, Maruti Suzuki, Grasim Industries, Dr Reddy's Labs and Bharti Airtel are the top losers.",neutral,neutral,4.309806371018113,positive,-1.7325392528424446,negative
2019-04-29 18:00:50.840,831.15,838.0,810.85,816.75,4116902.0,Aurobindo Pharma gets eco nod for AP plant expansion,₹ 250 crore expansion project is expected to generate 600 jobs,neutral,positive,-1.7325392528424446,negative,-2.9675045984058914,negative
2019-05-13 18:01:17.472,718.45,719.8,702.4,713.5,2081287.0,Pharma stocks bleed as US states file lawsuit against generic drug firms,"Lupin, Aurobindo Pharma, Dr Reddys, Glenmark, Wockhardt USA and Zydus have been named in the lawsuit.",negative,neutral,-0.688983227782037,neutral,-0.5466012613875231,neutral
2019-05-14 13:01:22.355,713.5,736.85,705.35,709.6,2925937.0,"US states file second lawsuit against Aurobindo Pharma, other firms for violating antitrust laws","The Hyderabad-based firm said it does not, at this time, anticipate that these matters will have a material impact on the company’s operations or business results",neutral,neutral,-0.5466012613875231,neutral,1.6691212567501197,positive
2019-05-14 18:02:34.415,713.5,736.85,705.35,709.6,2925937.0,"US states file 2nd lawsuit accusing Aurobindo Pharma, others firms for violating antitrust laws","Aurobindo Pharma said ""we expect that we will be filing papers with the Federal Court in due course denying each of the relevant accusations"".
",neutral,neutral,-0.5466012613875231,neutral,1.6691212567501197,positive
2019-05-17 10:02:29.969,728.4,728.4,662.0,670.0,11687283.0,Aurobindo Pharma falls 6% as USFDA classified inspection as OAI,"The share touched its 52-week high Rs 838 and 52-week low Rs 527.05 on 30 April, 2019 and 04 June, 2018, respectively. ",neutral,negative,-8.017572762218558,negative,-2.7106227106227108,negative
2019-05-17 13:01:43.970,728.4,728.4,662.0,670.0,11687283.0,Aurobindo Pharma falls 6% after USFDA classifies inspection as OAI,Aurobindo Pharma has already submitted its initial response to USFDA,neutral,neutral,-8.017572762218558,negative,-2.7106227106227108,negative
2019-05-17 23:00:27.323,728.4,728.4,662.0,670.0,11687283.0,USFDA classifies Aurobindo's three units under 'Official Action Indicated'," The US Food and Drug Administration (USFDA) has classified Aurobindo Pharma’s three facilities under Official Action Indicated.Aurobindo Pharma, in a filing in the BSE, said they have received letter",neutral,neutral,-8.017572762218558,negative,-2.7106227106227108,negative
2019-05-17 23:01:09.259,728.4,728.4,662.0,670.0,11687283.0,Aurobindo Pharma gets USFDA observations on 3 units,The US Food and Drug Administration (USFDA) has classified three units of Aurobindo Pharma Ltd as ‘Official Action Indicated (OAI). “The company has received letters from the USFDA classifying the ins,neutral,neutral,-8.017572762218558,negative,-2.7106227106227108,negative
2019-05-28 10:00:45.126,683.0,690.95,672.5,674.5,2725170.0,"Sun Pharma, LV Bank, PNB, 3M India results"," Over 150 companies will declare March quarter/FY19 results on Tuesday. Among them are 20Microns, 3M India, Adani Transmission, Amtek Auto, Aurobindo Pharma, DCW, Deccan Cement, Deep Industries, EIH A",neutral,neutral,-1.2445095168374818,negative,0.0583941605839382,neutral
2019-05-29 10:01:19.796,685.0,698.0,670.1,685.4,6187739.0,"Stocks in the news: DHFL, Sun Pharma, Airtel, Hudco and Aurobindo Pharma",Kotak Institutional Equities has downgraded Zee Entertainment Enterprises to reduce from add.,neutral,negative,0.0583941605839382,neutral,-1.0552182711766342,negative
2019-05-30 23:00:13.881,687.5,692.5,665.25,668.8,2820146.0,Growth across geographies keeps analysts positive on Aurobindo Pharma,"Product launches, acquisitions are expected to drive US, EU prospects",positive,positive,-2.720000000000007,negative,-0.3566009104704131,neutral
2019-06-03 18:00:34.281,650.0,659.75,648.4,653.7,2103959.0,Aurobindo Pharma slips 5% after detailed USFDA observations to unit 3,USFDA observed that responsibilities and procedures applicable to quality control unit are not in writing and fully followed,neutral,neutral,0.5692307692307762,neutral,-4.650807006807922,negative
2019-06-04 23:01:38.465,650.0,659.75,648.4,653.7,2103959.0,Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad,"None of the observations are repetitive and are more procedural in nature, Aurobindo Pharma said.Shares of Aurobindo Pharma closed at  ₹654.10 per scrip on the BSE, down 0.48% from its previous close",neutral,negative,0.5692307692307762,neutral,-4.650807006807922,negative
2019-06-06 10:01:13.482,653.65,653.7,621.75,623.25,4728486.0,"Stocks in the news: DHFL, Aurobindo Pharma, Eros, Cimmco and RattanIndia Power",Titagarh Wagons will be divesting 4.49 per cent stake in its subsidiary Cimmco in the open market.,neutral,neutral,-4.650807006807922,negative,-0.88,neutral
2019-06-07 18:01:52.395,625.0,633.0,610.25,619.5,3626735.0,"Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US",The drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless allegations' against the company.,neutral,neutral,-0.88,neutral,0.9078492809512296,positive
2019-06-13 18:00:37.127,637.0,637.0,602.8,616.7,5557774.0,FDA points out data integrity lapses at Aurobindo Pharma unit,"The FDA issued Form 483 with 10 observations to Aurobindo Pharma on the plant which was audited by the US drug regulator between May 13 and May 24.

",negative,neutral,-3.1868131868131795,negative,0.7263922518159807,neutral
2019-06-14 13:01:11.727,637.0,637.0,602.8,616.7,5557774.0,Aurobindo Pharma drops 5% on USFDA observations,Shares of Aurobindo Pharma declined to Rs 605.90. ,neutral,neutral,-3.1868131868131795,negative,0.7263922518159807,neutral
2019-06-16 13:00:24.291,619.5,629.0,613.45,624.0,1957143.0,Aurobindo Pharma lines up $200 million capex for FY20,Aurobindo Pharma Ltd. to invest $ 200 million on Capex and over 5% of sale value on R&D. ,neutral,neutral,0.7263922518159807,neutral,-0.1602564102564102,neutral
2019-06-17 10:02:22.498,619.5,629.0,613.45,624.0,1957143.0,Aurobindo Pharma to spend $200 million on Capex in FY20,"The acquisition will add approximately 300 products, including projects under development, as well as commercial and manufacturing capabilities in the USA.",neutral,positive,0.7263922518159807,neutral,-0.1602564102564102,neutral
2019-06-21 13:00:35.749,625.0,625.5,578.65,603.0,7436306.0,Despite a 1% decline in Nifty Pharma index Deutsche Bank is betting on these 3 stocks,"Deutsche's top picks are Torrent Pharma, Aurobindo Pharma and Cipla which all are buy calls.",neutral,neutral,-3.52,negative,-4.880429477794046,negative
2019-06-21 13:01:37.042,625.0,625.5,578.65,603.0,7436306.0,Aurobindo Pharma drops 6% after receiving warning letter from USFDA,This action follows the earlier inspection of the site by the USFDA in February 2019.,neutral,neutral,-3.52,negative,-4.880429477794046,negative
2019-06-23 18:01:27.789,614.7,614.7,582.3,584.7,4410588.0,Aurobindo Pharma continues to trend down,"To alter the medium-term decline, the stock needs to conclusively break above ₹725",negative,neutral,-4.880429477794046,negative,2.175767918088737,positive
2019-07-02 13:01:49.843,612.9,612.9,588.0,595.9,4992418.0,Hold Aurobindo Pharma; target of Rs 710: Sharekhan,"Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated June 28, 2019.

",neutral,positive,-2.7736988089410994,negative,2.1922428330522767,positive
2019-07-03 18:00:50.748,593.0,608.25,593.0,606.0,3851935.0,USFDA issues warning letter to Aurobindo Pharma,The warning letter is centered on the issue of the manufacture of Valsartan API.,neutral,neutral,2.1922428330522767,positive,-1.4710743801652857,negative
2019-07-04 10:02:02.811,593.0,608.25,593.0,606.0,3851935.0,Aurobindo Pharma pulled up by USFDA for ,The FDA recently issued a warning letter to the firm after inspecting its active pharmaceutical ingredient facility (Unit XI) in Andhra Pradesh’s Srikakulam district and stated that CGMP observations were similar in nature as those made at other facilities.,neutral,negative,2.1922428330522767,positive,-1.4710743801652857,negative
2019-07-09 13:00:13.937,606.4,607.0,589.35,595.3,2423920.0,Nifty Pharma index surges 3% led by Sun Pharma,"Sun Pharma jumped 6% and among top gainers in the pharma index, followed by shares of Piramal Ent, Glenmark and Aurobindo Pharma, which rose in the range of 3-4% respectively, were also among top contributors.",positive,positive,-1.8304749340369435,negative,-0.4449571522742142,neutral
2019-07-10 10:01:07.937,606.4,607.0,589.35,595.3,2423920.0,Aurobindo Pharma (₹604.1): Buy,"The stock of Aurobindo Pharma almost gained 3 per cent with good volume on Tuesday, rebounding from a key support at around ₹582. Investors with a short-term view can buy the stock at current levels.",neutral,positive,-1.8304749340369435,negative,-0.4449571522742142,neutral
2019-07-11 10:00:15.455,606.8,622.0,598.65,604.1,5208057.0,Aurobindo Pharma launches Cinacalcet Hydrochloride Tablets in US; stock up 1%,"Cinacalcet Hydrochloride tablets had an annual sale of ~US$1,449mn for the 12 months ending May 2019, as per IQVIA.",positive,neutral,-0.4449571522742142,neutral,-1.330578512396687,negative
2019-07-11 10:00:57.431,606.8,622.0,598.65,604.1,5208057.0,"Stocks in the news: DHFL, IndiGo, Aurobindo Pharma, Religare and GTPL Hathway",NCLT dismissed a petition by HDFC to initiate insolvency proceedings against RHC Holding.,neutral,positive,-0.4449571522742142,neutral,-1.330578512396687,negative
2019-07-12 18:00:52.874,605.0,608.85,593.8,596.95,2349592.0,Aurobindo Pharma Q1 PAT seen up 11.2% YoY to Rs. 506.7 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 16.3 percent Y-o-Y (down 6.5 percent Q-o-Q) to Rs. 4,863 crore, according to Prabhudas Lilladher.",positive,positive,-1.330578512396687,negative,-4.0,negative
2019-07-25 13:01:07.077,557.0,568.8,550.25,562.15,1645340.0,"Nifty Pharma index gains over 1.5% led by Cadila, Lupin, Cipla","Divi’s Lab, Aurobindo Pharma, Dr Reddy’s, and Sun Pharma also gained in today’s session in the range of 1-2% respectively.",positive,positive,0.9245960502692958,positive,-1.7639198218262768,negative
2019-07-29 23:02:57.061,554.0,574.45,549.5,551.95,3185136.0,Indian drug makers scouting for partners in China: report,"Indian pharma firms are seeking partners that can make tangible business contributions, safeguard IP, ensure operational control and manage talent, says a BofA-ML report.Dr Reddy’s, Aurobindo Pharma, Cipla, Sun Pharmaceuticals Industries are looking at China as a big opportunity",neutral,neutral,-0.3700361010830242,neutral,2.158273381294964,positive
2019-08-06 18:00:52.689,564.0,567.75,551.6,554.5,1887625.0,Aurobindo Pharma confident of all-round growth in the US market,"Aurobindo had reported Rs 19,563.6 crore in revenues in FY19 with an year-on-year growth of 18.5 per cent",positive,positive,-1.6843971631205674,negative,3.3879310344827545,positive
2019-08-07 10:00:28.954,564.0,567.75,551.6,554.5,1887625.0,"Tata Steel, Adani Group, HPCL results eyed"," About 90 companies will declare their June quarter results on Wednesday. Among these are Adani Gas, Adani Green, Adani Ports, Adani Power, Allcargo, Aster DM, AstraZeneca, Aurobindo Pharma, Bajaj Ele",neutral,neutral,-1.6843971631205674,negative,3.3879310344827545,positive
2019-08-07 10:03:15.112,564.0,567.75,551.6,554.5,1887625.0,"Board Meetings Today: Adani Ports, Cipla, HCL Technologies, M&M, Tata Steel","HPCL, Lupin, Adani Power, Aurobindo Pharma and India Cements will announce Q1 earnings today. ",neutral,neutral,-1.6843971631205674,negative,3.3879310344827545,positive
2019-08-07 23:00:30.888,580.0,602.45,571.65,599.65,12392212.0,Aurobindo Pharma Q1 results: Net profit rises 39.52%,"Consolidated total revenue from operations rose to  ₹5,444.60 crore for the quarter.Europe formulations revenue stood at  ₹1,391.6 crore, up 16.1% year-on-year",positive,positive,3.3879310344827545,positive,-1.0364842454394694,negative
2019-08-08 10:00:39.261,580.0,602.45,571.65,599.65,12392212.0,Aurobindo Pharma posts 39.5% rise in cons. net profit at Rs635.8cr,"Revenue from operations rose 28.1% yoy to Rs5,444.6cr during the quarter under review from Rs4,250cr in the corresponding quarter of the previous year.",positive,positive,3.3879310344827545,positive,-1.0364842454394694,negative
2019-09-08 23:00:52.327,620.0,627.8,616.7,624.4,2147012.0,Aurobindo’s lipid-lowering drug recalled,"Aurobindo Pharma Ltd has recalled 2,352 bottles of lipid-lowering Simvastatin tablets from the US market, according information available with the US Food and Drug Administration. According to the US",negative,negative,0.709677419354835,neutral,0.4727564102564175,neutral
2019-09-09 10:00:30.724,620.0,627.8,616.7,624.4,2147012.0,Aurobindo Pharma recalls over 2k bottles of lipid-lowering tablets from US,"Aurobindo Pharma USA Inc is recalling 2,352/1,000 count bottles of Simvastatin tablets USP 40 mg manufactured by Aurolife Pharma LLC. ",negative,negative,0.709677419354835,neutral,0.4727564102564175,neutral
2019-09-23 23:02:44.349,599.8,621.3,588.9,618.7,3666801.0,Insider trading: Sebi imposes Rs 22 cr fine on Aurobindo Pharma,Insider trading: Sebi imposes Rs 22 cr fine on Aurobindo Pharma,negative,negative,3.1510503501167206,positive,-2.687823834196895,negative
2019-09-24 10:01:24.631,599.8,621.3,588.9,618.7,3666801.0,"Stocks to watch: Aurobindo Pharma, RIL, Apollo Pipes, Phoenix Mills, ZEEL",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,3.1510503501167206,positive,-2.687823834196895,negative
2019-09-24 13:02:53.473,617.6,617.8,595.0,601.0,1951858.0,SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading  ,SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading  ,negative,negative,-2.687823834196895,negative,0.3626772172766125,neutral
2019-09-24 13:03:34.626,617.6,617.8,595.0,601.0,1951858.0,SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading,"Mumbai (Maharashtra) [India], Sep 24 (ANI): The Securities Exchange Board of India (SEBI) has imposed penalties of Rs 22.7 crore on Aurobindo Pharma, its related entities and promoters for violating insider trading rules with respect to a licensing deal it had entered with Pfizer in 2009.",negative,negative,-2.687823834196895,negative,0.3626772172766125,neutral
2019-09-25 13:02:51.640,606.6,616.5,604.0,608.8,1826828.0,Aurobindo Pharma declines 2% after SEBI passes adjudication order,"The share touched its 52-week high Rs 838 and 52-week low Rs 537 on 30 April, 2019 and 05 August, 2019, respectively. ",negative,positive,0.3626772172766125,neutral,-1.973684210526316,negative
2019-10-07 13:01:17.764,560.55,564.35,450.35,451.0,22698718.0,Aurobindo Pharma down 6% on receiving USFDA observations,"Shares of Aurobindo Pharma crashes over 6 per cent in early trade on Monday on the US drug regulator&#39;s adverse observation.After hitting a year low of ₹531.10, the stock is currently ruling at ₹53",negative,negative,-19.543305681919534,negative,0.0316355583676123,neutral
2019-10-07 18:02:41.566,560.55,564.35,450.35,451.0,22698718.0,"US FDA makes 7 observations in Aurobindo Pharma's unit-VII, lacks complete data",The observations were made after an inspection of the unit conducted during 19-27 September.The regulator observed that written production and process control procedures were not followed during production ,neutral,neutral,-19.543305681919534,negative,0.0316355583676123,neutral
2019-10-08 10:00:47.531,474.15,485.0,454.15,474.3,17996897.0,"The US Food and Drug Administration (USFDA) made seven observations for Aurobindo Pharma unit-VII at Polepally in Telangana. ,The US Food and Drug Administration (USFDA) made seven observations for Aurobindo Pharma unit-VII at Polepally in Telangana. ","The US Food and Drug Administration (USFDA) made seven observations for Aurobindo Pharma unit-VII at Polepally in Telangana. ,The US Food and Drug Administration (USFDA) made seven observations for Aurobindo Pharma unit-VII at Polepally in Telangana. ",neutral,neutral,0.0316355583676123,neutral,-2.573839662447255,negative
2019-10-09 10:01:30.876,474.15,485.0,454.15,474.3,17996897.0,"Stocks to watch: Infosys, Minda Ind, Indiabulls Ventures, Aurobindo Pharma",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,0.0316355583676123,neutral,-2.573839662447255,negative
2019-10-09 13:01:06.676,474.0,474.0,436.65,461.8,12091280.0,Aurobindo Pharma share price rose 5.13% to Rs 482 compared to the previous close of Rs 458.50 on BSE. ,Aurobindo Pharma share price rose 5.13% to Rs 482 compared to the previous close of Rs 458.50 on BSE. ,positive,positive,-2.573839662447255,negative,-6.129032258064516,negative
2019-10-09 13:03:12.869,474.0,474.0,436.65,461.8,12091280.0,"In a regulatory filing post market hours on Monday, Aurobindo Pharma said that it is ""confident of addressing these issues within the stipulated timeline"".
,In a regulatory filing post market hours on Monday, Aurobindo Pharma said that it is ""confident of addressing these issues within the stipulated timeline"".
","In a regulatory filing post market hours on Monday, Aurobindo Pharma said that it is ""confident of addressing these issues within the stipulated timeline"".
,In a regulatory filing post market hours on Monday, Aurobindo Pharma said that it is ""confident of addressing these issues within the stipulated timeline"".
",positive,positive,-2.573839662447255,negative,-6.129032258064516,negative
2019-10-09 18:04:18.511,474.0,474.0,436.65,461.8,12091280.0,Aurobindo Pharma recovers 5% after company's clarification on USFDA observations,"Aurobindo Pharma said that it is ""confident of addressing these issues within the stipulated timeline"".",neutral,positive,-2.573839662447255,negative,-6.129032258064516,negative
2019-10-10 10:03:28.186,474.0,474.0,436.65,461.8,12091280.0,Aurobindo Pharma rises 3% after firm's clarification on FDA observations,The exchange had sought a clarification from the company regarding declining share prices on the back of USFDA observations,positive,neutral,-2.573839662447255,negative,-6.129032258064516,negative
2019-10-10 18:00:12.967,465.0,466.1,435.35,436.5,10997276.0,Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDA,The FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this year.,negative,neutral,-6.129032258064516,negative,3.3786848072562305,positive
2019-10-11 18:00:15.114,465.0,466.1,435.35,436.5,10997276.0,Aurobindo Pharma hits 5-year low after promoters create pledge earlier this week,"""Pledge creation - on shortfall of security for the existing loans due to fall in share price,"" the company reasoned in its BSE filing.",negative,negative,-6.129032258064516,negative,3.3786848072562305,positive
2019-10-16 10:02:31.751,458.0,465.85,447.35,462.5,4684695.0,Arrest of CITU leaders sparks tension at Aurobindo Pharma,Large police force was deployed as a precautionary measure,negative,neutral,0.9825327510917032,positive,0.7135906584495646,neutral
2019-10-24 13:03:57.777,466.5,475.0,463.0,468.95,3181215.0,Aurobindo Pharma gets USFDA approval for Guaifenesin Extended-Release Tablets (OTC),"The approved product has an estimated market size of US$ 301 million for the twelve months ending July 2019, according to IRI database.",positive,neutral,0.5251875669882077,neutral,-0.2436698802839235,neutral
2019-10-24 18:01:51.812,466.5,475.0,463.0,468.95,3181215.0,Aurobindo Pharma gets USFDA nod for its expectorant tablets,"The company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin extended-release tablets in the strengths of 600 mg and 1,200 mg.",neutral,positive,0.5251875669882077,neutral,-0.2436698802839235,neutral
2019-10-25 10:02:47.488,466.5,475.0,463.0,468.95,3181215.0,USFDA nod may boost Aurobindo Pharma," Aurobindo Pharma has received final approval from the US Food &amp;amp; Drug Administration to manufacture Guaifenesin extended-release tablets, 600 mg and 1,200 mg. The product is expected to launch",positive,positive,0.5251875669882077,neutral,-0.2436698802839235,neutral
2019-11-05 10:01:10.495,478.0,485.5,470.4,473.55,3270045.0,Aurobindo Pharma under USFDA scrutiny,"Aurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinogenic impurities. Apart from Aurobindo, those impurities were detected in several other batches manufactured by drug makers. ",neutral,negative,-0.930962343096232,negative,-5.22105263157895,negative
2019-11-06 13:01:24.413,451.5,454.8,442.6,452.6,3915098.0,Aurobindo Pharma trades near 52-wk low as Hyd units come under US FDA lens,The management believes that these observations are related to procedural improvements and none of the observations are related to data integrity.,negative,neutral,0.2436323366555975,neutral,-2.8612461334511807,negative
2019-11-06 18:01:16.124,451.5,454.8,442.6,452.6,3915098.0,Aurobindo Pharma gets 8 observations for 2 plants from USFDA,"The company will be responding to the USFDA as per the prescribed time lines, the drug firm said. 
",neutral,neutral,0.2436323366555975,neutral,-2.8612461334511807,negative
2019-11-06 18:01:30.425,451.5,454.8,442.6,452.6,3915098.0,"Sensex rises 221 points, ICICI Bank, HDIL, DHFL, DLF stocks gain","Shares of Reliance Power, PC Jeweller, Corporation Bank, Sun Pharma Advanced, Dewan Housing Finance Limited or DHFL, Indiabulls Real Estate, DLF, Reliance Capital and Lakshmi Vilas Bank were among the major gainers, while stocks of Titan Company, Vodafone Idea, Bajaj Electricals, Prism Johnson, Apollo Tyres, SREI Infrastructure and Aurobindo Pharma were among the major losers.",positive,neutral,0.2436323366555975,neutral,-2.8612461334511807,negative
2019-11-07 10:01:39.837,451.5,454.8,442.6,452.6,3915098.0,Company gives cash award tochildren of contract workers,Aurobindo Pharma Private Limited Senior vice president U.N.B. Raju on Wednesday said that the company was giving top priority for the improvement of infrastructure in government schools under Corporat,neutral,positive,0.2436323366555975,neutral,-2.8612461334511807,negative
2019-11-08 18:01:24.259,452.6,456.25,436.5,439.65,3184468.0,Aurobindo Pharma says talks with US FTC on Sandoz deal making progress,"Aurobindo Pharma’s buyout of Sandoz assets delayed on US Federal Trade Commission query .The company, however, did not give details about the negotiations with the anti-trust watchdog",positive,neutral,-2.8612461334511807,negative,0.1258581235697966,neutral
2019-11-13 10:02:30.796,445.0,457.95,427.65,432.45,10082366.0,"Aurobindo Pharma has posted 4.6% growth in its net profit at Rs. 639.5 crore for the September quarter against Rs. 611.4 crore in the corresponding period last financial year. ,Aurobindo Pharma has posted 4.6% growth in its net profit at Rs. 639.5 crore for the September quarter against Rs. 611.4 crore in the corresponding period last financial year. ","Aurobindo Pharma has posted 4.6% growth in its net profit at Rs. 639.5 crore for the September quarter against Rs. 611.4 crore in the corresponding period last financial year. ,Aurobindo Pharma has posted 4.6% growth in its net profit at Rs. 639.5 crore for the September quarter against Rs. 611.4 crore in the corresponding period last financial year. ",positive,positive,-2.8202247191011263,negative,-3.792560281109894,negative
2019-11-14 10:02:37.200,412.65,412.65,389.35,397.0,16968377.0,"Buzzing stocks: YES Bank, Vodafone Idea, Adani Power, Aurobindo Pharma","The NSE Nifty index was trading 14.05 points down at 11,826.40.",neutral,negative,-3.792560281109894,negative,2.0398009950248728,positive
2019-11-14 13:04:45.430,402.0,415.95,396.25,410.2,8941692.0,Aurobindo Pharma plunges 9% as USFDA issues 14 observations,"
The Unit IV of the facility was inspected by USFDA from November 4 to November 13. 
",negative,neutral,2.0398009950248728,positive,2.724532851115132,positive
2019-11-15 10:02:32.294,402.0,415.95,396.25,410.2,8941692.0,"Aurobindo Pharma has received Form 483 with 14 observations from the US Food and Drug Administration (USFDA) for its Unit IV, a general injectable formulation manufacturing facility, in Pashamylaram, Hyderabad.,Aurobindo Pharma has received Form 483 with 14 observations from the US Food and Drug Administration (USFDA) for its Unit IV, a general injectable formulation manufacturing facility, in Pashamylaram, Hyderabad.","Aurobindo Pharma has received Form 483 with 14 observations from the US Food and Drug Administration (USFDA) for its Unit IV, a general injectable formulation manufacturing facility, in Pashamylaram, Hyderabad.,Aurobindo Pharma has received Form 483 with 14 observations from the US Food and Drug Administration (USFDA) for its Unit IV, a general injectable formulation manufacturing facility, in Pashamylaram, Hyderabad.",neutral,neutral,2.0398009950248728,positive,2.724532851115132,positive
2019-11-15 18:01:54.663,402.0,415.95,396.25,410.2,8941692.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Glenmark; Airtel surges 8%, IOC drags","The pharma index gained 2 percent led by Glenmark Phrama, Divis Labs, Cipla, Aurobindo Pharma, Biocon and Piramal Enterprises.",positive,positive,2.0398009950248728,positive,2.724532851115132,positive
2019-11-18 13:01:10.211,429.4,435.0,425.3,430.6,4172311.0,Pharma stocks advance; Glenmark surges over 15%,"The pharmaceutical stocks were trending higher in Monday&#39;s noon session with the Nifty Pharma index up 1.35 per cent. The shares of Glenmark Pharmaceuticals (up 15.12 per cent), Aurobindo Pharma (",positive,positive,0.2794597112249756,neutral,3.125,positive
2019-11-18 13:02:41.305,429.4,435.0,425.3,430.6,4172311.0,"Top intraday trading ideas for afternoon trade on Monday, November 18, 2019",Aurobindo Pharma is a 'Buy' call with a target price of Rs 430 and a stop loss of Rs 398.,neutral,neutral,0.2794597112249756,neutral,3.125,positive
2019-11-20 18:01:25.965,444.0,448.7,426.6,429.6,5783285.0,Nifty Pharma index hits two-month high; Sun Pharma surges 7%,"Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent each on the NSE.",positive,positive,-3.2432432432432377,negative,-0.9488544318444856,negative
2019-11-24 13:00:12.233,431.5,443.9,431.5,441.8,3944641.0,Aurobindo Pharma aims to become debt free in 3 years sans Sandoz deal,"In September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc, USA, a Novartis Division, for USD 900 million.",positive,positive,2.3870220162224824,positive,0.4285553174692629,neutral
2019-11-25 10:02:11.646,431.5,443.9,431.5,441.8,3944641.0,Aurobindo Pharma aims to become debt-free in the next three years,The company's net debt decreased by $71 million quarter-on-quarter to $522 million at the end of September 2019 against $593 million at the end of June 2019,positive,negative,2.3870220162224824,positive,0.4285553174692629,neutral
2019-11-26 10:00:39.060,443.35,449.5,439.9,445.25,4697307.0,"Credit Suisse maintains neutral on Aurobindo Pharma, target price Rs 500", Neutral  Aurobindo Pharma Ltd.  at a price target of Rs  500.0    .  ,positive,positive,0.4285553174692629,neutral,1.4442454097626485,positive
2019-11-28 23:04:11.279,454.0,461.85,445.6,451.0,4128365.0,Aurobindo Pharma arm to buy certain biz assets of Profectus BioSciences,The acquisition will lead to enhancement of research and development capabilities,neutral,positive,-0.6607929515418502,neutral,-0.3755246299977885,neutral
2019-11-29 10:17:26.102,454.0,461.85,445.6,451.0,4128365.0,Aurobindo Pharma to buy R&D assets of US based Profectus Biosciences,"Auro Vaccines LLC, an arm of  Aurobindo Pharma Ltd, has entered into a pact to acquire certain business assets from Profectus BioSciences Inc., US for an upfront cash consideration of $11.29 million (",neutral,positive,-0.6607929515418502,neutral,-0.3755246299977885,neutral
2019-11-29 13:02:40.963,454.0,461.85,445.6,451.0,4128365.0,"Stocks to watch: NBFCs, Aurobindo Pharma, YES Bank, Ashoka Buildcon, Airtel",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,-0.6607929515418502,neutral,-0.3755246299977885,neutral
2019-12-19 13:01:45.999,465.4,474.45,463.15,469.0,3213605.0,Aurobindo Pharma share price rallies 3% after Citi sees 89% potential upside,The brokerage also expects further clarity on units VII and IV in coming months.,positive,neutral,0.7735281478298287,neutral,-0.9325985587113256,negative
2020-01-02 23:00:56.565,461.0,471.9,457.2,460.2,2784106.0,Aurobindo Pharma Inc recalls Mirtazapine tablets in US,"The product is being recalled due to a label error on declared strength. Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, as per the company's announcement posted on the website of the United States Food and Drug Administration (USFDA). ",negative,negative,-0.1735357917570523,neutral,-3.1740837696334983,negative
2020-01-02 23:00:59.831,461.0,471.9,457.2,460.2,2784106.0,Aurobindo Pharma Inc recalls Mirtazapine tablets in US,The company said it is notifying its distributors by letter and is arranging for return of all of the recalled product. ,negative,neutral,-0.1735357917570523,neutral,-3.1740837696334983,negative
2020-01-03 10:02:59.828,461.0,471.9,457.2,460.2,2784106.0,"Stocks in the news: ONGC, IIFL Securities, YES Bank, Aurobindo Pharma and RIL","Sterlite Technologies bagged a Rs 1,800 crore project from Telangana Fiber Grid Corp",neutral,neutral,-0.1735357917570523,neutral,-3.1740837696334983,negative
2020-01-10 13:00:31.369,457.7,465.4,457.1,457.7,1683802.0,"Pharma shares in focus; Dr Reddy's, Divi's, Granules hit 52-week highs","Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.",positive,positive,0.0,neutral,0.0543478260869565,neutral
2020-01-16 10:03:25.718,485.9,487.7,474.85,475.75,1946078.0,"'BUY' or 'SELL' ideas from experts for Thursday, 16 January, 2020",Aurobindo Pharma is a 'Buy' call with a target price of Rs 535 and a stop loss of Rs 472.,neutral,neutral,-2.0889071825478447,negative,1.853791369920407,positive
2020-01-30 10:04:41.385,508.1,509.65,465.85,478.0,12707389.0,Aurobindo Pharma's unit VII facility gets OAI from USFDA,The company believes that this OAI classification will not have any material impact on the existing revenues or the supplies to our US business at this juncture.,neutral,neutral,-5.924030702617599,negative,0.280869655674612,neutral
2020-01-30 10:05:03.349,508.1,509.65,465.85,478.0,12707389.0,Coronavirus pandemic threatens to cut pharmaceutical industry’s lifeline,"Raw materials from China are used in making antibiotics, paracetamol, and diabetes and cardiovascular drugs, among others. Companies including Lupin, Sun Pharmaceuticals, Glenmark, Mankind, Dr Reddys, Torrent, Aurobindo Pharma and Abbott are hugely dependent on Chinese imports. ",negative,neutral,-5.924030702617599,negative,0.280869655674612,neutral
2020-01-30 13:00:47.476,480.65,487.0,477.1,482.0,3179111.0,"D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag","D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag",negative,negative,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 13:02:12.631,480.65,487.0,477.1,482.0,3179111.0,Aurobindo Pharma plunges 8% as USFDA classifies oral solids plant as OAI,"USFDA, that had conducted a Current Good Manufacturing Practice (cGMP) inspection at the company's Unit 7 an oral solids formulation manufacturing facility from Sept 19-27, 2019, issued 7 observations",negative,neutral,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 13:02:54.611,480.65,487.0,477.1,482.0,3179111.0,"BRIEF-India's Aurobindo Pharma's Unit VII Facility Classified By FDA As Official Action Indicated - Investing.com India
",Read BRIEF-India's Aurobindo Pharma's Unit VII Facility Classified By FDA As Official Action Indicated By Reuters,neutral,neutral,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 13:03:07.818,480.65,487.0,477.1,482.0,3179111.0,USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action,The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.,neutral,positive,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 18:00:55.250,480.65,487.0,477.1,482.0,3179111.0,USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action,"According to USFDA's definitions, OAI means ""objectionable conditions were found and regulatory administrative sanctions by FDA are indicated"" during inspections. The company said that it believes that this OAI classification will not have any material impact on the existing revenues or the supplies to its US business at this juncture.",neutral,neutral,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 18:01:24.345,480.65,487.0,477.1,482.0,3179111.0,USFDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action,Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing facility may be subject to regulatory actions. The company str,neutral,neutral,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-30 23:03:47.990,480.65,487.0,477.1,482.0,3179111.0,Aurobindo Pharma unit under USFDA scanner,"Aurobindo Pharma shares lost nearly 8% intraday after the drugmaker on Thursday said that post an inspection of its oral solids formulation manufacturing facility here, the U.S. Food and Drug Administ",neutral,negative,0.280869655674612,neutral,-3.061862112059997,negative
2020-01-31 13:03:10.986,480.1,485.7,460.2,465.4,1096727.0,Broker's call: Aurobindo Pharma (Hold),Emkay GlobalAurobindo Pharma (Hold)CMP: ₹479Target: ₹500The USFDA has classified Aurobindo Pharma’ Unit — VII plant as OAI (official action indicated) for the inspection held in October 2019. Unit —,neutral,neutral,-3.061862112059997,negative,2.1704093692919235,positive
2020-01-31 18:01:15.843,480.1,485.7,460.2,465.4,1096727.0,"Aurobindo Pharma's JV, Eugia Pharma receives USFDA approval for Methotrexate Tablets",Aurobindo now has a total of 420 ANDA approvals (393 Final approvals including 22 from Aurolife Pharma LLC and 27 tentative approvals) from USFDA.,positive,neutral,-3.061862112059997,negative,2.1704093692919235,positive
2020-02-05 23:04:03.941,508.85,514.7,506.1,511.9,2921643.0,"Sun Pharma, IL&FS, Auro Pharma results"," Over 100 companies will declare Q3 FY20 results on Thursday. Among these are Aarti Drugs, AB Fashion, Adani Power, Akzo Nobel, Aurobindo Pharma, Bata India, Dalmia Bharat, Eicher Motors, Glaxo Consum",neutral,neutral,0.5993907831384404,neutral,3.390476190476182,positive
2020-02-06 10:01:50.131,508.85,514.7,506.1,511.9,2921643.0,"Board Meetings Today: Sun Pharma, Hero MotoCorp, Eicher Motors, Lupin and IDFC"," Bata India, Aurobindo Pharma, NMDC and UCO Bank are some of the companies which will report Q3 results today.",neutral,neutral,0.5993907831384404,neutral,3.390476190476182,positive
2020-02-06 10:04:32.634,508.85,514.7,506.1,511.9,2921643.0,"Stocks to watch today on February 6: Sun Pharma, Adani Power, Eicher Motors, RITES, Hero MotoCorp, Aurobindo Pharma among others are the top stocks to watch out for in Thursday's trading session","Stocks to watch today on February 6: Sun Pharma, Adani Power, Eicher Motors, RITES, Hero MotoCorp, Aurobindo Pharma among others are the top stocks to watch out for in Thursday's trading session",neutral,neutral,0.5993907831384404,neutral,3.390476190476182,positive
2020-02-06 10:05:18.905,508.85,514.7,506.1,511.9,2921643.0,"Important results today: Eicher Motors, Hero MotoCorp, Sun Pharma, Indraprastha Gas","Eicher Motors, Hero MotoCorp, Sun Pharmaceutical, Lupin, Aurobindo Pharma, Metropolis Healthcare and RITES will release their December quarter numbers today.",neutral,neutral,0.5993907831384404,neutral,3.390476190476182,positive
2020-02-06 23:00:27.968,525.0,553.55,513.75,542.8,18745011.0,"Aurobindo Pharma Q3 net marginally down at Rs 705 cr, revenue up 12%","According to a filing with the bourses, revenues from operations during the quarter under review was up by nearly 12 per cent to Rs 5,895 crore. It was Rs 5,269.7 crore in Q3 FY19.",positive,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-06 23:00:50.980,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma net marginally down at Rs 705cr in Q3,"According to a filing with the bourses, revenues from operations during the quarter under review was up by nearly 12 per cent to Rs 5,895 crore.

",negative,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-06 23:03:32.739,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma Q3 PBT rises 6% to Rs 942.8 cr; revenues up 11.9%,"The formulations revenues for the quarter posted a growth of 17.4 per cent year-on-year at Rs 5,104 cr",positive,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 10:01:33.679,525.0,553.55,513.75,542.8,18745011.0,"Aurobindo Pharma sees dip in Q3 net profit; revenue, EBITDA rise","EBIDTA before Forex and Other income at Rs1,208cr, grew by 11.2% yoy; EBITDA margin for the quarter was at 20.5%.",negative,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 10:02:33.557,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma’s Q3 net down 1 per cent at Rs 705 crore,"Aurobindo Pharma Ltd’s consolidated net profit declined by one per cent at Rs 705 crore in the third quarter ended December 31, 2019 compared to Rs 712 crore in the corresponding quarter of previous f",neutral,negative,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 10:05:41.344,525.0,553.55,513.75,542.8,18745011.0,"Top stocks in focus: Wipro, Aurobindo Pharma, Adani Transmission, Hero MotoCorp, Eicher Motors",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 18:00:44.160,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma gains 5% post December quarter results,"The stock of the drug company was trading higher for the fifth straight day, up 14 per cent, against a 4 per cent rise in the S&P BSE Sensex during the period.",positive,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 18:00:46.008,525.0,553.55,513.75,542.8,18745011.0,"Nifty hovers around 12,100-mark; Aurobindo, Sun Pharma stocks surge","The Nifty Pharma index gained 1.5% in an otherwise weak market in the noon trade. The index gained 123 points led by Aurobindo Pharma, Piramal Ent, Glenmark and Sun Pharma.",neutral,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 18:01:10.488,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma jumps 7% on spike in volume; board declares dividend,"The stock witnessed spurt in volume by more than 2.12 times. It was trading with volumes of 358,893 shares, compared to its five day average of 181,376 shares, an increase of 97.87 percent.",positive,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 18:02:41.518,525.0,553.55,513.75,542.8,18745011.0,Aurobindo Pharma scrip gains over 4 per cent,Aurobindo Pharma Ltd’s scrip gained 4.57 per cent over previous close on the Bombay Stock Exchange (BSE) on Friday and is trading at Rs 534.14 after opening of trade.Aurobindo has on Thursday posted a,positive,positive,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-07 18:04:23.831,525.0,553.55,513.75,542.8,18745011.0,D-Street Buzz: Nifty Pharma outperforms led by Aurobindo Pharma; Eicher Motors drags,"The most active stocks included Indiabulls Housing Finance, State Bank of India, Aurobindo Pharma, Hero MotoCorp and Lupin.",neutral,neutral,3.390476190476182,positive,-1.0580080262677978,negative
2020-02-19 10:01:34.826,550.4,607.7,550.4,604.4,28734631.0,Aurobindo Pharma surges 19% as Unit IV receives EIR with VAI staus from FDA,The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from the US Food & Drug Administration (USFDA) for Unit IV.,positive,neutral,9.811046511627907,positive,-2.1975328813005364,negative
2020-02-19 10:01:59.647,550.4,607.7,550.4,604.4,28734631.0,"Buzzing stocks: Vodafone Idea, YES Bank, Aurobindo Pharma, IRCTC ",Aurobindo Pharma (Rs 325.02 crore) was leading the pack of most active stocks in value terms.,neutral,positive,9.811046511627907,positive,-2.1975328813005364,negative
2020-02-19 10:02:47.680,550.4,607.7,550.4,604.4,28734631.0,Aurobindo Pharma share price gains 19% on EIR from USFDA,"USFDA conducted inspection from November 4 to 13, 2019.",positive,neutral,9.811046511627907,positive,-2.1975328813005364,negative
2020-02-19 10:04:07.482,550.4,607.7,550.4,604.4,28734631.0,Aurobindo Pharma gets EIR from USFDA; stock surges 15%,The company's share price is trading higher by more than 15% in trade today.,positive,positive,9.811046511627907,positive,-2.1975328813005364,negative
2020-02-19 13:00:20.898,612.05,617.55,590.35,598.6,14550467.0,Aurobindo Pharma surges 18% on receiving EIR from USFDA,Prabhudas Lilladher has a ‘hold rating on the stock with a target at Rs 525. ,positive,positive,-2.1975328813005364,negative,-6.14116339384957,negative
2020-02-19 18:01:52.173,612.05,617.55,590.35,598.6,14550467.0,Aurobindo Pharma gets US FDA inspection report for Pashamylaram unit,The US FDA had inspected the pharmaceutical company’s unit during 4-13 November.The company had received Form 483 with 14 observations,neutral,neutral,-2.1975328813005364,negative,-6.14116339384957,negative
2020-02-20 13:03:28.050,612.05,617.55,590.35,598.6,14550467.0,"D-Street Buzz: IndusInd Bank, Zee Ent gains 2-4%; Indiabulls Housing most active","The most active stocks included Indiabulls Housing Finance, IndusInd Bank, Max Financial Services, IRCTC and Aurobindo Pharma.",positive,neutral,-2.1975328813005364,negative,-6.14116339384957,negative
2020-02-23 10:03:29.552,539.8,539.8,489.4,506.65,17112143.0,Stock query: Aurobindo Pharma in medium-term uptrend,The stock currently tests the next vital resistance at ₹600,positive,neutral,-6.14116339384957,negative,-1.5527343749999978,negative
2020-02-24 10:00:44.787,539.8,539.8,489.4,506.65,17112143.0,"Stocks to watch: Aurobindo Pharma, Bharti Airtel, Infratel, Vodafone Idea",Here's a look at the top stocks that may remain in focus today,neutral,neutral,-6.14116339384957,negative,-1.5527343749999978,negative
2020-02-24 13:02:55.030,512.0,514.35,497.0,504.05,6182226.0,Aurobindo Pharma slips 17% as USFDA revokes VAI status for Unit-IV,"Currently, Unit 4 has 15 abbreviated new drug applications (ANDA) approvals pending over the next one year.",neutral,neutral,-1.5527343749999978,negative,0.5222703981080083,neutral
2020-02-24 18:03:18.474,512.0,514.35,497.0,504.05,6182226.0,price of Aurobindo Pharma fell up to 18% to Rs 491.90 against previous close of Rs 599.55 on BSE,price of Aurobindo Pharma fell up to 18% to Rs 491.90 against previous close of Rs 599.55 on BSE,positive,positive,-1.5527343749999978,negative,0.5222703981080083,neutral
2020-02-24 18:03:42.203,512.0,514.35,497.0,504.05,6182226.0,Aurobindo Pharma share price tanks 18% after USFDA revokes VAI status for Unit 4,"Until clarity emerges, Emkay Global expects the stock to remain under pressure.",neutral,negative,-1.5527343749999978,negative,0.5222703981080083,neutral
2020-02-25 18:00:24.970,507.4,520.0,504.0,510.05,7011271.0,Avoid Aurobindo Pharma for now: Hemang Jani,"As uncertainty would linger on for some more time and as a large part of the companys business comes from that particular Unit-4, wait until there is some clarity on the overall revenue picture, says the Senior Vice President at Sharekhan.",neutral,neutral,0.5222703981080083,neutral,1.2201073694485114,positive
2020-02-26 13:00:28.891,512.25,521.8,508.45,518.5,5669590.0,Aurobindo Pharma gains 3% on red flags from USFDA,"USFDA inspected Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad of the company.",positive,neutral,1.2201073694485114,positive,-1.5585427625170356,negative
2020-02-26 13:00:47.134,512.25,521.8,508.45,518.5,5669590.0,Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility,"According to the US health regulator, a VAI classification ""means objectionable conditions or practices were found but the agency is not prepared to take or recommend any administrative or regulatory action"".",neutral,neutral,1.2201073694485114,positive,-1.5585427625170356,negative
2020-02-26 13:00:47.735,512.25,521.8,508.45,518.5,5669590.0,Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility,"
Shares of Aurobindo Pharma were trading at Rs 508.50 a piece on BSE.",neutral,neutral,1.2201073694485114,positive,-1.5585427625170356,negative
2020-03-11 13:04:53.368,439.8,439.8,371.0,375.0,6593528.0,"Hot Stocks: Here's why you should sell Aurobindo Pharma, HUL in the short term","A level below 10150 could drag the Nifty towards 9,800 support, derived from 61.8% Fibonacci Fan of the swing seen from 6825 (Feb 2016 Bottom) to 12430 (Jan 2020 Top).",neutral,neutral,-14.733969986357437,negative,22.55219053219641,positive
2020-03-13 13:00:45.720,340.1,448.7,340.05,416.8,7711391.0,"Select pharma shares in focus, Nifty Pharma rebounds 16% from day's low","Aurobindo Pharma moved higher by 20 per cent to Rs 449, and witnessed 32 per cent rally in the intra-day deal.",positive,positive,22.55219053219641,positive,1.5,positive
2020-03-27 10:02:03.983,388.0,407.05,378.35,394.1,6782374.0,Aurobindo Pharma gets EIR for Hyderabad facility by USFDA,The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from USFDA.,neutral,neutral,1.5721649484536142,positive,0.3221649484536082,neutral
2020-03-27 10:02:29.218,388.0,407.05,378.35,394.1,6782374.0,"Stocks to watch: NTPC, YES Bank, Future Group stks, Lupin, Aurobindo Pharma",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,1.5721649484536142,positive,0.3221649484536082,neutral
2020-03-27 13:02:29.804,388.0,407.05,378.35,394.1,6782374.0,Aurobindo Pharma gains 12% after USFDA issued EIR for Hyderabad facility,The stock is trading higher for the fourth straight day and has rallied 38 per cent during the period.,positive,positive,1.5721649484536142,positive,0.3221649484536082,neutral
2020-03-27 13:03:17.863,388.0,407.05,378.35,394.1,6782374.0,Aurobindo Pharma share price jumps 11% after US FDA nod for muscle relaxant,"The stock hit upper circuit of Rs 397.50 per share. It was quoting at Rs 399.00, up Rs 37.60, or 10.40 percent.",positive,positive,1.5721649484536142,positive,0.3221649484536082,neutral
2020-04-02 10:01:46.383,353.1,411.95,333.5,380.5,17165555.0,Novartis scraps deal with Aurobindo Pharma after failing to get FTC nod,Novartis AG said on Thursday it had scrapped the sale of its US dermatology and generic pill assets to India&#39;s Aurobindo Pharma Ltd after failing to get approval from a US regulator.Novartis said,neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-02 10:02:12.029,353.1,411.95,333.5,380.5,17165555.0,Novartis scraps sale of assets to Aurobindo Pharma after failing to get FTC nod,Novartis AG said on Thursday it had scrapped the sale of its U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd after failing to get approval from a U.S. regulator.,neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-02 10:02:13.861,353.1,411.95,333.5,380.5,17165555.0,Novartis scraps sale of assets to Aurobindo Pharma after failing to get FTC nod,Novartis said the decision to terminate the sale of Sandoz US's generic oral solids and dermatology businesses was taken after the companies did not get approval from the U.S. Federal Trade Commission within anticipated timelines.,neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-02 13:03:23.722,353.1,411.95,333.5,380.5,17165555.0,Aurobindo calls off acquisition deal with Sandoz; scrip down,"Aurobindo Pharma has called of its proposed acquisition of the US dermatology business and three manufacturing units of Sandoz, a division of Swiss drug maker Novartis.“This decision was taken as appr",neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-02 18:01:23.897,353.1,411.95,333.5,380.5,17165555.0,"Aurobindo Pharma, Novartis call off $1 billion deal with Sandoz","Deal mutually terminated as approval from U.S. FTC not obtained within anticipated timelines; Under the September 2018 pact, Aurobindo was to buy U.S. generic oral solids, dermatology businesses from Sandoz Inc.",neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-02 18:02:00.093,353.1,411.95,333.5,380.5,17165555.0,"Aurobindo Pharma on Thursday said the $900 million deal to acquire Sandoz Inc's US-based generic oral solids and dermatology businesses, has been mutually called off","Aurobindo Pharma on Thursday said the $900 million deal to acquire Sandoz Inc's US-based generic oral solids and dermatology businesses, has been mutually called off",negative,negative,7.759841404701211,positive,12.0,positive
2020-04-02 18:04:08.782,353.1,411.95,333.5,380.5,17165555.0,Novartis scraps sale of assets including Covid-19 drug to Aurobindo Pharma,"Novartis is donating 130 million hydroxychloroquine doses to support efforts against the epidemic, though the European Union has so far said there is no proof it works.",neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-03 10:02:37.808,353.1,411.95,333.5,380.5,17165555.0,"Stocks to watch today on April 3: Kilpest India, Cipla, TVS Motor, Aurobindo Pharma, JB Chemicals, AIMCO Pesticides among others are the top stocks to watch out for in Friday's trading session","Stocks to watch today on April 3: Kilpest India, Cipla, TVS Motor, Aurobindo Pharma, JB Chemicals, AIMCO Pesticides among others are the top stocks to watch out for in Friday's trading session",neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-03 10:02:43.705,353.1,411.95,333.5,380.5,17165555.0,"Stocks in the news: RIL, Aurobindo Pharma, Hero MotoCorp, Adani Ports, Future Retail and ONGC",Strides Pharma said it has ceased distribution of its ranitidine tablets in the US market. ,neutral,neutral,7.759841404701211,positive,12.0,positive
2020-04-03 10:04:32.541,353.1,411.95,333.5,380.5,17165555.0,Aurobindo Pharma calls off deal with Sandoz Inc; stock hits 10% lower circuit,"This decision was taken as approval from the US Federal Trade Commission for the transaction was not obtained within anticipated timelines, the pharma company said.",neutral,negative,7.759841404701211,positive,12.0,positive
2020-04-03 13:00:17.703,353.1,411.95,333.5,380.5,17165555.0,"Aurobindo Pharma stock opened 10% lower at Rs 352.95 and hit an intra day high of 395 , signaling weak signs of recovery","Aurobindo Pharma stock opened 10% lower at Rs 352.95 and hit an intra day high of 395 , signaling weak signs of recovery",negative,negative,7.759841404701211,positive,12.0,positive
2020-04-03 13:03:14.136,353.1,411.95,333.5,380.5,17165555.0,Aurobindo Pharma share price gains 4% despite calling off deal with Sandoz,Credit Suisse has downgraded the stock to underperform from neutral and has slashed target from Rs 450 to Rs 345 per share as USFDA approvals may remain weak.,positive,negative,7.759841404701211,positive,12.0,positive
2020-04-07 23:03:12.459,432.5,476.3,426.3,438.25,13184343.0,Aurobindo Pharma faces class action suit in US for concealing facts,Aurobindo Pharma allegedly concealed facts about cancer-causing agent NDMA in type-2 diabetes drug metformin,negative,negative,1.3294797687861273,positive,1.384615384615387,positive
2020-04-07 23:04:20.758,432.5,476.3,426.3,438.25,13184343.0,Aurobindo Pharma Faces Class Action Suit In U.S. For Hiding Facts, The petition claimed that the defendants have manufactured and distributed metformin drugs throughout the United States.,neutral,neutral,1.3294797687861273,positive,1.384615384615387,positive
2020-04-08 08:33:00.000,432.5,476.3,426.3,438.25,13184343.0,"Stocks to watch: SBI, Aurobindo Pharma, Wipro, Deepak Nitrite, Hero Moto",Heres a look at the top stocks that may remain in focus today.,neutral,neutral,1.3294797687861273,positive,1.384615384615387,positive
2020-04-08 10:01:49.040,432.5,476.3,426.3,438.25,13184343.0,Aurobindo Pharma faces class action suit in US for concealing information: Media Reports,"MSP Recovery claims filed the petition on April 3, in the US District Court for the Southern District of Florida on behalf of similarly-situated healthcare insurers to recover payments unlawfully induced by the drug makers- Aurobindo Pharma, Aurolife Pharma, LLC and Heritage Pharmaceuticals LLC.",negative,neutral,1.3294797687861273,positive,1.384615384615387,positive
2020-04-09 12:52:00.000,455.0,475.95,446.0,461.3,10725718.0,Aurobindo Pharma share price jumps 6% on USFDA nod for antidepressant,Aurobindo said this was the first ANDA to be approved out of APL Healthcare formulation facility in Hyderabad.,positive,positive,1.384615384615387,positive,8.851931330472103,positive
2020-04-09 13:00:48.695,455.0,475.95,446.0,461.3,10725718.0,Aurobindo Pharma gets USFDA nod for Fluoxetine tablets; stock rises 6%,The product will be launched in April 2020.,positive,neutral,1.384615384615387,positive,8.851931330472103,positive
2020-04-09 18:03:59.038,455.0,475.95,446.0,461.3,10725718.0,Aurobindo Pharma gets USFDA nod for generic antidepressant tablets,"The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in the strengths of 10 mg and 20 mg, Aurobindo Pharma said in a filing to BSE.  The tablets are generic version of Eli Lilly's Prozac tablets, it added. The product will be launched in April 2020.",neutral,positive,1.384615384615387,positive,8.851931330472103,positive
2020-04-09 21:51:10.000,455.0,475.95,446.0,461.3,10725718.0,Aurobindo Pharma weathers scrapping of Sandoz deal,"Shares of Aurobindo Pharma jumped even after it pulled out of the Sandoz deal. However, analysts remained cautious on the stock, downgrading it.Novartis and Aurobindo Pharma last week announced the mu",neutral,positive,1.384615384615387,positive,8.851931330472103,positive
2020-04-09 23:02:31.100,455.0,475.95,446.0,461.3,10725718.0,Aurobindo Pharma gets USFDA nod for Fluoxetine tablets,"Aurobindo Pharma on Thursday said it has received the final approval from US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine Tablets, 10 mg and 20 mg. The product will be lau",neutral,positive,1.384615384615387,positive,8.851931330472103,positive
2020-04-13 12:06:00.000,466.0,529.05,463.5,507.25,13847558.0,Share market update: Pharma shares advance; Aurobindo Pharma jumps 8%,The Nifty Pharma index was trading 4.21 per cent up at 9171.1 .,positive,positive,8.851931330472103,positive,-0.4885057471264281,neutral
2020-04-15 08:24:00.000,522.0,537.5,496.75,519.45,12644374.0,"Buy Aurobindo Pharma, target price Rs 560: Suruchi Kapoor",The analyst suggested a stoploss at Rs 475 .,neutral,neutral,-0.4885057471264281,neutral,5.88235294117647,positive
2020-04-15 12:25:00.000,518.5,549.0,511.0,549.0,9903825.0,Share market update: Pharma shares advance; Aurobindo Pharma rises 6%,The Nifty Pharma index was trading 3.27 per cent up at 9340.3 .,positive,positive,5.88235294117647,positive,-2.883928571428568,negative
2020-04-20 06:00:00.000,544.25,553.5,526.75,541.1,7892406.0,Nifty Pharma index declines; Nifty PSU Bank outperforms in trade today,"Dr Reddy’s and Cipla fell 2% each, followed by Lupin and Aurobindo Pharma, which are also down 1% on the Nifty Pharma index.",negative,negative,-0.5787781350482273,neutral,22.24105461393597,positive
2020-04-21 10:03:00.000,531.0,649.1,525.5,649.1,37162045.0,Aurobindo Pharma gains 15% as USFDA grants VAI to Unit IV facility,The facility remains important as it contributes more than 10 per cent to Aurobindos overall sales and about 20 per cent of the US sales,positive,neutral,22.24105461393597,positive,-1.4000000000000037,negative
2020-04-21 10:36:06.000,531.0,649.1,525.5,649.1,37162045.0,USFDA observation lifts Aurobindo Pharma,"Shares of Aurobindo Pharmaceuicals jumped 12 per cent in early trade on Tuesday to ₹605.50 on US drug regulator observation. &quot;Further to our intimations dated 13th November 2019, 19th February a",neutral,positive,22.24105461393597,positive,-1.4000000000000037,negative
2020-04-21 11:12:00.000,531.0,649.1,525.5,649.1,37162045.0,Aurobindo Pharma share price surges 17% after FDA’s VAI status for Hyderabad unit,"The US regulator determined the inspection classification of the company’s Hyderabad unit as Voluntary Action Indicated (VAI), the company said in a filing to the exchanges.",positive,neutral,22.24105461393597,positive,-1.4000000000000037,negative
2020-04-21 11:18:00.000,531.0,649.1,525.5,649.1,37162045.0,"Share market update: Aurobindo Pharma, UCO Bank among top gainers on BSE",The Nifty 50 index was trading 231.75 points down at 9030.10 .,positive,negative,22.24105461393597,positive,-1.4000000000000037,negative
2020-04-21 12:10:00.000,650.0,684.05,631.25,640.9,31128898.0,D-Street Buzz: Pharma stocks rally led by Aurobindo Pharma; Dr Reddy’s Labs jumps 3%,"Aurobindo Pharma was the top gainer followed by Divis Labs, Dr Reddy’s Labs and Cadila Healthcare.",positive,positive,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-21 12:17:00.000,650.0,684.05,631.25,640.9,31128898.0,Share market update: Pharma shares rise; Aurobindo Pharma surges 17%,The Nifty Pharma index was trading 3.65 per cent up at 9483.4 .,positive,positive,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-21 12:17:00.000,650.0,684.05,631.25,640.9,31128898.0,Aurobindo Pharma climbs 15% on VAI status for Hyderabad plant,Nearly 6 lakh shares of Aurobindo Pharma have changed hands on the BSE so far against its two-week average of 4.63 lakh shares.,positive,positive,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-21 12:56:00.000,650.0,684.05,631.25,640.9,31128898.0,Aurobindo Pharma gets VAI classification from USFDA for Hyderabad unit,"As per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions during the inspection, FDA will not take or recommend regulatory or enforcement action because the objectionable conditions do not meet the threshold for action at th…",neutral,neutral,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-21 13:44:00.000,650.0,684.05,631.25,640.9,31128898.0,"US FDA clears Aurobindo Pharma Unit IV, reverts classification to VAI","The latest classification, VAI, suggests that though certain objectionable conditions were found during the review, they did not warrant any further regulatory action",neutral,neutral,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-21 14:11:00.000,650.0,684.05,631.25,640.9,31128898.0,Aurobindo Pharma gets VAI classification from US regulator for Hyderabad unit,"Shares of Aurobindo Pharma were trading at Rs 631 per scrip on BSE, up steep 16.73 per cent from its previous close",neutral,positive,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-22 10:46:00.000,650.0,684.05,631.25,640.9,31128898.0,"Aurobindo Pharma shares jump 3% after Credit Suisse upgrade, raises target to Rs 665/sh",Credit Suisse is of the view that progress on net debt reduction has been good so far but is concerned on low growth outlook with earnings growth seen in single digits.,positive,negative,-1.4000000000000037,negative,-2.5257612148446684,negative
2020-04-22 14:29:00.000,645.35,664.45,623.7,629.05,14401447.0,Share market update: Pharma shares rise; Aurobindo Pharma gains 2%,The Nifty Pharma index was trading 0.51 per cent up at 9429.4 .,positive,positive,-2.5257612148446684,negative,-0.2464033065733971,neutral
2020-04-22 17:57:00.000,645.35,664.45,623.7,629.05,14401447.0,"Aurobindo Pharma share rises over 6% as Credit Suisse upgrades stock, raises target price",Share price of Aurobindo Pharma rose up to 6.18% in trade today after global research firm Credit Suisse upgraded the stock to neutral from underperform and raised target price to Rs 665 from Rs 345 per share. The stock hit an intra day high of Rs 684.25,positive,positive,-2.5257612148446684,negative,-0.2464033065733971,neutral
2020-04-23 11:11:00.000,645.35,664.45,623.7,629.05,14401447.0,Trending stocks: Aurobindo Pharma shares up 1% in early session,Shares of Aurobindo Pharma Ltd. traded 0.52 per cent up in trade at 11:09AM on Thursday .,positive,positive,-2.5257612148446684,negative,-0.2464033065733971,neutral
2020-04-23 12:14:00.000,629.05,654.5,618.5,627.5,12437493.0,"Buy Aurobindo Pharma, target price Rs 770: ICICI Direct","While the recent chain of setbacks on the cGMP front will continue to weigh, a positive outcome like this is likely to provide a silver lining to a stock that is available at ~11 rimes FY22E (~30-40 per cent discount to its historical band and ~50 per cent discount to Nifty Pharma).",neutral,positive,-0.2464033065733971,neutral,0.1587301587301587,neutral
2020-04-24 09:46:00.000,629.05,654.5,618.5,627.5,12437493.0,Nifty Pharma index gains; IT index slumps in today’s trade,"Piramal, Glenmark and Divis Lab are trading in the green, while Dr Reddy’s and Aurobindo Pharma were slipped into negative zone.",negative,neutral,-0.2464033065733971,neutral,0.1587301587301587,neutral
2020-04-24 09:46:00.000,629.05,654.5,618.5,627.5,12437493.0,Nifty Pharma index gains; IT index slump in today’s trade,"Piramal, Glenmark and Divis Lab are trading in the green, while Dr Reddy’s and Aurobindo Pharma were slipped into negative zone.",positive,neutral,-0.2464033065733971,neutral,0.1587301587301587,neutral
2020-04-29 14:24:00.000,633.05,641.0,609.05,625.8,6388166.0,Share market update: Pharma shares rise; Aurobindo Pharma up 1%,The Nifty Pharma index was trading 0.12 per cent up at 9397.0 .,positive,positive,-1.1452491904272963,negative,7.021276595744677,positive
2020-05-04 05:30:00.000,611.0,681.6,603.0,653.9,16902970.0,BRIEF-Aurobindo Pharma Gets USFDA Approval For Flucytosine Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,7.021276595744677,positive,-4.36026809247685,negative
2020-05-04 14:13:00.000,663.95,668.45,627.55,635.0,6451751.0,Share market update: Pharma shares gain; Aurobindo Pharma jumps 5%,The Nifty Pharma index was trading 1.0 per cent up at 9420.35 .,positive,positive,-4.36026809247685,negative,3.834622060912096,positive
2020-05-06 14:18:00.000,657.95,671.9,646.0,649.3,6619475.0,Share market update: Pharma shares rise; Aurobindo Pharma gains 2%,The Nifty Pharma index was trading 0.23 per cent up at 9202.6 .,positive,positive,-1.3146895660764633,negative,-0.9788299567493808,negative
2020-05-08 06:14:00.000,658.95,664.4,639.6,652.5,4928111.0,"Nifty Pharma index gains 2%; Dr Reddy’s, Biocon stocks jump","Glenmark, Aurobindo Pharma and Cadia were also trading in the positive zone.",positive,positive,-0.9788299567493808,negative,2.0737327188940093,positive
2020-05-08 14:14:35.000,658.95,664.4,639.6,652.5,4928111.0,"Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%","Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a ‘buy’ rating on them",positive,positive,-0.9788299567493808,negative,2.0737327188940093,positive
2020-05-13 09:03:00.000,700.0,701.0,668.45,676.0,6082590.0,"In pics | Stocks in the news: Maruti, Jubilant Lifesciences, Havells, Nestle India, Blue Star, Aurobindo Pharma",Asian Hotels (North) | JK Paper | IndiaMart InterMesh | Agro Tech Foods | TTK Prestige | Brooks Laboratories are also some of the stocks in focus today.,neutral,neutral,-3.428571428571429,negative,-1.607407407407411,negative
2020-05-13 12:17:00.000,675.0,681.9,655.35,664.15,6898459.0,Share market update: Pharma shares slip; Aurobindo Pharma dips 3%,The Nifty Pharma index was trading 1.03 per cent down at 9151.4 .,negative,negative,-1.607407407407411,negative,-0.0376052948255114,neutral
2020-05-13 13:05:00.000,675.0,681.9,655.35,664.15,6898459.0,"Buy Aurobindo Pharma, target price Rs 790: HDFC Securities",The brokerage expects the company to become net debt free by FY22.,neutral,positive,-1.607407407407411,negative,-0.0376052948255114,neutral
2020-05-14 05:30:00.000,675.0,681.9,655.35,664.15,6898459.0,BRIEF-Aurobindo Pharma Paid Settlement Amount Of 22 Mln Rupees To SEBI - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.607407407407411,negative,-0.0376052948255114,neutral
2020-05-14 12:51:00.000,664.8,675.3,657.3,664.55,4186553.0,Aurobindo Pharma Ltd. shares gain 0.1% as Sensex falls,"Shares of Aurobindo Pharma Ltd. traded 0.1 per cent up at Rs 676.8 at 12:50PM (IST) on Thursday, even as BSE benchmark Sensex dropped 608.54 points to 31400.07. The scrip had settled at Rs 676.15 in the previous session. The stock of Aurobindo Pharma Ltd. quoted a 52-week high and 52-week low of…",positive,positive,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 16:39:21.000,664.8,675.3,657.3,664.55,4186553.0,Teva moves US court against Aurobindo Pharma on cancer drug Bendeka,"Teva Pharmaceuticals, along with Cephalon Inc and Eagle Pharmaceuticals, has filed a petition in a US court against Aurobindo Pharma alleging that the Indian drug-maker is planning to come out with a",negative,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 18:01:00.000,664.8,675.3,657.3,664.55,4186553.0,"Aurobindo Pharma, promoters settle insider trading case with SEBI","The three other entities that have settled the matter with the regulator are Kambam P Reddy, Trident Chemphar Ltd and Veritaz Health Care Ltd.",neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 18:32:00.000,664.8,675.3,657.3,664.55,4186553.0,"Aurobindo Pharma, Promoters Settle Insider Trading Case With SEBI",Aurobindo Pharma has settled an alleged insider trading case with SEBI after paying over Rs 22 crore towards settlement charges.,neutral,positive,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 20:18:53.000,664.8,675.3,657.3,664.55,4186553.0,"Aurobindo Pharma, promoters pay ₹22 cr, settle case with SEBI","Press Trust of India Aurobindo Pharma, its promoter PV Ramprasad Reddy, his wife P Suneela Rani, and three other entities have settled an alleged insider trading case with markets regulator SEBI aft",neutral,positive,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 20:29:00.000,664.8,675.3,657.3,664.55,4186553.0,"Aurobindo Pharma, promoters settle insider trading case with Sebi - The Economic Times","Sebi had done an investigation into the trading in the scrip of Aurobindo Pharma during the period from July 22, 2008 to March 20, 2009",neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-14 23:18:13.000,664.8,675.3,657.3,664.55,4186553.0,"Aurobindo Pharma, promoters settle insider trading case",Case involved trading in firm’s scrip in violation of norms,neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 06:51:59.000,664.8,675.3,657.3,664.55,4186553.0,"Stocks To Watch: Aurobindo Pharma, Cipla, Indiabulls Real Estate, L&T Tech, Manappuram Finance, M&M Financial, Nippon Life",Here are the stocks to watch in trade today.,neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 07:59:00.000,664.8,675.3,657.3,664.55,4186553.0,"Top stocks in focus: Cipla, Unichem Labs, L&T Finance, Aurobindo Pharma, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 08:09:00.000,664.8,675.3,657.3,664.55,4186553.0,"Stocks to watch: Biocon, Cipla, Aurobindo Pharma, Tata Group stocks, Nocil",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 10:22:00.000,664.8,675.3,657.3,664.55,4186553.0,"Stocks in the news: Cipla, Aurobindo Pharma, GMR Infra, Indiabulls Real Estate and Ashok leyland",Here are a few stocks which may create some buzz in Fridays trade.,neutral,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 10:37:00.000,664.8,675.3,657.3,664.55,4186553.0,Trending stocks: Aurobindo Pharma shares down 1%,"A total of 67,853 shares changed hands on the counter till 10:35AM (IST).",negative,neutral,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-15 11:24:00.000,664.8,675.3,657.3,664.55,4186553.0,Buy Aurobindo Pharma; target of Rs 790: HDFC Securities,"HDFC Securities bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 790 in its research report dated May 13, 2020.",neutral,positive,-0.0376052948255114,neutral,0.6015037593984963,neutral
2020-05-25 11:23:00.000,725.0,734.8,709.15,717.0,3717928.0,Slideshow | Reliance Securities bets on these 5 stocks for 11-68% returns,"Reliance Securities bet on Bharti Airtel, Granules India, Aurobindo Pharma, Escorts and Alembic Pharma with an upside of 11-68 percent.",neutral,positive,-1.103448275862069,negative,-0.805779383161983,neutral
2020-05-29 09:23:52.000,715.9,750.35,711.2,735.0,8499197.0,"Aurobindo Pharma to invest Rs 1,500 cr in Andhra Pradesh","Aurobindo Pharma Ltd will invest ₹1,500 crore to ₹2,000 crore in Andhra Pradesh over next three years.This was announced by Madan Mohan Reddy, Director, Board of Aurobindo Pharma in Amaravati, in a me",neutral,neutral,2.667970386925552,positive,-2.28494623655914,negative
2020-05-29 13:44:00.000,715.9,750.35,711.2,735.0,8499197.0,"Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high","Dr Reddys, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.",neutral,positive,2.667970386925552,positive,-2.28494623655914,negative
2020-06-02 11:25:00.000,729.0,757.7,725.35,735.5,6276390.0,"Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018","Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.",positive,positive,0.8916323731138546,neutral,2.5679347826086927,positive
2020-06-03 05:30:00.000,736.0,758.7,735.15,754.9,5743161.0,BRIEF-Aurobindo Pharma March Quarter Consol Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 06:26:49.000,736.0,758.7,735.15,754.9,5743161.0,"Stocks To Watch: Aurobindo Pharma, BPCL, Britannia, HUL, ICICI Bank, Infosys, InterGlobe Aviation, ONGC, HPCL, RIL, TCS",Here are the stocks to watch in trade today.,neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 07:38:00.000,736.0,758.7,735.15,754.9,5743161.0,"Board Meetings Today: BPCL, Aurobindo Pharma, MAS Financial and Dishman Carbogen",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 07:46:43.000,736.0,758.7,735.15,754.9,5743161.0,Aurobindo Pharma Q4 Profit May Report Double-digit Growth Led By Key Geographies,The stock shot up 149 percent from its March lows especially after increased focus on healthcare worldwide due to COVID-19 crisis.,neutral,positive,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 09:07:45.000,736.0,758.7,735.15,754.9,5743161.0,"Stocks in focus: RIL, Aurobindo Pharma, Syngene International, Britannia, IndiGo, Lupin","Orient Hotels, DCM Shriram, BPCL, Aurobindo Pharma, MAS Financial Services, Cholamandalam Investment and Dishman Carbogen are among 15 companies which are scheduled to announce their March quarter earnings today",neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 09:31:00.000,736.0,758.7,735.15,754.9,5743161.0,"Stocks in news: ICICI Bank, Aurobindo Pharma, BPCL, Lupin, Britannia, IndiGo, Motherson Sumi and more","Stocks to watch today on May June 3: ICICI Bank, Aurobindo Pharma, BPCL, Lupin, Britannia, IndiGo, Motherson Sumi among others are the top stocks to watch out for in Wednesday’s trading session",neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 10:25:00.000,736.0,758.7,735.15,754.9,5743161.0,Trending stocks: Aurobindo Pharma shares up nearly 2%,"A total of 59,552 shares changed hands on the counter till 10:22AM (IST).",positive,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 10:36:00.000,736.0,758.7,735.15,754.9,5743161.0,"Stocks in the news: RIL, BPCL, IndiGo, Lupin, Dixon Tech, HUL, YES Bank and Aurobindo Pharma","MAS Financial Services, Orient Hotels and DCM Shriram will announce Q4 results today.",neutral,neutral,2.5679347826086927,positive,-1.6795865633074936,negative
2020-06-03 13:28:00.000,774.0,791.0,753.55,761.0,18785905.0,"Top stocks in focus: Aurobindo Pharma, BPCL, ICICI Bank, Kotak Mahindra Bank",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 16:09:00.000,774.0,791.0,753.55,761.0,18785905.0,"Share Market Update: Sensex ends 284 points higher, Nifty at 10,061; Bajaj Finance, Kotak Bank top gainers","Stock Market LIVE Updates: Companies set to announce their earnings are Aurobindo Pharma, DCM Shriram, BPCL, Cholamandalam Investment, MAS Financial Services, Duncan Engineering, DISA, Shriram Asset Management among others",positive,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 19:54:00.000,774.0,791.0,753.55,761.0,18785905.0,"Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore","In the fourth quarter ended March FY20, Aurobindo Pharma’s revenue from operations was recorded at Rs 6,158.4 crore",positive,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 20:16:06.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma’s Net Jumps By 45% To Rs 850 Crore In Q4,"For the full year 2019-20, revenue from operations was at Rs 23,098.5 crore witnessing a growth of 18.1 percent over 2018-19.",neutral,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 20:18:16.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma’s net jumps by 45% to ₹850 crore in Q4,"The net profit, after JV share and minority interest, jumped by 19.7% to ₹2,831 crore as against ₹2,364. 7 crore in FY ’19.Managing director of the company N Govindarajan said it closed FY ’20 with a healthy performance in Q4 and the growth was seen across all the geographies",positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 20:49:00.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue,Revenues from operations for the quarter under review registered 16.4% growth at Rs 6158.43 crore as compared to Rs 5324.47 crore in the year ago period,positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 21:30:35.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma hives off biosimilar business to subsidiary,"The decision was taken at the company’s board meeting on Wednesday, where it also finalised its earnings for the January-March quarter.The company also aims to improve operational efficiency of its business and is looking for a potential listing opportunity for the wholly-owned subsidiary in future",neutral,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 21:55:35.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma Q4 net up 45% at ₹850 cr,Aurobindo Pharma Ltd’s consolidated net profit increased 45.2 per cent at ₹850 crore in the fourth quarter ended March 31 against ₹585 crore in the same quarter last year. The total revenue of the Hyd,positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-03 22:29:36.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma net up 45%,Formulations business growth boosts performance,positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 00:13:39.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma net profit up 45.2% at Rs 849.8 crore in Q4,"The US market revenue witnessed a growth of 20.5% y-o-y to Rs 2,990.3 crore, accounting 48.6% of consolidated revenue.",positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 02:13:04.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma Q4 consolidated profit soars 45% on strong formulation sales,"The Hyderabad-based drugmaker’s revenue grew 16.4% at ₹6,158 crore, with sales of anti-retrovirals increasing 31% to ₹382 crore.Aurobindo Pharma’s research and development spend for the quarter stood at ₹238.9 crores, which is 3.9% of its revenue",positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 05:30:00.000,774.0,791.0,753.55,761.0,18785905.0,"BRIEF-Aurobindo Pharma Says ‘Form 483’ Issued With 9 Observations After USFDA Inspection Of Dayton, New Jersey Plant - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 06:28:10.000,774.0,791.0,753.55,761.0,18785905.0,"Stocks To Watch: Aurobindo Pharma, Berger Paints, BPCL, DB Corp, DLF, RIL, SRF",Here are the stocks to watch in trade today.,neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 07:44:48.000,774.0,791.0,753.55,761.0,18785905.0,"In Pics | Stocks In The News: GAIL India, HDFC Life, BPCL, NLC India, VST Tillers, JSPL",Neogen Chemicals | SH Kelkar | SP Apparels | SREI Infrastructure | Shree Renuka Sugars | Aurobindo Pharma | Cholamandalam Investment | Aurobindo Pharma | MAS Financial Services | DCM Shriram | Vesuvius India | Persistent Systems | Asian Oilfield Services | DB Corp are also in focus.,neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 08:03:00.000,774.0,791.0,753.55,761.0,18785905.0,"Stocks in the news: HDFC Life, RIL, DLF, Adani Enterprises, Aurobindo Pharma and JSPL","PNB Gilts, Igarashi Motors and TD Power are among a few companies which will announce their march quarter earnings today.",neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 08:58:00.000,774.0,791.0,753.55,761.0,18785905.0,"Stocks to watch: BPCL, HDFC Life, DLF, Aurobindo Pharma, RIL, SRF, GAIL",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 09:02:51.000,774.0,791.0,753.55,761.0,18785905.0,"Stocks in focus: HDFC Life, RIL, BPCL, Aurobindo Pharma, among others to remain in focus","NIIT, PNB Gilts, SRF, DLF, PI Industries, Chemfab Alkalis, Safari Industries, and Tourism Finance Corporation are among 15 companies that are scheduled to announce their March quarter earnings today",neutral,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 09:29:00.000,774.0,791.0,753.55,761.0,18785905.0,"Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY","That apart, the company informed the exchanges that the US FDA has classified the inspection of the companys oral solids formulation manufacturing facility at New Jersey as Official Action Indicated",positive,neutral,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 09:40:25.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma Share Price Hits 52-week High On Better Q4 Numbers; Credit Suisse Gives Target Of Rs 665,"Revenue from operations grew by 16.4 percent to Rs 6,158.4 crore during the quarter.",neutral,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 11:37:22.000,774.0,791.0,753.55,761.0,18785905.0,Aurobindo Pharma shares rally after robust quarterly earnings,Shares of Aurobindo Pharma on Thursday gained over 5 per cent to touch its one-year high level after the company reported a 45 per cent rise in consolidated net profit for the quarter ended March 2020,positive,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 11:48:12.000,774.0,791.0,753.55,761.0,18785905.0,"D-Street Buzz: Nifty Pharma Gains Led By Biocon; Lupin; Volumes Of Sun Pharma, Aurobindo Pharma Rise","Among the sectors, Nifty Pharma added over a percent led by Sun Pharma, Biocon, Lupin and Torrent Pharma which gained 2 percent each followed by Aurobindo Pharma, Cipla, Divis Labs and Dr Reddy’s Labs among others.",neutral,positive,-1.6795865633074936,negative,-2.6143790849673203,negative
2020-06-04 12:12:00.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma share hits 52-week high post Q4 earnings,"Aurobindo Pharma share price opened with a gain of 3.91% today and later touched an all-time high of Rs 791, rising 5.38% on BSE against the last closing value of Rs 750.65",neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 13:28:00.000,765.0,775.6,740.05,745.0,5600365.0,"Top stocks in focus: Aurobindo Pharma, BPCL, DB Corp, GAIL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 13:40:00.000,765.0,775.6,740.05,745.0,5600365.0,"Buy Aurobindo Pharma, target price Rs 870: ICICI Securities",The brokerage has raised its earnings estimates by 5-6 per cent to factor in higher revenue in US & emerging markets with better gross margin.,neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 13:57:00.000,765.0,775.6,740.05,745.0,5600365.0,"Stocks in news: Aurobindo Pharma, DLF, Powergrid, ONGC, HPCL, Indian Oil, Bharat Petroleum and more","Stocks to watch today on June 4: Aurobindo Pharma, DCM Shriram, Powergrid, ONGC, HPCL, Indian Oil, Bharat Petroleum among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 15:45:00.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma surges 5% on strong Q4 results,"“Strong execution and debt reduction should continue to drive the stocks outperformance. Aurobindo Pharma is one of our top large cap picks and a significant overweight,” said Emkay Global.",positive,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 16:29:00.000,765.0,775.6,740.05,745.0,5600365.0,"Aurobindo Pharma surges 5% on robust growth in Q4FY20; US, Europe drive sales","Aurobindo recorded a consolidated net profit of Rs849.8cr in Q4FY20 vs. Rs585.4cr in Q4FY19, resulting in 45.2% rise.",positive,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 16:47:06.000,765.0,775.6,740.05,745.0,5600365.0,FDA Issues Form 483 With 9 Observations To Aurobindo Pharma’s USA Facility,"The plant which makes oral solid manufacturing is situated at Dayton, New Jersey and was inspected by the FDA authorities from January 13, 2020 to February 12, 2020.",neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 17:13:00.000,765.0,775.6,740.05,745.0,5600365.0,"Sensex, Nifty trade lower; Aurobindo Pharma, Cipla stocks hit 52-week high","Vedanta, Tech Mahindra, Sun Pharma, Cipla and BPCL were among top gainers, on the other hand, Titan, Asian Paints, Kotak Bank, Britannia and HDFC were trading in the red.",neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 18:13:00.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma board approves to transfer Biosimilars biz for Rs361.46 cr,Aurobindo will transfer its Biosimilars business to another wholly-owned subsidiary CuraTeQ Biologics.,neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-04 20:40:50.000,765.0,775.6,740.05,745.0,5600365.0,U.S. FDA Issues Form 483 With Nine Observations To Aurobindo Pharma’s U.S. Facility,"The plant which makes oral solid manufacturing is situated at Dayton, New Jersey.",neutral,neutral,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 09:35:12.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma Share Price Gains 2% After CLSA Raises Target Price,CLSA increased FY21-22 EPS estimates by 8-10%.,neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 09:37:30.000,765.0,775.6,740.05,745.0,5600365.0,Buy Aurobindo Pharma; Target Of Rs 786: Emkay Global Financial,"Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 786 in its research report dated June 03, 2020.",neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 11:56:02.000,765.0,775.6,740.05,745.0,5600365.0,Buy Aurobindo Pharma; Target Of Rs 870: ICICI Securities,"ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 870 in its research report dated June 04, 2020.",neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 12:03:38.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma share price surges 159% since March; does it have more upside left? Check target price,"Pharmaceutical giant Aurobindo Pharma might have posted a strong January-March quarter with profits after tax surging 29.7% on-year basis and gross margins going up 2.9% from a year ago period, but the stock has little steam left now after jumping over 159% since its March lows.",positive,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 12:17:00.000,765.0,775.6,740.05,745.0,5600365.0,"Buy Aurobindo Pharma, target price Rs 880: Motilal Oswal","The brokerage raised the companys EPS estimate for FY20/FY21 by 4.4 per cent/9 per cent, and expects a 9 per cent earnings CAGR over FY20–22, led by new launches and increased market share in key markets,",neutral,positive,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-05 16:37:00.000,765.0,775.6,740.05,745.0,5600365.0,Aurobindo Pharma share gains 175% from its 52-week low; check what brokerages say,"Aurobindo Pharma stock erased early gains and fell in today’s trade as the USFDA issued a ‘Form 483’ with 9 observations to its subsidiary, AuroLife Pharma’s manufacturing facility in the US.",positive,negative,-2.6143790849673203,negative,-0.4968532626697582,neutral
2020-06-07 20:26:16.000,754.75,757.2,728.8,751.0,5304519.0,Accumulate Aurobindo Pharma; Target Of Rs 838: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated June 05, 2020.",neutral,positive,-0.4968532626697582,neutral,2.337748344370858,positive
2020-06-07 20:35:35.000,754.75,757.2,728.8,751.0,5304519.0,Hold Aurobindo Pharma Target Of Rs 840: Sharekhan,"Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 840 in its research report dated June 04, 2020.",neutral,positive,-0.4968532626697582,neutral,2.337748344370858,positive
2020-06-07 20:36:50.000,754.75,757.2,728.8,751.0,5304519.0,Buy Aurobindo Pharma; Target Of Rs 880: Motilal Oswal,"Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 880 in its research report dated June 04, 2020.",neutral,positive,-0.4968532626697582,neutral,2.337748344370858,positive
2020-06-07 20:50:06.000,754.75,757.2,728.8,751.0,5304519.0,Buy Aurobindo Pharma; Target Of Rs 835: Emkay Global Financial,"Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June 04, 2020.",neutral,positive,-0.4968532626697582,neutral,2.337748344370858,positive
2020-06-08 18:11:58.000,755.0,784.0,754.0,772.65,8617140.0,Teji Mandi: Hallow around Aurobindo Pharma deepens with strong international business!,"Aurobindo Pharma Ltd March quarter results were a step ahead of the Street’s expectations with revenues and profitability showing all-round improvement. Growth in Q4FY20 was led by Europe, the Rest of the World. The US market remained resilient on stocking of anti-infectives and anti-virals.",positive,positive,2.337748344370858,positive,2.822268147765424,positive
2020-06-11 17:25:15.000,765.0,784.5,763.7,773.5,4465632.0,"Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US","The complaint is the third to be filed in an ongoing investigation that is possibly the largest domestic corporate cartel case in the history of the United States.The lawsuit seeks damages, civil penalties, and actions by the court to restore competition to the generic drug market",neutral,neutral,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-11 21:17:10.000,765.0,784.5,763.7,773.5,4465632.0,"Aurobindo Pharma, Sun Pharma, Lupin Named In Lawsuit In The U.S.",The three Indian drugmakers are among the twenty-six that have been accused of manipulating generic drug prices across the U.S.,neutral,neutral,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-11 21:21:53.000,765.0,784.5,763.7,773.5,4465632.0,"Price ‘manipulation’: Sun Pharma, Lupin, Aurobindo named in US lawsuit","Aurobindo Pharma, Sun Pharma and Lupin are among the 26 drug makers facing a multi-state lawsuit filed in the US by Maryland Attorney General for alleged “conspiracy to artificially inflate and manipu",neutral,neutral,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-12 08:20:05.000,765.0,784.5,763.7,773.5,4465632.0,"Pricing Problems: Aurobindo Pharma, Sun Pharma, Lupin Named In Lawsuit In US","Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and the complaint names 26 corporate defe…",neutral,neutral,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-12 08:49:00.000,765.0,784.5,763.7,773.5,4465632.0,Top domestic pharma companies in US probe for price-fixing,"Domestic majors — including Sun Pharma, Lupin and Aurobindo Pharma — along with US biggies Sandoz, Pfizer and Mylan have been charged with price-fixing and collusion on topical dermatology medication in a fresh lawsuit filed in the US.",neutral,neutral,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-12 12:12:00.000,765.0,784.5,763.7,773.5,4465632.0,Share market update: Pharma shares slip; Aurobindo Pharma falls 3%,The Nifty Pharma index was trading 0.62 per cent down at 9872.05.,neutral,negative,1.1111111111111112,positive,0.3785406604881839,neutral
2020-06-15 23:55:46.000,779.7,785.1,756.1,767.25,3114768.0,"Cancel ‘108’ ambulance contract with Aurobindo Pharma, Kanna tells govt.",‘The company is charging exorbitantly for the service’,positive,neutral,-1.5967679876875778,negative,1.7584690974915984,positive
2020-06-17 12:04:00.000,788.95,798.1,783.0,788.2,2843559.0,Share market update: Pharma shares advance; Aurobindo Pharma gains 2%,The Nifty Pharma index was trading 0.72 per cent up at 9997.9.,positive,positive,-0.0950630584954686,neutral,-0.8618504435994873,neutral
2020-06-22 16:48:00.000,790.5,816.75,788.25,803.25,5476994.0,Aurobindo Pharma plans to launch 50-60 products in US in FY21,The company has received final approval for six ANDAs (abbreviated new drug application) and launched four products in the fourth quarter of last fiscal.,positive,positive,1.6129032258064515,positive,-2.278325123152709,negative
2020-06-22 19:01:46.000,790.5,816.75,788.25,803.25,5476994.0,"Despite political tensions, Aurobindo Pharma bullish on business in China",Drugmaker begins filing products from India for the Chinese market,positive,neutral,1.6129032258064515,positive,-2.278325123152709,negative
2020-06-23 12:03:00.000,812.0,819.75,785.1,793.5,3908131.0,Share market update: Pharma shares advance; Aurobindo Pharma rises 3%,The Nifty Pharma index was trading 1.16 per cent up at 10336.75.,positive,positive,-2.278325123152709,negative,0.0,neutral
2020-06-25 15:00:05.000,794.95,797.0,775.1,781.5,2719662.0,"Developing A Range Of Products For US, EU Markets: Aurobindo Pharma","The firm is developing eight inhalers and six nasal sprays, out of which two products have already been filed, Aurobindo Pharma Managing Director N Govindarajan said in an analyst call.",neutral,neutral,-1.6919303100824008,negative,0.701530612244898,neutral
2020-06-25 15:05:02.000,794.95,797.0,775.1,781.5,2719662.0,F&O Expiry: These 4 Stocks Have Given At Least 10% Return In Last 3 Series,"The four stocks that were winners in last 3 series were M&M, Vodafone Idea, Balkrishna Industries and Aurobindo Pharma",neutral,positive,-1.6919303100824008,negative,0.701530612244898,neutral
2020-06-25 15:46:00.000,794.95,797.0,775.1,781.5,2719662.0,"Aurobindo Pharma developing products to expand portfolio in US, EU markets","Currently, five products are under development, out of which the first two products would be filed towards the end of this year or early next year",positive,neutral,-1.6919303100824008,negative,0.701530612244898,neutral
2020-06-25 15:53:00.000,794.95,797.0,775.1,781.5,2719662.0,"Developing a range of products for US, EU markets: Aurobindo Pharma","The firm is developing eight inhalers and six nasal sprays, out of which two products have already been filed, Aurobindo Pharma Managing Director N Govindarajan said in an analyst call.",neutral,neutral,-1.6919303100824008,negative,0.701530612244898,neutral
2020-06-30 09:03:00.000,790.0,793.9,763.1,770.7,3493345.0,"Markets closed on a volatile note; Nifty holds 10,300 level","The Nifty Pharma index slipped ~1.5% as stocks like Sun Pharma, Dr Reddys, Cipla & Aurobindo Pharma trended lower along with an addition of short positions.",neutral,negative,-2.4430379746835382,negative,0.8990944372574444,neutral
2020-06-30 12:14:00.000,773.0,781.95,766.55,779.95,2931351.0,Share market update: Pharma shares dip; Aurobindo Pharma down 2%,The Nifty Pharma index was trading 0.88 per cent down at 10047.2.,negative,negative,0.8990944372574444,neutral,0.0,neutral
2020-07-06 07:41:00.000,777.85,786.6,764.5,768.5,2202881.0,"Stocks in the news: Reliance Ind, ICICI Bank, Future Retail, Indiabulls Housing, YES Bank, Biocon and NBCC","Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market.",neutral,negative,-1.202031239956293,negative,0.8054040010392369,neutral
2020-07-06 08:54:19.000,777.85,786.6,764.5,768.5,2202881.0,"Stocks in focus: ICICI Bank, Yes Bank, Coal India, Federal Bank, Lupin, Aurobindo Pharma, NBCC","Sadbhav Infrastructure Project, NBCC (India), BCL Industries, BMW Industries, Bodal Chemicals, DCW, Dynamic Industries, IFB Agro Industries, IFB Industries, JMD Ventures, Nyssa Corporation, Welcure Drugs & Pharmaceuticals are among 35 companies that are scheduled to announce their March quarter earn…",neutral,neutral,-1.202031239956293,negative,0.8054040010392369,neutral
2020-07-06 12:10:00.000,769.8,790.0,769.8,776.0,3052283.0,Share market update: Pharma shares down; Aurobindo Pharma dips 2%,The Nifty Pharma index was trading 1.02 per cent down at 9861.4.,negative,negative,0.8054040010392369,neutral,2.554278416347382,positive
2020-07-07 12:07:00.000,783.0,807.45,777.7,803.0,4306893.0,Share market update: Pharma shares up; Aurobindo Pharma gains 2%,The Nifty Pharma index was trading 0.19 per cent up at 9920.35.,positive,positive,2.554278416347382,positive,0.7663782447466063,neutral
2020-07-08 11:32:00.000,783.0,807.45,777.7,803.0,4306893.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma; Dr Reddy’s labs, Aarti Drugs gain 3-4%",Pharma index gained over a percent led by Aurobindo Pharma which gained over 3 percent followed by Dr Reddy’s Labs and Alkem Labs which were up 2 percent each.,positive,positive,2.554278416347382,positive,0.7663782447466063,neutral
2020-07-08 12:06:00.000,809.0,822.0,801.05,815.2,5297217.0,Share market update: Pharma shares advance; Aurobindo Pharma gains 3%,The Nifty Pharma index was trading 1.18 per cent up at 9994.35.,positive,positive,0.7663782447466063,neutral,1.04679802955665,positive
2020-07-09 10:10:00.000,809.0,822.0,801.05,815.2,5297217.0,Aurobindo Pharma share price at 52-week high on US FDA nod to blood pressure drug,"The stock, which has surged 86 percent in the last three months, hitting a new high of Rs 821.90.",positive,positive,0.7663782447466063,neutral,1.04679802955665,positive
2020-07-09 23:43:07.000,812.0,828.7,809.0,820.5,4736700.0,Bringing down response time for ambulances our goal: Aurobindo Pharma Foundation COO,108 service network strengthened across district,neutral,positive,1.04679802955665,positive,-2.079555071938102,negative
2020-07-10 10:34:00.000,812.0,828.7,809.0,820.5,4736700.0,"Pharma stocks gain led by Sun Pharma, Biocon; Aurobindo Pharma hits new 52-week high","Cipla, Dr Reddy’s Labs, Divis Labs and Torrent Pharma added 1-2 percent each.",positive,neutral,1.04679802955665,positive,-2.079555071938102,negative
2020-07-20 11:52:00.000,835.0,841.95,817.6,824.4,2277694.0,"D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher","Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.",positive,negative,-1.2694610778443145,negative,-2.974607013301091,negative
2020-07-30 10:53:00.000,814.0,830.8,807.75,822.6,3910040.0,"Pharma stocks gain led by Dr Reddy’s Labs, stock hits 52-week high; Cadila Health, Lupin rise","Dr Reddy’s Labs was the top gainer hitting new 52-week high followed by Divis Labs, Torrent Pharma, Lupin, Cadila Healthcare, Cipla and Aurobindo Pharma.",positive,positive,1.0565110565110594,positive,6.638246041412911,positive
2020-07-30 12:22:00.000,821.0,881.0,820.0,875.5,7946615.0,Nifty Pharma index rally nearly 3% led by Dr Reddy’s,"Shares of Divi’s Lab climbed 4.5%, followed by Torrent Pharma, Lupin, Biocon, Aurobindo Pharma and Sun Pharma were up over in the range of 3-2%, respectively.",positive,positive,6.638246041412911,positive,-0.7088144506688059,neutral
2020-07-30 13:50:07.000,821.0,881.0,820.0,875.5,7946615.0,Aurobindo Pharma Ltd stays supported,"Aurobindo Pharma Ltd is quoting at Rs 821.3, up 1.15% on the day as on 12:54 IST on the NSE. The stock is up 43.77% in last one year as compared to a 1.01% jump in NIFTY and a 34.14% jump in the Nifty Pharma index.",neutral,positive,6.638246041412911,positive,-0.7088144506688059,neutral
2020-07-31 16:25:59.000,821.0,881.0,820.0,875.5,7946615.0,"Sensex, Nifty fall for third consecutive session on Friday; here’s what to expect next week","Nifty Pharma surged over 3.5 per cent led by Torrent Pharma, Aurobindo Pharma, Cadila Healthcare and Sun Pharma",neutral,positive,6.638246041412911,positive,-0.7088144506688059,neutral
2020-08-04 08:09:33.000,868.5,874.65,850.5,867.0,2667511.0,Aurobindo Pharma Has Been The Alpha Among Indian Drugmakers This Year,A closer look at why the drugmaker has stood out among peers.,neutral,neutral,-0.1727115716753022,neutral,-0.5926352128883748,neutral
2020-08-04 22:32:00.000,869.0,882.65,853.1,863.85,3622641.0,Insider trading: SEBI asks Top Class to disgorge Rs 3.77cr made in Aurobindo Pharma’s scrip,"s. The amount has to be paid along with 12 percent per annum interest from March 4, 2009, till the date of actual payment of disgorgement amount within 45 days from the date of coming into force of the order, regulator said.",neutral,neutral,-0.5926352128883748,neutral,5.955967555040553,positive
2020-08-07 02:29:00.000,914.0,923.0,898.0,905.9,7553235.0,"Sensex, Nifty trade volatile; Lupin, Biocon stocks dip","Biocon, Torrent Pharma, Sun Pharma, Aurobindo Pharma and Cipla also fell in the pharma index.",neutral,negative,-0.8862144420131316,neutral,4.41949616648412,positive
2020-08-07 08:24:00.000,914.0,923.0,898.0,905.9,7553235.0,"Trade Spotlight: Aarti Drugs, Caplin Point & Aurobindo Pharma hit 52-week high, what should investors do?","Experts are of the view that investors should trade with caution, and a more sustainable move can be seen only a close above 11225. Immediate support is placed at 11,100 levels.",positive,neutral,-0.8862144420131316,neutral,4.41949616648412,positive
2020-08-07 11:48:00.000,914.0,923.0,898.0,905.9,7553235.0,Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding,"In November 2019, Aurobindo Pharma said its subsidiary Auro Vaccines LLC entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of USD 11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones.",neutral,positive,-0.8862144420131316,neutral,4.41949616648412,positive
2020-08-07 12:50:00.000,914.0,923.0,898.0,905.9,7553235.0,COVID-19 pandemic: Aurobindo Pharma developing vaccine; gets shortlisted for BIRAC funding,The company has successfully completed the Phase-I and Phase II studies. Phase-III clinical study is expected to be initiated by December 2020.,neutral,positive,-0.8862144420131316,neutral,4.41949616648412,positive
2020-08-07 12:54:12.000,914.0,923.0,898.0,905.9,7553235.0,Aurobindo Pharma working on COVID-19 vaccine; Shortlisted for BIRAC funding,"“During the year (FY20), we have further strengthened our presence in the vaccines segment through the acquisition of R&D assets from Profectus Biosciences through Auro Vaccines. Using those R&D assets, the team is working on developing several viral vaccines, including a vaccine for COVID-19,” it s…",neutral,positive,-0.8862144420131316,neutral,4.41949616648412,positive
2020-08-10 01:33:00.000,913.0,967.5,913.0,953.35,9690086.0,"Nifty Pharma index outperforms; Cipla, Divi’s Lab extends gain","Shares of Lupin climbed over 7%, followed by Aurobindo Pharma, Cadila, Sun Pharma and Torrent Pharma which are up in the range of 5-3%, respectively.",positive,positive,4.41949616648412,positive,-1.0520833333333357,negative
2020-08-10 07:22:00.000,913.0,967.5,913.0,953.35,9690086.0,"Market Ahead, Aug 10: Top factors that could guide markets this week","Among major earnings to be announced this week are Titan, Aurobindo Pharma, Bank of Baroda, BPCL, Hero MotoCorp, and MRF",neutral,neutral,4.41949616648412,positive,-1.0520833333333357,negative
2020-08-10 11:37:00.000,913.0,967.5,913.0,953.35,9690086.0,"D-Street Buzz: Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each","Lupin gained over 5 percent followed by Sun Pharma and Dr Reddy’s Labs up 3 percent each while Biocon, Cadila Healthcare and Aurobindo Pharma were the other gainers.",positive,positive,4.41949616648412,positive,-1.0520833333333357,negative
2020-08-10 17:09:00.000,960.0,964.65,932.1,949.9,5177139.0,"L&T, financials drive Sensex 142 points higher; Nifty above 11,250","Nifty Pharma rallied 5.46 per cent led by up to 12 per cent gains in Divis Labs, Lupin, Cipla, Aurobindo Pharma and Cadila Healthcare.",positive,positive,-1.0520833333333357,negative,-2.331674089599161,negative
2020-08-12 05:30:00.000,954.25,957.85,922.5,932.0,7897440.0,BRIEF-India’s Aurobindo Pharma June-Quarter Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 07:25:00.000,954.25,957.85,922.5,932.0,7897440.0,"Top stocks in focus: Aurobindo Pharma, Eicher Motors, Adani Ports, HDFC, Ashok Leyland",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 07:30:00.000,954.25,957.85,922.5,932.0,7897440.0,"Market Ahead, Aug 12: All you need to know before the opening bell","A total of 137 companies, including Aurobindo Pharma, Ashok Leyland, and Tata Power are scheduled to announce their June quarter results today",neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 07:43:00.000,954.25,957.85,922.5,932.0,7897440.0,"Stocks in the news: Aurobindo Pharma, Bharat Forge, Tata Power, JMC Projects, Adani Ports and Bosch","HDFC announced raising more than Rs 14,000 crore through a qualified institutional placement (QIP) issue of equity shares, warrants and bonds.",neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 07:57:00.000,954.25,957.85,922.5,932.0,7897440.0,Aurobindo Pharma Q1FY21; consolidated net profit rises by ~23% yoy,The company recorded a consolidated profit of ~Rs781cr in Q1FY21.,positive,positive,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 08:51:00.000,954.25,957.85,922.5,932.0,7897440.0,"Stocks to watch: Aurobindo Pharma, Wipro, Ashok Leyland, Eicher Motors",Heres a list of stocks that may trade actively in todays trading session.,neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 09:06:22.000,954.25,957.85,922.5,932.0,7897440.0,"Stocks in focus: IRCTC, HDFC, Wipro, Ashoka Buildcon, IndusInd Bank, defence, aerospace stocks","Ashok Leyland, Tata Power, Aurobindo Pharma, Bharat Forge, Century Plyboards, Cummins India, Graphite India, GSFC, Gulf Oil Lubricants, Natco Pharma, NCC, Sundram Fasteners, Transport Corporation of India, are among 137 companies that are scheduled to announce their quarterly earnings today.",neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 11:03:00.000,954.25,957.85,922.5,932.0,7897440.0,Was June quarter show a one-time surprise from Divi’s Lab?,"During a spectacular rally on Monday post June quarter earnings, the stock beat the likes of Cipla and Aurobindo Pharma to become the second-most valuable listed pharma company in India.",positive,positive,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 11:45:00.000,954.25,957.85,922.5,932.0,7897440.0,"Share Market News Live: Sensex drops 245 points, Nifty at 11,254; Cipla, Dr Reddy, Bajaj twins top losers","Dalal Street today: April-June quarterly earnings announcements by Aurobindo Pharma, Bharat Forge, Ashok Leyland, Tata Power, Cummins, Advanced Enzyme, Aster DM Healthcare, Natco Pharma will also set the tone for the stock market today",neutral,neutral,-2.331674089599161,negative,-4.8975188781014,negative
2020-08-12 12:15:00.000,927.0,927.0,875.0,881.6,11648547.0,"D-Street Buzz: Pharma stocks under pressure; Lupin, Biocon, Divis Labs, Cipla shed 2% each","Lupin, Cadila Healthcare, Divis Laboratories and Biocon shed over 2 percent each while Sun Pharma and Aurobindo Pharma were down a percent.",negative,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-12 13:42:00.000,927.0,927.0,875.0,881.6,11648547.0,"Prashant Jain-led HDFC MF sells RIL, D’Mart, top banks; exits Voda Idea, DLF","The AMC’s investment team led by market veteran Prashant Jain sold shares in large quantities in RIL, HDFC Bank, Aurobindo Pharma, Adani Ports, ITC, Axis Bank and SpiceJet, among others, and completely exited Vodafone Idea, DLF, ICICI Prudential Life.",neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-12 21:19:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore,"Revenue from operations for the quarter under review at Rs 5,924.8 crore increased by 8.8 percent YoY, with US formulation business showing a 15.6 percent growth at Rs 3,107.1 crore",positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-12 22:37:26.000,927.0,927.0,875.0,881.6,11648547.0,"Formulations, U.S. market boost Aurobindo Pharma in Q1",Drugmaker reports 23% increase in net profit,positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-12 22:41:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr,"Consolidated revenue from operations of the company stood at Rs 5,924.78 crore for the quarter under consideration. It was Rs 5,444.60 crore for the same period a year ago.",positive,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-12 23:46:47.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma net profit up 23% at Rs 780.6 crore in Q1,"Revenue from operations stood at Rs 5,924.8 crore, a growth of 8.8% over the corresponding previous period.",positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 07:14:24.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks To Watch: Aurobindo Pharma, BPCL, Eicher Motors, GAIL, Hero MotoCorp, Indiabulls Housing Finance",Here are the stocks to watch in trade today.,neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 07:31:00.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks in the news: Hero MotoCorp, Tata Steel, BPCL, Eicher Motors, GAIL, Aurobindo Pharma, Ashok Leyland and Grasim",MCX said it will launch a liquidity enhancement scheme in the newly launched segment ‘options on goods’ with gold mini contract.,neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 07:35:00.000,927.0,927.0,875.0,881.6,11648547.0,"Top stocks in focus: Eicher Motors, Aurobindo Pharma, Hero MotoCorp, BPCL, Grasim, Tata Steel",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 07:53:03.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks to Watch: InterGlobe Aviation, Aurobindo Pharma, Tata Power, IT companies",Private equity firm Westbridge Capital has bought 5.43 million shares or 1.41% stake in InterGlobe Aviation Ltd for ₹559 crore.Aurobindo Pharma reported a 22.81% rise in its consolidated net profit to ₹780.68 crore for the quarter ended on 30 June,neutral,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 08:45:00.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto",Heres a list of stocks that may trade actively in todays session,neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 08:53:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma consolidated net profit rises 22.77% in the June 2020 quarter,Sales rise 8.93% to Rs 5835.23 crore,positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 09:05:00.000,927.0,927.0,875.0,881.6,11648547.0,"Prashant Jain-led HDFC Mutual Fund sells RIL, top banks; exits Voda Idea","The AMC’s investment team led by market veteran Prashant Jain sold shares in large quantities in RIL, HDFC Bank, Aurobindo Pharma, Adani Ports, ITC, Axis Bank and SpiceJet, among others, and completely exited Vodafone Idea, DLF, ICICI Prudential Life.",neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 09:07:18.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks in focus: Eicher Motors, BPCL, Aurobindo Pharma, Hero MotoCorp, Indiabulls Housing, IT stocks","Eicher Motors, Bharat Petroleum Corporation, Hero MotoCorp, Tata Steel, GAIL India, Godrej Industries, Grasim Industries, Garden Reach Shipbuilders & Engineers and Shriram Transport Finance are among 178 companies that are scheduled to announce quarterly earnings today",neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 09:16:00.000,927.0,927.0,875.0,881.6,11648547.0,"Stocks in news: InterGlobe Aviation, Ashok Leyland, Aurobindo Pharma, Indiabulls Housing, Tata Power","Stocks to watch today: Hero MotoCorp, Tata Steel, Eicher Motors, Grasim Industries, Godrej Industries, Prestige Estates are among the top companies that will be reporting their April-June quarterly earnings",neutral,neutral,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 09:51:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit,"At operating level, its earnings before interest, tax, depreciation and amortisation (EBITDA) rose 9.7 percent YoY to Rs 1,257.4 crore, and margin expanded 10 bps to 21.2 percent in Q1FY21, compared to same period last year.",negative,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 09:57:49.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma Q1 net up 23% at ₹781 cr,"Total revenue company grew 8.8 per cent at ₹5,925 crore",positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 10:13:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma plunges 4% despite 23% rise in Q1 PAT; Revenue aided by performance in US market,"However, on a quarter-on-quarter basis, Aurobindo witnessed a downward trend in both top-line and bottom-line front.",negative,negative,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 10:16:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit,Interim dividend of Rs 1.25 per equity share of Re 1 has been approved by the board for FY21,negative,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 10:41:00.000,927.0,927.0,875.0,881.6,11648547.0,Aurobindo Pharma Q1 PAT jumps 23% to Rs 780 cr,The pharma companys consolidated net profit jumped 22.8% to Rs 780.68 crore on 8.9% increase in net sales to Rs 5835.23 crore in Q1 June 2020 over Q1 June 2019.,positive,positive,-4.8975188781014,negative,-0.8380673828674329,neutral
2020-08-13 13:45:35.000,888.95,900.0,863.3,881.5,5654662.0,ICICI Securities: Aurobindo Pharma’s Deleveraging Continues,ICICI Securities: Aurobindo Pharma’s Deleveraging Continues,neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-13 14:04:00.000,888.95,900.0,863.3,881.5,5654662.0,"This stock turned Rs 1 lakh into Rs 3 lakh in four months, did you miss the rally?","Share price of Aurobindo Pharma has delivered stellar returns to investors since March 23 this year. Aurobindo Pharma share price closed at Rs 294.35 on March 23, 2020 and rose to intra day high of Rs 934 today, translating into gains of 217% during t",negative,positive,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-13 14:39:00.000,888.95,900.0,863.3,881.5,5654662.0,Aurobindo Pharma stock falls over 6% post Q1 earnings; check what brokerages say,"Despite the pharma company reporting earnings above analysts’ estimates, shares of Aurobindo Pharma opened at its earlier closing price of Rs 934 on BSE and later touched an intraday low of Rs 875.2, falling 6.3%",negative,positive,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-13 15:12:10.000,888.95,900.0,863.3,881.5,5654662.0,Aurobindo Pharma Ltd (ARBQY) on Q1 2021 Results - Earnings Call Transcript,"Aurobindo Pharma Ltd (OTC:ARBQY) Q1 2021 Earnings Conference Call August 12, 2020 11:00 PM ET Company Participants Krishna Kiran - IR Officer Narayanan Govindarajan - MD & Executive Director Sanjeev Dani - COO & Head, Formulations P.V.",neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-13 15:50:06.000,888.95,900.0,863.3,881.5,5654662.0,Aurobindo Pharma Ltd leads losers in ‘A’ group,"TVS Srichakra Ltd, Suzlon Energy Ltd, HFCL Ltd and Essel Propack Ltd are among the other losers in the BSEs A group today, 13 August 2020.",positive,negative,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-13 20:23:00.000,888.95,900.0,863.3,881.5,5654662.0,Strong US portfolio to drive revenue growth for Aurobindo Pharma,Margins expected to improve on product mix and volume growth,positive,positive,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-14 01:28:00.000,888.95,900.0,863.3,881.5,5654662.0,Aurobindo Pharma soars 2% as USFDA approves Methocarbamol tablets,"Methocarbamol in USP, 750 mg is an AB-rated generic equivalent to the reference listed drug (RLD), Robaxin-750 tablets of Auxilium Pharmaceuticals, LLC.",neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-14 11:21:00.000,888.95,900.0,863.3,881.5,5654662.0,"Buy Aurobindo Pharma, target price Rs 1055: Motilal Oswal","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 52371.19 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-14 13:34:00.000,888.95,900.0,863.3,881.5,5654662.0,"COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020","He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary Auro Vaccines LLC.",neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-14 14:31:07.000,888.95,900.0,863.3,881.5,5654662.0,"COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020","Asked about the capex projections, Govindarajan said, “But for the current year, we still believe it should be in the range of $150 million to $200 million (of capex).”",neutral,neutral,-0.8380673828674329,neutral,-2.9755878051524283,negative
2020-08-17 17:06:00.000,863.0,882.9,855.0,870.0,3117701.0,Buy Aurobindo Pharma; target of Rs 1000: Emkay Global Financial,"Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 13, 2020.",neutral,positive,0.8111239860950173,neutral,-1.3360739979445069,negative
2020-08-19 05:30:00.000,875.7,889.6,862.1,864.0,2483251.0,2 Swing Trades,"Shares Analysis by Dinesh Sharma covering: Aurobindo Pharma Ltd., State Bank Of India. Read Dinesh Sharma’s latest article on Investing.com India.",neutral,neutral,-1.3360739979445069,negative,-0.6265227984684972,neutral
2020-08-19 11:07:00.000,875.7,889.6,862.1,864.0,2483251.0,Buy Aurobindo Pharma; target of Rs 1027: KR Choksey,"KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1027 in its research report dated August 17, 2020.",neutral,positive,-1.3360739979445069,negative,-0.6265227984684972,neutral
2020-08-20 07:16:00.000,861.9,874.95,855.55,856.5,2124914.0,"Hot Stocks | Aurobindo Pharma, Cummins India, LIC Housing Finance can return up to 12% return in short-term",Nifty registered a high above its previous double top resistance which indicates the continuation of higher high higher bottom formation on the daily timeframe.,positive,positive,-0.6265227984684972,neutral,-0.6083077457852964,neutral
2020-08-25 16:55:28.000,874.45,874.45,858.0,867.75,2108251.0,Merck Moves US Court Against Aurobindo Pharma on Diabetic Drug Janumet,"Janumet (metformin hydrochloride and sitagliptin Phosphate) which is indicated to control high blood sugar in people with type 2 diabetes clocked over USD two billion revenues globally including USD 589 million in the USA in 2019, according to Merck’s 2019 annual report.",neutral,neutral,-0.7661958945623015,neutral,1.070257206973929,positive
2020-08-25 23:10:19.000,874.45,874.45,858.0,867.75,2108251.0,Diabetic drug Janumet: Merck moves US court against Aurobindo Pharma,"Merck Sharp & Dohme Corp, a subsidiary of Merck & Co has filed a petition in a US court against Aurobindo Pharma Limited alleging the Indian drug maker is planning to come out with generic versions of its blockbuster drug Janumetbefore expiration of patent.Merck filed the possible patent i…",negative,neutral,-0.7661958945623015,neutral,1.070257206973929,positive
2020-09-02 08:17:00.000,821.0,833.0,802.3,816.95,2756077.0,"Stocks in the news: Infosys, ONGC, Yes Bank, Coal India, Hero Moto, NMDC, VST Tillers","Coal India, Yes Bank, Max Healthcare, Aurobindo Pharma and Emami are some other stocks that will be in the news today.",neutral,neutral,-0.493300852618752,neutral,1.4705882352941175,positive
2020-09-07 18:10:00.000,799.2,812.0,779.15,784.05,3341058.0,Vodafone Idea stock is just Rs 12 and the firm has big plans! Should you invest?,"Under the top BSE 200 scrips, Vodafone’s shares have risen 21% MoM. The stock has gained 65% year-to-date, ranking in the fourth position in top BSE 200 scrips, after Adani Green, Aurobindo Pharma, Divi’s Labs and Tata Consumer",neutral,positive,-1.895645645645657,negative,2.691841551317219,positive
2020-09-15 04:15:00.000,800.0,840.95,798.1,822.0,8180198.0,Aurobindo Pharma’s Covid-19 vaccine development gets support from BIRAC,"BIRAC is set up by Department of Biotechnology (DBT), Government of India and the support for Covid-19 vaccine is under the National Biopharma Mission.",positive,neutral,2.75,positive,-1.569905213270142,negative
2020-09-15 10:59:00.000,800.0,840.95,798.1,822.0,8180198.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Cipla, Dr Reddy’s Labs; JB Chemicals jumps 10%","The top gainers included Aurobindo Pharma which gained over 4 percent followed by Cipla, Dr Reddy’s Labs, Lupin and Sun Pharma which added 3 percent each.",positive,positive,2.75,positive,-1.569905213270142,negative
2020-09-15 12:26:00.000,844.0,851.35,823.1,830.75,9469156.0,"Nifty Pharma stocks outperform; JB Chemicals, Aurobindo Pharma stocks jump","Torrent Pharma, Sun Pharma, Biocon and Cadila gained 2% each, and Divi’s Lab also up 1%, while Alkem Lab slipped on the pharma index.",positive,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 16:09:14.000,844.0,851.35,823.1,830.75,9469156.0,DBT-BIRAC to support Aurobindo Pharma in vaccine development,"DBT- BIRAC supports pharma company Aurobindo Pharma Limited’s Covid-19 vaccine development under the National Biopharma Mission. Biotechnology Industry Research Assistance Council (BIRAC), set up by D",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 16:26:16.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma says covid vaccine development going on as per plans,Aurobindo is in the process of setting up a manufacturing facility for viral vaccines which will be used to produce the COVID-19 vaccine and other viral vaccines,neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 17:28:30.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine,"BIRAC has facilitated the establishment of ‘the r-VSV vaccine’ manufacturing platform for the first time in India by supporting Aurobindo Pharma’s COVID-19 vaccine development, the company said",positive,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 17:31:00.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccine,"Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 17:32:17.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma Ties Up with BIRAC to Develop Covid-19 Vaccine,Aurobindo said that it is in the process of setting up a state-of-art manufacturing facility for viral vaccines which will be used to produce the Covid-19 vaccine and other viral vaccines,neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 17:41:00.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine,"Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of Covid vaccine",neutral,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-15 23:48:32.000,844.0,851.35,823.1,830.75,9469156.0,"CSIR, Aurobindo Pharma Collaborate To Develop Covid-19 Vaccine","Three CSIR labs CCMB in Hyderabad, Chandigarh and Kolkata, are developing different vaccine candidates.",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 03:25:00.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma spurts on collaboration with CSIR to develop COVID-19 vaccine,Under the signed agreement between CSIR-Centre for Cellular and Molecular Biology (CCMB) and Aurobindo Pharma.,positive,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 06:16:00.000,844.0,851.35,823.1,830.75,9469156.0,CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines,"The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.As per the release issued by the Centre for Cellular & Molecular Biology (CCMB), under the signed agreement between CSIR- CCMB and Aurobindo P…",positive,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 06:54:17.000,844.0,851.35,823.1,830.75,9469156.0,"Stocks To Watch: Aurobindo Pharma, Future Enterprises, Hexaware, Indiabulls Housing, InterGlobe Aviation, Piramal Enterprises, SpiceJet, VA Tech Wabag",Here are the stocks to watch in trade today.,neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 07:30:00.000,844.0,851.35,823.1,830.75,9469156.0,"Top stocks in focus: SpiceJet, Aurobindo Pharma, Future Enterprises, Hexaware, Indiabulls Housing",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 08:40:00.000,844.0,851.35,823.1,830.75,9469156.0,"Infosys, Aurobindo Pharma, REC in focus","Infosys announced that it has been selected by Essential Utilities, one of the largest publicly traded water, wastewater and natural gas providers in the U.S., as a strategic partner to drive its digital transformation.",neutral,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 08:45:00.000,844.0,851.35,823.1,830.75,9469156.0,"Stocks in the news | Infosys, BSE, Max India, REC, Shilpa Medicare, Aurobindo Pharma, Hexaware Technologies","SpiceJet, Patel Integrated Logistics, Uflex, Power Mech Projects, Radico Khaitan, Sterlite Technologies, ITD Cementation India, Apollo Hospitals, and IRB Infrastructure are also among the stocks in focus today.",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 08:48:00.000,844.0,851.35,823.1,830.75,9469156.0,"Stocks to watch: Aurobindo Pharma, Hexaware Tech, SpiceJet, Max India, LVB",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 08:50:54.000,844.0,851.35,823.1,830.75,9469156.0,"Stocks in focus: Aurobindo Pharma, Lakshmi Vilas Bank, Spicejet, Hexaware, Future Enterprises, BSE","Developments around COVID-19 vaccine, trends in coronavirus cases, oil prices and other global cues will continue to sway market sentiment",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 09:20:00.000,844.0,851.35,823.1,830.75,9469156.0,"Stocks in news: Aurobindo Pharma, SpiceJet, Future Enterprises, Infosys, IRB Infrastructure","Stocks to watch today on September 16: Aurobindo Pharma, SpiceJet, Future Enterprises, Infosys, IRB Infrastructure among others are the top stocks to watch out for in Wednesday’s trading session.",neutral,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 09:27:00.000,844.0,851.35,823.1,830.75,9469156.0,"Sensex, Nifty trade flat; Aurobindo Pharma gains 3%","Among sectoral front, auto and pharma index gained the most amongst its peers while banks and metal indexes traded marginally lower.",positive,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 09:40:07.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma: Shot in the arm for Covid vaccine development programme,Vaccine capacity creation puts Aurobindo in the league of Serum institute of India and Cadila in the race for a Covid drug,neutral,positive,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 10:59:00.000,844.0,851.35,823.1,830.75,9469156.0,Aurobindo Pharma and CSIR collaborate to develop vaccines against COVID-19,"Apart from this collaboration, Aurobindo is already developing a vaccine for SARS COV-2 through its wholly
owned US subsidiary Auro Vaccines. The SARS COV-2 vaccine candidate is based on the company’s
proprietary replication-competent, attenuated,",positive,neutral,-1.569905213270142,negative,-2.049700707418834,negative
2020-09-16 17:25:00.000,826.95,827.0,807.0,810.0,2932662.0,Aurobindo Pharma stock rises 4% on pact with CSIR for making Covid-19 vaccine,Aurobindo Pharma share price rose 4% today after the pharma firm announced a collaboration with The Council of Scientific and Industrial Research (CSIR) to develop a Covid-19 vaccine. Aurobindo Pharma share price opened with a gain of 3.66% at Rs 847 aga,positive,positive,-2.049700707418834,negative,2.127137865506041,positive
2020-09-23 09:59:00.000,810.0,813.65,771.3,779.0,3818151.0,Stock pick of the week: Reasons why good days are here for Aurobindo Pharma,"Aurobindo Pharma reported better than expected numbers in the first quarter. Reasonable valuation, expected rerating, increase in cash flows and moving towards becoming debt-free are some of the other factors that have made the company a favourite of analysts",neutral,positive,-3.8271604938271606,negative,-3.483870967741935,negative
2020-09-23 12:14:00.000,775.0,777.5,738.05,748.0,4330927.0,Buy Aurobindo Pharma; target of Rs 975: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 975 in its research report dated September 22, 2020.",neutral,positive,-3.483870967741935,negative,2.3740053050397845,positive
2020-09-28 09:40:00.000,779.8,803.9,768.0,803.8,3310061.0,"Buy Aurobindo Pharma, target price Rs 1030: Motilal Oswal","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 45240.32 Crore) operating in Pharmaceuticals sector.",neutral,neutral,3.07771223390613,positive,-1.0434782608695623,negative
2020-09-28 23:22:00.000,805.0,809.9,790.35,796.6,3100528.0,Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal,"Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1030 in its research report dated September 27, 2020.",neutral,positive,-1.0434782608695623,negative,-0.0753248383654395,neutral
2020-10-05 06:05:00.000,825.0,848.0,811.5,846.0,4171041.0,Aurobindo Pharma: Multiple growth triggers to improve Street sentiment,"Rebound in injectable sales, multiple product launches, strong European outlook and reduction in net debt are key earning triggers",positive,positive,2.5454545454545454,positive,-1.2280080292832658,negative
2020-10-09 09:46:00.000,840.95,851.4,828.6,834.25,3327516.0,"Buy Aurobindo Pharma, target price Rs 865: Kotak Securities","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 49087.01 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.7967179975028296,neutral,-0.2995626385477203,neutral
2020-10-15 12:35:00.000,793.0,815.5,785.5,807.0,2605260.0,"Nifty Pharma trades lower; Sun Pharma, Lupin stocks down","On the flip side, Aurobindo Pharma and Biocon trading higher. on the pharma index",negative,positive,1.7654476670870116,positive,-1.3950617283950562,negative
2020-10-16 12:49:00.000,793.0,815.5,785.5,807.0,2605260.0,"Nifty Pharma gains over 1%; Cadila, Lupin, Biocon in the fast lane","Cadila, Lupin and Biocon were among top gainers to drive the index. While Dr Reddy’s, Cipla and Aurobindo Pharma also lifted the performance.",positive,positive,1.7654476670870116,positive,-1.3950617283950562,negative
2020-10-19 01:15:00.000,810.0,812.2,795.15,798.7,1738594.0,"Aurobindo Pharma to acquire 100% of MViyeS Pharma by next month, transaction costing Rs274cr","Aurobindo announced that the acquisition is expected to complete by November 15, 2020.",neutral,neutral,-1.3950617283950562,negative,-0.0625390869293308,neutral
2020-10-19 07:43:00.000,810.0,812.2,795.15,798.7,1738594.0,"Stock recommendation by Prabhudas Lilladher: Buy Hindalco, Aurobindo Pharma",The RSI indicator for Hindalco Industries has recently indicated a decent rise to imply strength,neutral,positive,-1.3950617283950562,negative,-0.0625390869293308,neutral
2020-10-22 05:30:00.000,807.0,807.0,749.2,779.0,12461167.0,BRIEF-Aurobindo Pharma Says Unit Gets Warning Letter From U.S. FDA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 09:22:00.000,807.0,807.0,749.2,779.0,12461167.0,"Aurobindo Pharma’s facility at Dayton, New Jersey receives USFDA warning",This letter follows the earlier letter dated 04 June 2020 issuing a OAI status for this facility. The company believes that the existing business from this facility will not be impacted. The Company will be engaging with the regulator and are fully,neutral,neutral,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 10:18:00.000,807.0,807.0,749.2,779.0,12461167.0,Aurobindo Pharma tumbles 4% as subsidiary receives a warning letter from USFDA,"Aurobindo further said, the company will be engaging with the regulator and are fully committed to resolving this issue at the earliest.",negative,neutral,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 10:19:00.000,807.0,807.0,749.2,779.0,12461167.0,Aurobindo Pharma tumbles after subsidiary gets warning letter,"Aurobindo Pharma fell 3.77% to Rs 774.95 after the companys wholly-owned step-down subsidiary, AuroLife Pharma LLC, received a warning letter from the US drug regulator for its oral solid manufacturing facility situated at Dayton, New Jersey.",negative,negative,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 10:41:00.000,807.0,807.0,749.2,779.0,12461167.0,Aurobindo Pharma declines 6% on USFDA warning letter for Dayton facility,The company said it would engage with the regulator and would try to resolve the issue at the earliest,negative,neutral,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 10:50:00.000,807.0,807.0,749.2,779.0,12461167.0,Nifty Pharma index slumps 2%; Aurobindo Pharma sinks 6%,"Shares of Dr Reddy is ~3% down, Cipla slipped over 2%, while Cadila, Lupin and Biocon are down over 1.5% each. On other hand, Divis Lab is slightly down on the pharma index.",negative,negative,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 10:55:00.000,807.0,807.0,749.2,779.0,12461167.0,Aurobindo Pharma arm’s New Jersey unit gets warning letter from USFDA,"This follows the earlier letter dated June 4, 2020, issuing an OAI (Official Action Indicated) status for this facility.",negative,neutral,-3.469640644361834,negative,0.2564102564102564,neutral
2020-10-22 12:08:50.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma Shares Fall 6% After U.S. FDA Warning Letter For Subsidiary,"AuroLife Pharma, Aurobindo Pharma’s wholly-owned step-down subsidiary, has received a warning letter from the U.S. FDA.",neutral,negative,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 12:53:00.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma receives USFDA approval for generic Acetaminophen injection for fever and pain relief,"The product will be launched in December 2020, the company said in the filing.",positive,neutral,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 12:56:00.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma shares plunge over 6% after USFDA warning letter for subsidiary,"AuroLife Pharma, a wholly-owned step-down subsidiary of the company, has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral solid manufacturing facility situated at Dayton, New Jersey, Aurobindo Pharma said in a BSE filing.",negative,negative,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 13:46:00.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen,The product will be launched in December 2020,neutral,neutral,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 14:06:00.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma receives USFDA final approval for Acetaminophen Injection,"Acetaminophen Injection is indicated for the treatment of mild to moderate pain in adult and pediatric patients 2 years and older. The injection is also set to treat moderate to severe pain with adjunctive
opioid analgesics in adult and pediatric",positive,neutral,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 19:18:00.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary,"Shares of Aurobindo Pharma on Thursday closed over 3 per cent lower after the companys step-down subsidiary received a warning letter from the US health regulator for its unit in New Jersey, US.",negative,negative,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 20:02:11.000,780.0,788.8,773.0,782.0,2214819.0,"Proof of Concept for Covid-19 Vaccine Being Developed, Will be Handed Over to Aurobindo Pharma: CCMB Chief",The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited last month announced the collaboration to develop a vaccine to protect against SARS- CoV-2.,neutral,positive,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 21:39:20.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma Pact: CSIR-Centre Developing Proof Of Concept For Covid-19 Vaccine,"This may take four to five months, CCMB Director Rakesh K Mishra said.",neutral,neutral,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 22:03:53.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo Pharma gets USFDA nod for generic pain killer,Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) for its generic Acetaminophen injection. It is indicated in the treatment of pain in adult and paediat,neutral,positive,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-22 23:22:42.000,780.0,788.8,773.0,782.0,2214819.0,Aurobindo tanks on FDA warning to unit,Aurobindo Pharma shares tanked almost 7% intraday on Thursday on the back of the U.S. Food and Drug Administration (USFDA) issuing a warning letter to the oral solid manufacturing facility of subsidia,neutral,positive,0.2564102564102564,neutral,-3.316831683168312,negative
2020-10-26 05:30:00.000,808.0,814.5,772.45,781.2,6699113.0,BRIEF-New Mountain Capital Says To Acquire Natrol From Aurobindo Pharma - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 08:27:00.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma to divest Natrol to New Mountain Capital,"The all-cash transaction is valued at USD 550 Million (or Rs4,048cr at the current exchange rate).",neutral,neutral,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 09:25:00.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma gains on selling US unit to New Mountain Capital,"Aurobindo Pharma rose 2.06% to Rs 799.15 after the company said it reached a definitive agreement to sell Natrol LLC., a wholly owned subsidiary of Aurobindo Pharma USA to an affiliate of New Mountain Capital to combine with Jarrow Formulas.",positive,positive,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 09:29:00.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma’s step down subsidiary to sell off business assets for USD 550 mn,Powered by Capital Market - Live News,neutral,neutral,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 10:34:00.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma share price rises 4% as subsidiary sells business assets,Jefferies served as the sole financial adviser and Sullivan & Cromwell LLP acted as legal counsel to Aurobindo.,positive,neutral,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 11:27:00.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma inks pact with New Mountain Capital to sell US-based unit for USD 550 mn,"The drug firm has reached a definitive agreement to sell Natrol, a unit of Aurobindo Pharma USA, Inc, to an affiliate of New Mountain Capital to combine with Jarrow Formulas, Aurobindo Pharma said in a statement.",neutral,positive,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 11:28:07.000,808.0,814.5,772.45,781.2,6699113.0,"Aurobindo Pharma to divest Natrol to New Mountain Capital for ₹4,048 cr.","Proceeds to be used for reducing debt, other new strategic initiatives",neutral,neutral,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 11:31:28.000,808.0,814.5,772.45,781.2,6699113.0,Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%,"The equity shares of Aurobindo Pharma are up nearly 4 per cent in early trade on Monday. The company has announced reaching a definitive agreement to sell Natrol LLC, a wholly-owned subsidiary of Auro",positive,positive,-3.316831683168312,negative,1.7125694932583522,positive
2020-10-26 20:11:00.000,782.45,797.6,778.3,795.85,2945043.0,Divestment of US subsidiary to leave Aurobindo Pharma cash positive,Divestment of the US subsidiary is at good valuations and will help attain net cash positive status,positive,positive,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 00:25:01.000,782.45,797.6,778.3,795.85,2945043.0,Aurobindo inks pact with New Mountain Capital to sell US-based unit for USD 550 mn,"Aurobindo Pharma on Monday said it has inked a pact to divest Natrol, a wholly-owned unit of its US-based subsidiary, to private equity firm New Mountain Capital for USD 550 million (around Rs 4,048 crore).",positive,positive,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 01:45:00.000,782.45,797.6,778.3,795.85,2945043.0,"Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore","Aurobindos stock reacted positively to the news, going up in morning trade but later settled flat at Rs 784.65 on the BSE",neutral,positive,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 07:15:00.000,782.45,797.6,778.3,795.85,2945043.0,"Top stocks in focus: Bharti Airtel, Tata Motors, IRCTC, Aurobindo Pharma, Torrent Pharma, Angel Broking",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 08:10:00.000,782.45,797.6,778.3,795.85,2945043.0,Top headlines: Aurobindo Pharma to sell Natrol; Navratri drives car sales,"From Aurobindo Pharmas plans to sell US-based Natrol to Kishore Biyani looking for mutual settlement, here are top headlines this morning",neutral,neutral,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 11:00:20.000,782.45,797.6,778.3,795.85,2945043.0,"Stocks To Watch: Aurobindo Pharma, Angel Broking, Bharti Airtel, SBI Life, Tata Motors",Here are the stocks to watch in trade today.,neutral,neutral,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 11:54:00.000,782.45,797.6,778.3,795.85,2945043.0,"Buy Aurobindo Pharma, target price Rs 985: Motilal Oswal","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 46171.96 Crore) operating in Pharmaceuticals sector.",neutral,neutral,1.7125694932583522,positive,-2.039531663099576,negative
2020-10-27 13:33:30.000,794.3,799.9,771.6,778.1,2216538.0,Motilal Oswal: Aurobindo Pharma’s Natrol Divestment - Review,Motilal Oswal: Aurobindo Pharma’s Natrol Divestment At Attractive Valuation,neutral,neutral,-2.039531663099576,negative,-0.903225806451613,negative
2020-10-27 14:00:00.000,794.3,799.9,771.6,778.1,2216538.0,Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct,"ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26, 2020.",neutral,positive,-2.039531663099576,negative,-0.903225806451613,negative
2020-10-28 13:19:00.000,775.0,781.35,756.1,768.0,2291711.0,Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal,"Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26, 2020.",neutral,positive,-0.903225806451613,negative,0.6702674562373888,neutral
2020-11-05 20:04:54.000,793.65,797.9,777.55,778.8,2095228.0,Aurobindo Pharma appoints director,With effect from 05 November 2020,neutral,neutral,-1.871101871101874,negative,0.0698013833365003,neutral
2020-11-09 08:42:00.000,787.95,790.0,774.5,788.5,2097712.0,Aurobindo Pharma announces completion of acquisition,Aurobindo Pharma announced that the company has completed acquisition of MViyeS Pharma Ventures on 6 November 2020.,neutral,positive,0.0698013833365003,neutral,-3.3586818757921417,negative
2020-11-09 16:28:00.000,789.0,790.4,754.0,762.5,3296166.0,Aurobindo Pharma completes acquisition of Eugia Pharma Specialities,"The company said that alongwith Eugia Pharma Specialities, MViyeS Pharma Ventures has also become 100% subsidiary of the company.",neutral,neutral,-3.3586818757921417,negative,6.048177083333339,positive
2020-11-11 05:30:00.000,768.0,815.0,766.15,814.45,7117811.0,BRIEF-India’s Aurobindo Pharma Sept-Quarter Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,6.048177083333339,positive,3.1307550644567224,positive
2020-11-11 05:30:00.000,768.0,815.0,766.15,814.45,7117811.0,BRIEF-Aurobindo Pharma- Approved Transfer Of Business Of Auronext Pharma To Eugia Pharma Specialities - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,6.048177083333339,positive,3.1307550644567224,positive
2020-11-11 06:56:00.000,768.0,815.0,766.15,814.45,7117811.0,"Bulls of Wednesday! Nifty Pharma outperforms 3%; Aurobindo Pharma, Lupin top gainers",The sector limited losses in benchmarks Sensex and Nifty which have pared early gains and were trading flat led by selling in heavyweight stocks.,positive,negative,6.048177083333339,positive,3.1307550644567224,positive
2020-11-11 12:04:33.000,814.5,864.0,800.0,840.0,17136313.0,India Tourism Development Corporation Ltd leads gainers in ‘A’ group,"Arvind Ltd, Aurobindo Pharma Ltd, Apollo Hospitals Enterprise Ltd and Bajaj Holdings & Investment Ltd are among the other gainers in the BSEs A group today, 11 November 2020.",positive,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-11 12:23:00.000,814.5,864.0,800.0,840.0,17136313.0,"4 Nifty, 3 pharma names among 40 stocks looked set to rally on MACD","The list included pharma names such as Aurobindo Pharma, Biocon and Pfizer.",positive,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-11 13:07:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo gets Q2 prescription right as net profit grows 26% to Rs806cr,"Aurobindo Pharma, one of India’s fastest growing pharma companies based out of Hyderabad, reported 15.77% growth in sales revenues at Rs6,483.44cr",positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-11 19:49:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%,"ARV revenue at Rs 502.7 crore increased 111.4 percent YoY and API revenue at Rs 829 crore rose 2.9 percent YoY for the quarter ended September 2020, the company said in its BSE filing.",positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-11 20:42:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma reports 26% increase in Q2 net profit at Rs 805 crore,The company said it received final approval for 10 ANDAs (abbreviated new drug applications) from USFDA,positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-11 21:40:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma Q2 results: Net profit up 26% at Rs 806 cr,"Consolidated total revenue from operations during the period under review stood at Rs 6,483.44 crore as against Rs 5,600.47 crore in the corresponding quarter last fiscal, it added.",positive,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 08:19:00.000,814.5,864.0,800.0,840.0,17136313.0,"Stocks in news: Indiabulls Housing, Coal India, Aurobindo Pharma, PowerGrid, and more",Here are the top stocks that are likely to be in focus in today’s trading,neutral,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 08:30:38.000,814.5,864.0,800.0,840.0,17136313.0,"Stocks To Watch: Aurobindo Pharma, Coal India, Power Grid, Shree Cement, SpiceJet",Here are the stocks to watch in trade today.,neutral,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 08:42:00.000,814.5,864.0,800.0,840.0,17136313.0,"Stocks in the news | Eicher Motors, Fortis Health, ICICI Bank, Coal India, GSPL, SpiceJet, Indiabulls Housing Finance","Aurobindo Pharma, Brigade Enterprises, Ashoka Buildcon, Prestige Estates Projects, Shree Cement, Power Grid Corporation, Apollo Hospitals Enterprises, InterGlobe Aviation, are also among the stocks in focus today.",neutral,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 08:52:00.000,814.5,864.0,800.0,840.0,17136313.0,"Stocks to watch: Aurobindo Pharma, Eicher Motors, IRCTC, Coal India, IGL",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 09:17:41.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma Q2 net up 26% at ₹806 crore,"Total revenue too increased 16% at ₹6,483 cr, compared to ₹5,600 cr YoY",positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 09:37:00.000,814.5,864.0,800.0,840.0,17136313.0,"Stocks in news: Ashoka Buildcon, SpiceJet, IndiGo, PNB, Aurobindo Pharma, ICICI Bank","Stocks to watch today on November 12: Ashoka Buildcon, SpiceJet, IndiGo, PNB, Aurobindo Pharma, ICICI Bank among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 09:48:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY,"Consolidated revenue from operations grew by 15.8 percent year-on-year to Rs 6,483.3 crore with the US formulation business showing a 12.5 percent growth YoY at Rs 3,189.8 crore in Q2.",positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 10:33:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma rallies 6% as Q2 net profit rises 26% YoY to Rs 805.65 cr,"The companys consolidated total revenue from operations stood at Rs 6,483.44 crore.",positive,neutral,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 11:07:00.000,814.5,864.0,800.0,840.0,17136313.0,Aurobindo Pharma share rises over 6% on strong Q2 earnings,Aurobindo Pharma share rose over 6% today after the firm reported a 26 per cent rise in consolidated net profit in Q2. The share rose up to 6.4% to Rs 863.60 against previous close of Rs 811 on BSE. The pharma share has gained 96.53% in one year and risen,positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 11:39:00.000,814.5,864.0,800.0,840.0,17136313.0,Why investors need to be overweight on pharma,"I remain very positive on pharma. Top pick still remains Aurobindo Pharma, says Dipan Mehta.",positive,positive,3.1307550644567224,positive,2.240896358543412,positive
2020-11-12 12:32:28.000,838.95,860.65,833.0,857.75,4768148.0,"Aurobindo Pharma Stock Gains On Record Operating Profit, Revenue In Two Years In Q2","Aurobindo Pharma’s revenue rose 15.8% year-on-year to Rs 6,483.4 crore in the quarter ended September.",neutral,positive,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-12 12:50:00.000,838.95,860.65,833.0,857.75,4768148.0,"Top stocks in focus: Eicher Motors, IRCTC, Coal India, Aurobindo Pharma, Metropolis Healthcare",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-12 13:02:00.000,838.95,860.65,833.0,857.75,4768148.0,Aurobindo Pharma shares jump 7% after Q2 results,Aurobindo Pharma on Wednesday reported a 26 per cent increase in consolidated net profit at Rs 805.65 crore in the second quarter ended September.,positive,positive,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-12 13:05:00.000,838.95,860.65,833.0,857.75,4768148.0,Stock market update: Nifty Pharma index rises 1%; Aurobindo Pharma jumps 5%,The index was trading 1.36 per cent up at 11727.95.,positive,positive,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-12 18:11:00.000,838.95,860.65,833.0,857.75,4768148.0,"Aurobindo Pharma soars 6% on recording double-digit growth in Q2 PAT to Rs806cr on higher operating profit, margins","EBIDTA before Forex and Other income was at Rs1,432.8cr vs Rs1,167.5cr in Q2 last year, grew by 22.7%; EBITDA margin for the quarter was at 22.1% vs. 20.8% in Q2 last year.",positive,positive,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-13 08:35:00.000,838.95,860.65,833.0,857.75,4768148.0,"Trade Spotlight: Indiabulls Housing, Aurobindo Pharma, Adani Green in focus","Stocks like Indiabulls Housing Finance rallied more than 7 percent, Aurobindo Pharma was up more than 3 percent, and Adani Green Energy rose to a fresh 52-week high of Rs 941.15 were some of the stocks in focus",neutral,positive,2.240896358543412,positive,-1.2180974477958235,negative
2020-11-17 08:39:00.000,858.6,875.9,848.45,854.0,5567000.0,"Nifty Pharma under pressure; Torrent Pharma, Lupin, Biocon drag the performance",Pfizer Inc and its group companies have filed a petition against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories in a US court.,positive,neutral,-0.5357558816678339,neutral,-1.7605633802816902,negative
2020-11-17 11:22:00.000,858.6,875.9,848.45,854.0,5567000.0,Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct,"ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated November 12, 2020.",neutral,positive,-0.5357558816678339,neutral,-1.7605633802816902,negative
2020-11-17 12:04:00.000,852.0,859.4,830.1,837.0,3434656.0,"Pfizer moves US court against Aurobindo Pharma, Dr Reddy’s on cancer drug",Pfizer Inc alleged that the drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent,negative,neutral,-1.7605633802816902,negative,-1.206690561529274,negative
2020-11-17 12:13:27.000,852.0,859.4,830.1,837.0,3434656.0,"Pfizer moves U.S. court against Aurobindo Pharma, Dr. Reddy’s on cancer drug",Pfizer filed the possible patent infringement petition against both the companies in the United States District Court for the District of Delaware on two counts last week,negative,neutral,-1.7605633802816902,negative,-1.206690561529274,negative
2020-11-17 16:30:10.000,852.0,859.4,830.1,837.0,3434656.0,"Pfizer sues Aurobindo, Dr Reddy’s over generic version of cancer drug",Pfizer Inc has filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories Ltd on their alleged separate plans to launch generic versions of its drug Ibrance (palbociclib),neutral,negative,-1.7605633802816902,negative,-1.206690561529274,negative
2020-11-17 17:16:00.000,852.0,859.4,830.1,837.0,3434656.0,"Pfizer drags Aurobindo Pharma, Dr Reddy’s to US court over cancer drug",Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week,neutral,neutral,-1.7605633802816902,negative,-1.206690561529274,negative
2020-11-17 17:47:00.000,852.0,859.4,830.1,837.0,3434656.0,Aurobindo Pharma consolidated net profit rises 26.00% in the September 2020 quarter,Sales rise 15.58% to Rs 6377.91 crore,positive,positive,-1.7605633802816902,negative,-1.206690561529274,negative
2020-11-18 12:59:00.000,837.0,862.0,821.95,826.9,3501660.0,Stock market update: Nifty Pharma index down 1%; Aurobindo Pharma sheds nearly 3%,The index was trading 1.24 per cent down at 11546.,negative,negative,-1.206690561529274,negative,0.3493344576281367,neutral
2020-11-18 13:57:00.000,837.0,862.0,821.95,826.9,3501660.0,Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 921 in its research report dated November 12, 2020.",neutral,positive,-1.206690561529274,negative,0.3493344576281367,neutral
2020-11-24 08:40:00.000,853.95,884.35,845.1,880.7,5765650.0,"Nifty Pharma picks up pace as investors turn bullish; Aurobindo Pharma, Biocon rallies","Dr Reddy’s Laboratories , Sun Pharma and Lupin were also among the top gainers to trade over 1%.",positive,positive,3.1325019029217165,positive,-3.531073446327684,negative
2020-11-24 12:25:00.000,885.0,889.85,850.3,853.75,3979322.0,Stock market update: Pharma stocks mixed; Aurobindo Pharma rises 1%,The Nifty Pharma index was trading 0.14 per cent up at 11753.1.,positive,positive,-3.531073446327684,negative,1.4010507880910683,positive
2020-11-25 08:04:00.000,885.0,889.85,850.3,853.75,3979322.0,"Weekly stock picks by Religare Broking: Buy Aurobindo Pharma, Marico",The chart pattern and positioning of oscillators are pointing towards a sharp up move in Aurobindo Pharma in the near future,neutral,positive,-3.531073446327684,negative,1.4010507880910683,positive
2020-11-25 08:24:00.000,885.0,889.85,850.3,853.75,3979322.0,"Nifty Pharma in a huge selloff, nosedives 1.5%; Aurobindo, Biocon, Sun Pharma laggards","On the index, major laggards were - Aurobindo Pharma, Biocon and Sun Pharma tumbling over 2% each.",neutral,negative,-3.531073446327684,negative,1.4010507880910683,positive
2020-11-25 15:24:00.000,856.5,873.25,850.0,868.5,3648546.0,Aurobindo Pharma tumbles after details of USFDA warning letter to unit,Aurobindo Pharma slipped 3.23% to Rs 851.70 after the U.S. Food and Drug Administration released details of the warning letter issued to the companys New Jersey unit in October 2020.,negative,negative,1.4010507880910683,positive,-0.3501722158438524,neutral
2020-11-26 13:05:00.000,871.0,893.5,862.8,867.95,5336236.0,Stock market update: Pharma stocks advance; Aurobindo Pharma rises over 1%,The Nifty Pharma index was trading 0.74 per cent up at 11721.35.,positive,positive,-0.3501722158438524,neutral,2.339514978601997,positive
2020-11-26 14:34:00.000,871.0,893.5,862.8,867.95,5336236.0,Over 20 stocks saw FY22E earnings upgrades in 3 out of past 4 quarters; worth a look?,"Among stocks, which saw consistent upward FY22 earnings revision (three out of the past four quarters) were Dr. Reddy’s, Aurobindo Pharma, Cipla, Tata Motors, and TATA Steel, Elara Capital highlighted in the report.",positive,positive,-0.3501722158438524,neutral,2.339514978601997,positive
2020-12-01 05:30:00.000,876.25,899.1,869.2,896.75,3350314.0,"BRIEF-Aurobindo Pharma Completes Sale Of Natrol, LLC - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.339514978601997,positive,-0.6927374301676029,neutral
2020-12-01 12:56:00.000,895.0,905.85,880.5,888.8,2969413.0,Aurobindo Pharma completes sale of US subsidiary’s Natrol to New Mountain,"Drug firm Aurobindo Pharma said it has completed the sale of Natrol LLC, a wholly-owned unit of its US-based subsidiary, to private equity firm New Mountain Capital",neutral,neutral,-0.6927374301676029,neutral,0.5754511425219261,neutral
2020-12-01 13:29:00.000,895.0,905.85,880.5,888.8,2969413.0,Aurobindo Pharma completes sale of Natrol LLC to New Mountain Capital,"Natrol’s annual sales for the 12 months ended March 31, 2020, stood at around USD 157 million.",neutral,neutral,-0.6927374301676029,neutral,0.5754511425219261,neutral
2020-12-01 21:36:27.000,895.0,905.85,880.5,888.8,2969413.0,Aurobindo Pharma completes sale of U.S. entity,"Aurobindo Pharma has completed the sale of Natrol LLC, a wholly owned, step-down subsidiary in the U.S., to private equity firm New Mountain Capital and Jarrow Formulas. On Tuesday, in a stock exchang",neutral,neutral,-0.6927374301676029,neutral,0.5754511425219261,neutral
2020-12-02 07:43:23.000,895.0,905.85,880.5,888.8,2969413.0,"Hot Stocks | Can bet on Aurobindo Pharma, Sun Pharma and Maharashtra Seamless for short term","On the technical front, secondary oscillators suggest that markets are likely to remain volatile in the coming sessions with wild swings on both sides.",neutral,negative,-0.6927374301676029,neutral,0.5754511425219261,neutral
2020-12-07 13:32:25.000,914.8,917.7,888.6,897.0,2533182.0,Aurobindo Pharma Ltd in demand,"Aurobindo Pharma Ltd is quoting at Rs 914.25, up 1.51% on the day as on 12:49 IST on the NSE. The stock is up 103.94% in last one year as compared to a 11.67% spurt in NIFTY and a 58.22% spurt in the Nifty Pharma index.",positive,positive,-1.9457804984696057,negative,-1.5521064301552108,negative
2020-12-08 09:24:00.000,914.8,917.7,888.6,897.0,2533182.0,"Stocks in news: Titan, Canara Bank, Aurobindo Pharma, Alkem Labs, Goa Carbon, Reliance Capital","Stocks to watch today on December 8: Titan, Canara Bank, Aurobindo Pharma, Alkem Labs, Goa Carbon, Reliance Capital among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,-1.9457804984696057,negative,-1.5521064301552108,negative
2020-12-08 19:55:22.000,902.0,908.0,885.2,888.0,2014208.0,Six COVID vaccine candidates in different clinical trial stage in India: Union Health Secretary,"Besides this, three COVID-19 vaccine candidates are in the pre-clinical stage of which one of the coronavirus vaccine candidates is in the pre-development stage being researched by Aurobindo Pharma, the official said.",neutral,neutral,-1.5521064301552108,negative,0.8380202474690716,neutral
2020-12-09 10:20:00.000,902.0,908.0,885.2,888.0,2014208.0,Aurobindo Pharma gains after USFDA approval for sedative drug,Aurobindo Pharma rose 1.13% to Rs 905.95 after the company said it received US drug regulators approval for dexmedetomidine HCL in 0.9% sodium chloride injection.,positive,positive,-1.5521064301552108,negative,0.8380202474690716,neutral
2020-12-09 10:55:46.000,902.0,908.0,885.2,888.0,2014208.0,Aurobindo Pharma Gets USFDA Nod For Sedative Drug,"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride in 0.9 per cent sodium chloride injection, 200 µg/50 mL and 400 µg/100 mL single dose flexible containers (bags), Aurobindo Pharma said in a regulatory fil…",neutral,positive,-1.5521064301552108,negative,0.8380202474690716,neutral
2020-12-09 11:00:00.000,902.0,908.0,885.2,888.0,2014208.0,Aurobindo Pharma gets USFDA nod for sedative drug,"Drug major Aurobindo Pharma On Wednesday said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients.",neutral,positive,-1.5521064301552108,negative,0.8380202474690716,neutral
2020-12-09 12:17:00.000,889.0,907.95,888.8,896.45,3423955.0,Aurobindo Pharma gets USFDA approval for drug used to sedate patients,"Drug major Aurobindo Pharma said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients",positive,positive,0.8380202474690716,neutral,-0.6666666666666667,neutral
2020-12-09 18:22:00.000,889.0,907.95,888.8,896.45,3423955.0,Aurobindo Pharma receives USFDA approval for Dexmedetomidine HCL in 0.9% sodium chloride injection,The product will be launched in January 2021.,positive,neutral,0.8380202474690716,neutral,-0.6666666666666667,neutral
2020-12-09 23:20:03.000,889.0,907.95,888.8,896.45,3423955.0,USFDA nod for Aurobindo Pharma’s generic sedative product,Drugmaker Aurobindo Pharma has received final approval from USFDA to manufacture and market Dexmedetomidine HCL 0.9% sodium chloride injection 200 µg (micro gram)/50 mL and 400 µg/100 mL single dose f,neutral,positive,0.8380202474690716,neutral,-0.6666666666666667,neutral
2020-12-15 08:29:00.000,893.0,893.95,871.2,874.0,2067302.0,Nifty Pharma sees volatility as investors cautious over fresh Covid-19 lockdown globally; Aurobindo Pharma dips 2%,"The index has touched an intraday low of 12,417.10.",negative,negative,-2.127659574468085,negative,-0.1708428246013667,neutral
2020-12-18 13:46:22.000,875.1,888.55,862.65,886.5,1829856.0,Buy Aurobindo Pharma: Target Of Rs 1024: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1024 in its research report dated December 17, 2020.",neutral,positive,1.3027082619129216,positive,-5.208743046580887,negative
2020-12-22 05:30:00.000,847.0,859.8,821.4,856.0,2373036.0,"Brokerages are Upbeat on Aurobindo Pharma, Average Target of Rs 990 - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.062573789846517,positive,3.294528521536665,positive
2020-12-24 09:15:00.000,902.5,912.0,878.25,910.3,4149618.0,"Stocks in news: Mrs Bectors Food, Airtel, RIL, HDFC, Tata Communications, Aurobindo Pharma","Stocks to watch today on December 24: Mrs Bectors Food, Airtel, RIL, HDFC, Tata Communications, Aurobindo Pharma among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 09:29:00.000,902.5,912.0,878.25,910.3,4149618.0,Aurobindo Pharma after tieup with COVAXX for COVID-19 vaccine in India,COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.,neutral,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 10:07:00.000,902.5,912.0,878.25,910.3,4149618.0,"Aurobindo Pharma set to make COVAXX’s potential COVID-19 vaccine for India, UNICEF","COVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 2021 in Asia, Latin America and the United States.",neutral,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 10:40:00.000,902.5,912.0,878.25,910.3,4149618.0,Aurobindo Pharma signs exclusive licensing agreement with COVAXX,To develop and commercialize COVID-19 vaccine UB-612 for India and UNICEF,positive,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 12:13:09.000,902.5,912.0,878.25,910.3,4149618.0,"Aurobindo Pharma Enters Licensing Pact With US Biotech COVAXX For Manufacture, Sale Of COVID-19 Vaccine",COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.,neutral,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 13:56:00.000,902.5,912.0,878.25,910.3,4149618.0,"Aurobindo Pharma, COVAXX to develop COVID-19 vaccine for India, UNICEF","COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate, named UB-612; vaccine’s main advantage is that it uses normal refrigeration for distribution",neutral,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 14:38:50.000,902.5,912.0,878.25,910.3,4149618.0,Aurobindo Pharma Signs Pact With Covaxx For Covid-19 Vaccine,"Aurobindo Pharma signs an exclusive agreement with Covaxx to develop, commercialise and manufacture UB-612 for India and UNICEF.",neutral,positive,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-24 23:21:45.000,902.5,912.0,878.25,910.3,4149618.0,Coronavirus | Aurobindo Pharma signs pact with Covaxx for COVID-19 vaccine,Aurobindo will manufacture the finished doses at its facilities in Hyderabad.,positive,neutral,0.8642659279778343,neutral,-1.2122200478364835,negative
2020-12-27 12:52:00.000,919.8,921.0,904.0,908.65,3114840.0,Hyderabad set to emerge as global hub for Covid-19 vaccine in 2021,"The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy’s and Hetero have tie ups for manufacturing the vaccine.",neutral,neutral,-1.2122200478364835,negative,-1.4295103516266794,negative
2020-12-27 17:25:00.000,919.8,921.0,904.0,908.65,3114840.0,Hyderabad poised to emerge as COVID-19 vaccine manufacturing hub in 2021,"The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy’s and Hetero have tie ups for manufacturing the vaccine",positive,neutral,-1.2122200478364835,negative,-1.4295103516266794,negative
2020-12-28 08:45:00.000,919.8,921.0,904.0,908.65,3114840.0,Here’s a Bull Spread Strategy on Aurobindo Pharma by HDFC Securities,The stock price has broken out from the downward slopping trendline,neutral,negative,-1.2122200478364835,negative,-1.4295103516266794,negative
2020-12-28 22:41:13.000,912.9,919.35,896.25,899.85,1914227.0,"Analyst Corner: Reiterate ‘buy’ on Aurobindo Pharma with TP of Rs 1,100","The Pfizer-BioNTech vaccine is priced at $19.5/dose in the US, while the Oxford-AstraZeneca vaccine is expected to be priced at $3/dose till the pandemic is officially declared over.",positive,neutral,-1.4295103516266794,negative,0.2041942604856537,neutral
2020-12-31 07:58:00.000,907.85,943.5,904.15,920.6,8622092.0,"Pharma stocks rally on hope for Covid-19 vaccine rollout in 2021; Aurobindo Pharma, Biocon, Sun Pharma shines","The index has gained to an intraday high of 12,986.45.",positive,positive,1.4044170292449194,positive,0.5521273140629975,neutral
2020-12-31 11:05:22.000,907.85,943.5,904.15,920.6,8622092.0,Sharekhan Bets On These 10 Stocks With 10-41% Upside,"Aurobindo Pharma, NTPC, L&T and LIC Housing are on the buying list of the broking house and could give 10-41 percent return.",neutral,neutral,1.4044170292449194,positive,0.5521273140629975,neutral
2021-01-05 13:04:22.000,979.9,983.6,954.45,967.8,2713574.0,"Aurobindo Pharma Ltd spurts 1.99%, gains for fifth straight session","Aurobindo Pharma Ltd is quoting at Rs 985, up 1.99% on the day as on 12:44 IST on the NSE. The stock is up 122.1% in last one year as compared to a 18% jump in NIFTY and a 65.35% jump in the Nifty Pharma.",positive,positive,-1.2348198795795513,negative,-1.1538065313691197,negative
2021-01-05 18:22:00.000,979.9,983.6,954.45,967.8,2713574.0,Aurobindo Pharma hits 52-week high on signing agreement with COVAXX to develop Covid-19 vaccine for India and UNICEF,"COVAXX’s UB-612 is the first multitope, synthetic peptide-based COVID-19 vaccine candidate in clinical trials and it utilizes normal refrigeration (no freezing required) for distribution",positive,neutral,-1.2348198795795513,negative,-1.1538065313691197,negative
2021-01-06 07:18:20.000,979.9,983.6,954.45,967.8,2713574.0,"Hot Stocks | Can Bet On Muthoot Finance, Lupin And Aurobindo Pharma For Short Term","On the derivative front, Put writers have been continuously adding up hefty open interest at 14,000 and 14,100 strikes which indicates limited downside in Nifty as of now.",neutral,positive,-1.2348198795795513,negative,-1.1538065313691197,negative
2021-01-08 11:33:48.000,957.0,967.0,940.6,946.25,2675167.0,"D-Street Buzz: Pharma Stocks Gain Led By Sun Pharma, Biocon; CLSA Picks DRL, Downgrades Aurobindo Pharma","CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform.",neutral,positive,-1.123301985370951,negative,1.6207114291728033,positive
2021-01-17 16:06:38.000,933.8,937.9,900.5,910.35,2664973.0,Aurobindo Realty to buy 41.12 per cent stake in Kakinada Seaports,"For Aurobindo Pharma promoters, this is the second port investment in four months.",neutral,positive,-2.511244377811088,negative,0.7163012806598679,neutral
2021-01-18 22:47:01.000,921.4,931.4,918.2,928.0,1405431.0,Aurobindo Pharma Q3 PAT Seen Up 17.2% YoY To Rs. 719 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 15.5 percent Y-o-Y (up 5 percent Q-o-Q) to Rs. 5,799.4 crore, according to Prabhudas Lilladher.",neutral,positive,0.7163012806598679,neutral,0.3886849492550107,neutral
2021-01-22 20:01:00.000,904.75,948.0,880.15,926.95,4865010.0,"Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs",The government has given approval to drug firms including Aurobindo Pharma and Karnataka Antibiotics & Pharmaceuticals under the PLI scheme,neutral,positive,2.453716496269693,positive,6.577540106951872,positive
2021-01-22 22:23:00.000,904.75,948.0,880.15,926.95,4865010.0,"Aurobindo, Kinvan, K’taka Antibiotics first to get PLI for drugs","While Aurobindo Pharma has committed an investment of Rs 3,039 crore to set up production facilities for three eligible products, Kinvan will invest Rs 447.17 crore to build 300 MT capacity plant to produce Clavulanic Acid",neutral,positive,2.453716496269693,positive,6.577540106951872,positive
2021-01-25 08:59:00.000,935.0,1023.7,932.0,996.5,14740779.0,Markets close lower; Reliance Industries underperform,"Pharma index closed ~2% higher led by a strong rally in the stocks like Aurobindo Pharma, Cipla & Dr Reddys.",negative,positive,6.577540106951872,positive,-4.661526136591235,negative
2021-01-25 10:25:00.000,935.0,1023.7,932.0,996.5,14740779.0,Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs,"Aurobindo Pharma (through Lyfius Pharma) has received government approval for setting up plants for production of Penicillin-G and 7-ACA, under the PLI scheme",positive,positive,6.577540106951872,positive,-4.661526136591235,negative
2021-01-25 13:45:49.000,935.0,1023.7,932.0,996.5,14740779.0,Aurobindo Pharma hits 52-week high on approval under PLI,"The company, through its subsidiaries including LyfiusPharma Pvt Ltd and Qule Pharma Pvt Ltd, received approval for three projects",positive,positive,6.577540106951872,positive,-4.661526136591235,negative
2021-01-25 15:57:01.000,935.0,1023.7,932.0,996.5,14740779.0,Why Aurobindo Pharma’s Shares Ended At A Record High,Aurobindo Pharma has received approval for three fermentation-based products under India’s production-linked incentive scheme.,neutral,positive,6.577540106951872,positive,-4.661526136591235,negative
2021-01-25 21:36:21.000,935.0,1023.7,932.0,996.5,14740779.0,Aurobindo Pharma’s scrip zooms 8%,Shares of Aurobindo Pharma surged 8 per cent on the BSE on Monday to ₹998 on incentive booster. The company’s project for production of penicillin G has been approved by the Centre under the Productio,neutral,positive,6.577540106951872,positive,-4.661526136591235,negative
2021-02-10 05:30:00.000,961.95,980.0,948.0,967.25,3622798.0,BRIEF-Aurobindo Pharma Dec-Quarter Consol Net Profit Jumps,BRIEF-Aurobindo Pharma Dec-Quarter Consol Net Profit Jumps,neutral,neutral,0.5509641873278189,neutral,-0.8575966119640045,neutral
2021-02-10 11:00:00.000,961.95,980.0,948.0,967.25,3622798.0,"Stocks in the news: Titan, Eicher Motors, Gujarat Gas, Hindalco, GAIL & Tata Steel","Aurobindo Pharma, IGL, Page Industries, Bata India and Gujarat State Petronet are among companies which will announce their December quarter results on Wednesday.",neutral,neutral,0.5509641873278189,neutral,-0.8575966119640045,neutral
2021-02-10 12:47:00.000,944.5,969.7,928.0,936.4,6337100.0,"Aurobindo Pharma Q3 PAT 4-Fold at Rs2,946.46cr on exceptional gains","Aurobindo Pharma reported 7.97% growth in gross revenues for the Dec-20 quarter on consolidated basis at Rs6,364.91cr",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 13:04:21.000,944.5,969.7,928.0,936.4,6337100.0,Aurobindo Pharma Ltd up for five straight sessions,"Aurobindo Pharma Ltd is quoting at Rs 960.05, up 0.06% on the day as on 12:44 IST on the NSE. The stock is up 75.14% in last one year as compared to a 24.64% gain in NIFTY and a 53.7% gain in the Nifty Pharma.",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 20:32:08.000,944.5,969.7,928.0,936.4,6337100.0,Aurobindo Pharma Q3 net up 17% at ₹836 crore,"Aurobindo Pharma Ltd’s consolidated net profit increased 17 per cent at ₹836 crore in the third quarer ended December 31, 2020, against ₹715 crore in the corresponding quarter of the previous year.As",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 20:46:00.000,944.5,969.7,928.0,936.4,6337100.0,"Aurobindo Pharma Q3 results: Net profit zooms over four-fold to Rs 2,946 cr","The consolidated revenue from operations of the company stood at Rs 6,364.91 crore. It was Rs 5,895 crore for the same period a year ago.",neutral,neutral,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 21:30:00.000,944.5,969.7,928.0,936.4,6337100.0,"Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr","Aurobindo Pharma reported an over four-fold jump in its consolidated net profit to Rs 2,946.32 crore for the quarter ended December 31, 2020 mainly on account of one time exceptional gains.",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 22:20:50.000,944.5,969.7,928.0,936.4,6337100.0,"Aurobindo Pharma Q3 Net Profit Zooms Over 4-fold To Rs 2,946.32 Crore","The company had posted a net profit of Rs 705.31 crore in the corresponding period of the previous fiscal, Aurobindo Pharma said in a filing to BSE.",neutral,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-10 23:02:01.000,944.5,969.7,928.0,936.4,6337100.0,Aurobindo net rises fourfold on U.S. sale,"Aurobindo Pharma on Wednesday reported a fourfold jump in third-quarter consolidated profit to ₹2,946.3 crore, boosted mainly by one-time gains from the sale of a step-down subsidiary in the U.S.Exclu",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 07:19:42.000,944.5,969.7,928.0,936.4,6337100.0,"Stocks To Watch: ACC, Aurobindo Pharma, Coal India, Eicher Motors, ITC, Magma Fincorp, Power Grid",Here are the stocks to watch in trade today.,neutral,neutral,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 07:38:42.000,944.5,969.7,928.0,936.4,6337100.0,"Stocks In The News | Bata India, Indraprastha Gas, Titan, Magma Fincorp, Majesco, Mawana Sugars","Aurobindo Pharma, Bank of India, Titan Company, Ador Welding, Magma Fincorp, Entertainment Network India, Sadbhav Infrastructure Project, JB Chemicals are also among the stocks in focus today.",neutral,neutral,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 07:57:33.000,944.5,969.7,928.0,936.4,6337100.0,"Results: Aurobindo Pharma Q3 net profit zooms over 4-fold to Rs 2,946.32 crore","Drug firm Aurobindo Pharma on Wednesday reported an over four-fold jump in consolidated net profit to Rs 2,946.32 crore for the quarter ended December 2020, mainly on account of exceptional gains.The company had posted a net profit of Rs 705.31 crore in the corresponding period of the prev…",neutral,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 08:26:00.000,944.5,969.7,928.0,936.4,6337100.0,"Stocks in focus: Metropolis Healthcare, Bata, Aurobindo Pharma & more","Here are the top stocks that are likely to be in focus in today’s trading. Metropolis Healthcare, Bata, Aurobindo Pharma & more.",neutral,neutral,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 09:10:35.000,944.5,969.7,928.0,936.4,6337100.0,"Bank of India, Aurobindo Pharma, Bata India: Top stocks for Investors Today","The stock market on Wednesday, February 10, closed in the red for the second consecutive day and witnessed volatility throughout the session.",neutral,negative,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 09:30:00.000,944.5,969.7,928.0,936.4,6337100.0,"Stocks in news: Aurobindo Pharma, Titan, Crompton Greaves, Bank of India, Bharat Petroleum","Stocks to watch today on February 11: Aurobindo Pharma, Titan, Crompton Greaves, Bank of India, Bharat Petroleum among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 10:07:00.000,944.5,969.7,928.0,936.4,6337100.0,"Aurobindo Pharma Q3 PAT spurts 318% to Rs 2,946 cr","The drug maker’s consolidated net profit jumped 317.70% to Rs 2,946.32 crore on a 9.5% rise in net sales at Rs 6,353.13 crore in Q3 December 2020 over Q3 December 2019.",positive,positive,-0.8575966119640045,neutral,-1.8839050131926147,negative
2021-02-11 16:16:49.000,947.5,947.5,923.55,929.65,2627756.0,Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct,Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct,neutral,neutral,-1.8839050131926147,negative,-0.213903743315508,neutral
2021-02-12 09:28:00.000,947.5,947.5,923.55,929.65,2627756.0,"Buy Aurobindo Pharma, target price Rs 1100: Motilal Oswal","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 54796.98 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.8839050131926147,negative,-0.213903743315508,neutral
2021-02-12 11:06:46.000,947.5,947.5,923.55,929.65,2627756.0,Aurobindo Pharma: Vaccine And API Plans Inject Add-on Growth Levers,"In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to $650-700 million in three years backed by new plants in the US and Vizag",neutral,positive,-1.8839050131926147,negative,-0.213903743315508,neutral
2021-02-12 16:17:00.000,947.5,947.5,923.55,929.65,2627756.0,Aurobindo Pharma steady as analysts watch numbers for near-term growth,"The company’s investments across segments will take at least two years to play out, say analysts",positive,positive,-1.8839050131926147,negative,-0.213903743315508,neutral
2021-02-12 21:51:47.000,947.5,947.5,923.55,929.65,2627756.0,Covid-19: Aurobindo Pharma working on ‘multiple’ vaccines,Drug-maker to double production capacity to 480 million doses by 2021,neutral,positive,-1.8839050131926147,negative,-0.213903743315508,neutral
2021-02-15 05:30:00.000,935.0,944.9,928.7,933.0,1586847.0,Three Weeks Later: A Relook at Aurobindo Pharma,Three Weeks Later: A Relook at Aurobindo Pharma,neutral,neutral,-0.213903743315508,neutral,0.3376024864691164,neutral
2021-02-15 18:59:28.000,933.05,942.7,923.7,936.2,1823648.0,Buy Aurobindo Pharma; Target Of Rs 1165: ICICI Direct,"ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated February 11, 2021.",neutral,positive,0.3376024864691164,neutral,-1.508021390374334,negative
2021-02-16 17:24:15.000,935.0,943.0,915.65,920.9,2105692.0,Buy Aurobindo Pharma; Target Of Rs 1100: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 11, 2021.",neutral,positive,-1.508021390374334,negative,-1.0616401256635326,negative
2021-02-19 05:30:00.000,911.7,921.8,883.0,886.0,3290127.0,BRIEF-Aurobindo Pharma Gets USFDA Approval For Droxidopa Capsules,BRIEF-Aurobindo Pharma Gets USFDA Approval For Droxidopa Capsules,neutral,neutral,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 08:02:00.000,911.7,921.8,883.0,886.0,3290127.0,Aurobindo Pharma receives USFDA approval for Droxidopa Capsules,"The approved product has an estimated market size of US$ 352 million for the twelve months ending December 2020, according to IQVIA.",positive,neutral,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 10:46:02.000,911.7,921.8,883.0,886.0,3290127.0,Weekly Tactical Pick | Aurobindo Pharma,"Valuation at a discount to peers, but significant scope for margin improvement",neutral,positive,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 11:33:00.000,911.7,921.8,883.0,886.0,3290127.0,Aurobindo Pharma gets USFDA nod for generic hypotension drug,"The drug maker said that it received final approval from the US Food & Drug Administration (US FDA) to manufacture and market droxidopa capsules, 100 mg, 200 mg and 300 mg.",neutral,positive,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 12:32:55.000,911.7,921.8,883.0,886.0,3290127.0,Aurobindo Pharma Gets USFDA Nod For Generic Droxidopa Capsules,The approved product is a generic version of Lundbeck NA Ltd’s Northera capsules.,neutral,neutral,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 13:29:00.000,911.7,921.8,883.0,886.0,3290127.0,Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules,"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg, Aurobindo Pharma said in a regulatory filing.",neutral,positive,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 19:30:41.000,911.7,921.8,883.0,886.0,3290127.0,Aurobindo Pharma Hopes To Submit Phase 2/3 Data Of UB-612 COVID-19 Vaccine By July 2021,"Aurbindo has sought permission from Indian drug regulator CDSCO to conduct Phase-2/3 trial of the vaccine candidate in India, as the animal studies and Phase-I clinical trial were conducted in Taiwan.",neutral,positive,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-19 22:17:15.000,911.7,921.8,883.0,886.0,3290127.0,U.S. FDA nod for Aurobindo’s Droxidopa capsules,"Drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (US FDA) to manufacture and market Droxidopa capsules, 100 mg, 200 mg and 300 mg. Droxidopa Capsules a",neutral,positive,-2.818909729077552,negative,-3.995485327313767,negative
2021-02-22 09:08:00.000,886.0,890.7,849.0,850.6,3200517.0,Nifty closes lower; Pharma stocks underperformed,"Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positions",negative,negative,-3.995485327313767,negative,0.7288972490006974,neutral
2021-02-22 09:08:00.000,886.0,890.7,849.0,850.6,3200517.0,Nifty close lower; Pharma stocks underperformed,"Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positions",negative,negative,-3.995485327313767,negative,0.7288972490006974,neutral
2021-02-23 05:30:00.000,850.6,862.7,837.0,856.8,3014479.0,BRIEF-Aurobindo Pharma Says Entered Agreements To Invest 53.8 Mln Rupees Each In 2 Solar Power Co’s,BRIEF-Aurobindo Pharma Says Entered Agreements To Invest 53.8 Mln Rupees Each In 2 Solar Power Co’s,neutral,neutral,0.7288972490006974,neutral,-0.1564310544611845,neutral
2021-02-23 18:13:00.000,863.0,868.45,851.1,861.65,1100181.0,Aurobindo Pharma invests in solar power generating companies,To avail benefit of captive consumption of solar power,neutral,neutral,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-23 19:14:34.000,863.0,868.45,851.1,861.65,1100181.0,Aurobindo Pharma acquire 26% stake each in 2 solar power firms,"Aurobindo Pharma has entered into binding agreements to invest ₹5.38 crore each in NVNR (Ramannapet I) Power Plant and NVNR (Ramannapet II) Power Plant, aggregating to ₹10.76 crore",neutral,positive,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-24 07:38:59.000,863.0,868.45,851.1,861.65,1100181.0,"Stocks To Watch: Aurobindo Pharma, GAIL, NTPC, Tata Consumer, United Spirits",Here are the stocks to watch in trade today...,neutral,neutral,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-24 07:44:00.000,863.0,868.45,851.1,861.65,1100181.0,"Stocks in the news: Tata Consumer, GAIL, UPL, NTPC, Zuari Agro and Aurobindo Pharma",Tata Consumer Products will be included in the index from March 31.,neutral,neutral,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-24 10:04:00.000,863.0,868.45,851.1,861.65,1100181.0,Aurobindo Pharma to invest Rs10.8cr in two Hyderabad-based solar power generating companies,Aurobindo will be holding 26% of the share capital in each of the solar power generating companies.,neutral,neutral,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-24 10:29:00.000,863.0,868.45,851.1,861.65,1100181.0,Aurobindo Pharma acquires 26% stake each in 2 solar power firms,The drug maker has entered into binding agreements to invest Rs 5.38 crore each in two Hyderabad based solar power generating companies.,neutral,positive,-0.1564310544611845,neutral,-0.6626332469029098,neutral
2021-02-24 13:00:00.000,867.75,875.2,856.35,862.0,2572256.0,"Top stocks in focus: Aurobindo Pharma, NTPC, Tata Consumer, Pfizer, SPARC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.6626332469029098,neutral,0.2944640753828033,neutral
2021-02-26 09:09:52.000,849.0,871.95,844.45,851.5,3863508.0,"Top Buy And Sell Ideas By Mitessh Thakkar, Yogesh Mehta For Short Term","Mitessh Thakkar of mitesshthakkar.com suggests buying Aurobindo Pharma with a stop loss of Rs 876, target at Rs 835 and Coal India with a stop loss of Rs 146, target at Rs 165.",neutral,positive,0.2944640753828033,neutral,2.5494094257981468,positive
2021-03-01 08:01:00.000,855.1,879.0,849.4,876.9,1650664.0,"Aurobindo Pharma bags approval to transfer stakes in subsidiaries Lyfius, Qule and business undertaking in Unit-10","Lyfius Pharma, Qule Pharma and Aurobindo Antibiotics are wholly-owned subsidiaries of Aurobindo Pharma.",positive,neutral,2.5494094257981468,positive,-0.0338983050847406,neutral
2021-03-01 11:53:00.000,855.1,879.0,849.4,876.9,1650664.0,Board of Aurobindo Pharma approves restructuring of subsidiaries,At meeting held on 27 February 2021,neutral,neutral,2.5494094257981468,positive,-0.0338983050847406,neutral
2021-03-09 13:50:38.000,853.0,863.95,850.1,855.5,1523454.0,Aurobindo Pharma Ltd eases for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 851.3, down 1.32% on the day as on 13:19 IST on the NSE. The stock jumped 89.11% in last one year as compared to a 42.9% rally in NIFTY and a 58.89% spurt in the Nifty Pharma index.",positive,positive,0.2930832356389214,neutral,-2.5834292289988547,negative
2021-03-17 07:26:00.000,839.5,852.1,832.0,832.95,2108159.0,"Nifty Pharma shed 164 pts amid resurgence in Covid-19 cases; Lupin, Cipla, Sun Pharma drags; Aurobindo only gainer","Except for Aurobindo Pharma, all stocks listed on Nifty Pharma were under sharp selloff with heavyweights Lupin, Cipla and Sun Pharma being top laggards.",negative,negative,-0.7802263251935622,neutral,-2.880067061852578,negative
2021-03-22 10:21:00.000,830.1,849.5,826.0,839.4,3067809.0,Aurobindo Pharma Ltd. shares gain 1.81% as Sensex falls,"On the technical charts, the RSI of the stock stood at 41.16.",positive,neutral,1.120346946151061,positive,0.9725536992840068,positive
2021-03-31 13:17:08.000,879.0,886.95,866.35,881.0,1437477.0,Aurobindo Pharma Ltd gains for third straight session,"Aurobindo Pharma Ltd is quoting at Rs 881.55, up 1.28% on the day as on 12:49 IST on the NSE. The stock is up 124.71% in last one year as compared to a 78.58% jump in NIFTY and a 75.14% jump in the Nifty Pharma index.",positive,positive,0.2275312855517633,neutral,0.5631399317406195,neutral
2021-03-31 15:26:54.000,879.0,886.95,866.35,881.0,1437477.0,Buy Aurobindo Pharma: Target Of Rs 1100: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 30, 2021.",neutral,positive,0.2275312855517633,neutral,0.5631399317406195,neutral
2021-04-01 12:10:00.000,879.0,886.95,866.35,881.0,1437477.0,Apollo LogiSolutions ties up with Indigo for new vaccine delivery platform,"The company is also in talks with vaccine makers - Serum Institute of India, Bharat Biotech, Zydus Cadilla and Aurobindo Pharma for vaccine supplies",neutral,neutral,0.2275312855517633,neutral,0.5631399317406195,neutral
2021-04-01 13:52:00.000,879.0,886.95,866.35,881.0,1437477.0,Aurobindo Pharma Ltd. shares drop 0.12% as Sensex rises,The stock quoted a 52-week high of Rs 1023.1 and a 52-week low of Rs 333.35.,negative,negative,0.2275312855517633,neutral,0.5631399317406195,neutral
2021-04-05 10:36:00.000,879.0,893.65,871.0,883.95,1557343.0,Share price of Aurobindo Pharma Ltd. falls as Nifty weakens,"A total of 56,225 shares changed hands on the counter till 10:36AM (IST).",positive,neutral,0.5631399317406195,neutral,1.3942416685558778,positive
2021-04-06 11:28:00.000,882.2,894.9,878.5,894.5,1505932.0,Aurobindo Pharma Ltd. shares up 0.2% as Sensex rises,"A total of 17,744 shares changed hands on the counter till 11:28AM (IST)",positive,neutral,1.3942416685558778,positive,0.6239901944397915,neutral
2021-04-07 12:25:00.000,910.45,919.85,906.0,907.6,1470093.0,Share price of Aurobindo Pharma jumps as Sensex gains 556.45 points,"Promoters held 48.86 per cent stake in the company as of 31-Dec-2020, while FII and DII ownership stood at 24.99 per cent and 9.94 per cent, respectively.",positive,neutral,-0.3130320171343866,neutral,5.099778270509978,positive
2021-04-08 11:38:00.000,910.45,919.85,906.0,907.6,1470093.0,Share price of Aurobindo Pharma jumps as Sensex gains 337.15 points,"Promoters held 48.86 per cent stake in the company as of 31-Dec-2020, while FII and DII ownership stood at 24.99 per cent and 9.94 per cent, respectively.",positive,neutral,-0.3130320171343866,neutral,5.099778270509978,positive
2021-04-08 13:04:11.000,902.0,952.95,901.3,948.0,3904411.0,Aurobindo Pharma receives NCLT approval for scheme of amalgamation,Powered by Capital Market - Live News,positive,neutral,5.099778270509978,positive,-2.6257042627830387,negative
2021-04-09 10:07:00.000,902.0,952.95,901.3,948.0,3904411.0,Aurobindo Pharma shares rise 1.87% as Sensex climbs,"A total of 13,158 shares changed hands on the counter till 10:06AM (IST)",positive,neutral,5.099778270509978,positive,-2.6257042627830387,negative
2021-04-12 10:20:00.000,940.7,949.25,906.0,916.0,2966415.0,Aurobindo Pharma shares down 0.49% as Sensex falls,"A total of 52,693 shares changed hands on the counter till 10:20AM (IST)",negative,neutral,-2.6257042627830387,negative,-0.7251117653472878,neutral
2021-04-13 13:48:00.000,917.1,925.0,889.5,910.45,1688720.0,Aurobindo Pharma shares decline 0.63% as Sensex climbs,"A total of 94,416 shares changed hands on the counter till 01:48PM (IST)",negative,neutral,-0.7251117653472878,neutral,-0.3271537622682661,neutral
2021-04-15 10:21:00.000,917.0,932.0,900.0,914.0,4386103.0,Aurobindo Pharma stock price down 0.08 per cent as Sensex slides,"As of 31-Dec-2020, promoters held 48.86 per cent stake in the company, while FIIs held 24.99 per cent and domestic institutional investors had 9.94 per cent.",negative,neutral,-0.3271537622682661,neutral,3.8096277698941137,positive
2021-04-16 12:05:00.000,916.1,959.0,910.5,951.0,4378624.0,Aurobindo Pharma shares up 2.36% as Nifty gains,"A total of 52,551 shares changed hands on the counter till 12:05PM (IST).",positive,neutral,3.8096277698941137,positive,1.8795811518324657,positive
2021-04-16 19:49:00.000,916.1,959.0,910.5,951.0,4378624.0,5 pharma stocks that could do well going ahead: Daljit Singh Kohli,"Cipla, Cadila, Dr Reddys, Gland Pharma and Aurobindo Pharma are in the preferred list, says Daljeet Singh Kohli",neutral,neutral,3.8096277698941137,positive,1.8795811518324657,positive
2021-04-19 10:10:00.000,955.0,974.0,932.2,972.95,4575119.0,Aurobindo Pharma shares drop 0.15% as Sensex falls,"On the technical charts, the RSI of the stock stood at 66.77.",negative,neutral,1.8795811518324657,positive,0.1938775510204058,neutral
2021-04-20 10:10:00.000,980.0,1006.25,976.5,981.9,6951186.0,Share price of Aurobindo Pharma rises as Nifty strengthens,"A total of 96,401 shares changed hands on the counter till 10:10AM (IST).",positive,neutral,0.1938775510204058,neutral,0.4403056834859972,neutral
2021-04-22 10:43:00.000,987.95,1015.0,975.0,992.3,7247661.0,Aurobindo Pharma shares gain 1.36% as Sensex falls,"A total of 153,588 shares changed hands on the counter till 10:43AM (IST)",positive,neutral,0.4403056834859972,neutral,-0.3460554691810066,neutral
2021-04-22 13:17:08.000,996.95,1008.9,980.1,993.5,3337174.0,Aurobindo Pharma Ltd stays in winning mode,"Aurobindo Pharma Ltd is quoting at Rs 987.9, up 0.06% on the day as on 12:49 IST on the NSE. The stock is up 57.05% in last one year as compared to a 53.8% jump in NIFTY and a 43.83% jump in the Nifty Pharma.",positive,positive,-0.3460554691810066,neutral,-2.8028028028028027,negative
2021-04-22 13:30:01.000,996.95,1008.9,980.1,993.5,3337174.0,Aurobindo Pharma’s Stock Extends Gains As JPMorgan Sees Possible Re-Rating,"The Hyderabad-based drugmaker’s stock rose as much as 2.7% to Rs 1,014, just shy of its all-time high, with high trading volume.",neutral,positive,-0.3460554691810066,neutral,-2.8028028028028027,negative
2021-04-22 19:13:00.000,996.95,1008.9,980.1,993.5,3337174.0,Strong injectables portfolio to support Aurobindo Pharma’s growth,The stock has been underperforming recent months and trades at a discount to peers,positive,positive,-0.3460554691810066,neutral,-2.8028028028028027,negative
2021-04-23 12:27:00.000,996.95,1008.9,980.1,993.5,3337174.0,Aurobindo Pharma declines 0.99% as Sensex slides,"The stock traded at a P/E multiple of 10.75, while the price-to-book value ratio stood at 1.44.",negative,neutral,-0.3460554691810066,neutral,-2.8028028028028027,negative
2021-04-27 11:59:00.000,976.1,983.8,963.75,970.8,1853044.0,Share price of Aurobindo Pharma rises as Nifty strengthens,"A total of 27,965 shares changed hands on the counter till 11:59AM (IST).",positive,neutral,-0.542977153980132,neutral,-1.432311720314189,negative
2021-04-28 09:42:00.000,973.95,981.0,959.05,960.0,1447595.0,"Next pharma runup could be led by Aurobindo Pharma, Laurus Labs, Glenmark: Chakri Lokapriya","“While a big run has been made in some of these pharma stocks, another 25% plus run this year is eminently possible.”",neutral,positive,-1.432311720314189,negative,0.2901253756087404,neutral
2021-04-28 13:38:00.000,965.1,989.0,962.05,967.9,2274549.0,Aurobindo Pharma shares drop 0.22% as Sensex rises,"On the technical charts, the RSI of the stock stood at 63.91.",negative,neutral,0.2901253756087404,neutral,1.550829875518677,positive
2021-04-29 10:26:00.000,965.1,989.0,962.05,967.9,2274549.0,Aurobindo Pharma shares gain 2.52% as Sensex rises,"A total of 32,836 shares changed hands on the counter till 10:26AM (IST)",positive,neutral,0.2901253756087404,neutral,1.550829875518677,positive
2021-04-30 11:23:00.000,964.0,989.0,964.0,978.95,2006097.0,Aurobindo Pharma shares gain 0.9% as Sensex falls,"A total of 25,272 shares changed hands on the counter till 11:23AM (IST)",positive,neutral,1.550829875518677,positive,-1.0921710727773857,negative
2021-05-03 13:01:00.000,973.95,980.0,950.0,956.85,1673460.0,Share price of Aurobindo Pharma falls as Nifty weakens,"A total of 34,832 shares changed hands on the counter till 01:01PM (IST).",neutral,neutral,-1.7557369474819058,negative,6.989865217845573,positive
2021-05-04 11:48:00.000,973.95,980.0,950.0,956.85,1673460.0,Aurobindo Pharma shares up 0.53% as Nifty gains,"A total of 18,051 shares changed hands on the counter till 11:48AM (IST).",positive,neutral,-1.7557369474819058,negative,6.989865217845573,positive
2021-05-05 10:26:00.000,957.1,1024.9,955.8,1024.0,6011953.0,Share price of Aurobindo Pharma rises as Nifty strengthens,"A total of 29,650 shares changed hands on the counter till 10:26AM (IST).",positive,neutral,6.989865217845573,positive,-2.859903381642514,negative
2021-05-06 10:51:00.000,1035.0,1039.0,1000.0,1005.4,4589902.0,Share price of Aurobindo Pharma falls as Nifty strengthens,"A total of 105,926 shares changed hands on the counter till 10:51AM (IST).",positive,neutral,-2.859903381642514,negative,0.5846794173025446,neutral
2021-05-07 10:31:00.000,1009.1,1023.0,1001.0,1015.0,2292297.0,Aurobindo Pharma shares gain 0.94% as Sensex rises,"On the technical charts, the RSI of the stock stood at 67.32.",positive,neutral,0.5846794173025446,neutral,2.664769102419392,positive
2021-05-10 10:36:00.000,1018.85,1061.75,1016.1,1046.0,4111553.0,Aurobindo Pharma stock price up 2.45 per cent as Sensex climbs,"As of 31-Mar-2021, promoters held 48.86 per cent stake in the company, while FIIs held 24.37 per cent and domestic institutional investors had 8.84 per cent.",positive,neutral,2.664769102419392,positive,-1.3388358366524349,negative
2021-05-10 12:07:02.000,1041.95,1063.9,1018.9,1028.0,2665716.0,HDFC Securities Picks These 9 Mid And Smallcap Stocks For Long Term,"NMDC, Aurobindo Pharma, Birla Corporation and ACC among mid and smallcaps stocks that broking house picks for staggered buying.",neutral,neutral,-1.3388358366524349,negative,-1.7827809450188463,negative
2021-05-11 11:29:00.000,1041.95,1063.9,1018.9,1028.0,2665716.0,Share price of Aurobindo Pharma falls as Sensex drops 307.26 points,"Promoters held 48.86 per cent stake in the company as of 31-Mar-2021, while FII and DII ownership stood at 24.37 per cent and 8.84 per cent, respectively.",positive,neutral,-1.3388358366524349,negative,-1.7827809450188463,negative
2021-05-11 15:53:00.000,1034.9,1039.0,1005.05,1016.45,2775261.0,Largecap-focussed PMSes lagged in April; midcap specialists fared better,"Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent. Sun Pharma, Dr Reddys Labs, Cipla, Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio.",positive,positive,-1.7827809450188463,negative,-1.1644975046482022,negative
2021-05-17 11:28:00.000,1009.9,1017.0,1000.2,1003.0,1351345.0,Aurobindo Pharma shares gain 0.15% as Sensex rises,"A total of 17,742 shares changed hands on the counter till 11:27AM (IST)",positive,neutral,-0.6832359639568252,neutral,-0.104482810090061,neutral
2021-05-18 12:40:00.000,1000.15,1029.9,1000.15,1018.95,2426027.0,Share price of Aurobindo Pharma jumps as Sensex gains 644.53 points,"A total of 168,290 shares changed hands on the counter till 12:40PM (IST)",positive,neutral,1.8797180422936628,positive,0.5674036392095435,neutral
2021-05-19 11:33:00.000,1000.15,1029.9,1000.15,1018.95,2426027.0,Aurobindo Pharma shares up 0.72% as Nifty drops,"A total of 54,273 shares changed hands on the counter till 11:33AM (IST).",positive,neutral,1.8797180422936628,positive,0.5674036392095435,neutral
2021-05-20 10:41:00.000,1022.2,1031.0,1011.0,1028.0,2163173.0,Share price of Aurobindo Pharma jumps as Sensex drops 34.2 points,"Promoters held 48.86 per cent stake in the company as of 31-Mar-2021, while FII and DII ownership stood at 24.37 per cent and 8.84 per cent, respectively.",positive,neutral,0.5674036392095435,neutral,-1.9512668672944289,negative
2021-05-26 13:17:19.000,1023.7,1037.9,1015.1,1031.0,1904561.0,Aurobindo Pharma Ltd soars 1.1%,"Aurobindo Pharma Ltd is quoting at Rs 1033.95, up 1.1% on the day as on 12:49 IST on the NSE. The stock is up 44.93% in last one year as compared to a 64.16% spurt in NIFTY and a 49.46% spurt in the Nifty Pharma index.",neutral,positive,0.713099540881113,neutral,-1.0745401742497602,negative
2021-05-31 07:46:06.000,1029.0,1032.0,983.55,1001.0,6476100.0,"Buzzing Stocks: Aurobindo Pharma, PNB, Archies And Others That Will Be In Focus Today",Check out the companies making the biggest headlines before the bell.,neutral,neutral,-2.7210884353741496,negative,-3.454463885150289,negative
2021-05-31 08:30:00.000,1029.0,1032.0,983.55,1001.0,6476100.0,"Stocks to watch: HDFC Bank, M&M, BoB, Affle (India), Aurobindo Pharma, PNB","Bank of Baroda (BoB) reported a standalone net loss of Rs 1,047 crore in the quarter ended March 2021, as it shifted to a new tax regime",neutral,negative,-2.7210884353741496,negative,-3.454463885150289,negative
2021-05-31 08:30:55.000,1029.0,1032.0,983.55,1001.0,6476100.0,"Stocks to Watch: Bank of Baroda, BPCL, Canara Bank, Wipro, HDFC Bank, M&M","Aurobindo Pharma, Honeywell Automation,, Narayana Hrudalaya, Shilpa Medicare, Jamna Auto Industries, Marksans Pharma, Kolte Patil Developers and Chemcon Speciality Chemicals will declare March quarter results today",neutral,neutral,-2.7210884353741496,negative,-3.454463885150289,negative
2021-05-31 08:31:19.000,1029.0,1032.0,983.55,1001.0,6476100.0,"Bharti Airtel, SBI, Coal India, Aurobindo Pharma, Glenmark Pharma, BoB stocks in focus",Trends on SGX Nifty suggest a gap-down start for the BSE Sensex and Nifty 50 with drop of 56 points or 0.36 per cent.,neutral,neutral,-2.7210884353741496,negative,-3.454463885150289,negative
2021-05-31 13:47:00.000,1003.05,1008.6,959.25,968.4,4939402.0,"Important results today: Aurobindo Pharma, Chemcon Speciality, Shilpa Medicare, Kolte-Patil Developers","JBF Industries, Karda Constructions, Kolte-Patil Developers, Lasa Supergenerics, Lloyds Steels Industries, Magma Fincorp will release quarterly earnings today.",neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 13:49:00.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma Q4 PAT declines 7% YoY to Rs 801 cr,"On a consolidated basis, Aurobindo Pharma posted 7.18% decline in net profit to Rs 801.1 crore on 1.18% decline in net sales to Rs 5,991.68 crore in Q4 FY21 over Q4 FY20.",negative,negative,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 14:16:00.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma consolidated net profit declines 5.68% in the March 2021 quarter,Sales decline 1.18% to Rs 5991.68 crore,negative,negative,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 14:47:00.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma Q4 results: Co reports net profit at Rs 801 crore,"For the fiscal ended March this year, the company posted a net profit of Rs 5,333.83 crore. It was Rs 2,843.67 crore in the preceding fiscal year, the filing said.",neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 20:38:06.000,1003.05,1008.6,959.25,968.4,4939402.0,"Aurobindo Pharma, Vaxxinity Seek DCGI Nod To Begin Phase-2/3 Of COVID-19 Jab UB-612","N Govindarajan, Managing Director of Aurobindo Pharma, at the company’s earnings call on Monday said that the drug maker expects the approval of UB-612 in December or January next year if everything goes according to their plan.",neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 22:01:46.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma Q4 net down 7.2%,Total revenue declined 2.5 per cent,negative,negative,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-05-31 22:31:07.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma net slips 7% on lower revenue,Aurobindo Pharma has posted a 7% decline in consolidated net profit to ₹801.2 crore for the quarter ended March on the back of lower revenue from operations. The firm said total revenue from operation,negative,negative,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 02:32:01.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma Ltd. ADR 2021 Q4 - Results - Earnings Call Presentation (OTCMKTS:ARBQY),The following slide deck was published by Aurobindo Pharma Ltd.,neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 08:44:23.000,1003.05,1008.6,959.25,968.4,4939402.0,"ITC, Infosys, Radico Khaitan, Magma Fincorp, PNB Housing, Aurobindo Pharma stocks in focus","Nifty futures were trading 52.50 points or 0.34 per cent higher at 15,632.50 on Singaporean Exchange, suggesting a positive opening for BSE Sensex and Nifty 50 on Tuesday",neutral,positive,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 09:31:01.000,1003.05,1008.6,959.25,968.4,4939402.0,"What Should Investors Do With Aurobindo Pharma Post Q4 Results: Buy, Sell Or Hold?",Here is what brokerages have to say about the stock and the company after the March quarter earnings announcement,neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 10:08:54.000,1003.05,1008.6,959.25,968.4,4939402.0,Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal,Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal,neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 10:13:00.000,1003.05,1008.6,959.25,968.4,4939402.0,"Buy Aurobindo Pharma, target price Rs 1150: Motilal Oswal","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 57597.77 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 11:36:30.000,1003.05,1008.6,959.25,968.4,4939402.0,"Aurobindo Pharma: US Reopening, Traction For COVID Vaccine Near-term Growth Opportunity","The most positive development for the last fiscal year has been a sharp reduction in leverage which positions Aurobindo Pharma for capex commitments in the API, vaccine and biosimilars space",neutral,positive,-3.454463885150289,negative,-0.5664263645726055,neutral
2021-06-01 12:56:48.000,971.0,984.25,962.75,965.5,3281546.0,Buy Aurobindo Pharma: Target Of Rs 1185: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1185 in its research report dated May 31, 2021.",neutral,positive,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-01 13:52:00.000,971.0,984.25,962.75,965.5,3281546.0,"Results Review For Aurobindo Pharma, Alkyl Amines, Aditya Birla Fashion and Retail","Results Review For Aurobindo Pharma, Alkyl Amines, Aditya Birla Fashion and Retail",neutral,neutral,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-01 15:00:22.000,971.0,984.25,962.75,965.5,3281546.0,Moneycontrol Pro Panorama | Macro Resilience Explains Buoyant Equities,"In today’s edition of Moneycontrol Pro Panorama: PMI cheers, economy’s wounds healing, the GDP questions, growth capsule for Aurobindo Pharma, the simmering prices and much more",neutral,neutral,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-01 16:19:00.000,971.0,984.25,962.75,965.5,3281546.0,Aurobindo Pharma share slips 4% post earnings; here’s what brokerages say,"For the fiscal year 2021, revenue from operations grew 7.3 per cent to Rs 24,774.63 crore from Rs 23,098.5 crore in the previous year",negative,positive,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-01 21:36:00.000,971.0,984.25,962.75,965.5,3281546.0,Lack of near-term triggers to cap upsides in Aurobindo Pharma,Upsides from capex and investments across segments are at least three years away,positive,neutral,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-02 05:30:00.000,971.0,984.25,962.75,965.5,3281546.0,Analysts Are Bullish on Aurobindo Pharma After Q4 Results,Analysts Are Bullish on Aurobindo Pharma After Q4 Results,neutral,neutral,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-02 05:47:03.000,971.0,984.25,962.75,965.5,3281546.0,"Despite weak Q4, forward prospects look strong for Aurobindo Pharma",Aurobindo’s growing injectables business in the US keeps forward prospects’ growth and profitability firm,positive,positive,-0.5664263645726055,neutral,-0.1546391752577319,neutral
2021-06-02 13:38:42.000,970.0,973.3,962.0,968.5,1284927.0,Buy Aurobindo Pharma; Target Of Rs 1165: ICICI Direct,"ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1165 in its research report dated Jun 01, 2021.",neutral,positive,-0.1546391752577319,neutral,-1.4902363823227132,negative
2021-06-02 16:15:05.000,970.0,973.3,962.0,968.5,1284927.0,Buy Aurobindo Pharma Target Of Rs 1139: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1139 in its research report dated Jun 01, 2021.",neutral,positive,-0.1546391752577319,neutral,-1.4902363823227132,negative
2021-06-03 13:50:59.000,973.0,974.5,956.05,958.5,1504971.0,Aurobindo Pharma Ltd drops for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 966.25, down 0.02% on the day as on 13:19 IST on the NSE. The stock jumped 27.23% in last one year as compared to a 55.88% rally in NIFTY and a 40.09% spurt in the Nifty Pharma index.",neutral,positive,-1.4902363823227132,negative,-0.3163736320730205,neutral
2021-06-04 16:25:29.000,973.0,974.5,956.05,958.5,1504971.0,Accumulate Aurobindo Pharma; Target Of Rs 1044: KR Choksey,"KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1044 in its research report dated Jun 03, 2021.",neutral,positive,-1.4902363823227132,negative,-0.3163736320730205,neutral
2021-06-09 12:41:00.000,960.3,977.5,960.05,966.4,1696309.0,Aurobindo Pharma shares gain 0.33% as Sensex rises,"A total of 107,940 shares changed hands on the counter till 12:41PM (IST)",positive,neutral,0.6352181609913593,neutral,4.437564499484004,positive
2021-06-10 11:39:00.000,960.3,977.5,960.05,966.4,1696309.0,Share price of Aurobindo Pharma jumps as Sensex gains 207.25 points,"Promoters held 48.86 per cent stake in the company as of 31-Mar-2021, while FII and DII ownership stood at 24.37 per cent and 8.84 per cent, respectively.",positive,neutral,0.6352181609913593,neutral,4.437564499484004,positive
2021-06-11 12:01:00.000,969.0,1016.45,961.5,1012.0,6840182.0,Aurobindo Pharma shares rise 0.22 per cent in Friday’s trading session,The Relative Strength Index of the stock stood at 44.85 on Friday.,positive,neutral,4.437564499484004,positive,-2.079637295485908,negative
2021-06-14 12:16:00.000,997.05,1003.75,987.7,998.0,1401277.0,Aurobindo Pharma declines 1.21% as Sensex slides,"The stock traded at a P/E multiple of 10.96, while the price-to-book value ratio stood at 1.44.",negative,neutral,0.0952810791835961,neutral,-1.0060362173038229,negative
2021-06-15 13:47:00.000,994.0,1009.5,980.85,984.0,2969693.0,Share price of Aurobindo Pharma jumps as Sensex gains 204.26 points,"A total of 64,881 shares changed hands on the counter till 01:47PM (IST)",positive,neutral,-1.0060362173038229,negative,-1.7216716051905612,negative
2021-06-16 11:12:00.000,994.0,1009.5,980.85,984.0,2969693.0,Aurobindo Pharma shares fall 0.3% as Nifty drops,The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 737.9.,negative,negative,-1.0060362173038229,negative,-1.7216716051905612,negative
2021-06-17 07:20:36.000,978.7,989.15,946.9,961.85,2756072.0,"Buzzing Stocks: Power Grid, Tata Steel, Aurobindo Pharma And Other Stocks In News Today",Stocks in the news: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-1.7216716051905612,negative,-1.4828303850156088,negative
2021-06-17 11:09:00.000,978.7,989.15,946.9,961.85,2756072.0,Aurobindo Pharma slides after promoter pares stake,"Kambam Spoorthi, promoter of the drug company, sold 6 lakh equity shares, or 0.102% stake, of Aurobindo Pharma on 14 June 2021 through open market sale.",neutral,neutral,-1.7216716051905612,negative,-1.4828303850156088,negative
2021-06-17 12:40:00.000,961.0,968.6,917.75,946.75,2771898.0,Aurobindo Pharma shares drop 1.47% as Sensex falls,"On the technical charts, the RSI of the stock stood at 46.43.",negative,neutral,-1.4828303850156088,negative,1.066878980891715,positive
2021-06-18 12:50:00.000,961.0,968.6,917.75,946.75,2771898.0,Aurobindo Pharma shares down 1.58% as Nifty drops,"A total of 148,137 shares changed hands on the counter till 12:50PM (IST).",negative,neutral,-1.4828303850156088,negative,1.066878980891715,positive
2021-06-18 14:17:41.000,961.0,968.6,917.75,946.75,2771898.0,Aurobindo Pharma Ltd down for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 948.25, down 1.4% on the day as on 13:19 IST on the NSE. The stock jumped 21.04% in last one year as compared to a 52.16% rally in NIFTY and a 40.99% spurt in the Nifty Pharma index.",negative,positive,-1.4828303850156088,negative,1.066878980891715,positive
2021-06-21 09:33:39.000,942.0,956.6,931.0,952.05,1210318.0,15400 A Decisive Support For Nifty; Stay Selective And Stick To Quality In Small & Midcaps: Mehul Kothari Of AnandRathi,"Kothari is bullish on UBL, Sun Pharma and Aurobindo Pharma for the short term",neutral,positive,1.066878980891715,positive,-0.146612210702689,neutral
2021-06-22 13:26:00.000,953.2,957.0,940.25,941.5,1374320.0,Aurobindo Pharma share price up 0.93 per cent,"A total of 41,391 shares changed hands on the counter till 01:26PM (IST).",positive,neutral,-1.2274443978178813,negative,-0.2551562832234719,neutral
2021-06-23 13:42:00.000,940.6,949.7,932.5,938.2,1479060.0,Aurobindo Pharma shares down 0.17% as Nifty drops,"A total of 31,728 shares changed hands on the counter till 01:42PM (IST).",negative,neutral,-0.2551562832234719,neutral,1.0638297872340423,positive
2021-06-24 12:34:00.000,940.0,959.05,939.6,950.0,1755852.0,Share price of Aurobindo Pharma falls as Sensex gains 312.37 points,"A total of 32,104 shares changed hands on the counter till 12:34PM (IST)",positive,neutral,1.0638297872340423,positive,1.985085600252072,positive
2021-06-25 12:04:00.000,940.0,959.05,939.6,950.0,1755852.0,Aurobindo Pharma shares gain 1.32% as Sensex rises,The stock quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 737.9.,positive,negative,1.0638297872340423,positive,1.985085600252072,positive
2021-06-29 12:09:00.000,969.1,975.0,963.3,965.0,913923.0,Aurobindo Pharma shares up 0.92% as Nifty drops,"A total of 50,916 shares changed hands on the counter till 12:09PM (IST).",positive,neutral,-0.4230729542874856,neutral,0.9996892157878474,positive
2021-06-29 13:32:17.000,969.1,975.0,963.3,965.0,913923.0,Aurobindo Pharma Ltd gains for third consecutive session,"Aurobindo Pharma Ltd is quoting at Rs 977.55, up 1.01% on the day as on 12:54 IST on the NSE. The stock is up 26.67% in last one year as compared to a 53.12% spurt in NIFTY and a 43.44% spurt in the Nifty Pharma index.",positive,positive,-0.4230729542874856,neutral,0.9996892157878474,positive
2021-07-02 07:20:20.000,979.75,1013.0,973.05,998.9,7426483.0,"Stocks To Watch: Gail, NCC, Eicher Motors, Hero MotoCorp, Lupin, NMDC, Coal India, Aurobindo Pharma",Here are the stocks to watch in trade today...,neutral,neutral,1.9545802500637888,positive,-0.4668719578821938,neutral
2021-07-02 10:04:00.000,979.75,1013.0,973.05,998.9,7426483.0,Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%,The company said the transfer of the business undertaking will be done for a lumpsum consideration of Rs 876 crore,positive,neutral,1.9545802500637888,positive,-0.4668719578821938,neutral
2021-07-02 10:48:32.000,979.75,1013.0,973.05,998.9,7426483.0,Aurobindo Pharma To Sell Injectables Unit To Subsidiary For Rs 876 Crore; Stock Rallies,Aurobindo Pharma to sell its injectables unit to wholly owned Eugia Pharma for Rs 876 crore.,neutral,neutral,1.9545802500637888,positive,-0.4668719578821938,neutral
2021-07-02 16:43:00.000,979.75,1013.0,973.05,998.9,7426483.0,Aurobindo Pharma restructuring to unlock value for shareholders: Vishal Manchanda,“Aurobindo injectable business can trade at up to 35x valuation. Aurobindos current trading multiple is around 10x. So there is a large upside the company is being able to kind of unlock for shareholders.”,positive,positive,1.9545802500637888,positive,-0.4668719578821938,neutral
2021-07-12 14:31:25.000,942.1,964.7,938.2,963.15,1722954.0,Aurobindo Pharma Ltd stays slippery,"Aurobindo Pharma Ltd is quoting at Rs 945.85, down 0.3% on the day as on 13:24 IST on the NSE. The stock jumped 16.84% in last one year as compared to a 45.22% rally in NIFTY and a 41.94% spurt in the Nifty Pharma index.",negative,positive,2.2343700244135394,positive,-0.7731958762886598,neutral
2021-07-13 11:38:10.000,942.1,964.7,938.2,963.15,1722954.0,Aurobindo Pharma Q1 PAT Seen Up 1.3% YoY To Rs 791.1 Cr: KRChoksey,"Net Sales are expected to increase by 3.8 percent Y-o-Y (up 2.4 percent Q-o-Q) to Rs 6,148 crore, according to KRChoksey.",neutral,positive,2.2343700244135394,positive,-0.7731958762886598,neutral
2021-07-15 13:52:53.000,957.0,978.85,955.45,972.7,2249182.0,These pharma stocks are Centrum Broking’s top picks in the sector,"Its top stock picks in the pharma sector includes names like Dr Reddy’s Labs, Aurobindo Pharma and more",neutral,neutral,1.6405433646813004,positive,-0.031052686057351,neutral
2021-07-26 00:02:18.000,968.45,968.45,951.5,952.4,748937.0,Wage hike for pharma unit workers hailed,"Aurobindo Pharma Pydibhimavaram Contractors’ Association on Sunday thanked the company management for enhancing wages by about ₹2,000 per month for contractor workers in spite of financial challenges",neutral,positive,-1.6572874180391417,negative,-4.831778639555604,negative
2021-07-27 13:49:34.000,914.1,920.0,877.05,919.25,2749881.0,"Markets slip as healthcare, banking stocks drag","Healthcare stocks including Sun Pharma lost 2.7%, APL Ltd 11%, SPARC 8%, Alembic Ltd 6%, Ipca Lab 4%, and Aurobindo Pharma 4%. .Banking stocks also fell with Axis Bank losing 3%, Kotak Mahindra Bank 2.2%, Bandhan Bank 1.1%, and Indusind Bank 0.6%.",neutral,negative,0.5633956897494778,neutral,-1.3043478260869563,negative
2021-08-05 14:02:00.000,912.6,912.6,899.5,900.6,755787.0,Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine,"Drug major Aurobindo Pharma is looking to commercialise a COVID-19 vaccine, build a portfolio of biosimilar products, expand API production as part of its growth plans going ahead, as per company’s annual report for 2020-21. The Hyderabad-based drug major is looking to develop products with higher c…",neutral,positive,-1.314924391847469,negative,-1.2222222222222223,negative
2021-08-05 14:23:00.000,912.6,912.6,899.5,900.6,755787.0,Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine,"The Hyderabad-based drug major is looking to develop products with higher complexity, focus on injectables business and expand business in high growth markets like China.",neutral,positive,-1.314924391847469,negative,-1.2222222222222223,negative
2021-08-05 14:32:10.000,912.6,912.6,899.5,900.6,755787.0,Aurobindo Pharma Channelising Efforts To Commercialise COVID-19 Vaccine,"The Hyderabad-based drug major is looking to develop products with higher complexity, focus on injectables business and expand business in high growth markets like China.",neutral,positive,-1.314924391847469,negative,-1.2222222222222223,negative
2021-08-05 16:10:01.000,912.6,912.6,899.5,900.6,755787.0,"Aurobindo pharma plans to commercialise Covid19 vaccine, ties up with US-based Vaxxinity",Vaxxinity has applied for phase 2/3 clinical trials in India,positive,neutral,-1.314924391847469,negative,-1.2222222222222223,negative
2021-08-05 17:30:00.000,912.6,912.6,899.5,900.6,755787.0,"Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production","The Hyderabad-based drug major is looking to develop products with higher complexity, focus on injectables business and expand business in high growth markets like China",positive,positive,-1.314924391847469,negative,-1.2222222222222223,negative
2021-08-09 17:30:00.000,890.0,898.8,871.3,878.25,1181939.0,"Nutanix India registers 24% growth in Q3, onboards NKGSB, Aurobindo Pharma as clients",Aurobindo Pharma choose Nutanix HCI over legacy 3-tier architecture to build a software defined data centre platform to enable simplified IT operations.,positive,positive,-1.3202247191011236,negative,-3.0690826727066844,negative
2021-08-12 08:13:15.000,862.0,864.4,822.1,832.0,4082450.0,"Markets may remain volatile; Tata Steel, Eicher Motors, Hero Moto in focus","Among key companies Tata Steel, Bharat Petroleum, Eicher Motors, Hero Motocorp, NMDC, Aurobindo Pharma, IRCTC, Ashok Leyland, Page Industries, Bharat Forge, Oil India and GR Infraproject will announce June quarter earnings today.",negative,neutral,-3.480278422273782,negative,-5.651364764267985,negative
2021-08-12 08:14:00.000,862.0,864.4,822.1,832.0,4082450.0,"Market Ahead Podcast, August 12: Top factors that could guide markets today","Ashok Leyland, Aurobindo Pharma, Eicher Motors, Hero MotoCorp, IRCTC, Natco Pharma, Oil India, Page Industries, BPCL and Tata Steel are among key companies slated to post their quarterly earnings",neutral,neutral,-3.480278422273782,negative,-5.651364764267985,negative
2021-08-12 08:27:35.000,862.0,864.4,822.1,832.0,4082450.0,"Stocks to Watch: ITC, L&T, Power Grid, PNB Housing","Tata Steel, Bharat Petroleum, Eicher Motors, Hero Motocorp, NMDC, Aurobindo Pharma, IRCTC, Ashok Leyland, Page Industries, Bharat Forge, Oil India, GR Infraproject, among other companies will announce June quarter earnings today.",neutral,neutral,-3.480278422273782,negative,-5.651364764267985,negative
2021-08-12 14:04:53.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Ltd drops for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 842.6, down 1.62% on the day as on 13:24 IST on the NSE. The stock tumbled 4.39% in last one year as compared to a 44.75% rally in NIFTY and a 23.48% spurt in the Nifty Pharma index.",neutral,negative,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-12 15:31:18.000,806.0,822.0,754.0,760.45,20366512.0,GIC Housing Finance Ltd leads losers in ‘A’ group,"Lupin Ltd, GE Power India Ltd, Aurobindo Pharma Ltd and Cadila Healthcare Ltd are among the other losers in the BSE’s ‘A’ group today, 12 August 2021.",positive,negative,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-12 21:30:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Q1 consolidated net profit declines 2% to Rs 770 crore,"Aurobindo Pharma on Thursday reported a 1.68 per cent decline in its consolidated net profit to Rs 769.97 crore for the quarter ended on June 30, 2021, mainly on account of reduction in expenses",negative,negative,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-12 21:57:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr,"Hyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in the US markets.",positive,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 00:08:01.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Q1 net profit declines 2% to Rs 770 cr; revenue down marginally,,negative,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 00:50:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Q1 net profit declines 2% to Rs 770 cr,"Consolidated total revenue from operations of the company stood at Rs 5,701.98 crore for the quarter under consideration. It was Rs 5,924.78 crore for the same period a year ago, it added.",negative,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 07:11:54.000,806.0,822.0,754.0,760.45,20366512.0,"Stocks To Watch: Coal India, Tata Steel, Future Group, Hero Moto, Aurobindo Pharma, Eicher Motors, ONGC",Here are the stocks to watch in trade today...,neutral,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 08:33:00.000,806.0,822.0,754.0,760.45,20366512.0,"Tata Steel, Hero MotoCorp, Aurobindo Pharma to react to their results",Tata Steel reported consolidated net profit of Rs 8906.95 crore in Q1FY22 against net loss of Rs 4416.56 crore in Q1FY21. Total income jumped 108.49% to Rs 53656.31 crore.,neutral,positive,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 09:13:20.000,806.0,822.0,754.0,760.45,20366512.0,Stocks that are likely to see action today,"Focus on Eicher Motors, IRCTC, Aurobindo Pharma and Kesoram Industries",neutral,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 09:49:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma dips 5% on weak operational performance in June quarter,Aurobindo Pharma has entered into definitive agreements under which the Company will subscribe to fresh equity shares in Cronus amounting to Rs 420 crore,negative,positive,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 10:12:33.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Q1 Results: Profit Falls Missing Estimates As U.S. Revenue Contracts,Aurobindo Pharma’s Q1 profit misses estimates as its U.S. formulations revenue contracts.,neutral,negative,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 10:27:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma to subscribe fresh shares in Cronus Pharma Specialities for Rs420cr,"After this investment, Aurobindo will own 51 % of the equity share capital of Cronus.",neutral,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 11:43:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma Q1 PAT rises 9% YoY to Rs 770 cr,"Aurobindo Pharma posted an 8.9% rise in consolidated net profit to Rs 770 crore on 2.9% rise in net sales to Rs 5,702 crore in Q1 FY22 over Q1 FY21.",positive,positive,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 16:40:00.000,806.0,822.0,754.0,760.45,20366512.0,Nifty Pharma defies bull run; Aurobindo Pharma slumps 6% post Q1 result; Cadila top gainer,Aurobindo Pharma Q1 PAT declines 2% to Rs770cr.,negative,negative,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 17:30:00.000,806.0,822.0,754.0,760.45,20366512.0,Aurobindo Pharma to invest Rs 420 cr in veterinary firm Cronus for 51% stake,"The veterinary company has 67 products in its pipeline out of which 22 have been filed and six have been approved by the Centre for Veterinary Medicine, United States FDA",neutral,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-13 20:03:00.000,806.0,822.0,754.0,760.45,20366512.0,Near term upsides for Aurobindo Pharma stock capped on weak US outlook,The company has been making small acquisitions to bridge the growth gap,positive,neutral,-5.651364764267985,negative,-3.851174934725848,negative
2021-08-16 14:23:41.000,739.25,754.5,728.3,730.0,5652700.0,"Aurobindo Pharma: Value Proposition Intact, But Consolidation Can Take Longer","In this injectables space, Aurobindo pharma remains constructive and plans to grow from the current annual sales base of $400 million to 650-700 million in three years, backed by new plants in the US and Vizag.",neutral,positive,-1.2512681772066283,negative,-1.6440412033563092,negative
2021-08-16 15:00:39.000,739.25,754.5,728.3,730.0,5652700.0,"Aurobindo Pharma Q1 Review: Analysts Cautious On U.S. Generics, Antiretroviral Sales Slowdown",Here’s what brokerages have to say about Aurobindo’s Q1 FY22 results...,neutral,neutral,-1.2512681772066283,negative,-1.6440412033563092,negative
2021-08-17 12:50:00.000,732.95,746.8,716.0,720.9,7719139.0,"Aurobindo Pharma hits 52-week low, slips 25% in one month",The stock of the pharmaceutical company was trading at its lowest level since June 2020,negative,negative,-1.6440412033563092,negative,-5.617198335644938,negative
2021-08-20 11:35:34.000,721.0,721.0,677.0,680.5,8263555.0,Aurobindo Pharma Unit-1 Gets 7 Observations; Company Says Responding To USFDA,The spokesperson of Aurobindo Pharma said there are no repeat observations or anything related to data integrity and that they are in the process of submitting a response to the USFDA.,neutral,neutral,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-20 17:30:00.000,721.0,721.0,677.0,680.5,8263555.0,Aurobindo Pharma cancels Rs 420 cr deal to acquire 51% stake in Cronus Pharma,"The company had entered into binding agreements with Cronus for the acquisition of 51 per cent ownership by subscribing to 95,059,963 equity shares of Rs 10 each at a premium of Rs 34.18 per equity share aggregating to Rs 420 crore.",neutral,positive,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-20 21:37:56.000,721.0,721.0,677.0,680.5,8263555.0,"Aurobindo Pharma, Cronus Pharma terminate acquisition deal",The deal would have allowed Aurobindo own 51% stake in Cronus,neutral,neutral,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-20 21:42:00.000,721.0,721.0,677.0,680.5,8263555.0,Aurobindo Pharma’s Rs 450-cr deal to acquire 51% in Cronus Pharma cancelled,Aurobindo Pharma Ltd on Friday said its Rs 450-crore deal to acquire 51 per cent stake in Cronus Pharma Specialities India Pvt Ltd (Cronus) has been cancelled,neutral,neutral,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-20 21:47:31.000,721.0,721.0,677.0,680.5,8263555.0,Aurobindo Pharma Says Rs 450-crore Deal To Acquire 51% In Cronus Pharma Cancelled,"In a regulatory filing on Friday, Aurobindo Pharma said, ‘The board of directors in its meeting held today has approved the termination of the aforesaid agreements, and the parties have mutually agreed and terminated the said agreements.’",neutral,positive,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-20 22:02:00.000,721.0,721.0,677.0,680.5,8263555.0,Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelled,"On August 12, the company had announced that it had entered into definitive agreements to subscribe to fresh equity shares in Hyderabad-based Cronus, a generic veterinary pharmaceutical products firm engaged in development, manufacturing and sale of these items.",neutral,positive,-5.617198335644938,negative,-4.240381915192367,negative
2021-08-22 17:30:00.000,712.2,726.2,678.15,682.0,12911178.0,"Aurobindo Pharma, Cadila, 3 others in race to acquire Sterling Biotech","Last month, the liquidator had invited bids for the liquidation process of Sterling Biotech to sell it as a going concern at a reserve price of Rs 548.46 crore",neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 07:25:33.000,712.2,726.2,678.15,682.0,12911178.0,"Stocks To Watch: Cadila Healthcare, Power Grid, Aurobindo Pharma, Infosys, Max Healthcare",Here are the stocks to watch in trade today...,neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 07:36:29.000,712.2,726.2,678.15,682.0,12911178.0,"Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 08:14:50.000,712.2,726.2,678.15,682.0,12911178.0,Aurobindo Pharma - Details On 483 Issued By U.S. FDA Towards Unit-I: Prabhudas Lilladher,Aurobindo Pharma - Details On 483 Issued By U.S. FDA Towards Unit-I: Prabhudas Lilladher,neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 08:23:00.000,712.2,726.2,678.15,682.0,12911178.0,"Nuvoco Vistas, Aurobindo Pharma, Cadila Healthcare in spotlight",Shares of Nuvoco Vistas Corporation will debut on the bourses today. The issue price has been fixed at Rs 570 per share.,neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 08:53:08.000,712.2,726.2,678.15,682.0,12911178.0,Stocks that will see action today,"Infosys, Aurobindo Pharma, Zydus Cadila, Arvind Fashions, TVS Motor Co",neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 09:27:00.000,712.2,726.2,678.15,682.0,12911178.0,Aurobindo Pharma terminates acquisition deal with Cronus Pharma,The deal would have allowed the drug make own 51% stake in Cronus Pharma Specialities India.,neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 09:40:00.000,712.2,726.2,678.15,682.0,12911178.0,Aurobindo Pharma calls off agreement to pick stake in Cronus; stock up 6%,"Aurobindo Pharma, on August 12, 2021, had entered into binding agreements with Cronus Pharma Specialities India Private Limited for acquisition of 51 per cent ownership",positive,positive,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 09:49:24.000,712.2,726.2,678.15,682.0,12911178.0,Aurobindo Pharma Shares Jump 4% After Global Research Firm Retains Outperform Call,"CLSA is of the view that the Cronus Pharma acquisition cancelled allays capital allocation concern, adding that key near-term trigger is value unlocking from the ongoing demerger of the injectable portfolio.",neutral,positive,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 10:56:02.000,712.2,726.2,678.15,682.0,12911178.0,Aurobindo Pharma: Termination Of Inorganic Bet Allays Capital Allocation Concerns,We believe termination of the Cronus Pharma acquisition deal should help remove corporate governance/capital allocation fears,neutral,positive,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 11:02:00.000,712.2,726.2,678.15,682.0,12911178.0,Chakri Lokapriya is betting on these 3 value buys in pharma. Should you?,"“In the last week or so, some of the pharma companies have corrected significantly. Glenmark, Cadila and Aurobindo Pharma are three stocks which make good value buys.”",neutral,neutral,-4.240381915192367,negative,0.4160583941605873,neutral
2021-08-23 12:34:41.000,685.0,691.3,660.3,687.85,9554394.0,Aurobindo Pharma Shares Gain On Cronus Deal Termination,Aurobindo Pharma terminated a deal to acquire a 51% stake in Cronus Pharma.,neutral,negative,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-23 12:44:26.000,685.0,691.3,660.3,687.85,9554394.0,Aurobindo Pharma jumps nearly 7% after cancelling ₹420-cr Cronus Pharma deal,Aurobindo Pharma announced on August 12 that it had entered into definitive agreements to subscribe to fresh equity shares in Hyderabad-based Cronus.,positive,positive,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-23 13:25:10.000,685.0,691.3,660.3,687.85,9554394.0,Buy Aurobindo Pharma; Target Of Rs 915: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated August 13, 2021.",neutral,positive,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-23 17:06:00.000,685.0,691.3,660.3,687.85,9554394.0,Aurobindo Pharma stock gains despite board nods for terminating Rs420cr acquisition deal with Cronus Pharma,"Earlier, in August this year, the company had entered into binding agreements with Cronus Pharma Specialities India for the acquisition of 51% ownership in the latter.",positive,positive,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-23 17:30:00.000,685.0,691.3,660.3,687.85,9554394.0,Why Aurobindo Pharma share rose 7% today,Aurobindo Pharma stock has gained after 10 days of consecutive fall,positive,positive,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-23 18:03:17.000,685.0,691.3,660.3,687.85,9554394.0,Aurobindo Pharma Faces Delay In Getting Its COVID-19 Vaccine Plan Rolling,"Aurobindo Pharma has exclusive rights to develop and commercialise UB-612 in India and to UNICEF, and non-exclusive rights in other select emerging markets. The company can supply up to 480 million doses of UB-612 for India and other countries.",neutral,positive,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-24 09:30:16.000,685.0,691.3,660.3,687.85,9554394.0,"Aurobindo Pharma’s Cronus Rethink Is Positive, But It Needs To Do More",Aurobindo Pharma terminated an agreement to acquire a majority stake in Cronus Pharma after the proposal stoked capital allocation concerns,neutral,negative,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-24 11:23:00.000,685.0,691.3,660.3,687.85,9554394.0,"IndusInd Bank, Aurobindo Pharma Among 5 Stocks In Which Foreign Brokerages Cut Target Price","With Indian markets scaling new highs, experts have turned cautious and advise investors to shift focus to largecaps from mid and small-cap space.",neutral,neutral,0.4160583941605873,neutral,0.3679122781705315,neutral
2021-08-25 13:31:19.000,699.95,707.9,693.6,704.0,4714519.0,Aurobindo Pharma Ltd rises for third straight session,"Aurobindo Pharma Ltd is quoting at Rs 701.6, up 1.95% on the day as on 12:54 IST on the NSE. The stock is down 19.16% in last one year as compared to a 44.27% jump in NIFTY and a 20.57% jump in the Nifty Pharma index.",positive,positive,0.5786127580541401,neutral,0.2545968882602482,neutral
2021-08-26 07:06:25.000,699.95,707.9,693.6,704.0,4714519.0,Hot Stocks | Here’s Why HDFC Bank And Aurobindo Pharma Are Good Short-term Bets,"The immediate support for the Nifty is placed near 16,400 level and resistance is pegged near 16,900 level, said Rohan Patil of Bonanza Portfolio",neutral,neutral,0.5786127580541401,neutral,0.2545968882602482,neutral
2021-08-27 07:47:00.000,707.0,718.0,698.05,708.8,7217868.0,Two stock recommendations from Osho Krishan of Anand Rathi,Aurobindo Pharma has corrected over 35 per cent from its lifetime high and has plunged below all its major exponential moving averages,neutral,negative,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 08:36:00.000,707.0,718.0,698.05,708.8,7217868.0,"Infosys, Wipro, Aurobindo Pharma in spotlight","Infosys Public Services Inc. (IPS), a subsidiary of Infosys announced that it will enable Manitoba Public Insurance (MPI), a Crown corporation that delivers auto insurance and driver services, to digitize driver licensing, vehicle registration, and",neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 08:44:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma’s arm Eugia receives USFDA nod for Cyclophosphamide Injection,Aurobindo Pharma announced that its subsidiary Eugia Pharma Specialities (Eugia) has received a approval from the U.S.Food & Drug Administration (USFDA) for its Cyclophosphamide Injection 500 mg/2.5 mL and 1 g/5 mL vials.,neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 09:03:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma’s subsidiary Eugia receives USFDA nod for Cyclophosphamide injection; Stock ends 1.5% up,The company’s product will be available in ready-to-use (RTU) injection preparation.,neutral,neutral,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 09:13:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma’s subsidiary Eugia receives USFDA approval for Cyclophosphamide Injection,Aurobindo’s product will be available in ready-to-use (RTU) injection preparation. The product shall be launched in the US market in the near term and will be manufactured in Eugia’s manufacturing facility in India.,positive,neutral,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 09:55:37.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma Share Price Up Nearly 2% On USFDA Approval For An Injection,Aurobindo’s Cyclophosphamide Injection will be available in ready-to-use (RTU) injection preparation.,neutral,neutral,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 10:59:45.000,707.0,718.0,698.05,708.8,7217868.0,"D-Street Buzz: Pharma Stocks Edge Higher Led By Aurobindo Pharma; Sun Pharma, Dr Reddy’s Rise","The pharma index was trading a percent higher, while the Sensex was down 6.14 points at 55,942.96 and the Nifty was up 12.80 points at 16649.70",neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 13:31:13.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma Ltd extends winning spree,"Aurobindo Pharma Ltd is quoting at Rs 709.85, up 1.54% on the day as on 12:49 IST on the NSE. The stock is down 18.3% in last one year as compared to a 43.26% gain in NIFTY and a 19.72% gain in the Nifty Pharma.",positive,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 13:37:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules,"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg, Aurobindo Pharma said in a regulatory filing. The company said the product will be launched immediately.",neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 13:39:34.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma Gets USFDA Nod For Cancer Treatment Injection,"The company’s subsidiary “Eugia Pharma Specialities Ltd has received a 505(b)(2) NDA approval from the US Food & Drug Administration (USFDA) for its Cyclophosphamide Injection 500 mg/2.5 mL and 1 g/5 mL vial,” Aurobindo Pharma said in a regulatory filing.",neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 14:09:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma gets USFDA nod for cancer treatment injection,Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection,neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 17:30:00.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo Pharma shares gain 3% on USFDA approval for Cyclophosphamide injection,This is the 19th product to be approved (including 3 tentative approvals) for Eugia. Aurobindo now has a total of 482 ANDA approvals (453 Final approvals and 29 tentative approvals) from USFDA,positive,neutral,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 17:30:00.000,707.0,718.0,698.05,708.8,7217868.0,"Stocks in news: SpiceJet, Infosys, Wipro, SAIL, Aurobindo Pharma and more","On August 26, the benchmark indices ended on a flat note in range-bound trade amid a weak trend in global markets and sustained foreign fund outflows",neutral,negative,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-08-27 21:47:48.000,707.0,718.0,698.05,708.8,7217868.0,Aurobindo arm gets U.S. FDA nod for anti-cancer drug,"Aurobindo Pharma arm Eugia Pharma Specialities has got the U.S. FDA’s approval for Cyclophosphamide Injection 500 mg/2.5 mL and 1 g/5 mL vials, which is used in the treatment of certain types of cance",neutral,positive,0.2545968882602482,neutral,0.1540616246498631,neutral
2021-09-13 13:50:14.000,736.15,750.9,733.6,747.95,2373717.0,Aurobindo Pharma Ltd drops for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 737.35, down 0.59% on the day as on 13:24 IST on the NSE. The stock tumbled 7.39% in last one year as compared to a 51.8% rally in NIFTY and a 27.73% spurt in the Nifty Pharma index.",neutral,negative,1.6029341846091243,positive,1.3736996532408734,positive
2021-09-16 05:30:00.000,762.7,762.7,750.65,753.0,1678529.0,Why Brokerages are Bullish on Aurobindo Pharma,Why Brokerages are Bullish on Aurobindo Pharma,neutral,neutral,-1.2717975612954038,negative,-1.4694201747418618,negative
2021-09-20 12:18:00.000,713.0,729.6,707.1,725.2,2656815.0,Aurobindo Pharma’s price correction is a good entry point: What makes it stock pick of the week,"Aurobindo has a good generic ecosystem and with its vertically integrated model and low product concentration, it should be able to tide over recent USFDA warnings. Its strong product pipeline is another strength, making it a favourite of analysts.",positive,positive,1.7110799438990247,positive,1.0226644555002733,positive
2021-09-23 03:01:00.000,739.0,739.0,727.6,732.0,2002561.0,Aurobindo Pharma’s subsidiary CuraTeQ submits its first biosimilar filing with EMA,"Dr Satakarni Makkapati, CEO of CuraTeQ said,",neutral,neutral,-0.9472259810554804,negative,-2.011689547369861,negative
2021-09-23 09:39:03.000,739.0,739.0,727.6,732.0,2002561.0,Stocks that will see action today,"Focus on IDFC, Aurobindo Pharma, Infosys, Jubilant Foodworks, Escorts, Jubilant Ingrevia, Adani Ports, Gujarat Sidhee Cement, Mphasis",neutral,neutral,-0.9472259810554804,negative,-2.011689547369861,negative
2021-09-23 10:21:00.000,739.0,739.0,727.6,732.0,2002561.0,Aurobindo Pharma’s subsidiary submits biosimilar filing with EMA,Aurobindo Pharma on Thursday announced that its subsidiary has submitted first biosimilar filing to European Medicines Agency.,neutral,neutral,-0.9472259810554804,negative,-2.011689547369861,negative
2021-09-23 14:53:02.000,735.7,737.2,717.5,720.9,1957076.0,Aurobindo Pharma’s Subsidiary Seeks Marketing Approval Of Its First Biosimilar Product From EMA,Aurobindo Pharma is developing biosimilars for global markets through its subsidiary CuraTeQ Biologics with focus on oncology and immunology segments.,neutral,neutral,-2.011689547369861,negative,-0.4137931034482758,neutral
2021-09-29 13:17:05.000,720.7,735.85,720.35,724.0,1973717.0,"Aurobindo Pharma Ltd soars 1.43%, Gains for third straight session","Aurobindo Pharma Ltd is quoting at Rs 735.4, up 1.43% on the day as on 12:54 IST on the NSE. The stock is down 7.67% in last one year as compared to a 56.98% gain in NIFTY and a 23.16% gain in the Nifty Pharma index.",positive,positive,0.4578881642847168,neutral,-1.011220390635816,negative
2021-09-29 20:34:00.000,720.7,735.85,720.35,724.0,1973717.0,Aurobindo Pharma’s subsidiary opens new logistics and industrial facility in Lyon,"The state-of-the-art facility covers a surface area exceeding 25,000 m2 and built on a 7-hectare site. The new site has been completed with an investment of over EURO 20 million and is principally dedicated for the storage, preparation and",neutral,neutral,0.4578881642847168,neutral,-1.011220390635816,negative
2021-09-29 21:59:00.000,720.7,735.85,720.35,724.0,1973717.0,aurobindo: Aurobindo’s French arm Arrow Generiques sets up new logistics hub near Lyon - Times of India,"International Business News: HYDERABAD: Aurobindo Pharma Limited on Wednesday informed the bourses that its French subsidiary, Arrow Generiques SAS (popularly known locally as Lab.",neutral,positive,0.4578881642847168,neutral,-1.011220390635816,negative
2021-09-30 08:40:55.000,720.7,735.85,720.35,724.0,1973717.0,Stocks that will see action today (Sept 30),"Focus on Sterling & Wilson, IndiaMart, Aurobindo Pharma, Gokul Agro, Persistent Systems",neutral,neutral,0.4578881642847168,neutral,-1.011220390635816,negative
2021-10-01 22:08:00.000,721.9,724.35,706.5,714.6,2873359.0,N Govindarajan steps down as Aurobindo Pharma managing director,"Govindarajan has decided to step down due to “personal reasons”, Aurobindo Pharma said in a regulatory filing",neutral,negative,-1.011220390635816,negative,3.154929577464786,positive
2021-10-01 22:09:06.000,721.9,724.35,706.5,714.6,2873359.0,Aurobindo Pharma MD resigns,"Drugmaker Aurobindo Pharma on Friday said N.Govindarajan has tendered resignation as its Managing Director and as a Director on the Board. Stating that he has resigned due to personal reasons, the com",neutral,neutral,-1.011220390635816,negative,3.154929577464786,positive
2021-10-01 22:16:00.000,721.9,724.35,706.5,714.6,2873359.0,Aurobindo Pharma Managing Director N Govindarajan resigns,"“His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December 31, 2021,” Aurobindo Pharma said in a regulatory filing.",neutral,neutral,-1.011220390635816,negative,3.154929577464786,positive
2021-10-03 12:20:00.000,710.0,751.9,708.0,732.4,5364414.0,"Drug makers Glenmark, Aurobindo recall products in US","Glenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartrate Inhalation Solution. Aurobindo Pharma USA Inc, a unit of Aurobindo Pharma, is recalling 2,820 bottles of Metoprolol tartrate tablets”.",negative,negative,3.154929577464786,positive,-1.153898675406245,negative
2021-10-03 12:21:00.000,710.0,751.9,708.0,732.4,5364414.0,"Drug makers Glenmark, Aurobindo Pharma recall products in US market",Glenmark and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols and presence of foreign substance,negative,negative,3.154929577464786,positive,-1.153898675406245,negative
2021-10-04 06:23:00.000,710.0,751.9,708.0,732.4,5364414.0,"Aurobindo MD’s exit alone may not lift stock, new team must start well","In six weeks of the cancellation of the Rs 420-crore controversial acquisition of Cronus Pharma, a veterinary products company, the managing director of Aurobindo Pharma, India’s second-largest pharma company by revenue, is stepping down.",negative,negative,3.154929577464786,positive,-1.153898675406245,negative
2021-10-04 09:33:20.000,710.0,751.9,708.0,732.4,5364414.0,Stocks that will see action today,"Focus is on NTPC, Grasim Ind, Cummins, Aurobindo Pharma, Pfizer, Sona BLW, Tech Mahindra, GR Infraprojects, Sheela Foam, PSP Projects, HealthCare Global Enterprises",neutral,neutral,3.154929577464786,positive,-1.153898675406245,negative
2021-10-04 12:25:55.000,732.3,734.9,718.2,723.85,2237462.0,Nifty Pharma index gives breakout. Experts give ‘buy’ tag to these stocks,Pharma major Divi’s Lab share price surged around 10 per cent while Aurobindo Pharma shares added 4 per cent in early session,positive,positive,-1.153898675406245,negative,-1.6517549896765311,negative
2021-10-04 18:02:00.000,732.3,734.9,718.2,723.85,2237462.0,N Govindarajan resigns as Managing Director of Aurobindo Pharma,The Board places on record its sincere appreciation for the remarkable contribution made by N. Govindarajan during his tenure.,neutral,positive,-1.153898675406245,negative,-1.6517549896765311,negative
2021-10-05 08:00:00.000,732.3,734.9,718.2,723.85,2237462.0,Aurobindo Pharma clarifies on news of recalling products in US market; Stock dips 1.5%,"The Company confirmed on the matter which involved recall of 2,820 bottles of Metoprolol tartrate tablets in the US market.",neutral,negative,-1.153898675406245,negative,-1.6517549896765311,negative
2021-10-05 12:04:00.000,726.5,729.4,712.15,714.5,1923676.0,Aurobindo Pharma slips on recalling products in US market,"Aurobindo Pharma fell 1.11% to Rs 724 after the drug maker confirmed the recall of 2,820 bottles of metroprolol tartrate tables in the US market.",negative,negative,-1.6517549896765311,negative,0.0972627483673658,neutral
2021-10-06 17:39:01.000,719.7,726.4,716.35,720.4,1511781.0,Aurobindo Pharma Q2 PAT May Dip 17.3% YoY To Rs 666.3 Cr: Prabhudas Lilladher,"Net Sales are expected to decrease by 9.5 percent Y-o-Y (up 1.4 percent Q-o-Q) to Rs 5,771.5 crore, according to Prabhudas Lilladher.",neutral,negative,0.0972627483673658,neutral,-0.7628294036061026,neutral
2021-10-08 14:26:46.000,721.0,730.45,713.1,715.5,2176823.0,DCGI sees Merck drug less effective against moderate Covid: Report,"Aurobindo Pharma Ltd wants to discontinue a late-stage trial of Merck drug in moderate Covid-19 patients, DCGI’s expert committee said on Friday",negative,neutral,-0.7628294036061026,neutral,0.5078614164463583,neutral
2021-10-08 23:04:00.000,721.0,730.45,713.1,715.5,2176823.0,Two Indian drugmakers seek to end trials of Merck’s antiviral drug for moderate COVID-19,"The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-19.",neutral,positive,-0.7628294036061026,neutral,0.5078614164463583,neutral
2021-10-08 23:42:00.000,721.0,730.45,713.1,715.5,2176823.0,"Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck’s molnupiravir","In a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients and continue the phase III trial in mild Covid patients”, as per the minutes of the meeting. ET has seen the minutes of the SEC meeting.",neutral,neutral,-0.7628294036061026,neutral,0.5078614164463583,neutral
2021-10-12 07:38:00.000,722.0,735.5,720.05,729.65,2501840.0,Aurobindo Pharma trades flat after clarification on news item,"We have faced challenges in patient recruitment at this juncture and are evaluating further course of action,” the company added.",neutral,negative,1.059556786703598,positive,-0.8843537414965987,neutral
2021-11-08 08:31:43.000,690.05,693.7,662.1,671.2,4486303.0,"Reliance, Britannia, Aurobindo Pharma, Future Retail, NTPC, IndusInd Bank stocks in focus","Nifty futures were trading 71 points or 0.40 per cent up at 18,011.50 on Singaporean Exchange, suggesting a gap-up opening for BSE Sensex and Nifty 50.",neutral,positive,-2.7316861097021827,negative,-1.1661807580174928,negative
2021-11-08 09:22:55.000,690.05,693.7,662.1,671.2,4486303.0,"Pre-Market Report: Britannia, Aurobindo Pharma Results Quarterly Results, Paytm IPO To Watch Out For",Markets were closed for the Diwali vacation since Thursday. How investors react on Monday would depend on what they see as a priority.,neutral,neutral,-2.7316861097021827,negative,-1.1661807580174928,negative
2021-11-08 16:16:00.000,686.0,713.5,673.75,678.0,10470577.0,"Britannia, Sobha, Aurobindo Pharma, Ujjivan Small Finance Bank, Wockhardt among key earnings today","Other companies that will announce their Q2 today are - 3i Infotech, Action Construction Equipment, Balrampur Chini Mills, Elgi Equipments, GVK Power & Infrastructure, HG Infra Engineering, KRBL.",neutral,neutral,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-08 17:30:00.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr,"Aurobindo Pharma’s consolidated total revenue from operations during the period under review stood at Rs 5,941.92 crore.",negative,neutral,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-08 20:59:25.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma Q2 Net Profit Declines Nearly 14% To Rs 697 Crore,"The company had posted a net profit of Rs 807.25 crore in the corresponding period of the previous fiscal, Aurobindo Pharma said in a regulatory filing.",neutral,positive,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-08 21:12:15.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma’s Q2 net down 2.1% at ₹697 cr,"Total revenue too falls to ₹5,942 crore",negative,neutral,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-08 22:05:00.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore,The drug firm on Monday reported a decline in its consolidated net profit,negative,negative,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-09 07:54:33.000,686.0,713.5,673.75,678.0,10470577.0,"Buzzing Stocks: Aurobindo Pharma, Reliance Industries, Motherson Sumi Systems, And Others In The News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-09 08:05:00.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma consolidated net profit declines 13.72% in the September 2021 quarter,Sales decline 7.65% to Rs 5889.93 crore,negative,negative,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-09 08:34:00.000,686.0,713.5,673.75,678.0,10470577.0,"RIL, Aurobindo Pharma, Britannia Industries to be watched","Reliance Eagleford Upstream Holding, LP (REUHLP) a wholly owned step-down subsidiary of Reliance Industries (RIL), announced the signing of agreements with Ensign Operating III, LLC (Ensign), a Delaware limited liability company to divest its",neutral,positive,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-09 11:43:29.000,686.0,713.5,673.75,678.0,10470577.0,Aurobindo Pharma posts encouraging US sales recovery during Q2,"Aurobindo Pharma also did well with filings for new products. It filed 27 ANDAs, including 5 injectables with US FDA in Q2FY22, the highest ever ANDA filings in a quarter by the company",positive,positive,-1.1661807580174928,negative,3.151693667157581,positive
2021-11-09 13:01:04.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma’s (ARBQY) Management on Q2 2022 Results - Earnings Call Transcript,"Aurobindo Pharma Ltd. ADR (OTC:ARBQY) Q2 2022 Earnings Conference Call November 08, 2021 8:30 PM ET Company Participants Arvind Bothra – Investor Relations P.V.",neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-09 13:02:00.000,679.0,706.9,678.0,700.4,8249320.0,"Top stocks in focus: Aurobindo Pharma, Reliance Industries, Cadila, Britannia, 3i Infotech",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-09 17:30:00.000,679.0,706.9,678.0,700.4,8249320.0,"Stocks in news: Aurobindo Pharma, Reliance Industries, Future Retail, Britannia Industries and more","On November 8, benchmark indices closed higher despite negative global cues. Sensex rose 477.99 points to 60,545 and Nifty gained 151 points to 18,068 after a volatile session.",neutral,positive,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-09 18:09:00.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma stock rises 1% despite Q2 consolidated PAT contracts to Rs697cr,API revenues were lower at Rs781cr. The sharp fall in sales came from the 71% fall in sales of anti-retroviral sales.,positive,negative,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-09 21:18:06.000,679.0,706.9,678.0,700.4,8249320.0,"Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market","But plans for a vaccine did not take off, says MD",positive,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 06:31:00.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma’s COVID-19 vaccine plan in limbo after partner fails to get EUA in Taiwan,"Aurobindo Pharma on Tuesday said that its COVID-19 vaccine UB-612 programme hasn’t progressed, as its partner Vaxxinity failed to secure the emergency use authorization (EUA) in Taiwan.",neutral,negative,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 08:29:00.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma receives OAI status from USFDA on Hyderabad-based API manufacturing unit; Stock soars over 3%,Aurobindo will be engaging with the regulator and is fully committed to resolving the status of this facility at the earliest.,neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 09:22:00.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma receives USFDA’s OAI status for its API manufacturing facility,The Company believes that this inspection classification will not impact the continuing commercial supplies to the US market from this facility.,neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 11:08:58.000,679.0,706.9,678.0,700.4,8249320.0,Aurobindo Pharma Shares Gain For Second Straight Day On Upbeat Analyst Calls,Here’s what brokerages have to say about Aurobindo’s Q2 results:,neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 11:38:00.000,679.0,706.9,678.0,700.4,8249320.0,"Results Review For Mahindra & Mahindra, Britannia Industries, Aurobindo Pharma","Results Review For Mahindra & Mahindra, Britannia Industries, Aurobindo Pharma",neutral,neutral,3.151693667157581,positive,-1.6547277936962688,negative
2021-11-10 12:58:08.000,698.0,701.45,684.0,686.45,2315670.0,Aurobindo Pharma Shares Rise After Global Brokerage Upgrades Stock To ‘buy’,"CLSA has upgraded Aurobindo Pharma to ‘buy’ from ‘outperform’, with the target at Rs 830 a share, an upside of 19 percent from the current market price",neutral,positive,-1.6547277936962688,negative,-0.2028985507246344,neutral
2021-11-11 09:46:00.000,698.0,701.45,684.0,686.45,2315670.0,Daljeet Singh Kohli on 2 pharma stocks to add or buy afresh now,“Aurobindo Pharma and Alkem Laboratories are the two stocks that can be added or bought afresh.”,positive,neutral,-1.6547277936962688,negative,-0.2028985507246344,neutral
2021-11-18 07:15:00.000,668.0,668.7,634.05,640.1,4593825.0,Panel to meet today to take up applications seeking nod for Molnupiravir,"The firms whose applications that will be taken up are Dr Reddy’s Laboratories which has filed for approval in a consortium with five other companies and MSD, Hetero Labs, Natco Pharma, Aurobindo Pharma, Optimus Pharma, Strides Pharma, MSN Pharma and BDR Pharmaceuticals.",neutral,positive,-4.176646706586823,negative,-1.813775310765368,negative
2021-11-18 14:06:00.000,668.0,668.7,634.05,640.1,4593825.0,Aurobindo Pharma shares down 4.48% as Nifty drops,"A total of 218,748 shares changed hands on the counter till 02:06PM (IST).",negative,neutral,-4.176646706586823,negative,-1.813775310765368,negative
2021-11-22 12:24:00.000,625.1,652.6,623.0,650.2,1882817.0,Share price of Aurobindo Pharma falls as Nifty weakens,"A total of 55,854 shares changed hands on the counter till 12:24PM (IST).",neutral,neutral,4.015357542793157,positive,0.826952526799384,neutral
2021-11-23 12:24:00.000,653.0,670.5,651.15,658.4,1928947.0,Aurobindo Pharma shares up 1.48% as Nifty drops,"A total of 62,404 shares changed hands on the counter till 12:24PM (IST).",positive,neutral,0.826952526799384,neutral,1.4481765107286306,positive
2021-11-24 11:06:00.000,653.0,670.5,651.15,658.4,1928947.0,Aurobindo Pharma shares up 2.91% as Nifty gains,The stock quoted a 52-week high price of Rs 1063.75 and low of Rs 620.55.,positive,negative,0.826952526799384,neutral,1.4481765107286306,positive
2021-11-25 10:20:00.000,659.45,675.0,655.05,669.0,2952746.0,Aurobindo Pharma shares up 0.85% as Nifty falls,The stock quoted a 52-week high price of Rs 1063.75 and low of Rs 620.55.,positive,negative,1.4481765107286306,positive,1.0628742514970095,positive
2021-11-25 13:16:24.000,668.0,691.15,664.05,675.1,4929603.0,Aurobindo Pharma Ltd rises for third consecutive session,"Aurobindo Pharma Ltd is quoting at Rs 667, up 1.24% on the day as on 12:54 IST on the NSE. The stock is down 23.39% in last one year as compared to a 34.53% spurt in NIFTY and a 14.62% spurt in the Nifty Pharma index.",positive,positive,1.0628742514970095,positive,-4.044117647058823,negative
2021-11-26 10:10:00.000,668.0,691.15,664.05,675.1,4929603.0,Aurobindo Pharma shares up 2.84% as Nifty falls,The stock quoted a 52-week high price of Rs 1063.75 and low of Rs 620.55.,positive,negative,1.0628742514970095,positive,-4.044117647058823,negative
2021-11-26 12:29:00.000,668.0,691.15,664.05,675.1,4929603.0,Aurobindo Pharma spurts after LIC picks up stake,"Aurobindo Pharma advanced 2.43% to Rs 685.50 after Life Insurance Corporation of India (LIC) bought 79,000 equity shares or 0.02% stake of Aurobindo Pharma on 24 November 2021.",neutral,positive,1.0628742514970095,positive,-4.044117647058823,negative
2021-11-26 13:22:00.000,668.0,691.15,664.05,675.1,4929603.0,"Top stocks in focus: Reliance Industries, Engineers India, Tarsons Products, Aurobindo Pharma, Nagarjuna Fertilizers",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.0628742514970095,positive,-4.044117647058823,negative
2021-11-29 13:19:00.000,653.0,672.25,648.6,655.65,2789740.0,Share price of Aurobindo Pharma falls as Sensex gains 404.02 points,"A total of 95,291 shares changed hands on the counter till 01:19PM (IST)",positive,neutral,0.4058192955589551,neutral,-0.0753012048192771,neutral
2021-11-30 13:34:00.000,664.0,668.9,653.35,663.5,1466802.0,Aurobindo Pharma shares gain 1.85% as Sensex rises,"A total of 84,187 shares changed hands on the counter till 01:34PM (IST)",positive,neutral,-0.0753012048192771,neutral,1.6616314199395772,positive
2021-12-01 12:28:00.000,662.0,674.7,661.25,673.0,1471933.0,Share price of Aurobindo Pharma rises as Nifty strengthens,"A total of 87,665 shares changed hands on the counter till 12:28PM (IST).",positive,neutral,1.6616314199395772,positive,-0.3469402819812538,neutral
2021-12-02 11:06:00.000,662.0,674.7,661.25,673.0,1471933.0,Aurobindo Pharma rises 1.37% as Sensex climbs,"The stock traded at a P/E multiple of 7.54, while the price-to-book value ratio stood at 2.36.",positive,neutral,1.6616314199395772,positive,-0.3469402819812538,neutral
2021-12-03 13:30:00.000,677.35,678.0,669.5,675.0,1090014.0,Aurobindo Pharma shares rise 0.34 per cent in Friday’s trading session,The Relative Strength Index of the stock stood at 49.21 on Friday.,positive,neutral,-0.3469402819812538,neutral,-1.9333333333333265,negative
2021-12-05 18:15:10.000,675.0,675.0,660.0,661.95,1183123.0,"Aurobindo Pharma, Unichem Laboratories recall products in US; amid manufacturing issues","Aurobindo Pharma, Unichem Laboratories recall products in US; amid manufacturing issues",negative,negative,-1.9333333333333265,negative,1.8283469326080424,positive
2021-12-06 00:16:00.000,675.0,675.0,660.0,661.95,1183123.0,"Aurobindo Pharma, Unichem Laboratories recall products in US market","Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world’s largest market for medicines, due to manufacturing issues.",negative,negative,-1.9333333333333265,negative,1.8283469326080424,positive
2021-12-06 05:30:00.000,675.0,675.0,660.0,661.95,1183123.0,"Stocks in Focus on Dec 6: Indiabulls Housing Finance, Aurobindo Pharma & More","Stocks in Focus on Dec 6: Indiabulls Housing Finance, Aurobindo Pharma & More",neutral,neutral,-1.9333333333333265,negative,1.8283469326080424,positive
2021-12-07 06:49:00.000,661.8,678.6,658.2,673.9,1896816.0,Panel seeks extra data on Merck’s Covid drug,"The SEC of the Central Drugs Standard Control Organisation (CDSCO) on Monday reviewed applications from Dr Reddy’s, Hetero Labs, Natco Pharma, Aurobindo Pharma, Optimus Pharma, Strides Pharma, MSN Pharma and BDR Pharmaceuticals.",neutral,neutral,1.8283469326080424,positive,4.412202380952378,positive
2021-12-07 12:58:00.000,672.0,703.25,672.0,701.65,2514176.0,Aurobindo Pharma shares up 1.95% as Nifty gains,"A total of 46,588 shares changed hands on the counter till time (IST).",positive,neutral,4.412202380952378,positive,0.4629629629629629,neutral
2021-12-08 11:57:00.000,672.0,703.25,672.0,701.65,2514176.0,Aurobindo Pharma shares gain 1.62% as Sensex rises,"A total of 19,479 shares changed hands on the counter till 11:57AM (IST)",positive,neutral,4.412202380952378,positive,0.4629629629629629,neutral
2021-12-09 11:06:00.000,702.0,708.5,700.4,705.25,2313366.0,Aurobindo Pharma shares up 0.36% as Nifty falls,The stock quoted a 52-week high price of Rs 1063.75 and low of Rs 620.55.,positive,negative,0.4629629629629629,neutral,-0.7900677200902807,neutral
2021-12-10 11:16:00.000,708.8,714.0,703.0,703.2,1873313.0,Share price of Aurobindo Pharma jumps as Sensex drops 210.1 points,"Promoters held 48.76 per cent stake in the company as of 30-Sep-2021, while FII and DII ownership stood at 21.71 per cent and 9.28 per cent, respectively.",positive,neutral,-0.7900677200902807,neutral,-1.897748194306752,negative
2021-12-13 12:14:00.000,694.8,715.0,692.25,708.35,2659008.0,"Buy Aurobindo Pharma, target price Rs 900: Axis Securities","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 41118.24 Crore) operating in Pharmaceuticals sector.",neutral,neutral,1.9502014968336312,positive,-2.669202056482857,negative
2021-12-13 13:14:00.000,694.8,715.0,692.25,708.35,2659008.0,Aurobindo Pharma shares fall 1.58% as Nifty drops,"A total of 57,209 shares changed hands on the counter till time (IST).",negative,neutral,1.9502014968336312,positive,-2.669202056482857,negative
2021-12-14 10:05:00.000,694.8,715.0,692.25,708.35,2659008.0,Aurobindo Pharma shares gain 3.07% as Sensex falls,"On the technical charts, the RSI of the stock stood at 59.82.",positive,neutral,1.9502014968336312,positive,-2.669202056482857,negative
2021-12-15 11:52:00.000,709.95,713.7,691.0,691.0,1861835.0,Aurobindo Pharma shares drop 1.19% as Sensex falls,"A total of 28,189 shares changed hands on the counter till 11:52AM (IST)",negative,neutral,-2.669202056482857,negative,-1.549497847919649,negative
2021-12-16 13:11:00.000,687.1,689.0,665.3,682.0,1878165.0,Aurobindo Pharma shares fall 1.78 per cent in Thursday’s trading session,The Relative Strength Index of the stock stood at 48.71 on Thursday.,negative,neutral,-0.742250036384809,neutral,0.6474396703943462,neutral
2021-12-17 13:14:00.000,687.1,689.0,665.3,682.0,1878165.0,Aurobindo Pharma shares gain 0.33% as Sensex falls,"On the technical charts, the RSI of the stock stood at 50.25.",positive,neutral,-0.742250036384809,neutral,0.6474396703943462,neutral
2021-12-20 10:10:00.000,679.6,689.0,664.55,684.0,2574199.0,Aurobindo Pharma shares rise 0.32 per cent in Monday’s trading session,The Relative Strength Index of the stock stood at 48.42 on Monday.,positive,neutral,0.6474396703943462,neutral,-0.1370851370851436,neutral
2021-12-21 14:00:00.000,691.0,719.9,689.85,717.5,2407963.0,Aurobindo Pharma shares up 0.4% as Nifty gains,"A total of 36,060 shares changed hands on the counter till 02:00PM (IST).",positive,neutral,3.835021707670044,positive,-0.3448275862068966,neutral
2021-12-22 11:52:00.000,691.0,719.9,689.85,717.5,2407963.0,Aurobindo Pharma shares rise 1.4% as Sensex climbs,"A total of 35,706 shares changed hands on the counter till 11:52AM (IST)",positive,neutral,3.835021707670044,positive,-0.3448275862068966,neutral
2021-12-22 13:31:18.000,725.0,726.7,717.65,722.5,1493010.0,Aurobindo Pharma Ltd up for third straight session,"Aurobindo Pharma Ltd is quoting at Rs 707, up 1.91% on the day as on 12:54 IST on the NSE. The stock is down 20.5% in last one year as compared to a 24.2% gain in NIFTY and a 5.4% gain in the Nifty Pharma index.",positive,positive,-0.3448275862068966,neutral,-2.151427389325613,negative
2021-12-23 10:21:00.000,725.0,726.7,717.65,722.5,1493010.0,"Buy Aurobindo Pharma, target price Rs 828: HDFC Securities","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 42322.35 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.3448275862068966,neutral,-2.151427389325613,negative
2021-12-23 12:53:00.000,725.1,725.9,705.1,709.5,1482667.0,Aurobindo Pharma stock price up 0.87 per cent as Sensex climbs,"As of 30-Sep-2021, promoters held 48.76 per cent stake in the company, while FIIs held 21.71 per cent and domestic institutional investors had 9.28 per cent.",positive,neutral,-2.151427389325613,negative,1.873239436619712,positive
2021-12-24 09:08:00.000,725.1,725.9,705.1,709.5,1482667.0,"Buy Aurobindo Pharma, target price Rs 745: Kotak Securities","Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 42369.22 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-2.151427389325613,negative,1.873239436619712,positive
2021-12-24 12:58:00.000,725.1,725.9,705.1,709.5,1482667.0,Aurobindo Pharma shares down 2.12% as Sensex falls,"A total of 41,193 shares changed hands on the counter till 12:58PM (IST)",negative,neutral,-2.151427389325613,negative,1.873239436619712,positive
2021-12-27 10:25:00.000,710.0,728.8,707.1,723.3,1974541.0,Shares of Aurobindo Pharma rise as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 833.93.",positive,neutral,1.873239436619712,positive,-0.4807692307692308,neutral
2021-12-28 13:44:00.000,732.0,735.65,723.0,724.25,1851139.0,Aurobindo Pharma shares down 0.41% as Nifty gains,"A total of 93,688 shares changed hands on the counter till 01:44PM (IST).",negative,neutral,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 08:47:00.000,732.0,735.65,723.0,724.25,1851139.0,"DRL, Aurobindo Pharma, Adani Enterprises in focus",Dr. Reddy’s Laboratories (DRL) announced that it has received emergency-use authorisation from the Drugs Controller General of India (DCGI) to manufacture and market the oral anti-viral drug Molnupiravir capsules 200mg for the treatment of adult,neutral,positive,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 08:53:09.000,732.0,735.65,723.0,724.25,1851139.0,Stocks that will see action today,"Buzzing Stocks: Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Cipla, Torrent Pharmaceuticals, Strides Pharma Science, Aurobindo Pharma, Natco Pharma, Mishtann Food",neutral,neutral,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 10:02:00.000,732.0,735.65,723.0,724.25,1851139.0,"Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high","Sun Pharma, Cipla, Natco, Dr Reddy’s, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI",positive,neutral,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 10:23:00.000,732.0,735.65,723.0,724.25,1851139.0,Pharma stocks gain as DGCI approves emergency use of COVID pill Molnupiravir,"Shares of Strides Pharma were up 2.3 per cent while those of Cipla gained 1.4 per cent. Dr Reddys scrip registered a gain of close to a per cent while Aurobindo Pharma and Natco Pharma were up 0.9 and 1.3 per cent, respectively.",positive,positive,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 11:16:00.000,732.0,735.65,723.0,724.25,1851139.0,Aurobindo Pharma rises 0.54% as Sensex slides,"The stock traded at a P/E multiple of 8.21, while the price-to-book value ratio stood at 2.36.",positive,neutral,-1.0587431693989071,negative,-0.2473206924979327,neutral
2021-12-29 13:05:00.000,727.8,731.5,721.2,726.0,1088394.0,"Top stocks in focus: Aurobindo Pharma, IndiGrid, Natco Pharma, GR Infraprojects, Dr Reddy’s",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.2473206924979327,neutral,0.8471074380165258,neutral
2021-12-29 14:44:00.000,727.8,731.5,721.2,726.0,1088394.0,"DCGI approves Aurobindo Pharma to manufacture and distribute Molnupiravir, to be marketed as Molnaflu","For the generic version of Molnupiravir, Aurobindo enjoys backward integration with in-house API manufacturing which equips it with stronger control on supply chain and cost efficiencies.",neutral,positive,-0.2473206924979327,neutral,0.8471074380165258,neutral
2021-12-30 11:11:00.000,727.8,731.5,721.2,726.0,1088394.0,Aurobindo Pharma shares down 0.03% as Nifty gains,"A total of 21,858 shares changed hands on the counter till 11:11AM (IST).",negative,neutral,-0.2473206924979327,neutral,0.8471074380165258,neutral
2021-12-31 13:23:00.000,726.0,739.8,720.5,732.15,1769548.0,Aurobindo Pharma rises 2.05% as Sensex climbs,"The stock traded at a P/E multiple of 8.28, while the price-to-book value ratio stood at 2.36.",positive,neutral,0.8471074380165258,neutral,-0.9212843788104684,negative
2021-12-31 22:31:00.000,726.0,739.8,720.5,732.15,1769548.0,Aurobindo Pharma names K Nithyananda Reddy as managing director,"“Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Companys growth journey since inception. A veteran of the pharma industry, he has expertise in manufacturing technology and has been actively involved in the overall affairs and the strategic decision makin…",neutral,neutral,0.8471074380165258,neutral,-0.9212843788104684,negative
2022-01-03 08:16:40.000,738.1,738.9,727.05,731.3,1085821.0,"Stocks To Watch: GMR Infra, Future Retail, RBL Bank, Aurobindo Pharma, Adani Enterprises",Here are the stocks to watch in trade today...,neutral,neutral,-0.9212843788104684,negative,-1.6482768015256808,negative
2022-01-03 13:54:00.000,734.1,736.95,721.0,722.0,1132678.0,Aurobindo Pharma shares drop 0.29% as Sensex rises,"A total of 17,511 shares changed hands on the counter till 01:54PM (IST)",negative,neutral,-1.6482768015256808,negative,-0.1452081316553821,neutral
2022-01-04 13:44:00.000,723.1,730.15,717.25,722.05,1144768.0,Aurobindo Pharma shares down 1.28% as Nifty gains,"A total of 23,748 shares changed hands on the counter till 01:44PM (IST).",negative,neutral,-0.1452081316553821,neutral,-0.1461886529759769,neutral
2022-01-05 12:43:00.000,718.25,726.85,715.1,717.2,771234.0,Aurobindo Pharma shares rise 0.16% as Nifty gains,The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55.,positive,negative,-0.1461886529759769,neutral,-1.662049861495845,negative
2022-01-06 10:41:00.000,718.25,726.85,715.1,717.2,771234.0,Aurobindo Pharma launches COVID-19 drug Molnupiravir in India,"Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based drug maker said. Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.",neutral,neutral,-0.1461886529759769,neutral,-1.662049861495845,negative
2022-01-06 11:10:46.000,718.25,726.85,715.1,717.2,771234.0,Aurobindo Pharma’s Covid-19 Drug Molnupiravir Launches In India,Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.,neutral,positive,-0.1461886529759769,neutral,-1.662049861495845,negative
2022-01-06 11:21:00.000,718.25,726.85,715.1,717.2,771234.0,Aurobindo Pharma stock price down 0.15 per cent as Sensex slides,"As of 30-Sep-2021, promoters held 48.76 per cent stake in the company, while FIIs held 21.71 per cent and domestic institutional investors had 9.28 per cent.",negative,neutral,-0.1461886529759769,neutral,-1.662049861495845,negative
2022-01-06 11:52:02.000,718.25,726.85,715.1,717.2,771234.0,Aurobindo Pharma Launches COVID-19 Drug Molnupiravir In India,"business,companies,coronavirus,COVID-19,Omicron,Aurobindo Pharma,Molnupiravir",neutral,neutral,-0.1461886529759769,neutral,-1.662049861495845,negative
2022-01-06 12:17:10.000,722.0,723.0,707.3,710.0,1249869.0,Aurobindo Pharma launches COVID-19 treatment drug Molnupiravir,Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses,neutral,neutral,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-06 13:20:55.000,722.0,723.0,707.3,710.0,1249869.0,Aurobindo Pharma Launches Anti-Covid Drug Molnupiravir in India Day After ICMR Flags ‘Major Safety Concerns’,Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.,neutral,positive,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-06 19:05:13.000,722.0,723.0,707.3,710.0,1249869.0,Aurobindo Pharma launches Molnupiravir at ₹50 per capsule,"Molnupiravir is for treatment of adult Covid19 patients, who have high risk of progression of the disease including hospitalization or death",neutral,neutral,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-06 22:48:41.000,722.0,723.0,707.3,710.0,1249869.0,Aurobindo prices Molnupiravir at ₹50 per capsule,"Aurobindo Pharma has launched molnupiravir 200mg, the anti-viral drug that recently got emergency use authorisation in India for COVID-19 treatment, under the Molnaflu brand, at almost ₹50 per capsule",neutral,positive,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-07 09:28:13.000,722.0,723.0,707.3,710.0,1249869.0,Stocks that will see action today (December 7),"Buzzing stocks: Reliance Ind, Aurobindo Pharma, Ircon, HFCL, Anand Rathi, Hinduja Global, Brightcom, Suditi",neutral,neutral,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-07 13:50:55.000,722.0,723.0,707.3,710.0,1249869.0,Aurobindo Pharma Ltd down for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 713.95, down 0.56% on the day as on 13:24 IST on the NSE. The stock tumbled 24.49% in last one year as compared to a 23.88% rally in NIFTY and a 4.74% spurt in the Nifty Pharma index.",negative,negative,-1.662049861495845,negative,3.0339125560538083,positive
2022-01-10 10:56:00.000,713.6,740.0,712.0,735.25,3079313.0,Shares of Aurobindo Pharma rise as Nifty gains,"On the technical charts, the 200-day moving average of the stock stood at Rs 827.97.",positive,neutral,3.0339125560538083,positive,-2.834008097165992,negative
2022-01-11 07:24:00.000,741.0,742.0,713.4,720.0,2913958.0,Aurobindo Pharma’s subsidiary CuraTeQ expands licensing deal with Orion for biosimilars distribution in select European markets,"Earlier in 2020, CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia.",positive,positive,-2.834008097165992,negative,-1.229451581710178,negative
2022-01-11 09:51:00.000,741.0,742.0,713.4,720.0,2913958.0,Aurobindo Pharma taps PEs for stake sale in injectable business,"As part of expanding the injectable business, Aurobindo is setting up a dedicated injectable facility in Vizag for the EU and other global markets",neutral,positive,-2.834008097165992,negative,-1.229451581710178,negative
2022-01-11 10:34:00.000,741.0,742.0,713.4,720.0,2913958.0,Aurobindo Pharma skids 3% as drugmaker plans to sell 30-35% stake in injectable business,"TPG Capital Management, Advent International, Bain Capital and Blackstone have been sounded off for a potential transaction, valuing the business at Rs 15,000 crore. The Carlyle Group and PAG are the two other firms which have been reached out for a potential deal, ET reported, quoting sources.",neutral,neutral,-2.834008097165992,negative,-1.229451581710178,negative
2022-01-11 13:22:12.000,723.9,724.0,711.45,715.0,1132978.0,Aurobindo Pharma Arm CuraTeQ Expands Scope Of Distribution Pact With Orion,"Earlier in 2020, CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for Indian company’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia.",neutral,positive,-1.229451581710178,negative,0.0069550702462189,neutral
2022-01-11 13:56:00.000,723.9,724.0,711.45,715.0,1132978.0,Aurobindo Pharma declines 2.03% as Sensex climbs,"The stock traded at a P/E multiple of 8.14, while the price-to-book value ratio stood at 2.36.",negative,neutral,-1.229451581710178,negative,0.0069550702462189,neutral
2022-01-11 14:06:00.000,723.9,724.0,711.45,715.0,1132978.0,Aurobindo Pharma arm CuraTeQ expands scope of distribution pact with Orion,Aurobindo Pharma on Tuesday said its subsidiary CuraTeQ Biologics has expanded the scope of its marketing and distribution agreement with Orion Corporation (Orion),positive,positive,-1.229451581710178,negative,0.0069550702462189,neutral
2022-01-11 15:00:00.000,723.9,724.0,711.45,715.0,1132978.0,"Aurobindo Pharma subsidiary, CuraTeQ expands scope of agreement signed with Orion","Aurobindo Pharma announced that its subsidiary, CuraTeQ Biologics has expanded the scope of its marketing and distribution agreement with Orion Corporation to commercialize its biosimilars pipeline to include the Baltic states in Europe.",positive,positive,-1.229451581710178,negative,0.0069550702462189,neutral
2022-01-13 10:25:00.000,718.9,726.5,715.5,718.95,1020900.0,Share price of Aurobindo Pharma rises as Nifty weakens,"A total of 8,378 shares changed hands on the counter till 10:25AM (IST).",positive,neutral,0.0069550702462189,neutral,1.4577259475218658,positive
2022-01-13 15:09:08.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma Q3 PAT May Dip 73% YoY To Rs 795.3 Cr: Prabhudas Lilladher,"Net Sales are expected to decrease by 2.7 percent Y-o-Y (up 4.2 percent Q-o-Q) to Rs 6,190.4 crore, according to Prabhudas Lilladher.",neutral,negative,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 05:30:00.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma Slides Over 3% on Receiving Warning Letter from US FDA: Details,Aurobindo Pharma Slides Over 3% on Receiving Warning Letter from US FDA: Details,neutral,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 09:47:01.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma Falls Over 3% After Bulk Drug Manufacturing Unit Receives Warning Letter From US,The unit inspected in August by the US Food and Drug Administration was issued a Form 483 with seven observations of violations of good manufacturing practices.,neutral,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 09:53:00.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma slips after API unit gets USFDA warning letter,Aurobindo Pharma fell 1.89% to Rs 704.30 after the company said its Active Pharmaceutical Ingredient (API) manufacturing facility in Hyderabad has received US drug regulator’s warning letter.,neutral,negative,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 10:44:02.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma Gets Warning Letter From USFDA For API Facility,"The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a regulatory filing.",neutral,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 10:46:05.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma Shares Fall On Receiving Warning Letter From USFDA,"The action follows the recent inspection of the facility by the USFDA in August 2021, the drugmaker said in a stock exchange filing.",neutral,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 10:52:00.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma gets warning letter from USFDA for API facility,"The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a regulatory filing.",negative,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 12:40:00.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma down 5% on USFDA warning letter for Hyderabad unit,The company believes that this will not impact the existing business from this facility.,negative,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 14:01:00.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma shares drop 3.22% as Sensex falls,"A total of 301,363 shares changed hands on the counter till 02:01PM (IST)",negative,neutral,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 16:40:49.000,686.0,705.0,684.45,696.0,5836118.0,Aurobindo Pharma receives warning letter from US FDA for API facility,Aurobindo Pharma receives warning letter from US FDA for API facility,negative,negative,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 18:13:00.000,686.0,705.0,684.45,696.0,5836118.0,Market Movers: What ails Aurobindo Pharma and Tata Teleservices’ freefall,"Shares of Aurobindo Pharma also had a bad day. The stock fell 3 per cent after the US Food and Drugs Administration (USFDA) shot off a letter to the company warning for Unit I, an API manufacturing facility of the company in Hyderabad.",neutral,negative,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-14 20:57:00.000,686.0,705.0,684.45,696.0,5836118.0,"Market wrap: Sensex stages smart recovery, ends 12 pts down; Nifty holds 18,250",Mindtree dips 4% on profit booking after December quarter results; Aurobindo Pharma ends 5% down on US FDA warning letter for unit; India Cements gains 4%; hits highest level since January 2008,neutral,negative,1.4577259475218658,positive,-1.8317115054378872,negative
2022-01-17 09:18:18.000,698.8,699.75,684.5,686.0,2222501.0,How Will Aurobindo Pharma Value Its Injectable Business?,Aurobindo Pharma is reportedly selling stake in injectables business. How will it value it?,neutral,neutral,-1.8317115054378872,negative,-2.405247813411078,negative
2022-01-17 13:19:00.000,686.0,695.0,666.65,669.5,3530937.0,Aurobindo Pharma shares fall 1.24% as Nifty gains,The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55.,negative,negative,-2.405247813411078,negative,0.4037081339712987,neutral
2022-01-19 12:38:00.000,670.55,673.75,660.05,661.05,1671359.0,Share price of Aurobindo Pharma falls as Nifty weakens,"A total of 69,373 shares changed hands on the counter till 12:38PM (IST).",neutral,neutral,-1.4167474461263143,negative,-0.8620689655172481,neutral
2022-01-20 12:49:00.000,661.2,676.6,650.1,655.5,2115415.0,Aurobindo Pharma shares down 0.92% as Nifty falls,The stock quoted a 52-week high price of Rs 1063.75 and low of Rs 620.55.,negative,negative,-0.8620689655172481,neutral,-6.796857121061876,negative
2022-01-21 11:12:00.000,661.2,676.6,650.1,655.5,2115415.0,Aurobindo Pharma share price down 0.17 per cent,"A total of 59,509 shares changed hands on the counter till 11:12AM (IST).",negative,neutral,-0.8620689655172481,neutral,-6.796857121061876,negative
2022-01-25 14:52:00.000,609.7,621.6,590.1,619.25,3004713.0,Aurobindo Pharma shares rise 1.09% as Sensex climbs,"A total of 130,044 shares changed hands on the counter till 02:52PM (IST)",positive,neutral,1.5663441036575287,positive,-0.899732511955916,neutral
2022-01-27 14:41:00.000,619.2,638.0,612.4,624.6,2302303.0,USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant,The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms at its Telangana-based plant.,neutral,negative,0.8720930232558103,neutral,0.0473186119873745,neutral
2022-01-27 14:48:59.000,619.2,638.0,612.4,624.6,2302303.0,USFDA Pulls Up Aurobindo Pharma For Manufacturing Lapses At API Plant,"In a letter to company’s Managing Director Narayanan Govindarajan, the US health regulator noted that its inspectors during an inspection between August 2-12, 2021, found significant deviations from standard manufacturing practices for active pharmaceutical ingredients (API) at the company’s Doultab…",neutral,positive,0.8720930232558103,neutral,0.0473186119873745,neutral
2022-02-01 10:41:00.000,644.8,660.0,634.45,658.5,2180997.0,Aurobindo Pharma shares rise 1.13% as Nifty gains,The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 590.25.,positive,negative,2.124689826302737,positive,1.815431164901664,positive
2022-02-08 11:52:00.000,651.0,657.95,643.1,649.35,825695.0,Shares of Aurobindo Pharma fall as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 804.19.",neutral,neutral,-0.2534562211981532,neutral,-0.4794885455514256,neutral
2022-02-09 09:21:49.000,656.95,666.4,651.1,653.8,1452553.0,Stocks that will see action today (Feb 9),"Buzzing stocks: Vedanta, Tata Power, Wipro, Tata Communications, ICICI Bank, Nykaa, BSE, Airtel, Thermax, Lupin, ACC, Aurobindo Pharma, PowerGrid, Bosch, GMR Infra, Paras Defence, SAIL, Sundaram-Clayton",neutral,neutral,-0.4794885455514256,neutral,4.8924731182795735,positive
2022-02-09 20:04:00.000,651.0,688.95,643.0,682.85,8145253.0,Aurobindo Pharma net profit dips 22% to Rs 604 cr in December quarter,The Hyderabad-based drug maker had reported a consolidated net profit of Rs 777.3 crore in the same period of previous fiscal,negative,neutral,4.8924731182795735,positive,3.553148876196135,positive
2022-02-09 23:26:03.000,651.0,688.95,643.0,682.85,8145253.0,Aurobindo Pharma Q3 net slides 80% on costs,‘Quarter’s performance impacted by high input and freight costs’,neutral,negative,4.8924731182795735,positive,3.553148876196135,positive
2022-02-10 10:16:00.000,651.0,688.95,643.0,682.85,8145253.0,"Aurobindo plans domestic formulation foray, sets 1000 cr sales target in next 3yrs","Aurobindo Pharma is largely an export oriented drug maker, while it does have an India business which is business-to-business (B2B) involving sale of active pharmaceutical ingredients to other drug makers. Aurobindo has net cash of $211 million as on December 2021. The drug maker is also in the proc…",positive,neutral,4.8924731182795735,positive,3.553148876196135,positive
2022-02-10 14:40:06.000,674.05,702.5,674.05,698.0,4093995.0,Aurobindo Pharma Ltd (ARBQY) on Q3 2022 Results - Earnings Call Transcript,"Aurobindo Pharma Ltd (OTC:ARBQY) Q3 2022 Earnings Conference Call February 09, 2022, 22:00 ET Company Participants Arvind Bothra - Head, IR & Corporate Communications Santhanam...",neutral,neutral,3.553148876196135,positive,-1.7685699848408287,negative
2022-02-11 11:01:00.000,674.05,702.5,674.05,698.0,4093995.0,"Results Review for PGCIL, Tata Power, Aurobindo Pharma, Petronet LNG, Prestige","Results Review for PGCIL, Tata Power, Aurobindo Pharma, Petronet LNG, Prestige",neutral,neutral,3.553148876196135,positive,-1.7685699848408287,negative
2022-02-11 14:22:13.000,674.05,702.5,674.05,698.0,4093995.0,Will the Street reward Aurobindo Pharma’s bet on domestic formulations?,"The Aurobindo Pharma stock currently trades at a valuation of 6.6x FY23e EV/EBITDA, which is at a substantial discount to its Indian peers with an exposure in the US market",neutral,positive,3.553148876196135,positive,-1.7685699848408287,negative
2022-02-15 12:02:28.000,692.95,697.65,681.3,688.0,1703287.0,Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey,"KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 756 in its research report dated February 11, 2022.",neutral,positive,-0.7143372537701198,neutral,-3.223490559264849,negative
2022-02-15 14:25:28.000,692.95,697.65,681.3,688.0,1703287.0,Accumulate Aurobindo Pharma; target of Rs 759: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 759 in its research report February 10, 2022.",neutral,positive,-0.7143372537701198,neutral,-3.223490559264849,negative
2022-02-17 20:14:16.000,671.0,671.15,653.0,655.8,3391767.0,Buy Aurobindo Pharma; target of Rs 875: Sharekhan,"Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 875 in its research report dated February 10, 2022.",neutral,positive,-2.265275707898666,negative,-2.3740458015267105,negative
2022-02-22 14:04:47.000,640.0,644.65,634.3,635.7,1198895.0,Aurobindo Pharma Ltd continues to fall,"Aurobindo Pharma Ltd is quoting at Rs 617.35, down 3.4% on the day as on 13:24 IST on the NSE. The stock tumbled 27.68% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.",negative,negative,-0.6718749999999929,neutral,-2.9110555600354737,negative
2022-02-27 10:56:00.000,619.95,627.95,610.3,625.0,1759238.0,"Aurobindo, Sun Pharma recall products in US market","According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections.",negative,negative,0.8145818211145986,neutral,0.5438311688311724,neutral
2022-02-27 12:48:00.000,619.95,627.95,610.3,625.0,1759238.0,"Aurobindo, Sun Pharma recall products in US market for defaulting norms",Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.,negative,negative,0.8145818211145986,neutral,0.5438311688311724,neutral
2022-02-27 17:30:00.000,619.95,627.95,610.3,625.0,1759238.0,"Aurobindo, Sun Pharma recall products from US market","According to the USFDA, the Princeton-based Aurobindo Pharma USA Inc is recalling the affected lot due to “failed impurities/degradation specifications”.",negative,negative,0.8145818211145986,neutral,0.5438311688311724,neutral
2022-02-28 08:35:23.000,619.95,627.95,610.3,625.0,1759238.0,Stocks that will see action today (February 28),"Buzzing stocks: Biocon, Sun Pharma, Aurobindo Pharma, Zomato, Reliance Ind, Adani Power, SJVN, Ircon, Muthoot FInance, Star Housing Fin, Vodafone Idea, Bharti Airtel, Hindalco",neutral,neutral,0.8145818211145986,neutral,0.5438311688311724,neutral
2022-03-11 15:04:34.000,629.9,645.0,622.2,642.2,2308991.0,"D-Street Buzz: Pharma stocks outperform; Sun Pharma, Cipla hit fresh highs","Cipla, Laurus Labs and Sun Pharma which gained over 3 percent each followed by Torrent Pharma, Dr Reddy’s Labs and Aurobindo Pharma.",positive,positive,1.9526909033179976,positive,-1.7186406407963402,negative
2022-03-21 12:00:15.000,680.0,694.25,674.9,685.75,3264207.0,Why is Aurobindo Buzzing Up? Possibility of Open Offer From Blackstone | Investing.com India,"Shares Analysis by JET AGE covering: Blackstone Group Inc, Aurobindo Pharma Ltd.. Read JET AGE’s latest article on Investing.com India.",neutral,neutral,0.8455882352941176,neutral,0.8219975267331021,neutral
2022-03-21 12:16:00.000,680.0,694.25,674.9,685.75,3264207.0,Aurobindo Pharma soars on bagging license to manufacture Pfizer’s COVID-19 drug,Aurobindo Pharma jumped 6.76% to Rs 683.50 after the company announced the signing of sub-license agreement for manufacturing a generic version of Pfizer’s COVID-19 oral treatment nirmatrelvir.,positive,positive,0.8455882352941176,neutral,0.8219975267331021,neutral
2022-03-21 12:29:00.000,680.0,694.25,674.9,685.75,3264207.0,Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug,"Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.",positive,positive,0.8455882352941176,neutral,0.8219975267331021,neutral
2022-03-21 13:31:41.000,680.0,694.25,674.9,685.75,3264207.0,Aurobindo Pharma Ltd jumps 6.48%,"Aurobindo Pharma Ltd is quoting at Rs 681.85, up 6.48% on the day as on 12:54 IST on the NSE. The stock is down 18.37% in last one year as compared to a 16.42% gain in NIFTY and a 15.02% gain in the Nifty Pharma index.",positive,positive,0.8455882352941176,neutral,0.8219975267331021,neutral
2022-03-23 13:05:19.000,690.0,724.0,688.9,719.05,4967878.0,"Aurobindo Pharma Ltd spurts 0.47%, gains for fifth straight session","Aurobindo Pharma Ltd is quoting at Rs 690.7, up 0.47% on the day as on 12:49 IST on the NSE. The stock is down 19.3% in last one year as compared to a 18.51% jump in NIFTY and a 14.66% jump in the Nifty Pharma.",positive,positive,4.210144927536225,positive,-1.2981660828353658,negative
2022-03-24 10:15:00.000,690.0,724.0,688.9,719.05,4967878.0,Aurobindo Pharma shares up 1.64% as Nifty gains,"A total of 24,830 shares changed hands on the counter till 10:15AM (IST).",positive,neutral,4.210144927536225,positive,-1.2981660828353658,negative
2022-03-28 17:30:00.000,714.5,715.0,679.0,693.0,4096779.0,Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 crore,"The acquisition will greatly help the company as a launch pad for marketing biosimilar and other products in India, Aurobindo Pharma said in a statement.",neutral,positive,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-28 20:00:00.000,714.5,715.0,679.0,693.0,4096779.0,Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore,"The transaction comes into effect from April 1, 2022 and is expected to close by May 2022",neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-28 20:03:18.000,714.5,715.0,679.0,693.0,4096779.0,Aurobindo Pharma buys domestic formulation business of Veritaz for ₹171 cr,,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-28 20:58:00.000,714.5,715.0,679.0,693.0,4096779.0,Aurobindo Pharma acquires Veritaz’ domestic business for Rs 171 cr,Move marks Aurobindo’s increasing focus on Indian market,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-28 21:53:00.000,714.5,715.0,679.0,693.0,4096779.0,Aurobindo Pharma buys Veritaz for Rs 171 crore to enter domestic formulation business,Veritaz had a turnover of Rs 133 crore for the nine-month period ended December 2021 and it had a turnover of Rs 127 crore for the full year FY21.,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 07:16:26.000,714.5,715.0,679.0,693.0,4096779.0,"Buzzing Stocks | Aurobindo Pharma, GR Infra, Power Grid, others in news today",Stocks In the News: Check out the companies making headlines before the opening bell.,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 07:46:36.000,714.5,715.0,679.0,693.0,4096779.0,"Stocks to Watch: Aurobindo Pharma, Airtel, BPCL, Tata Power","Indian indices climbed higher on Monday amid volatility, snapping a 3-day losing streak, as shares in Asian market largely remained positive.",neutral,positive,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 07:58:00.000,714.5,715.0,679.0,693.0,4096779.0,"Stocks to Watch: Aurobindo Pharma, RIL, Ruchi Soya, Tata Power, PowerGrid",Shares of drugmaker Aurobindo will be in focus as the company has acquired the domestic formulation business of Veritaz Healthcare on a slump sale basis at Rs 171 crore.,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 08:43:00.000,714.5,715.0,679.0,693.0,4096779.0,"Aurobindo Pharma, Tata Power, Ruchi Soya in focus",Aurobindo Pharma: The board of directors of the company has approved the acquisition of business and certain assets of Veritaz Healthcare Limited (Veritaz). Veritaz operates in pharmaceutical industry in India and sells branded generic formulations,neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 08:59:00.000,714.5,715.0,679.0,693.0,4096779.0,Stocks that will see action today,"Buzzing stocks: Ruchi Soya, Aurobindo Pharma, Tata Power, PowerGrid, Sudarshan Chemical, Megasoft, M&M Financial, Swelect Energy, Zensar Tech, Mafatlal, Kilpest, Anjani Portland",neutral,neutral,-3.009097270818754,negative,-3.619102005853383,negative
2022-03-29 13:15:00.000,700.45,700.45,671.15,675.1,4618890.0,Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 cr,"Aurobindo Pharma, after market hours on Monday, 28 March 2022, announced the acquisition of Veritaz Healthcare’s business and certain assets for a cash consideration of Rs 171 crore.",neutral,neutral,-3.619102005853383,negative,-1.8670979123787184,negative
2022-03-29 14:02:00.000,700.45,700.45,671.15,675.1,4618890.0,Aurobindo Pharma acquires domestic formulations business of Veritaz Healthcare,"The transaction comes into effect from April 1, 2022, and is expected to close by May 2022.",neutral,neutral,-3.619102005853383,negative,-1.8670979123787184,negative
2022-04-01 10:45:00.000,673.85,684.45,663.0,682.5,1697679.0,Aurobindo Pharma shares rise 1.79% as Nifty gains,The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 584.2.,positive,negative,1.2836684722119132,positive,1.0817131998245837,positive
2022-04-05 13:32:58.000,702.0,714.7,697.8,702.0,1071797.0,Aurobindo Pharma Ltd spurts 2.53%,"Aurobindo Pharma Ltd is quoting at Rs 709.9, up 2.53% on the day as on 12:54 IST on the NSE. The stock is down 20.49% in last one year as compared to a 22.63% spurt in NIFTY and a 10.4% spurt in the Nifty Pharma index.",neutral,positive,0.0,neutral,-1.1299435028248588,negative
2022-04-20 11:11:00.000,664.0,679.35,657.15,670.3,1126313.0,Aurobindo Pharma shares gain 1.49% as Sensex rises,"A total of 32,948 shares changed hands on the counter till 11:11AM (IST)",positive,neutral,0.9487951807228848,positive,-0.126122115883971,neutral
2022-04-22 14:17:45.000,670.0,685.7,665.0,667.0,1526307.0,"Aurobindo Pharma Ltd soars 1.14%, rises for third straight session","Aurobindo Pharma Ltd is quoting at Rs 681.65, up 1.14% on the day as on 12:54 IST on the NSE. The stock is down 31.38% in last one year as compared to a 20.57% gain in NIFTY and a 2.74% gain in the Nifty Pharma index.",positive,positive,-0.4477611940298507,neutral,-3.3633815620028686,negative
2022-04-24 11:39:00.000,660.05,666.6,635.0,637.85,1261913.0,"Aurobindo, Sun Pharma recall products in US market","​​​While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes.",negative,negative,-3.3633815620028686,negative,-0.140867115354512,neutral
2022-04-24 11:54:57.000,660.05,666.6,635.0,637.85,1261913.0,"Aurobindo, Sun Pharma recall products in U.S. market","While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat lack of vitamin B12, Sun Pharma is recalling a drug used to increase the production of tears in eyes",neutral,negative,-3.3633815620028686,negative,-0.140867115354512,neutral
2022-04-24 12:04:00.000,660.05,666.6,635.0,637.85,1261913.0,"Aurobindo, Sun Pharma, Jubilant recall products in US market: USFDA","Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons",neutral,negative,-3.3633815620028686,negative,-0.140867115354512,neutral
2022-05-03 17:32:35.000,649.8,650.4,622.6,623.5,1669251.0,Aurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib,"The approval by the US Food and Drug Administration (USFDA) is for single-dose vial of Bortezomib for injection of strength 3.5 mg/vial, Aurobindo Pharma said in a regulatory filing.",neutral,neutral,-4.047399199753763,negative,-0.7460317460317533,neutral
2022-05-04 14:01:00.000,630.0,641.5,624.65,625.3,991679.0,Aurobindo Pharma gets USFDA nod to market generic cancer drug Bortezomib,"The product, which is indicated for the treatment of multiple myeloma (cancer of plasma cells) and mantle cell lymphoma (cancer of lymph nodes), is being launched immediately",neutral,neutral,-0.7460317460317533,neutral,-1.9828895818341687,negative
2022-05-04 17:38:00.000,630.0,641.5,624.65,625.3,991679.0,Aurobindo Pharma arm Eugia Pharma gets USFDA nod for Bortezomib for Injection; Stock down 2%,"The approved product has a market size of US$ 1172 million for the twelve months ending March 2022, according to IQVIA.",neutral,neutral,-0.7460317460317533,neutral,-1.9828895818341687,negative
2022-05-10 21:47:17.000,597.0,607.55,560.25,584.25,4391668.0,Aurobindo Pharma unit in Hyderabad under U.S. FDA scanner,HYDERABAD,neutral,neutral,-2.135678391959799,negative,-2.4657534246575303,negative
2022-05-11 08:46:15.000,597.0,607.55,560.25,584.25,4391668.0,"Stocks that will see action on May 11, 2022","Buzzing stocks: Punjab National Bank, Adani Ports, Aurobindo PHarma, Dr Agarwals Eye, RITES, MTAR Tech, Gujarat Alkalies, GAIL India, WIpro, GR Infraprojects, Gulshan Polyols",neutral,neutral,-2.135678391959799,negative,-2.4657534246575303,negative
2022-05-11 09:33:17.000,597.0,607.55,560.25,584.25,4391668.0,Aurobindo Pharma hits 52-week low after six observations from US,"The US FDA inspected oral manufacturing facility at Jedcherla, Hyderabad from May 2 to 10",negative,neutral,-2.135678391959799,negative,-2.4657534246575303,negative
2022-05-11 10:07:09.000,597.0,607.55,560.25,584.25,4391668.0,"Stocks To Watch Today: Aurobindo Pharma, DB Realty, SBI, Vodafone Idea, Wipro",Here are the stocks to watch going into trade today..,neutral,neutral,-2.135678391959799,negative,-2.4657534246575303,negative
2022-05-11 10:34:00.000,597.0,607.55,560.25,584.25,4391668.0,Aurobindo Pharma hits 52-week low after USFDA issues six observations,"Aurobindo Pharma fell 0.84% to Rs 598 after the drug maker was issued a ‘form 483’ with six observations from the United States Food and Drug Administration (USFDA) for the oral manufacturing facility situated at Jedcherla, Hyderabad.",negative,negative,-2.135678391959799,negative,-2.4657534246575303,negative
2022-05-11 14:52:00.000,584.0,584.8,561.5,569.6,2427036.0,Aurobindo Pharma gets six observations from USFDA for Unit VII; Stock sheds 2%,The Company will respond to the US FDA within the stipulated timeline.,neutral,neutral,-2.4657534246575303,negative,-3.7592688394550713,negative
2022-05-11 17:30:00.000,584.0,584.8,561.5,569.6,2427036.0,"Aurobindo Pharma stock hits fresh 52-week low, slips 7% intra day","Aurobindo Pharma touched an intraday low of Rs 560.6, down 7.04 percent on BSE. Market cap of the firm fell to Rs 34,626 crore on BSE.",negative,negative,-2.4657534246575303,negative,-3.7592688394550713,negative
2022-05-16 14:17:35.000,551.1,555.05,533.2,534.0,3321611.0,Aurobindo Pharma Ltd eases for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 550.35, down 2.17% on the day as on 13:19 IST on the NSE. The stock tumbled 45.09% in last one year as compared to a 6.09% rally in NIFTY and a 9.22% fall in the Nifty Pharma index.",positive,negative,-3.1028851388132868,negative,4.483176437692228,positive
2022-05-17 12:42:00.000,536.45,566.65,534.1,560.5,6086633.0,Aurobindo hits 2-year low; dips 11% in a week on USFDA’s 6 observations,Analysts at ICICI Securities expect Aurobindo Pharma’s adjusted PAT to de-grow 30.4 per cent year-on-year (YoY) to Rs 557.90 crore in the March 2022 quarter.,negative,positive,4.483176437692228,positive,-5.831611106119156,negative
2022-05-26 17:44:00.000,540.0,543.2,525.0,530.05,1972558.0,Aurobindo Pharma’s step-down subsidiary bags USFDA Approval for Pemetrexed for Injection; stock adds ~1%,"This is the 139th ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.",positive,neutral,-1.8425925925926008,negative,-1.6728624535315983,negative
2022-05-30 06:37:28.000,538.0,539.0,522.2,529.0,2416184.0,"Stocks to Watch Today | Aurobindo Pharma, Sun TV Network, FSN E-Commerce and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.6728624535315983,negative,0.6977182726758525,neutral
2022-05-30 08:27:00.000,538.0,539.0,522.2,529.0,2416184.0,"Corporate Radar: LIC Q4 results, JSW Steel’s dividend, Tilaknagar’s referential issue & more","LIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announce their quarterly earnings today.",neutral,neutral,-1.6728624535315983,negative,0.6977182726758525,neutral
2022-05-30 09:00:30.000,538.0,539.0,522.2,529.0,2416184.0,Stocks that will see action today May 30,"Buzzing stocks: ITC, United Spirits, Indosolar, Adani Enterprises, Aurobindo Pharma, Adani Green Energy, JK Tyre, Meghmani Finechem, Delhivery, Jubilant Foods, Dish TV and Coffee Day",neutral,neutral,-1.6728624535315983,negative,0.6977182726758525,neutral
2022-05-30 20:48:57.000,530.3,549.0,525.05,534.0,8150554.0,Aurobindo Pharma Q4 Results: Profit Falls 28% Missing Estimates,"Aurobindo Pharma’s fourth-quarter profit fell, missing estimates, on one-time charges.",neutral,negative,0.6977182726758525,neutral,1.0911125617830877,positive
2022-05-30 21:24:55.000,530.3,549.0,525.05,534.0,8150554.0,"Aurobindo Pharma’s Q4 net profit down 28%, revenue slips to Rs 5,809 crore","The EBITDA stood at Rs 974.3 crore, marking a 23.6 percent decline as against Rs 1,274.7 crore reported in Q4 FY21.",negative,negative,0.6977182726758525,neutral,1.0911125617830877,positive
2022-05-30 21:33:49.000,530.3,549.0,525.05,534.0,8150554.0,Aurobindo Pharma Q4 net down 28%,"The revenue too declined by 3.3 per cent to ₹5,809 crore",negative,negative,0.6977182726758525,neutral,1.0911125617830877,positive
2022-05-30 22:05:00.000,530.3,549.0,525.05,534.0,8150554.0,Aurobindo Pharma Q4 net profit falls 28% to Rs 576 cr; revenue dips 3%,Aurobindo Pharma Ltd on Monday reported a 28 per cent decline in its consolidated net profit at Rs 576.14 crore in the fourth quarter ended March 2022.,positive,negative,0.6977182726758525,neutral,1.0911125617830877,positive
2022-05-31 09:44:38.000,530.3,549.0,525.05,534.0,8150554.0,Aurobindo Pharma Ltd. ADR 2022 Q4 - Results - Earnings Call Presentation (OTCMKTS:ARBQY),The following slide deck was published by Aurobindo Pharma Ltd.,neutral,neutral,0.6977182726758525,neutral,1.0911125617830877,positive
2022-05-31 17:20:21.000,536.15,554.85,533.15,542.0,5010124.0,Aurobindo Pharma Ltd. ADR (ARBQY) Management on Q4 2022 Results - Earnings Call Transcript,"Aurobindo Pharma Ltd. ADR (OTC:ARBQY) Q4 2022 Earnings Conference Call May 30, 2022 11:00 PM ET Company Participants Deepti Thakur - Investor Relations P.V.",neutral,neutral,1.0911125617830877,positive,-1.6206261510128832,negative
2022-06-01 23:37:05.000,543.0,546.4,527.05,534.2,2202201.0,Near-term growth and cost challenges to weigh on Aurobindo Pharma stock,"While valuations are now attractive, product approvals and progress on the injectable guidance are among key long term term triggers",negative,positive,-1.6206261510128832,negative,-1.6652711880174982,negative
2022-06-02 09:47:03.000,543.0,546.4,527.05,534.2,2202201.0,Aurobindo Pharma Q4 Review - Operating Margins Remain Weak As Cost Pressures Continue To Weigh: Nirmal Bang,Aurobindo Pharma Q4 Review - Operating Margins Remain Weak As Cost Pressures Continue To Weigh: Nirmal Bang,neutral,neutral,-1.6206261510128832,negative,-1.6652711880174982,negative
2022-06-02 17:30:00.000,537.45,539.15,526.2,528.5,2590039.0,"Taking Stock | Sell-off continues for fourth day; Nifty ends below 16,200, Sensex falls 276 pts","Over 250 stocks, including Wipro, Torrent Pharmaceuticals, Jindal Saw, Hindustan Zinc, Granules India, Aurobindo Pharma, Ashoka Buildcon, IDFC First Bank, and KEC International, touched their 52-week low on the BSE.",neutral,negative,-1.6652711880174982,negative,-0.6748407946012651,neutral
2022-06-02 18:10:07.000,537.45,539.15,526.2,528.5,2590039.0,Dividend stocks to watch: These 11 stocks shall turn ex-dividend next week,"Shareholders of Faze Three, Aurobindo Pharma, INEOS Styrolution India, Pearl Global Industries, India Motor Parts and Accessories, Kansai Nerolac Paints, Welspun Corp, Craftsman Automation, Elecon Engineering Company, Asian Paints and Shree Digvijay Cement Company should keep an eye next week as the…",neutral,neutral,-1.6652711880174982,negative,-0.6748407946012651,neutral
2022-06-03 15:06:08.000,537.45,539.15,526.2,528.5,2590039.0,Aurobindo Pharma Q4 Review - Products Mix Recover Back: KRChoksey,Aurobindo Pharma Q4 Review - Products Mix Recover Back: KRChoksey,neutral,neutral,-1.6652711880174982,negative,-0.6748407946012651,neutral
2022-06-07 12:50:08.000,519.0,525.0,512.2,523.1,1199831.0,Aurobindo Pharma unit gets USFDA nod for prostate cancer drug,"The drug maker announced that its wholly owned subsidiary, Eugia Pharma Specialties, received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Leuprolide Acetate injection, 14 mg/2.8 mL MDV (Kit).",neutral,positive,0.7899807321772683,neutral,1.8138195777351336,positive
2022-06-07 13:04:06.000,519.0,525.0,512.2,523.1,1199831.0,Aurobindo Pharma’s arm receives USFDA approval for Leuprolide Acetate Injection,Used in palliative treatment of advance prostatic cancer,positive,neutral,0.7899807321772683,neutral,1.8138195777351336,positive
2022-06-07 15:45:22.000,519.0,525.0,512.2,523.1,1199831.0,Eugia Pharma gets USFDA nod for prostate cancer drug,Aurobindo Pharma subsidiary to make and market leuprolide acetate injection,neutral,neutral,0.7899807321772683,neutral,1.8138195777351336,positive
2022-06-07 17:21:00.000,519.0,525.0,512.2,523.1,1199831.0,Aurobindo Pharma bags USFDA approval for Leuprolide Acetate Injection; stock slips ~1%,Leuprolide Acetate for injection is indicated for the treatment used to treat the symptoms associated with advanced prostate cancer by way of Palliative treatment of advanced prostatic cancer.,positive,neutral,0.7899807321772683,neutral,1.8138195777351336,positive
2022-06-09 19:12:07.000,525.0,537.5,520.7,531.45,1852556.0,Aurobindo Pharma approves fourth interim dividend of ₹4.50 per share,Fixes June 7 as record date,neutral,positive,1.228571428571437,positive,-2.5195810134943897,negative
2022-06-14 22:12:00.000,535.0,541.7,530.5,536.65,1610722.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, short-covering was seen in 65 stocks including RBL Bank, Nippon Life India, Havells India, ICICI Lombard General Insurance Company, and Aurobindo Pharma",neutral,neutral,0.3084112149532668,neutral,-3.351851851851856,negative
2022-06-20 06:25:21.000,518.0,523.95,503.45,512.95,1914589.0,"Stocks to Watch Today | Wipro, Aurobindo Pharma, Galaxy Surfactants and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-0.974903474903466,negative,4.0058479532163656,positive
2022-06-20 07:35:16.000,518.0,523.95,503.45,512.95,1914589.0,"Stocks to Watch Today: Wipro, Cipla, Aurobindo Pharma, Nazara Tech, and Others","Stocks to watch today: Shares of firms like Wipro, Cipla, Aurobindo Pharma, Nazara Tech, and others will be in focus in Monday’s trade",neutral,neutral,-0.974903474903466,negative,4.0058479532163656,positive
2022-06-20 08:40:22.000,518.0,523.95,503.45,512.95,1914589.0,"Stocks that will see action on June 20, 2022","Buzzing stocks: Nazara Tech, Wipro, Aurobindo Pharma, Cipla, Alkem Lab, Sadbhav Infra, NTPC, Max Ventures, Star Housing Fin, Muthoot Capital, Vadilal Ind, Balkrishna Paper, Indian Hume Pipes, NTPC, Engineers India",neutral,neutral,-0.974903474903466,negative,4.0058479532163656,positive
2022-06-20 12:04:06.000,513.0,536.85,513.0,533.55,1980257.0,Aurobindo Pharma acquires 51% stake in GLS Pharma,The drug maker on Saturday announced that its board has approved acquisition of 51% stake in Hyderabad-based GLS Pharma for a cash consideration of Rs 28.05 crore.,neutral,positive,4.0058479532163656,positive,-2.5631396113040985,negative
2022-06-27 15:17:01.000,517.2,522.55,508.3,521.95,1836770.0,SEBI issues warning letter to Aurobindo Pharma over US FDA audit disclosures,Aurobindo Pharma said that it had received a warning letter from the Securities Exchange Board of India (SEBI).,neutral,negative,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-27 17:30:00.000,517.2,522.55,508.3,521.95,1836770.0,SEBI issues warning to Aurobindo Pharma over ongoing USFDA audit,The Sebi warning letter observes that the company had ″disclosed very limited and restricted information″ and that it did not disclose the detailed reasons and neither considered USFDA’s observations as serious.,negative,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-27 17:39:00.000,517.2,522.55,508.3,521.95,1836770.0,Aurobindo Pharma receives Sebi’s warning letter over ongoing USFDA audit,"The letter is in regards to certain disclosures made by the company on the ongoing USFDA audit of company’s Unit-1 and observations made by the USFDA between the period 2019 to 2022, Aurobindo Pharma Ltd (APL) said in a regulatory filing.",neutral,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-27 19:05:39.000,517.2,522.55,508.3,521.95,1836770.0,SEBI warns Aurobindo Pharma over USFDA audit,Aurobindo Pharma has received SEBI’s warning over an ongoing USFDA audit.,neutral,negative,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-27 20:48:48.000,517.2,522.55,508.3,521.95,1836770.0,USFDA audit: SEBI warns Aurobindo Pharma on non-compliance with disclosure norms,"Warning letters of the USFDA were not taken ‘seriously’ by the drug maker, says SEBI",neutral,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-27 20:56:27.000,517.2,522.55,508.3,521.95,1836770.0,SEBI warns Aurobindo Pharma over U.S. FDA audit disclosure,Firm disclosed “very limited and restricted information” to stock exchanges about an U.S. FDA plant audit,neutral,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-28 00:54:00.000,517.2,522.55,508.3,521.95,1836770.0,Aurobindo Pharma receives warning from SEBI for non-disclosures related to USFDA audit,"The market regulator, in its letter to Aurobindo Pharma dated June 24, said the company had disclosed very limited and restricted information related to the inspection. The only fact disclosed by the company was that a warning letter was received from USFDA.",negative,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-28 06:44:47.000,517.2,522.55,508.3,521.95,1836770.0,"Stocks To Watch Today: Aurobindo Pharma, Cipla, IDFC First, Star Health, Mahindra",Here are the stocks to watch in today’s trade,neutral,neutral,0.9184068058778034,positive,-0.819672131147541,neutral
2022-06-29 12:33:00.000,513.0,519.0,510.4,511.95,1744870.0,Aurobindo Pharma shares drop 1.35% as Sensex falls,The stock quoted a 52-week high of Rs 1012.9 and a 52-week low of Rs 503.4.,negative,negative,-0.2046783625731016,neutral,2.049780380673499,positive
2022-07-07 13:04:27.000,550.0,553.35,541.1,545.4,538379.0,"Aurobindo Pharma Ltd soars 0.57%, rises for fifth straight session","Aurobindo Pharma Ltd is quoting at Rs 547.1, up 0.57% on the day as on 12:44 IST on the NSE. The stock is down 42.52% in last one year as compared to a 2.32% spurt in NIFTY and a 13.06% spurt in the Nifty Metal.",positive,positive,-0.8363636363636404,neutral,0.0551774875850569,neutral
2022-07-10 12:33:00.000,543.7,549.9,535.75,544.0,1164264.0,"Aurobindo Pharma on track to develop complex products, expand global footprint","“In the US, around 220 abbreviated new drug applications (ANDAs) are awaiting final approval..With the pandemic situation easing, your company will resume its development trajectory, with a focus on developing a product range of complicated injectables,” it informed shareholders.",positive,positive,0.0551774875850569,neutral,-0.8778414341156903,neutral
2022-07-10 13:09:02.000,543.7,549.9,535.75,544.0,1164264.0,"Aurobindo Pharma to develop complex products, expand global footprint",Aurobindo Pharma remains focused on developing complex and differentiated products in multiple areas to drive the next phase of growth,positive,positive,0.0551774875850569,neutral,-0.8778414341156903,neutral
2022-07-11 17:30:00.000,541.1,544.95,534.1,536.35,787646.0,"Stocks in news: Tata Motors, TCS, Avenue Supermarts, Dr Reddy’s Labs and more","Stocks in news: Tata Motors, Aurobindo Pharma, TCS, M&M, Avenue Supermarts, Dr Reddy’s Laboratories and more",neutral,neutral,-0.8778414341156903,neutral,4.302877898854432,positive
2022-07-12 09:52:53.000,541.1,544.95,534.1,536.35,787646.0,Top Indian pharma stocks to buy: Here are BNP Paribas’ picks,"Sharing its top stock picks, BNP Paribas said it continues to prefer Sun Pharma and Aurobindo Pharma",positive,positive,-0.8778414341156903,neutral,4.302877898854432,positive
2022-07-19 12:41:01.000,561.0,562.8,556.3,559.1,798083.0,"Rupee breaches 80: Watch out these levels on forex-sensitive Infy, IndiGo","Among select export-oriented shares, Aurobindo Pharma seems well placed on the charts with a potential upside of 9 per cent in the near term.",neutral,positive,-0.338680926916217,neutral,-0.5012531328320924,neutral
2022-07-26 17:53:57.000,525.0,543.5,524.95,541.0,1099202.0,Today’ Pick: Aurobindo Pharma (₹525.85): SELL,Book profits at ₹490,neutral,neutral,3.0476190476190474,positive,-0.110294117647063,neutral
2022-08-02 11:32:00.000,557.0,580.45,547.3,572.25,2206604.0,Aurobindo Pharma shares drop 0.7% as Sensex falls,The stock quoted a 52-week high of Rs 929.2 and a 52-week low of Rs 503.4.,negative,negative,2.7378815080789947,positive,-2.104893878266971,negative
2022-08-02 17:30:00.000,570.1,571.55,553.0,558.1,2002823.0,Aurobindo Pharma’s Andhra unit gets 3 USFDA observations,"As per US Food and Drug Administration (USFDA), Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that in its judgement may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.",neutral,neutral,-2.104893878266971,negative,1.5396938412246517,positive
2022-08-02 22:17:46.000,570.1,571.55,553.0,558.1,2002823.0,Aurobindo Pharma’s Andhra unit gets Form 483 with 3 USFDA observations,"The company said it has responded to the warning letter and carried out the committed corrections and the USFDA authorities inspected the facility from July 25 to August 2, 2022.",neutral,neutral,-2.104893878266971,negative,1.5396938412246517,positive
2022-08-03 10:04:25.000,570.1,571.55,553.0,558.1,2002823.0,Aurobindo Pharma slides after Andhra unit gets Form 483 with 3 USFDA observations,Aurobindo Pharma fell 1.61% to Rs 565.60 after the company said that US drug regulator issued Form 483 with three observations after inspecting its manufacturing facility at Pydibhimavaram in Andhra Pradesh.,neutral,negative,-2.104893878266971,negative,1.5396938412246517,positive
2022-08-03 16:05:00.000,561.8,572.4,553.85,570.45,1487469.0,Aurobindo Pharma’s Unit XI receives ‘Form 483’ with 3 observations from USFDA; stock slips ~3%,"On May 17, 2019, the said Unit was classified as OAI, and a warning letter was issued to the company on June 20, 2019.",neutral,neutral,1.5396938412246517,positive,-1.0627177700348471,negative
2022-08-11 07:47:54.000,571.8,577.9,567.25,576.0,1316309.0,"Stocks to Watch Today | Aurobindo Pharma, Coal India, Eicher Motors and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,0.7345225603357898,neutral,3.0869565217391304,positive
2022-08-11 08:04:00.000,571.8,577.9,567.25,576.0,1316309.0,"Stocks to watch: Eicher Motors, Tata Consumer, Coal India, BoB, IRCTC","Stocks to watch today: Apollo Hospitals, Trent, Aurobindo Pharma will report their June quarter results (Q1FY23) on Thursday, July 11; Bank of Baroda raised their MCLR rate by 5-20 bps across tenors.",neutral,positive,0.7345225603357898,neutral,3.0869565217391304,positive
2022-08-11 19:00:38.000,575.0,604.0,571.15,592.75,6166164.0,Aurobindo Pharma’s Q1 net down 32% at ₹520 cr,"During the quarter, it received final approval for 10 ANDAs",negative,positive,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-11 20:22:45.000,575.0,604.0,571.15,592.75,6166164.0,Aurobindo Pharma Q1 net profit down by 32% to Rs 520.5 cr; revenue up 9.4%,"K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said, investments in product portfolio continued at a healthy pace as reflected in the filings and launches in the quarter.”",negative,positive,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-11 22:25:58.000,575.0,604.0,571.15,592.75,6166164.0,Aurobindo Pharma Q1 net slides 32% to ₹520 cr.,"Net sales rose 9% to ₹6,177 crore",neutral,positive,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-12 05:30:00.000,575.0,604.0,571.15,592.75,6166164.0,"Q1 Snippets of Key Stocks: Apollo Hospitals, Bharat Forge, Aurobindo Pharma & More","Q1 Snippets of Key Stocks: Apollo Hospitals, Bharat Forge, Aurobindo Pharma & More",neutral,neutral,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-12 06:52:32.000,575.0,604.0,571.15,592.75,6166164.0,"Stocks To Watch: Adani Enterprises, Hero MotoCorp, Sterling And Wilson, Aurobindo Pharma, Apollo Hospitals",U.S. stocks trimmed gains following a rally after softer inflation data on Wednesday. Treasury yields also retreated.,neutral,negative,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-12 07:13:28.000,575.0,604.0,571.15,592.75,6166164.0,"Stocks to Watch Today | Aurobindo Pharma, ONGC, LIC, Hero MotoCorp, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-12 07:23:41.000,575.0,604.0,571.15,592.75,6166164.0,"Stocks to Watch Today: Aurobindo Pharma, LIC, ONGC, Hero MotoCorp, and Others","Stocks to watch today: Shares of firms like Aurobindo Pharma, LIC, ONGC, Hero MotoCorp, and others will be in focus in Friday’s trade",neutral,neutral,3.0869565217391304,positive,-1.8736346832465092,negative
2022-08-16 11:26:35.000,595.1,602.9,582.9,583.95,2157770.0,Aurobindo Pharma arm gets final USFDA nod for Vasopressin injection,The injection is indicated to increase blood pressure in adults who suffer from sudden relaxation of blood vessels.,neutral,neutral,-1.8736346832465092,negative,-1.6554885813736309,negative
2022-08-16 12:10:00.000,588.95,588.95,577.2,579.2,1398907.0,Aurobindo Pharma arm gets final US FDA nod for Vasopressin injection,"New Delhi, Aug 16 (PTI) Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for its generic version of Vasopressin injection.",neutral,positive,-1.6554885813736309,negative,0.1203162598831291,neutral
2022-08-16 13:19:44.000,588.95,588.95,577.2,579.2,1398907.0,Aurobindo Pharma Q1 Review - U.S. Scale Up Is Key: Prabhudas Lilladher,Aurobindo Pharma Q1 Review - U.S. Scale Up Is Key: Prabhudas Lilladher,neutral,neutral,-1.6554885813736309,negative,0.1203162598831291,neutral
2022-08-16 14:04:28.000,588.95,588.95,577.2,579.2,1398907.0,USFDA approves Aurobindo Pharma owned Eugia’s generic Vasopressin injection,Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for its generic version of Vasopressin injection,positive,positive,-1.6554885813736309,negative,0.1203162598831291,neutral
2022-08-16 15:08:27.000,588.95,588.95,577.2,579.2,1398907.0,Aurobindo Pharma Arm Gets Final US FDA Nod For Vasopressin Injection,"The Vasopressin injection, to be manufactured and marketed by Aurobindo Pharma’s arm Eugia Pharma, is indicated to increase blood pressure in adults.",neutral,neutral,-1.6554885813736309,negative,0.1203162598831291,neutral
2022-08-16 19:21:52.000,588.95,588.95,577.2,579.2,1398907.0,Aurobindo Pharma arm gets U.S. FDA nod for Vasopressin shot,HYDERABAD,neutral,neutral,-1.6554885813736309,negative,0.1203162598831291,neutral
2022-08-17 17:36:58.000,581.8,586.45,566.1,582.5,2187538.0,Accumulate Aurobindo Pharma; target of Rs 635: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 635 in its research report dated August 15, 2022.",neutral,positive,0.1203162598831291,neutral,-2.80013700976195,negative
2022-08-18 07:16:00.000,581.8,586.45,566.1,582.5,2187538.0,Aurobindo Pharma completes acquisition of 51% stake in GLS Pharma; Stock rises,GLS Pharma has now become the subsidiary of Aurobindo Pharma.,positive,neutral,0.1203162598831291,neutral,-2.80013700976195,negative
2022-08-18 14:11:00.000,583.9,587.0,567.1,567.55,1527200.0,Aurobindo Pharma stock price up 0.67 per cent as Sensex slides,"As of 30-Jun-2022, promoters held 48.76 per cent stake in the company, while FIIs held 20.71 per cent and domestic institutional investors had 9.82 per cent.",positive,neutral,-2.80013700976195,negative,-2.742504409171068,negative
2022-08-19 10:28:26.000,583.9,587.0,567.1,567.55,1527200.0,Aurobindo Pharma completes acquisition of 51% stake in GLS Pharma,The deal is valued at ₹28 crore,neutral,neutral,-2.80013700976195,negative,-2.742504409171068,negative
2022-08-19 16:04:39.000,583.9,587.0,567.1,567.55,1527200.0,Accumulate Aurobindo Pharma; target of Rs 626: KR Choksey,"KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 626 in its research report dated August 18, 2022.",neutral,positive,-2.80013700976195,negative,-2.742504409171068,negative
2022-08-24 08:59:00.000,560.4,566.0,557.0,559.2,882932.0,Aurobindo Pharma’s WOS gets USFDA Approval for Medroxyprogesterone Acetate,"Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL, 1 mL Single-Dose Vial is bioequivalent and medically equivalent to Pfizer Inc.’s Depo-Provera Injectable Suspension.",neutral,neutral,-0.2141327623126216,neutral,-1.2936381357433908,negative
2022-08-24 21:19:50.000,564.3,564.55,553.5,557.0,1074209.0,Aurobindo Pharma arm gets U.S. FDA nod for contraceptive,HYDERABAD,neutral,neutral,-1.2936381357433908,negative,-1.5322580645161208,negative
2022-08-29 12:31:04.000,539.7,547.3,538.3,545.45,1119930.0,Auro Pharma slips as US plant gets Form 483 with one observation from USFDA,Aurobindo Pharma declined 1.67% to Rs 540.70 after US FDA issued Form 483 with one observation to Aurolife Pharma LLC’s North Carolina plant following the inspection conducted in August 2022.,neutral,neutral,1.0654067074300535,positive,-1.3568023469013526,negative
2022-08-29 13:15:12.000,539.7,547.3,538.3,545.45,1119930.0,"Anand Rathi bullish on this pharma stock, sees strong upside in 3 months","On daily chart, Aurobindo Pharma has bullish crab harmonic pattern which is looking lucrative, said brokerage Anand Rathi",positive,positive,1.0654067074300535,positive,-1.3568023469013526,negative
2022-08-29 16:19:00.000,539.7,547.3,538.3,545.45,1119930.0,Aurobindo Pharma subsidiary’s plant gets one observation from USFDA,"“At the end of the inspection, Aurolife has been issued a ‘Form 483’ with 1 observation and the observation is procedural in nature and there are no data integrity issues,” Aurobindo Pharma said.",neutral,neutral,1.0654067074300535,positive,-1.3568023469013526,negative
2022-09-01 21:37:00.000,545.9,551.0,534.0,534.2,1632651.0,Aurobindo Pharma’s arm to invest around Rs 300 crore for biologics manufacturing facilities,"​​The board of directors of CuraTeQ Biologics Pvt Ltd, at its meeting held on Thursday, approved the expansion of its operations by establishing another mammalian cell culture manufacturing facility of higher capacity to cater to the future requirements, Aurobindo Pharma said in a regulatory filing.",neutral,positive,-2.1432496794284543,negative,-0.0462962962962963,neutral
2022-09-01 22:10:00.000,545.9,551.0,534.0,534.2,1632651.0,Aurobindo Pharma’s arm to invest around Rs 300 cr for capacity expansion,"Aurobindo Pharma on Thursday said its wholly-owned arm, CuraTeQ Biologics, plans to invest around Rs 300 crore on capacity expansion of biologics manufacturing facilities",neutral,positive,-2.1432496794284543,negative,-0.0462962962962963,neutral
2022-09-02 08:05:41.000,545.9,551.0,534.0,534.2,1632651.0,"Stocks to Watch Today: Infosys, Hero Moto, Aurobindo Pharma, Eicher Motors, and Others","Stocks to watch today: Shares of firms like Infosys, Hero Moto, Aurobindo Pharma, Eicher Motors, and others will be in focus in Friday’s trade",neutral,neutral,-2.1432496794284543,negative,-0.0462962962962963,neutral
2022-09-02 08:53:31.000,545.9,551.0,534.0,534.2,1632651.0,Stocks that will see action today (Sept 2),"Buzzing stocks: Adani Enterprises, Shree Cement, Infosys, Aurobindo Pharma, UPL, Ramco Systems, Kernex Micro, SIS, Best Agrolife",neutral,neutral,-2.1432496794284543,negative,-0.0462962962962963,neutral
2022-09-02 09:04:13.000,545.9,551.0,534.0,534.2,1632651.0,"Adani Enterprises, Eicher Motors, Aurobindo Pharma in focus","Adani Enterprises, Shree Cement: Adani Enterprises will replace Shree Cement from National Stock Exchange’s benchmark index Nifty 50. The changes will become effective from 30 September 2022.",neutral,neutral,-2.1432496794284543,negative,-0.0462962962962963,neutral
2022-09-12 13:45:58.000,553.9,554.8,547.7,553.0,799178.0,U.S. FDA Flags Three Procedural Lapses At Aurobindo Pharma’s Andhra Pradesh Unit,"The U.S. FDA has issued Aurobindo Pharma a Form 483 with three observations, but none of them are related to data integrity.",neutral,neutral,-0.1624842029247115,neutral,1.5682656826568264,positive
2022-09-28 11:26:00.000,500.0,505.1,497.95,499.65,998081.0,Shares of Aurobindo Pharma as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 607.39.",neutral,neutral,-0.0700000000000045,neutral,0.8127663792249029,neutral
2022-10-03 12:51:18.000,536.0,545.7,533.0,545.0,1876396.0,"Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs","Shares of Glenmark Pharma, Granules India, Divi’s Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday’s intra-day trade",positive,positive,1.6791044776119404,positive,-1.2546595145013348,negative
2022-10-06 13:04:26.000,541.1,544.0,537.1,538.8,619557.0,Aurobindo Pharma Ltd up for five straight sessions,"Aurobindo Pharma Ltd is quoting at Rs 547.45, up 0.59% on the day as on 12:44 IST on the NSE. The stock is down 23.92% in last one year as compared to a 2.24% drop in NIFTY and a 9.28% drop in the Nifty Metal.",positive,positive,-0.4250600628349784,neutral,0.0934579439252336,neutral
2022-10-11 13:55:00.000,513.95,518.15,505.65,517.85,897518.0,Aurobindo Pharma shares fall 3.42% as Nifty drops,"A total of 383,982 shares changed hands on the counter till time (IST).",negative,neutral,0.758828679832664,neutral,-0.3957146993533355,neutral
2022-10-23 12:08:51.000,529.0,529.0,522.05,523.1,110215.0,"Dr Reddy’s, Cipla, and Aurobindo units recall products in US market","Leading drug firms Dr Reddy’s Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration",negative,negative,-1.1153119092627557,negative,-1.0857142857142943,negative
2022-10-23 17:30:00.000,529.0,529.0,522.05,523.1,110215.0,"With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy’s looking at?","There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among others.",neutral,negative,-1.1153119092627557,negative,-1.0857142857142943,negative
2022-11-02 13:16:28.000,556.4,559.9,551.8,558.25,564048.0,Aurobindo Pharma Ltd gains for third straight session,"Aurobindo Pharma Ltd is quoting at Rs 558.7, up 1.63% on the day as on 12:49 IST on the NSE. The stock is down 18.53% in last one year as compared to a 1.37% jump in NIFTY and a 1.98% jump in the Nifty Metal index.",positive,positive,0.3324946081955469,neutral,-1.152918044508007,negative
2022-11-08 09:33:14.000,556.5,564.7,539.8,541.0,1305648.0,Aurobindo Pharma units recall products in US market for manufacturing issues,"According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets.",negative,negative,-2.785265049415993,negative,-10.662313432835816,negative
2022-11-08 09:50:00.000,556.5,564.7,539.8,541.0,1305648.0,Aurobindo units recall products in US market for manufacturing issues,"The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc. As per the USFDA, the company is recalling the affected lot due to “Current good manufacturing practices CGMP deviations: Detecti…",negative,negative,-2.785265049415993,negative,-10.662313432835816,negative
2022-11-10 10:44:40.000,536.0,539.2,464.2,478.85,15481080.0,Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy,"Benoy Babu of Pernod Ricard and Sarath Reddy of Aurobindo Pharma have been arrested under sections of the Prevention of Money Laundering Act (PMLA), they said",neutral,negative,-10.662313432835816,negative,0.6185567010309279,neutral
2022-11-10 12:07:41.000,485.0,497.0,480.6,488.0,6050622.0,Aurobindo Pharma slumps 6% amid reports of Sarath Reddy’s arrest by ED,"According to reports, ED has arrested Sarath Reddy, director of Aurobindo Pharma, under the money laundering act in the now scrapped Delhi Excise policy case.",negative,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 14:50:20.000,485.0,497.0,480.6,488.0,6050622.0,Aurobindo Pharma slumps after ED arrests director Sarath Reddy,Aurobindo Pharma fell 12.02% to Rs 476.30 after the company informed that its director P. Sarath Chandra Reddy has been arrested by Enforcement Directorate (ED).,negative,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 15:04:34.000,485.0,497.0,480.6,488.0,6050622.0,Team Lease Services Ltd leads losers in ‘A’ group,"Aurobindo Pharma Ltd, Navneet Education Ltd, Quess Corp Ltd and Everest Kanto Cylinder Ltd are among the other losers in the BSE’s ‘A’ group today, 10 November 2022.",positive,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 15:33:52.000,485.0,497.0,480.6,488.0,6050622.0,Aurobindo Pharma shares tank over 11% after ED arrests director Sarath Reddy,"The pharma company’s scrip had recorded an intra-day low of Rs 464.50 apiece on BSE, down 14 percent from its previous close.",neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 15:48:13.000,485.0,497.0,480.6,488.0,6050622.0,"Aurobindo Pharma director, businessman arrested by ED in Delhi liquor case","ED also arrested an executive of spirits giant Pernod Ricard’s Benoy Babu, under sections of the Prevention of Money Laundering Ac",negative,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 15:49:27.000,485.0,497.0,480.6,488.0,6050622.0,"Sensex dips 420 pts on weak global cues; Aurobindo Pharma down 12%, TaMo 5%","CLOSING BELL: Hero MotoCorp, HDFC Bank, Kotak Bank, ONGC, Bharti Airtel, and Dr Reddy’s Labs, meanwhile, eked out gains up to 2.6 per cent",negative,positive,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 16:50:33.000,485.0,497.0,480.6,488.0,6050622.0,Nifty November futures trade at premium,"Tata Motors, Aurobindo Pharma and Axis Bank were the top traded contracts.",positive,neutral,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 17:30:00.000,485.0,497.0,480.6,488.0,6050622.0,‘Not in any way connected with operations’: Aurobindo Pharma on arrest of its promoter Sarath Reddy by ED,The statement comes just hours after Reddy was arrested by the Enforcement Directorate (ED) in connection with Delhi’s liquor policy scam.,neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 17:30:00.000,485.0,497.0,480.6,488.0,6050622.0,"Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu","The agency has arrested Aurobindo Pharma director Sharath Reddy, and Pernod Ricard general manager Benoy Babu under sections of the Prevention of Money Laundering Act (PMLA).",neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 17:30:00.000,485.0,497.0,480.6,488.0,6050622.0,Aurobindo Pharma shares tank over 7% after ED arrests company’s director,"Aurobindo Pharma stock crashed 7.42 per cent to Rs 501.20 against the previous close of Rs 541.40 on BSE. The pharma stock is trading lower than 5 day, 20 day, 50 day, 100 day and 200 day moving averages",negative,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 17:30:00.000,485.0,497.0,480.6,488.0,6050622.0,Delhi excise policy case: ED arrests 2 pvt company executives,"The two arrested were Benoy Babu, general manager of liquor company Pernod Ricard, and P Sarath Chandra Reddy, whole-time director and promoter of Aurobindo Pharma, and they were taken into custody shortly after midnight.",neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 17:30:00.000,485.0,497.0,480.6,488.0,6050622.0,"Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter’s arrest","Earlier today, the ED arrested Reddy and Pernod Ricard general manager Benoy Babu under sections of the Prevention of Money Laundering Act (PMLA) in connection with liquor trade in the money laundering investigation into the now-scrapped Delhi excise policy case",neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 18:58:00.000,485.0,497.0,480.6,488.0,6050622.0,Director’s arrest no way linked to operations: Aurobindo Pharma,"“Further to the disclosure of even date, the company further learnt that the arrest of P Sarath Chandra Reddy, whole-time director/promoter group of the company, is not in any way connected with the operations of Aurobindo Pharma Limited or its subsidiaries,” the company said in a statement.",neutral,neutral,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 19:06:52.000,485.0,497.0,480.6,488.0,6050622.0,Liquor scam: ED arrests Aurobindo Pharma’s Director Sarath Reddy,Aurobindo’s scrip closed down 11.7 per cent to end at ₹478.10 on the BSE on Thursday,neutral,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 20:20:57.000,485.0,497.0,480.6,488.0,6050622.0,Aurobindo Pharma shares tumble after arrest of director by ED,Drugmaker says P. Sarath Chandra Reddy’s arrest not connected with its operations,negative,negative,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 21:40:59.000,485.0,497.0,480.6,488.0,6050622.0,"Delhi excise scam resulted in ₹2,631-cr loss to public exchequer: ED",Says Aurobindo Pharma’s whole time director P Sharath Chandra Reddy was one the king pins of liquor scam,neutral,neutral,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 22:24:18.000,485.0,497.0,480.6,488.0,6050622.0,ED arrests two persons in Delhi excise policy case,"The accused were identified as Benoy Babu, who worked as a general manager with a liquor company, and Sharath Reddy, director of Aurobindo Pharma",negative,neutral,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-10 22:51:38.000,485.0,497.0,480.6,488.0,6050622.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 82 stocks in which a short build-up was seen including Deepak Nitrite, Ramco Cements, Aurobindo Pharma, Piramal Enterprises, and Axis Bank.",neutral,neutral,0.6185567010309279,neutral,3.468085106382981,positive
2022-11-13 11:00:46.000,470.0,492.0,457.0,486.3,9220049.0,Movers & Shakers: 10 stocks that moved the most last week,"Zomato, Britannia Industries, Aurobindo Pharma, Indigo Paints, and Ramco Cements among stocks that shook the most",neutral,neutral,3.468085106382981,positive,0.4083299305839118,neutral
2022-11-14 09:20:15.000,470.0,492.0,457.0,486.3,9220049.0,Bottomline | The worrisome case of Aurobindo Pharma,"For equity investors, even a hint of suspect governance is a big red flag. It isn’t surprising, therefore, that the Aurobindo Pharma stock came under selling pressure on November 10 after it was reported that its Director, P Sarath Chandra Reddy, had been arrested by the Enforcement Directorate.",negative,negative,3.468085106382981,positive,0.4083299305839118,neutral
2022-11-14 09:45:22.000,470.0,492.0,457.0,486.3,9220049.0,"Aurobindo Pharma slips 7%, hits over 2-year low on weak Q2 results",The company said the second quarter performance was subdued mainly due to the macro-environment factors and higher competitive intensity for some products in the US,negative,negative,3.468085106382981,positive,0.4083299305839118,neutral
2022-11-14 11:36:49.000,470.0,492.0,457.0,486.3,9220049.0,Aurobindo Pharma shares tumble nearly 7% in early trade; hit 52-week low after Q2 earnings,"Aurobindo Pharma’s shares plunge 6.52% to ₹457.20 on the BSE, while it declined 6.60% to ₹457 at the NSE",negative,negative,3.468085106382981,positive,0.4083299305839118,neutral
2022-11-14 17:30:00.000,489.8,494.8,480.0,491.8,3093386.0,Aurobindo Pharma shares hit 52-week low post weak Q2 show,"The stock crashed over 14 per cent on Friday following the arrest of P Sarath Chandra Reddy, one of the promoters of Aurobindo Pharma.",negative,negative,0.4083299305839118,neutral,-2.769857433808559,negative
2022-11-15 09:13:24.000,489.8,494.8,480.0,491.8,3093386.0,Aurobindo Pharma Q2 Results Review - U.S. Drags Down Overall Performance; Outlook Cautious: ICICI Direct,U.S. price erosion continues. U.S. injectable and ex-injectable business have de-grown by 28% YoY and 15% YoY.,neutral,positive,0.4083299305839118,neutral,-2.769857433808559,negative
2022-11-17 14:20:14.000,476.75,476.8,465.8,469.0,1214011.0,"Aurobindo Pharma earnings under pressure due to muted performance in US, Europe","The US sales that contributed more than half to total formulation sales, declined 11.1% year-on-year during the September quarter, while the European formulation sales declined 8.8% year-on-year",negative,negative,-1.6255899318300997,negative,-0.4301075268817204,neutral
2022-11-17 17:30:00.000,476.75,476.8,465.8,469.0,1214011.0,"Stocks in news: Paytm, Wipro, Nykaa, Global Health and more","Stocks to watch out for today: Paytm, Wipro, Page Industries, Nykaa, Aurobindo Pharma, Global Health, Ircon International, Hindustan Zinc and more",neutral,neutral,-1.6255899318300997,negative,-0.4301075268817204,neutral
2022-11-18 12:16:06.000,476.75,476.8,465.8,469.0,1214011.0,Aurobindo Pharma gets USFDA nod for new injection,Amphotericin B Liposome for Injection is expected to be launched by Q4 FY23,neutral,neutral,-1.6255899318300997,negative,-0.4301075268817204,neutral
2022-11-18 19:05:22.000,476.75,476.8,465.8,469.0,1214011.0,Aurobindo Pharma arm’s copy of fungal infection drug gets U.S. FDA nod,HYDERABAD,neutral,neutral,-1.6255899318300997,negative,-0.4301075268817204,neutral
2022-11-21 08:37:40.000,465.0,469.6,461.7,463.0,1111882.0,"Stocks that will see action on November 21, 2022","Steel stocks, RHI Magnesita, IEX, CDSL, Aarti Industries, Deepak Fertilisers, Tata Motors, Dr Reddy’s Lab, Policybazaar, Aurobindo Pharma, Strides Arcolab, Natural Capsules, Ashoka Buildcon, 3i Infotech, BEL, BPCL, Engineers India, Jindal Stainless, ZF Steering and Zomato, REC, Kanoria Chem",neutral,neutral,-0.4301075268817204,neutral,-0.6790256520801848,neutral
2022-11-21 16:48:00.000,463.9,467.5,459.0,460.75,1092918.0,Aurobindo Pharma aims to complete Rs 2000 Cr Pen-G plant in Andhra Pradesh by March′24,"Out of Rs 2000 crore, the drug maker has already spent around Rs 500 crore and Rs 1,500 crore is going to be spent in the coming year. The production capacity of the plant will be around 15,000 tonnes annually. The pant been approved under Production Linked Incentive (PLI) Scheme for Promotion of Do…",neutral,neutral,-0.6790256520801848,neutral,-0.6378378378378353,neutral
2022-11-24 15:54:27.000,458.6,465.35,455.3,463.95,1327177.0,Hold Aurobindo Pharma; target of Rs 540: ICICI Direct,"ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.",neutral,positive,1.1665939816833768,positive,0.6458557588805167,neutral
2022-11-25 15:31:59.000,458.6,465.35,455.3,463.95,1327177.0,Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.",neutral,neutral,1.1665939816833768,positive,0.6458557588805167,neutral
2022-11-28 00:01:00.000,464.5,469.6,463.5,467.5,875062.0,Medley-Cipla deal talks called off over valuation issues,This is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility and valuation mismatch. Hyderabad-based Aurobindo Pharma had also scrapped the demerger and sale of its injectables arm Eugia Pharma Specialities to Blackstone e…,neutral,neutral,0.6458557588805167,neutral,-0.2245989304812858,neutral
2022-11-30 11:47:00.000,468.0,470.95,464.0,468.4,1243427.0,Share price of Aurobindo Pharma jumps as Sensex gains 105.79 points,"A total of 18,390 shares changed hands on the counter till 11:47AM (IST)",positive,neutral,0.0854700854700806,neutral,-0.2023213715259266,neutral
2022-12-07 18:21:58.000,462.55,462.9,457.75,459.2,716926.0,Accumulate Aurobindo Pharma; target of Rs 550: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 550 in its research report dated November 16, 2022.",neutral,positive,-0.7242460274564961,neutral,-1.3043478260869563,negative
2022-12-09 21:17:39.000,460.0,461.7,450.1,454.0,1008667.0,Aurobindo Pharma Ltd slips for fifth straight session,"Aurobindo Pharma Ltd is quoting at Rs 454.7, down 0.9% on the day as on 13:19 IST on the NSE. The stock tumbled 35.44% in last one year as compared to a 5.59% rally in NIFTY and a 5.09% fall in the Nifty Metal index.",negative,negative,-1.3043478260869563,negative,-0.5506607929515419,neutral
2022-12-23 08:11:36.000,446.5,454.45,435.9,438.55,1862583.0,"Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains","According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.",positive,positive,-1.7805151175811846,negative,-0.3754693366708334,neutral
2022-12-29 11:16:49.000,441.0,444.5,435.1,437.4,1185711.0,Aurobindo Pharma gets USFDA nod for generic of Revatio drug,"Aurobindo Pharma gets USFDA nod for generic of Revatio drug.
The drug is a generic version of Viatris Inc’s Revatio oral suspension. It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.",neutral,neutral,-0.81632653061225,neutral,-0.4545454545454545,neutral
2023-01-02 14:08:00.000,434.8,447.3,433.5,441.75,1447046.0,Shares of Aurobindo Pharma fall as Nifty gains,"On the technical charts, the 200-day moving average of the stock stood at Rs 547.38.",positive,neutral,1.598436062557495,positive,-0.316921335597052,neutral
2023-01-04 11:16:05.000,441.75,444.95,438.05,440.35,957477.0,Auro Pharma’s subsidiary get US FDA nod for MDS treatment drug,Aurobindo Pharma said that its wholly owned subsidiary Eugia Pharma Specialities has received US Food & Drug Administration (US FDA) approval to manufacture and market Azacitidine for injection.,neutral,positive,-0.316921335597052,neutral,0.8970137390711906,neutral
2023-01-04 13:21:33.000,440.35,444.95,437.7,444.3,779150.0,Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection,"Aurobindo Pharma’s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.",neutral,positive,0.8970137390711906,neutral,-0.5740011254924055,neutral
2023-01-10 10:15:00.000,442.7,451.9,442.2,451.0,1302949.0,Aurobindo Pharma shares up 1.1% as Sensex falls,"A total of 4,155 shares changed hands on the counter till 10:15AM (IST)",positive,neutral,1.874858820871925,positive,-1.545253863134658,negative
2023-01-19 07:04:01.000,443.1,448.75,441.2,445.0,1640784.0,"Buzzing Stocks: Hindustan Unilever, IndusInd Bank, Aurobindo Pharma, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,0.4287971112615611,neutral,-0.4484304932735426,neutral
2023-01-19 09:33:32.000,443.1,448.75,441.2,445.0,1640784.0,Aurobindo Pharma shares fall as USFDA issues ‘Form 483’ with 2 observations,"We will respond to the USFDA within the stipulated timelines and work closely with the regulator to close the observations at the earliest, Aurobindo Pharma said.",negative,neutral,0.4287971112615611,neutral,-0.4484304932735426,neutral
2023-01-19 10:04:18.000,443.1,448.75,441.2,445.0,1640784.0,Aurobindo Pharma arm gets 2 observations from USFDA,"The drug maker on Wednesday announced that the United States Food and Drug Administration (US FDA) inspected its wholly owned subsidiary, APL Health Care’s Unit I & III, at Jadcherla in Telangana, during 9 January to 18 January 2023.",neutral,neutral,0.4287971112615611,neutral,-0.4484304932735426,neutral
2023-01-27 12:24:43.000,418.25,423.6,409.0,419.1,1404176.0,"Adani Green, Adani Ports and 31 other BSE500 stocks hit 52-week lows","Shares of Indus Tower, Vodafone Idea, Aurobindo Pharma, TV18 Broadcast, Voltas and Whirlpool of India were among total 33 stocks from the S&P BSE 500 index that hit their respective 52-week lows",negative,neutral,0.2032277346084932,neutral,-1.092830551218929,negative
2023-02-03 17:30:00.000,410.65,411.8,397.2,403.75,1460698.0,"For LIC, Adani is not the biggest problem","Apart from Adani Group stocks, LIC’s holdings in companies like Future Lifestyle Fashions, Piramal Enterprises, Omaxe, Indus Towers, Laurus Labs, Jet Airways (India), Sunteck Realty, Bombay Dyeing, GTL Infrastructure, Aurobindo Pharma and Jaypee Infratech among others have also taken a huge beating …",neutral,neutral,-1.680262997686589,negative,2.722772277227723,positive
2023-02-07 20:13:26.000,421.45,450.7,415.5,446.0,4059182.0,U.S. FDA gives nod for Aurobindo Pharma’s Diclofenac Sodium Topical Solution,HYDERABAD,neutral,neutral,5.825127535888008,positive,-0.7976631839119225,neutral
2023-02-08 09:03:01.000,421.45,450.7,415.5,446.0,4059182.0,"Stocks that will see action on February 8, 2023","BSE, CDSL, RVNL, PC Jeweller, Muthoot Finance, broking stocks, Aurobindo Pharma, NTPC, Adani Power, Adani Wilmar, 3M India, Cummins India, Equitas Bank, Escorts, Eureka Ind, Gati, Godrej Agro, GTL, GTL Infra, Midhani, Minda Corp, Samvardhana Motherson, Piramal Enterprises, Tracxn Technologies, Tren…",neutral,neutral,5.825127535888008,positive,-0.7976631839119225,neutral
2023-02-08 14:59:21.000,445.05,452.0,435.75,441.5,2086660.0,Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug,The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA’s approval to manufacture and market Diclofenac Sodium Topical Solution USP.,positive,positive,-0.7976631839119225,neutral,4.798657718120803,positive
2023-02-08 20:42:31.000,445.05,452.0,435.75,441.5,2086660.0,Aurobindo Pharma gets USFDA nod for osteoarthritis drug,The product is expected to be launched in Q1 FY24; scrip zooms 6%,neutral,neutral,-0.7976631839119225,neutral,4.798657718120803,positive
2023-02-09 07:20:23.000,445.05,452.0,435.75,441.5,2086660.0,"Stocks to Watch: Adani Total, Airtel, Adani Power, L&T, Tata Steel","LIC, IRCTC, Hindalco, HPCL, Adani Total, Zomato, Aurobindo Pharma, and Bajaj Consumer Care will be among the stocks in focus as they declare their December quarter earnings today.",neutral,neutral,-0.7976631839119225,neutral,4.798657718120803,positive
2023-02-09 08:47:38.000,445.05,452.0,435.75,441.5,2086660.0,"Stocks that will see action on February 9, 2023","LIC, Hindalco, HPCL, Zomato, HAL, IRCTC, Adani Total Gas, Aurobindo Pharma, Bajaj Consumer Care, Bombay Dyeing, GIC, Jet Airways, MRF, Page Industries, Suzlon, Voltas, Adani Total Gas, Syngenta, TCS, Techno Electric, Symphony, Uno Minda, IVP, IOB, KIMS, Lupin",neutral,neutral,-0.7976631839119225,neutral,4.798657718120803,positive
2023-02-09 19:24:00.000,447.0,471.7,447.0,468.45,9894221.0,Aurobindo Pharma Q3 net down 18.7 pc at ₹491 crore,"Revenue increased 6.7 per cent to ₹6,407 crore",negative,positive,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-09 20:30:53.000,447.0,471.7,447.0,468.45,9894221.0,"Aurobindo Pharma Q3 Results: Profit Falls, Misses Estimates","Aurobindo Pharma’s Q3 revenue rose 7% to Rs 6,407 crore, against an estimate of Rs 6,142 crore.",neutral,positive,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-09 21:03:39.000,447.0,471.7,447.0,468.45,9894221.0,Aurobindo Pharma’s consolidated net profit down 18.7% at Rs 491 Cr in Q3,Aurobindo Pharma Limited on Thursday said its consolidated net profit for the quarter ended January 31 was down by 18.7 per cent to Rs 491.2 crore against Rs 604.3 crore in Q3FY22.,negative,negative,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-09 22:33:18.000,447.0,471.7,447.0,468.45,9894221.0,Aurobindo Pharma Q3 net drops 18% to ₹491 crore,Firm declares interim dividend of ₹3 per equity share of ₹1 each,negative,neutral,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-10 07:28:47.000,447.0,471.7,447.0,468.45,9894221.0,"Stocks to Watch: LIC, Adani Group, Zomato, IRCTC, HPCL, Aurobindo Pharma","M&M, ABB India, AstraZeneca India, BHEL, Delhivery, Dish TV India JK Lakshmi Cement, Inox Wind, and Inox Green will be among the stocks in focus as they declare their December quarter earnings today.",neutral,neutral,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-10 10:15:55.000,447.0,471.7,447.0,468.45,9894221.0,Aurobindo Pharma shares gain even as Q3 profit sinks; board declares 300% dividend,"Aurobindo Pharma declared an interim dividend of Rs 3 per equity share for shares of Re 1 each. The interim dividend will be paid on or before March 3 with the record date being February 17, the company said.",positive,neutral,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-10 16:27:04.000,447.0,471.7,447.0,468.45,9894221.0,Aurobindo Pharma Ltd. ADR (ARBQY) Q3 2023 Earnings Call Transcript,"Aurobindo Pharma Ltd. ADR (OTC:ARBQY) Q3 2023 Earnings Conference Call February 10, 2023 10:00 PM ETCompany RepresentativesDr.",neutral,neutral,4.798657718120803,positive,0.6383657835939993,neutral
2023-02-15 20:56:04.000,474.0,482.5,470.5,479.75,1597960.0,Buy Aurobindo Pharma; target of Rs 565: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 565 in its research report dated February 11, 2023.",neutral,positive,1.2130801687763713,positive,-0.9842931937172752,negative
2023-02-16 13:31:17.000,477.5,479.3,467.8,472.8,1005641.0,Aurobindo Pharma Ltd up for fifth session,"Aurobindo Pharma Ltd is quoting at Rs 481.45, up 1.57% on the day as on 12:44 IST on the NSE. The stock is down 28.64% in last one year as compared to a 4.4% jump in NIFTY and a 7.68% jump in the Nifty Metal.",neutral,positive,-0.9842931937172752,negative,-1.4649681528662373,negative
2023-02-17 10:16:27.000,477.5,479.3,467.8,472.8,1005641.0,Is there a sign of reversal in Aurobindo Pharma?,I am holding shares of Aurobindo Pharma at an average cost of ₹740. Is there a possibility of a reve,positive,neutral,-0.9842931937172752,negative,-1.4649681528662373,negative
2023-02-17 12:41:00.000,477.5,479.3,467.8,472.8,1005641.0,"Aurobindo Pharma’s three units in Telangana gets VAI classification by USFDA, shares gain","VAI means USFDA will not take regulatory action because the objectionable conditions if found are minor and may not qualify for enforcement action. The three units that were classified as VAI are Unit I and Unit-III, manufacture tablets, capsules and soft gel Capsules and a Derma manufacturing facil…",neutral,neutral,-0.9842931937172752,negative,-1.4649681528662373,negative
2023-02-28 11:07:00.000,458.8,466.9,456.9,461.0,1826014.0,Aurobindo Pharma shares rise 0.6% as Nifty drops,The stock quoted a 52-week high price of Rs 730.0 and a 52-week low of Rs 397.3.,positive,negative,0.479511769834348,neutral,0.9676016525331694,positive
2023-03-02 15:42:12.000,463.4,465.0,458.55,459.9,618480.0,Buy Aurobindo Pharma; target of Rs 554: Geojit,"Geojit is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 554 in its research report dated March 02, 2023.",neutral,positive,-0.7552870090634441,neutral,1.2241360632650802,positive
2023-03-02 18:43:29.000,463.4,465.0,458.55,459.9,618480.0,Broker’s Call: Aurobindo Pharma (Buy),Geojit Retail Equity Research,neutral,neutral,-0.7552870090634441,neutral,1.2241360632650802,positive
2023-03-08 10:31:37.000,463.1,471.55,458.6,462.0,1418734.0,Aurobindo Pharma arm gets USFDA nod for cancer drug,"The pharmaceutical company on Wednesday announced that its wholly owned subsidiary, Eugia Pharma Specialities has received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lenalidomide Capsules.",neutral,positive,-0.2375296912114063,neutral,-1.3469827586206895,negative
2023-03-08 21:17:00.000,464.0,466.5,456.25,457.75,920903.0,Aurobindo Pharma arm gets U.S. FDA nod for cancer drug copy,Aurobindo Pharma said the product is expected to be launched in October and it will be a volume specific launch,neutral,neutral,-1.3469827586206895,negative,-0.2747252747252747,neutral
2023-03-09 15:50:13.000,455.0,455.5,445.65,453.75,920608.0,Hold Aurobindo Pharma; target of Rs 516: Sharekhan,"Sharekhan recommended hold rating on Aurobindo Pharma with a target price of Rs 516 in its research report dated February 10, 2023.",neutral,positive,-0.2747252747252747,neutral,-0.5530973451327433,neutral
2023-03-10 00:25:00.000,455.0,455.5,445.65,453.75,920608.0,BRS’ Kavitha to appear before ED tomorrow in Delhi excise case,"The agency has alleged Pillai “represented the south group,” an alleged liquor cartel linked to Aurobindo Pharma promoter Sarath Reddy, YSRCP Ongole MP Magunta Srinivasulu Reddy and Kalvakuntla, among others. ED has alleged Pillai represented the ’benami investments of Kalvakuntla in the case. Her s…",neutral,neutral,-0.2747252747252747,neutral,-0.5530973451327433,neutral
2023-03-14 16:46:15.000,453.05,470.5,453.0,458.0,1810075.0,Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated February 10, 2023.",neutral,neutral,1.0925946363536008,positive,4.047567095788788,positive
2023-03-23 11:53:00.000,479.0,488.0,475.75,485.0,2082886.0,Aurobindo Pharma shares up 1.1% as Nifty gains,"A total of 35,939 shares changed hands on the counter till time (IST).",positive,neutral,1.2526096033402925,positive,2.8600823045267445,positive
2023-03-27 17:30:00.000,510.8,514.05,498.35,510.0,2307737.0,"Auro Pharma, IGL, Anuras & Aegis Logistics: These 4 stocks are headed for up to 22% rise in near term",Aurobindo Pharma on the weekly chart has decisively broken out above the medium term ‘falling channel’ at Rs 485 with strong bullish candle indicating a positive bias.,positive,neutral,-0.1566170712607696,neutral,-0.392156862745098,neutral
2023-03-28 11:44:39.000,510.8,514.05,498.35,510.0,2307737.0,Inverse H&S in pharma index could revive a positive bias for short-term,"Pharma shares like Aurobindo Pharma, Zydus Lifesciences, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals may rise up to 14 per cent.",positive,positive,-0.1566170712607696,neutral,-0.392156862745098,neutral
2023-04-03 17:30:00.000,519.0,528.6,516.45,519.0,2005065.0,"Adani Group, Ultratech, NCC, Bata India among stocks to watch out for today","Stocks to watch out for today: Adani Group, Aurobindo Pharma, Ultratech Cement, NCC, Bata India and more",neutral,neutral,0.0,neutral,0.3742802303263043,neutral
2023-04-05 15:35:10.000,526.0,536.8,525.3,535.2,1847368.0,Aurobindo Pharma appoints Sanjay Chaturvedi as CEO of its subsidiary,The company also appointed Venkat Nageswar Chalasani as the Independent Director of Apitoria Pharma.,neutral,neutral,1.7490494296578032,positive,0.5597014925373134,neutral
2023-04-16 17:38:34.000,565.3,569.2,556.1,558.0,1414984.0,Aurobindo Pharma Foundation sets up oncology block at MNJ Institute with ₹80 cr,"Aurobindo Pharma Foundation (APF), the philanthropic and CSR arm of Aurobindo Pharma, has built a state-of-the-art oncology block for MNJ Institute of Oncology and State Cancer Institute, Hyderabad with ₹80 crore. The funding was an initiative under Corporate Social Responsibility (CSR) of the Hyder…",neutral,neutral,-1.2913497258092967,negative,3.17332618217574,positive
2023-04-25 13:11:50.000,600.0,615.75,598.65,613.0,3390175.0,"Escorts, Bank of India: Select midcap stocks are poised for up to 20% gains","Zydus Lifesciences, in particular, has been scaling 52-week highs with momentum staying highly elevated. Also, Aurobindo Pharma shares have seen a steeper rise, with aggressive chart structures.",positive,positive,2.166666666666667,positive,0.3912299290895716,neutral
2023-05-11 14:16:00.000,608.7,614.35,599.05,608.2,904026.0,Aurobindo Pharma shares fall 2.33% as Nifty gains,"A total of 33,832 shares changed hands on the counter till time (IST).",negative,neutral,-0.0821422704123542,neutral,1.2888301387970842,positive
2023-05-19 21:48:58.000,598.0,606.55,581.25,589.15,1920021.0,US. FDA issues Form 483 with four observations to Aurobindo Pharma,‘Four observations procedural in nature’,neutral,neutral,-1.4799331103678968,negative,3.583617747440273,positive
2023-05-23 21:54:38.000,601.0,606.95,596.4,604.25,610057.0,Pharma company lends support to tennis player,"The Aurobindo Pharma Foundation has offered ₹6 lakh aid to Uppada-based tennis player Penupothula Lakshmi Sai Subhash, for his further training",neutral,neutral,0.5407653910149751,neutral,0.3473370823685118,neutral
2023-05-26 19:59:09.000,591.25,618.0,591.25,616.15,1552257.0,Aurobindo Pharma arm copy of Pfizer’s drug gets U.S. FDA nod,"Aurobindo Pharma subsidiary Eugia Pharma Specialties has received the final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Carboprost Tromethamine Injection USP 250 mcg/mL, single-dose vials.",neutral,positive,4.211416490486254,positive,-1.658481603735602,negative
2023-05-28 11:04:12.000,621.05,621.05,584.65,610.75,4196878.0,Aurobindo Pharma to transfer shares in subsidiary to Curateq Biologics,This transfer of shares worth Rs 10 lakh is part of verticalization of business operations.,neutral,neutral,-1.658481603735602,negative,5.773145509323353,positive
2023-05-29 09:02:27.000,621.05,621.05,584.65,610.75,4196878.0,"Stocks to watch on May 29, 2023","Buzzing stocks: RITES, PFC, IRCTC, RVNL, Aurobindo Pharma, Sun Pharma, Reliance Industries, Lupin, Alfa Transformers",neutral,neutral,-1.658481603735602,negative,5.773145509323353,positive
2023-05-29 11:49:49.000,621.05,621.05,584.65,610.75,4196878.0,Aurobindo Pharma slumps 3% after weak Q4 numbers,"Aurobindo Pharma reported a 12 percent YoY decline in net profit at Rs 506 crore. Investec, however, has a ‘buy’ call on the stock, with a target price of Rs 560 . The company has shown strong performance in the US market, it said",negative,negative,-1.658481603735602,negative,5.773145509323353,positive
2023-05-29 17:30:00.000,614.05,655.0,612.75,649.5,9344697.0,"Adani Transmission, IRCTC, Sun Pharma, M&M, Ion Exchange among stocks to watch out for today","Stocks to watch out for today: Adani Transmission, IRCTC, Sun Pharma, M&M, Ion Exchange, Aurobindo Pharma, Balkrishna Industries, SAIL, Grasim and more",neutral,neutral,5.773145509323353,positive,1.2086220169361082,positive
2023-05-29 17:30:00.000,614.05,655.0,612.75,649.5,9344697.0,"BHEL, Aurobindo Pharma, NHPC: How to trade these stocks amid the results buzz?","On the daily chart, BHEL has started trading below the 20-day SMA, which is a sign of weakness. At present, the stock is outperforming the benchmark indices.",neutral,positive,5.773145509323353,positive,1.2086220169361082,positive
2023-05-30 11:47:53.000,614.05,655.0,612.75,649.5,9344697.0,"Stocks In Focus: UltraTech, ONGC, Techno Electric, Aurobindo Pharma & More | BQ Prime","Stocks In Focus: UltraTech, ONGC, Techno Electric, Aurobindo Pharma & More | BQ Prime #ONGC to invest Rs 1 lakh crore in energy transmission for 2038 net-zero targets.ICICI Direct’s Pankaj Pandey shares his view and the other top stocks in trade today.",neutral,neutral,5.773145509323353,positive,1.2086220169361082,positive
2023-05-30 17:30:00.000,649.5,662.95,647.15,657.35,3848433.0,Aurobindo Pharma shares jumped 7% today. Here’re price targets for stock,"Aurobindo Pharma shares are trading at 13 times FY25E EPS. This captures the risk associated with export-related headwinds, but not the R&D monetisation, a brokerage said.",positive,neutral,1.2086220169361082,positive,-0.03813882532418,neutral
2023-05-30 17:30:00.000,649.5,662.95,647.15,657.35,3848433.0,"Sensex rises over 100 points, Nifty trades near 18,650; Hikal & Aurobindo Pharma jump up to 11%","The 30-share BSE Sensex climbed 130 points or 0.21 per cent to trade at 62,976, while the broader NSE Nifty moved 37 points or 0.20 per cent higher to trade at 18,635. Mid- and small-cap shares were positive as Nifty Midcap 100 gained 0.40 per cent and the small-cap 100 was up 0.09 per cent.",positive,positive,1.2086220169361082,positive,-0.03813882532418,neutral
2023-05-31 08:46:02.000,649.5,662.95,647.15,657.35,3848433.0,Buy Aurobindo Pharma; target of Rs 660: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 660 in its research report dated May 29, 2023.",neutral,positive,1.2086220169361082,positive,-0.03813882532418,neutral
2023-05-31 08:50:26.000,649.5,662.95,647.15,657.35,3848433.0,"Stocks to watch on May 31, 2023","Buzzing stocks: Coal India, Sona BLW, HDFC Life Insurance, Lupin, HDFC Asset Management, Aurobindo Pharma, Axis Bank, Sun Pharma, Kalpataru Power",neutral,neutral,1.2086220169361082,positive,-0.03813882532418,neutral
2023-05-31 12:45:19.000,655.5,661.0,646.15,655.25,1653827.0,"Stocks In Focus: Auto Stocks , HDFC AMC, Coal India, Aurobindo Pharma, & More | BQ Prime","Stocks In Focus: Auto Stocks , HDFC AMC, Coal India, Aurobindo Pharma, & More | BQ Prime #LemonTree records its best-ever Gross ARR, EBITDA, PBT, and PAT.Vridhi Investment’s Vivek Karwa shares his view on the top stocks in trade today.",neutral,positive,-0.03813882532418,neutral,0.4175840862500949,neutral
2023-06-01 12:49:41.000,658.55,663.7,652.35,661.3,1224405.0,Hold Aurobindo Pharma; target of Rs 716: Sharekhan,"Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 716 in its research report dated May 30, 2023.",neutral,positive,0.4175840862500949,neutral,-0.5957318452605281,neutral
2023-06-01 16:41:34.000,658.55,663.7,652.35,661.3,1224405.0,Hold Aurobindo Pharma; target of Rs 665: KR Choksey,"KR Choksey recommended hold rating on Aurobindo Pharma with a target price of Rs 665 in its research report dated May 31, 2023.",neutral,positive,0.4175840862500949,neutral,-0.5957318452605281,neutral
2023-06-01 20:47:39.000,658.55,663.7,652.35,661.3,1224405.0,Aurobindo Pharma’s Reddy turns approver in Delhi excise case,Rouse Avenue Court allowed Reddy to turn approver in the case and pardoned him of his offence on assurance that he would voluntary offer full disclosure of irregularities committed in the scam,neutral,neutral,0.4175840862500949,neutral,-0.5957318452605281,neutral
2023-06-05 19:23:11.000,662.0,665.75,653.05,664.05,547407.0,Aurobindo Pharma completes plant installation in China,Aurobindo Pharma has completed the installation of its plant in China and is planning to commission it in the first quarter of next fiscal,neutral,neutral,0.3096676737160052,neutral,0.8146487294469426,neutral
2023-06-08 13:10:00.000,668.45,670.45,661.75,667.7,999236.0,"Chart Check: After 11% rally in a month, this pharma stock races to fresh 52-week high; time to buy or book profits?",Aurobindo Pharma’s stock prices have surged by approximately 11% in one month to reach a fresh 52-week high in June 2023. Analysts suggest that the stock may continue to rise and recommend short-term traders to purchase the stock while expecting a target of Rs 890 levels in the next six months. The …,positive,positive,-0.1121998653601615,neutral,-0.879940343027588,neutral
2023-06-23 12:20:17.000,668.0,701.0,665.75,700.0,4072511.0,Aurobindo Pharma gains 2% on subsidiary’s licence deal for leukemia drug,"Eugia Pharma has signed a voluntary sub-licensing agreement with Medicines Patent Pool to make and sell Nilotinib capsules, originally developed by Novartis, for chronic myeloid leukemia in 44 low and middle-income countries",positive,positive,4.790419161676647,positive,3.1254470032899477,positive
2023-06-23 12:50:00.000,668.0,701.0,665.75,700.0,4072511.0,Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drug,India’s Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Medicines Patent Pool to develop and market an anti-cancer drug- Nilotinib capsules. Nilotinib capsules are used for the treatment of chronic myeloid leukemia.,positive,positive,4.790419161676647,positive,3.1254470032899477,positive
2023-06-23 13:41:00.000,668.0,701.0,665.75,700.0,4072511.0,Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib Capsules,Shares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with Medicines Patent Pool to create and market a generic version of Nilotinib Capsules. Aurobindo Pharmas wholly-owned subsidiary Eugia Pharma Specialities has entere…,positive,positive,4.790419161676647,positive,3.1254470032899477,positive
2023-06-23 14:16:40.000,668.0,701.0,665.75,700.0,4072511.0,Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop drug,"Aurobindo Pharma on Friday said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market an anti-cancer drug.",positive,positive,4.790419161676647,positive,3.1254470032899477,positive
2023-06-26 07:02:00.000,699.1,725.3,696.6,720.95,5014549.0,"Stocks in news: TCS, HDFC Life, Shree Cement, Aurobindo Pharma, Bank of Maharashtra",The European Medicines Agencys (EMA) Committee has accepted Aurobindo Pharma subsidiary CuraTeQ Biologics’ request to withdraw the applications for marketing authorization of ZEFYLTI (a filgrastim biosimilar) and DYRUPEG (a pegfilgrastim biosimilar).,neutral,neutral,3.1254470032899477,positive,-0.4293628808864297,neutral
2023-06-26 08:49:44.000,699.1,725.3,696.6,720.95,5014549.0,"Stocks to Watch: TCS, IndusInd Bank, Infosys, Axis Bank, RVNL, Aurobindo Pharma, and Others - News18","Stocks to watch: Shares of firms like TCS, IndusInd Bank, Infosys, Axis Bank, RVNL, Aurobindo Pharma, and others will be in focus on Monday’s trade.",neutral,neutral,3.1254470032899477,positive,-0.4293628808864297,neutral
2023-06-26 09:31:46.000,699.1,725.3,696.6,720.95,5014549.0,Stocks that will see action today (June 26),"Shree Cements, ICICI Securities, ICICI Bank, Aurobindo Pharma, J&K Bank, Godrej Properties, Ipca Lab, Asian Paints, RVNL, Cambridge Tech, AU Small Finance Bank, HDC Life, HDFC and Zydus LifeSciences are the stocks to watch on June 26, 2023",neutral,neutral,3.1254470032899477,positive,-0.4293628808864297,neutral
2023-06-28 13:29:00.000,718.0,741.85,714.5,736.05,3201161.0,Next big delta in pharma to come from biosimilars: Nithya Balasubramanian,"“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactical recommendation for the next couple of quarters for the reasons that you just read out. In the case of Gland Pharma, Bernstein sees operational leverage.”",neutral,neutral,2.513927576601665,positive,-1.2228260869565215,negative
2023-06-29 20:35:14.000,736.0,738.75,725.6,727.0,1873624.0,Aurobindo Pharma arm in Puerto Rico to halt production for expansion works,Restructuring to enhance production volumes,negative,positive,-1.2228260869565215,negative,-2.0876253261914632,negative
2023-06-30 07:00:00.000,736.0,738.75,725.6,727.0,1873624.0,US FDA uncovers fresh faults at India’s second-biggest drugmaker Aurobindo Pharma,"Auditors uncovered “deficient” manufacturing equipment cleaning and storage controls during a visit last month to an Aurobindo Pharma Ltd. facility in Anakapalli, eastern India, according to a FDA report obtained by Bloomberg News through a Freedom of Information Act request.",negative,neutral,-1.2228260869565215,negative,-2.0876253261914632,negative
2023-06-30 08:17:12.000,736.0,738.75,725.6,727.0,1873624.0,US FDA Uncovers Fresh Faults At Aurobindo Pharma,US Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest drugmakers as the watchdog continues to unearth wide-ranging lapses across the country’s factories while working through a pandemic-era inspection backlog.,neutral,negative,-1.2228260869565215,negative,-2.0876253261914632,negative
2023-06-30 09:39:18.000,736.0,738.75,725.6,727.0,1873624.0,US FDA uncovers fresh faults at Aurobindo Pharma,US FDA officials found multiple faults at a plant run by Aurobindo Pharma as the watchdog continues to unearth wide-ranging lapses across the country’s factories while working through a pandemic-era inspection backlog.,negative,negative,-1.2228260869565215,negative,-2.0876253261914632,negative
2023-06-30 09:51:32.000,736.0,738.75,725.6,727.0,1873624.0,Aurobindo Pharma shares fall as subsidiary undertakes facility restructuring,"The share touched a 52-week high of Rs 741.40 and a 52-week low of Rs 397.30 on 28 June, 2023 and 03 February, 2023, respectively.",neutral,negative,-1.2228260869565215,negative,-2.0876253261914632,negative
2023-07-03 14:32:00.000,717.4,718.8,708.85,713.15,1010351.0,"BSE, Godrej Properties among 10 overbought stocks trading with bearish RSI","Investors should be aware of indicators such as the Relative Strength Index (RSI), which can provide insights into a stock’s overbought or oversold conditions. ETMarkets has selected 10 stocks, including Aurobindo Pharma and REC Ltd., that are currently trading in the overbought zone but have a bear…",neutral,neutral,-0.5924170616113744,neutral,1.9834365648270584,positive
2023-07-05 06:41:35.000,718.45,732.75,714.75,732.7,1450749.0,"Buzzing Stocks: SBI, BHEL, LTIMindtree, Aurobindo Pharma, Lupin, others in focus",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,1.9834365648270584,positive,4.2349726775956285,positive
2023-07-05 07:03:00.000,718.45,732.75,714.75,732.7,1450749.0,"Stocks in news: LTIMindtree, Mankind Pharma, RBL Bank, Suzlon Energy, Aurobindo Pharma","Mankind Pharma, a recent entrant to the stock exchanges, has been included to several Nifty indices including Nifty500, Nifty Midcap150, Nifty Midcap100 and Nifty200.",neutral,neutral,1.9834365648270584,positive,4.2349726775956285,positive
2023-07-05 08:58:50.000,718.45,732.75,714.75,732.7,1450749.0,Stocks that will see action today (July 5),"Stocks likely to see action on July 5 are PSU banks, BHEL, LTIMindtree, Aurobindo Pharma, Genus Power, Lodha, Samvardhana Motherson, IOC, Suzlon, Strides Pharma, Syngene International, Bandhan Bank",neutral,neutral,1.9834365648270584,positive,4.2349726775956285,positive
2023-07-05 09:54:44.000,718.45,732.75,714.75,732.7,1450749.0,Aurobindo Pharma gains on positive Phase-3 results of breast cancer drug,"This phase 3 study is a multi-centre, randomized, double-blinded study involving females with metastatic HER2- positive breast cancer, company said.",positive,neutral,1.9834365648270584,positive,4.2349726775956285,positive
2023-07-05 11:35:00.000,718.45,732.75,714.75,732.7,1450749.0,Nischal Maheshwari on 6 stock picks in pharma and IT,"“We continue to like largecap pharma stocks. Aurobindo Pharma has done well, coming up from the bottom and they are getting their act right. That is a bit of an outlier but looks interesting at these prices. So our top picks out there are Sun Pharma and Dr Reddys, followed by Aurobindo.”",neutral,neutral,1.9834365648270584,positive,4.2349726775956285,positive
2023-07-06 22:05:16.000,750.95,763.25,737.0,746.35,3129107.0,Trade setup for Friday: Top 15 things to know before the opening bell,"We have seen a long build-up in 80 stocks including Aurobindo Pharma, Delta Corp, GAIL India, Mahindra and Mahindra, and PVRInox, based on the open interest (OI) percentage.",neutral,positive,-0.6125574272588085,neutral,-1.8114011720831,negative
2023-07-10 10:12:33.000,750.8,751.6,725.25,737.2,2245421.0,Aurobindo Pharma arm enters into license agreement with US company; shares fall,"Under the terms of the agreement, CuraTeQ has been granted exclusive license rights to commercialise BFI-751 in all major regulated markets, certain semi-regulated, and emerging markets worldwide.",positive,positive,-1.8114011720831,negative,-0.2710027100271002,neutral
2023-07-10 19:13:00.000,738.0,743.35,735.0,736.0,1049939.0,Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumab,"CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based BioFactura to commercialize BFI-751, a proposed biosimilar to Stelara (ustekinumab). Ustekinumab is used for treating Crohn’s disease, ulcerative colitis, plaque…",positive,positive,-0.2710027100271002,neutral,-0.4081632653061224,neutral
2023-07-12 18:48:00.000,742.4,742.9,720.55,725.4,1085233.0,Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tablets,Aurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulator for generic Sevelamer hydrochloride tablets used to control serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The approval granted by…,neutral,positive,-2.2898706896551726,negative,1.4681668496158131,positive
2023-07-12 21:58:50.000,742.4,742.9,720.55,725.4,1085233.0,Aurobindo Pharma arm gets U.S. FDA nod for Sevelamer Hydrochloride tablets,"APL Healthcare, a subsidiary of Aurobindo Pharma, has been granted final approval by the U.S. FDA to produce and market Sevelamer Hydrochloride Tablets 400 mg and 800 mg, used to control serum phosphorus in dialysis patients. The estimated market size is $37 million. This is the 57th ANDA approved f…",neutral,positive,-2.2898706896551726,negative,1.4681668496158131,positive
2023-07-14 11:24:39.000,728.8,742.95,723.4,739.5,1286330.0,Aurobindo Pharma Q1 PAT seen up 6.1% YoY to Rs. 552.3 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 5.1 percent Y-o-Y (up 1.3 percent Q-o-Q) to Rs. 6,555.2 crore, according to Prabhudas Lilladher.",positive,positive,1.4681668496158131,positive,-0.148839726676126,neutral
2023-07-14 15:08:24.000,728.8,742.95,723.4,739.5,1286330.0,F&O Query: Should I hold or sell Aurobindo Pharma call option?,"Hold Aurobindo Pharma (₹738) 755-strike call option. Close watch needed as time decay risk high. Exit when stock hits ₹770, re-enter if it breaches resistance. Rally to ₹820 possible if resistance breached.",neutral,neutral,1.4681668496158131,positive,-0.148839726676126,neutral
2023-07-17 10:30:49.000,739.05,745.95,734.9,737.95,955507.0,USFDA indicates voluntary action for Aurobindo Pharma’s AP Plant,"Aurobindo Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for Unit XIV located in Anakapalli District, Andhra Pradesh.",neutral,neutral,-0.148839726676126,neutral,1.8985203702452629,positive
2023-07-17 21:20:07.000,740.05,757.2,730.45,754.1,1218319.0,U.S. FDA issues EIR to Aurobindo Pharma plant in A.P.,"Hyderabad-based Aurobindo Pharma’s Unit XIV in Anakapalli, AP, received EIR from US FDA classifying the facility as VAI. FDA conducted inspection, issued Form 483 with 4 observations of procedural nature. Company to respond and work closely with FDA to close observations.",neutral,neutral,1.8985203702452629,positive,-0.8057059833575516,neutral
2023-07-21 02:11:00.000,775.0,791.55,771.0,780.0,2306422.0,Aurobindo Pharma eyes $5-B revenue in 5 years,"Aurobindo Pharma has undergone a significant reorganisation, restructuring its operations into three subsidiaries. Eugia Pharma Specialities is dedicated to injectables and specialty oral solid dosages; Curateq Biologics focusing on vaccines, biosimilars, and peptides; Apitoria Pharma, an API divisi…",neutral,neutral,0.6451612903225806,neutral,1.0816379088333734,positive
2023-07-24 12:24:14.000,785.3,791.0,775.65,788.2,1173980.0,"Stocks that will see action: July 24, 2024","Deccan Gold Mines Ltd, Brightcom Group, Naukri Internet Services, SoftTech Engineers, Hikal Ltd, SJVN Ltd, Lupin, Power Finance Corp, Aurobindo Pharma, Biocon, Arunachal Pradesh, Aarti Drugs, Trident, GNA Axles, Jaykay Enterprises, Equipp Social Impact Tech & SenecaGlobal form JV, & Results Calendar…",neutral,neutral,0.3692856233286758,neutral,0.3365079365079336,neutral
2023-07-25 13:44:00.000,787.5,796.5,784.55,790.15,1121856.0,Aurobindo Pharma arm gets USFDA nod for Plerixafor injection,Aurobindo Pharma said Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or mult…,neutral,positive,0.3365079365079336,neutral,4.291417165668659,positive
2023-07-25 20:55:06.000,787.5,796.5,784.55,790.15,1121856.0,Eugia Pharma receives USFDA approval for Plerixafor injection,"Aurobindo Pharma’s subsidiary, Eugia Pharma, has received USFDA approval for Plerixafor Injection, a bioequivalent and therapeutically equivalent product to Mozobil Injection. It is indicated for mobilising hematopoietic stem cells in patients with non-Hodgkin’s lymphoma or multiple myeloma.",positive,positive,0.3365079365079336,neutral,4.291417165668659,positive
2023-07-25 21:08:01.000,787.5,796.5,784.55,790.15,1121856.0,Aurobindo Pharma arm gets U.S. FDA nod for Plerixafor injection,"Eugia Pharma Specialities, a subsidiary of Aurobindo Pharma, has received U.S. FDA approval to manufacture and market Plerixafor Injection. The product is bioequivalent and therapeutically equivalent to Mozobil Injection and has an estimated market size of $210 million. It is indicated for use in co…",neutral,positive,0.3365079365079336,neutral,4.291417165668659,positive
2023-07-26 13:18:26.000,801.6,846.5,791.05,836.0,6309129.0,Aurobindo Pharma hits 52-week high on FDA clean chit to Telangana unit,"The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities",positive,neutral,4.291417165668659,positive,1.3575757575757632,positive
2023-07-27 10:27:46.000,801.6,846.5,791.05,836.0,6309129.0,Aurobindo Pharma soars to 52-week high on setting up subsidiary in Russia,Aurobindo Pharma will also pour in investments worth $100 million in the new subsidiary.,positive,neutral,4.291417165668659,positive,1.3575757575757632,positive
2023-08-01 15:13:16.000,814.45,820.0,805.65,816.8,1818828.0,"Aurobindo Pharma gets USFDA approval for Saxagliptin tablets, plans immediate launch","Aurobindo Pharma has received USFDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg, bioequivalent and therapeutically equivalent to AstraZeneca’s RLD Onglyza Tablets. The company is eligible for 180 days of shared generic drug exclusivity and has 466 ANDA approvals. Saxagliptin Tablets are prescr…",positive,positive,0.2885382773650818,neutral,2.289656856759067,positive
2023-08-01 19:34:58.000,814.45,820.0,805.65,816.8,1818828.0,"Aurobindo, Glenmark each get U.S. FDA nod for copy of AstraZeneca’s diabetes drug","Drugmakers Aurobindo Pharma and Glenmark Pharmaceuticals have each got U.S. Food and Drug Administration (U.S. FDA) final approval for Saxagliptin 2.5 mg and 5 mg tablets, which will be a generic version of AstraZeneca’s diabetes drug Onglyza 2.5 mg and 5 mg tablets.",neutral,positive,0.2885382773650818,neutral,2.289656856759067,positive
2023-08-07 08:55:25.000,847.05,874.3,839.05,865.3,2742837.0,"Stocks to watch on August 7, 2023","Buzzing stocks of Aurobindo Pharma, BHEL, Ganesha Eco, Oil India, Infosys, Biocon, Adani Enterprises, Delta Corp, Fortis Healthcare, Reliance Industries, ICICI Bank, ICICI Lombard GIC, India Cements, Barbeque, GIC Housing, Max Healthcare, Gland Pharma, Indigo Paints, Policybazaar, Sobha, Tata Chen, …",neutral,neutral,2.1545363319756805,positive,-0.5287356321839106,neutral
2023-08-07 10:09:19.000,847.05,874.3,839.05,865.3,2742837.0,Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection,"The company’s board of directors will meet on August 12, 2023, to consider and approve the standalone and consolidated unaudited financial results of the company for the first quarter ended June 30, 2023.",positive,neutral,2.1545363319756805,positive,-0.5287356321839106,neutral
2023-08-07 21:32:41.000,870.0,875.0,852.05,865.4,1132787.0,Aurobindo shares surge after U.S. FDA nod for generic antibacterial injection,"Drugmaker Aurobindo Pharma’s shares hit a new 52-week intra-day high on Monday in the backdrop of its subsidiary Eugia Pharma Specialities receiving a final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Vancomycin Hydrochloride for Injection USP, 1.25 g/via…",positive,positive,-0.5287356321839106,neutral,1.0228709343753564,positive
2023-08-13 12:01:43.000,866.55,887.7,850.65,870.85,3606823.0,Aurobindo Pharma Q1 Results: Profit Rises On Better Than Expected Margin Performance,Margin expansion helps Aurobindo Pharma beat profit estimates,neutral,positive,0.4962206450868465,neutral,0.3268348623853237,neutral
2023-08-15 04:05:08.000,872.0,884.35,855.05,874.85,2864394.0,Aurobindo Pharma Ltd. ADR (ARBQY) Q1 2024 Earnings Call Transcript,"Aurobindo Pharma Ltd. ADR (OTC:ARBQY) Q1 2024 Results Conference Call August 13, 2023 11:00 PM ETCompany ParticipantsDeepti Thakur - Investor RelationsDr.",neutral,neutral,0.3268348623853237,neutral,-1.5947786606129346,negative
2023-08-16 20:37:12.000,881.0,882.85,864.1,866.95,1380225.0,Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection,Icatibant injection is indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older,neutral,neutral,-1.5947786606129346,negative,-0.9526558891454964,negative
2023-08-16 21:05:17.000,881.0,882.85,864.1,866.95,1380225.0,Accumulate Aurobindo Pharma; target of Rs 900: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 900 in its research report dated August 14, 2023.",neutral,positive,-1.5947786606129346,negative,-0.9526558891454964,negative
2023-08-16 21:08:27.000,881.0,882.85,864.1,866.95,1380225.0,Aurobindo Pharma’s generic FDC drug to treat children living with HIV gets U.S. FDA’s tentative nod,Commercial production to commence in the third quarter of FY24,neutral,neutral,-1.5947786606129346,negative,-0.9526558891454964,negative
2023-08-17 06:47:55.000,881.0,882.85,864.1,866.95,1380225.0,"Buzzing Stocks: Aurobindo Pharma, Paytm, Essar Shipping, Skipper, others in news today","Stocks to watch: Check out the companies making headlines before the opening bell on August 17, 2023.",neutral,neutral,-1.5947786606129346,negative,-0.9526558891454964,negative
2023-08-17 09:59:03.000,881.0,882.85,864.1,866.95,1380225.0,Aurobindo Pharma shares surge on plans to launch HIV tablet,The tablet will used for the treatment of children living with HIV weighing 6 kg to 25 kg and aged at least three months.,positive,neutral,-1.5947786606129346,negative,-0.9526558891454964,negative
2023-08-21 15:44:12.000,843.1,848.0,828.8,841.05,2886567.0,Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023.",neutral,positive,-0.2431502787332544,neutral,-0.8714209496709967,neutral
2023-08-21 17:03:00.000,843.1,848.0,828.8,841.05,2886567.0,"Alembic, Aurobindo recall drugs in US market","Alembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bottles of Tobramycin Ophthalmic Solution due to “Failed Impurities/Degradation Specifications.” Meanwhile, Aurobindo Pharma is recalling 48 bottles of Rufinamide …",negative,negative,-0.2431502787332544,neutral,-0.8714209496709967,neutral
2023-08-23 17:30:00.000,840.2,846.85,831.5,833.65,893999.0,"Is Pharma back on growth track? Here’s why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma","Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.",neutral,positive,-0.7795762913592083,neutral,-1.1124401913875543,negative
2023-08-24 17:16:32.000,836.0,841.0,824.95,826.7,1473621.0,Accumulate Aurobindo Pharma; target of Rs 907: KR Choksey,"KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 907 in its research report dated August 24, 2023.",neutral,positive,-1.1124401913875543,negative,-0.1686950234968041,neutral
2023-08-24 23:38:00.000,836.0,841.0,824.95,826.7,1473621.0,"Aurobindo puts its injectables business on the block, again","Aurobindo Pharma promoters have begun the process of selling a majority stake in its injectables business, Eugia Pharma Specialities, after negotiations with potential suitors failed to meet valuation expectations. The promoters have hired investment bank Moelis to manage the sale.",neutral,neutral,-1.1124401913875543,negative,-0.1686950234968041,neutral
